
<html lang="en"     class="pb-page"  data-request-id="12a5d32b-85ce-43fc-9932-3d2d94dc9ee1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2011.54.issue-6;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm1014605;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors" /></meta><meta name="dc.Creator" content="Noel D.  D’Angelo" /></meta><meta name="dc.Creator" content="Tae-Seong  Kim" /></meta><meta name="dc.Creator" content="Kristin  Andrews" /></meta><meta name="dc.Creator" content="Shon K.  Booker" /></meta><meta name="dc.Creator" content="Sean  Caenepeel" /></meta><meta name="dc.Creator" content="Kui  Chen" /></meta><meta name="dc.Creator" content="Derin  D’Amico" /></meta><meta name="dc.Creator" content="Dan  Freeman" /></meta><meta name="dc.Creator" content="Jian  Jiang" /></meta><meta name="dc.Creator" content="Longbin  Liu" /></meta><meta name="dc.Creator" content="John D.  McCarter" /></meta><meta name="dc.Creator" content="Tisha  San Miguel" /></meta><meta name="dc.Creator" content="Erin L.  Mullady" /></meta><meta name="dc.Creator" content="Michael  Schrag" /></meta><meta name="dc.Creator" content="Raju  Subramanian" /></meta><meta name="dc.Creator" content="Jin  Tang" /></meta><meta name="dc.Creator" content="Robert C.  Wahl" /></meta><meta name="dc.Creator" content="Ling  Wang" /></meta><meta name="dc.Creator" content="Douglas A.  Whittington" /></meta><meta name="dc.Creator" content="Tian  Wu" /></meta><meta name="dc.Creator" content="Ning  Xi" /></meta><meta name="dc.Creator" content="Yang  Xu" /></meta><meta name="dc.Creator" content="Peter  Yakowec" /></meta><meta name="dc.Creator" content="Kevin  Yang" /></meta><meta name="dc.Creator" content="Leeanne P.  Zalameda" /></meta><meta name="dc.Creator" content="Nancy  Zhang" /></meta><meta name="dc.Creator" content="Paul  Hughes" /></meta><meta name="dc.Creator" content="Mark H.  Norman" /></meta><meta name="dc.Description" content="Phosphoinositide 3-kinase α (PI3Kα) is a lipid kinase that plays a key regulatory role in several cellular processes. The mutation or amplification of this kinase in humans has been implicated in t..." /></meta><meta name="Description" content="Phosphoinositide 3-kinase α (PI3Kα) is a lipid kinase that plays a key regulatory role in several cellular processes. The mutation or amplification of this kinase in humans has been implicated in t..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 18, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm1014605" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm1014605" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm1014605" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm1014605" /></link>
        
    
    

<title>Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm1014605" /></meta><meta property="og:title" content="Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0019.jpeg" /></meta><meta property="og:description" content="Phosphoinositide 3-kinase α (PI3Kα) is a lipid kinase that plays a key regulatory role in several cellular processes. The mutation or amplification of this kinase in humans has been implicated in the growth of multiple tumor types. Consequently, PI3Kα has become a target of intense research for drug discovery. Our studies began with the identification of benzothiazole compound 1 from a high throughput screen. Extensive SAR studies led to the discovery of sulfonamide 45 as an early lead, based on its in vitro cellular potency. Subsequent modifications of the central pyrimidine ring dramatically improved enzyme and cellular potency and led to the identification of chloropyridine 70. Further arylsulfonamide SAR studies optimized in vitro clearance and led to the identification of 82 as a potent dual inhibitor of PI3K and mTOR. This molecule exhibited potent enzyme and cell activity, low clearance, and high oral bioavailability. In addition, compound 82 demonstrated tumor growth inhibition in U-87 MG, A549, and HCT116 tumor xenograft models." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm1014605"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm1014605">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm1014605&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm1014605&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm1014605&amp;href=/doi/10.1021/jm1014605" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 1789-1811</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm1014549" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm1014692" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Noel+D.++D%E2%80%99Angelo">Noel D. D’Angelo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tae-Seong++Kim">Tae-Seong Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristin++Andrews">Kristin Andrews</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shon+K.++Booker">Shon K. Booker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sean++Caenepeel">Sean Caenepeel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kui++Chen">Kui Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Derin++D%E2%80%99Amico">Derin D’Amico</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Freeman">Dan Freeman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Jiang">Jian Jiang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Longbin++Liu">Longbin Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+D.++McCarter">John D. McCarter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tisha++San+Miguel">Tisha San Miguel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erin+L.++Mullady">Erin L. Mullady</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Schrag">Michael Schrag</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raju++Subramanian">Raju Subramanian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jin++Tang">Jin Tang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+C.++Wahl">Robert C. Wahl</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ling++Wang">Ling Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+A.++Whittington">Douglas A. Whittington</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tian++Wu">Tian Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ning++Xi">Ning Xi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yang++Xu">Yang Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Yakowec">Peter Yakowec</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Yang">Kevin Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leeanne+P.++Zalameda">Leeanne P. Zalameda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nancy++Zhang">Nancy Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Hughes">Paul Hughes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+H.++Norman">Mark H. Norman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Departments of <sup>⊥</sup>High-Throughput Screening/Molecular Pharmacology, <sup>†</sup>Medicinal Chemistry, <sup>‡</sup>Molecular Structure, <sup>§</sup>Oncology Research, <sup>∥</sup>Pharmaceutics, and <sup>#</sup>Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span></div><div class="aff-info" id="aff2"><span class="aff-text">Departments of <sup>¶</sup>High-Throughput Screening/Molecular Pharmacology and <sup>○</sup>Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div><div class="corresp-info"><strong>*</strong>Telephone: 805-313-6550. Fax: 805-480-3016. E-mail: <a href="/cdn-cgi/l/email-protection#c4a0a5aaa3a1a8ab84a5a9a3a1aaeaa7aba9"><span class="__cf_email__" data-cfemail="0f6b6e61686a63604f6e62686a61216c6062">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm1014605&amp;href=/doi/10.1021%2Fjm1014605" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 1789–1811</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 18, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 November 2010</li><li><span class="item_label"><b>Published</b> online</span>18 February 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 March 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm1014605" title="DOI URL">https://doi.org/10.1021/jm1014605</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1789%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNoel%2BD.%2BD%25E2%2580%2599Angelo%252C%2BTae-Seong%2BKim%252C%2BKristin%2BAndrews%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D6%26contentID%3Djm1014605%26title%3DDiscovery%2Band%2BOptimization%2Bof%2Ba%2BSeries%2Bof%2BBenzothiazole%2BPhosphoinositide%2B3-Kinase%2B%2528PI3K%2529%252FMammalian%2BTarget%2Bof%2BRapamycin%2B%2528mTOR%2529%2BDual%2BInhibitors%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1811%26publicationDate%3DMarch%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm1014605"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4865</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">77</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm1014605" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Noel&quot;,&quot;last_name&quot;:&quot;D. D’Angelo&quot;},{&quot;first_name&quot;:&quot;Tae-Seong&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Kristin&quot;,&quot;last_name&quot;:&quot;Andrews&quot;},{&quot;first_name&quot;:&quot;Shon&quot;,&quot;last_name&quot;:&quot;K. Booker&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;Caenepeel&quot;},{&quot;first_name&quot;:&quot;Kui&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Derin&quot;,&quot;last_name&quot;:&quot;D’Amico&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Freeman&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Longbin&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;D. McCarter&quot;},{&quot;first_name&quot;:&quot;Tisha&quot;,&quot;last_name&quot;:&quot;San Miguel&quot;},{&quot;first_name&quot;:&quot;Erin&quot;,&quot;last_name&quot;:&quot;L. Mullady&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Schrag&quot;},{&quot;first_name&quot;:&quot;Raju&quot;,&quot;last_name&quot;:&quot;Subramanian&quot;},{&quot;first_name&quot;:&quot;Jin&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;C. Wahl&quot;},{&quot;first_name&quot;:&quot;Ling&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;A. Whittington&quot;},{&quot;first_name&quot;:&quot;Tian&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Ning&quot;,&quot;last_name&quot;:&quot;Xi&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Yakowec&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Leeanne&quot;,&quot;last_name&quot;:&quot;P. Zalameda&quot;},{&quot;first_name&quot;:&quot;Nancy&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Hughes&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;H. Norman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;1789-1811&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm1014605&quot;},&quot;abstract&quot;:&quot;Phosphoinositide 3-kinase α (PI3Kα) is a lipid kinase that plays a key regulatory role in several cellular processes. The mutation or amplification of this kinase in humans has been implicated in the growth of multiple tumor types. Consequently, PI3Kα has become a target of intense research for drug discovery. Our studies began with the identification of benzothiazole compound 1 from a high throughput screen. Extensive SAR studies led to the discovery of sulfonamide 45 as an early lead, based on its in vitro cellular potency. Subsequent modifications of the central pyrimidine ring dramatically improved enzyme and cellular potency and led to the identification of chloropyridine 70. Further arylsulfonamide SAR studies optimized in vitro clearance and led to the identification of 82 as a potent dual inhibitor of PI3K and mTOR. This molecule exhibited potent enzyme and cell activity, low clearance, and high oral bioavailability. In addition, compound 82 demonstrated tumor growth inhibition in U-87 MG, A549, and H&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1014605&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1014605" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1014605&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1014605" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm1014605&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1014605" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm1014605&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm1014605&amp;href=/doi/10.1021/jm1014605" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm1014605" /></input><a href="/doi/pdf/10.1021/jm1014605" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm1014605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm1014605%26sid%3Dliteratum%253Aachs%26pmid%3D21332118%26genre%3Darticle%26aulast%3DD%25E2%2580%2599Angelo%26date%3D2011%26atitle%3DDiscovery%2Band%2BOptimization%2Bof%2Ba%2BSeries%2Bof%2BBenzothiazole%2BPhosphoinositide%2B3-Kinase%2B%2528PI3K%2529%252FMammalian%2BTarget%2Bof%2BRapamycin%2B%2528mTOR%2529%2BDual%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D6%26spage%3D1789%26epage%3D1811%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290703" title="Pyridines">Pyridines</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jmcmar.2011.54.issue-6/production/jmcmar.2011.54.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Phosphoinositide 3-kinase α (PI3Kα) is a lipid kinase that plays a key regulatory role in several cellular processes. The mutation or amplification of this kinase in humans has been implicated in the growth of multiple tumor types. Consequently, PI3Kα has become a target of intense research for drug discovery. Our studies began with the identification of benzothiazole compound <b>1</b> from a high throughput screen. Extensive SAR studies led to the discovery of sulfonamide <b>45</b> as an early lead, based on its in vitro cellular potency. Subsequent modifications of the central pyrimidine ring dramatically improved enzyme and cellular potency and led to the identification of chloropyridine <b>70</b>. Further arylsulfonamide SAR studies optimized in vitro clearance and led to the identification of <b>82</b> as a potent dual inhibitor of PI3K and mTOR. This molecule exhibited potent enzyme and cell activity, low clearance, and high oral bioavailability. In addition, compound <b>82</b> demonstrated tumor growth inhibition in U-87 MG, A549, and HCT116 tumor xenograft models.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72716" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72716" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that play key regulatory roles in cell proliferation, survival, and cell translation. The PI3K’s are divided into three classes based on structural differences and in vitro substrate specificity.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> Class I PI3Ks, which utilize both a catalytic and a regulatory subunit, catalyze the phosphorylation of the 3′-OH position of phosphatidylinositol 4,5-biphosphate (PIP2) to generate phosphatidylinositol 3,4,5-triphosphate (PIP3).<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> The phosphatase and tensin homologue gene (PTEN) catalyze the dephosphorylation process, thereby providing a feedback mechanism to regulate the amount of PIP3 that is generated.<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6-9)</a> This regulation is important for maintaining normal cell growth because the generation of PIP3 leads to the downstream activation of serine−threonine kinase Akt (AKT, also known as protein kinase B or PKB), which in turn results in the promotion of downstream cellular processes such as cell growth, proliferation, survival, and metabolism.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a></div><div class="NLM_p">The activation of PI3K signaling has been thought to contribute to tumor growth in humans via three distinct mechanisms: (1) activating point mutations in the gene that encodes the p110α catalytic domain of PI3K (PIK3CA),<a onclick="showRef(event, 'ref10 ref12 ref13 ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref10 ref12 ref13 ref14 ref15 ref16 ref17 ref18">(10, 12-18)</a> (2) the amplification of the PIK3CA gene,<a onclick="showRef(event, 'ref1 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref1 ref19 ref20 ref21">(1, 19-21)</a> and (3) loss of function of PTEN.<a onclick="showRef(event, 'ref1 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref1 ref22 ref23 ref24 ref25">(1, 22-25)</a> In all three cases, the net result is activation that leads to increased levels of PIP3 production and the promotion of cell growth and survival. PI3K signaling subsequently leads to the activation of downstream targets such as the serine−threonine kinase, PKB, and the mammalian target of rapamycin (mTOR), which integrates signals from growth factors, nutrients, and cellular engergetics to promote cell growth and survival.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Since many human cancers have been found to be associated with somatic genetic alterations that result in activation of PI3K signaling, considerable attention has been directed toward targeting PI3K via ATP-competitive small molecule inhibitors, either selectively or in conjuction with mTOR inhibition.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a> Several small-molecule inhibitors of both categories have recently been reported, and a number of these are currently undergoing clinical trials, including dual PI3K/mTOR inhibitors such as 2-methyl-2-[4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-<i>c</i>]quinolin-1-yl]phenyl]propionitrile (BEZ235, Novartis), <i>N</i>-(4-(<i>N</i>-(3-(3,5-dimethoxyphenylamino)quinoxalin-2-yl)sulfamoyl)phenyl)-3-methoxy-4-methylbenzamide (XL765, Exelixis), and 2,4-difluoro-<i>N</i>-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide (GSK2126458, GlaxoSmithKline), as well as selective PI3K inhibitors such as 4-(2-(1<i>H</i>-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-<i>d</i>]pyrimidin-4-yl)morpholine dimethanesulfonate (GDC-0941, Genentech), 5-[2,6-di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine (BKM120, Novartis), and <i>N</i>-(3-(benzo[<i>c</i>][1,2,5]thiadiazol-5-ylamino)quinoxalin-2-yl)-4-methylbenzenesulfonamide (XL147, Sanofi/Exelixis).<a onclick="showRef(event, 'ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32 ref33">(29-33)</a> Herein, we describe our initial efforts in this field that led to the discovery and optimization of a potent series of benzothiazole PI3K/mTOR dual inhibitors.</div><div class="NLM_p">We conducted a high-throughput screen and identified <b>1</b> as an initial hit. This compound exhibited good PI3Kα enzyme potency (<i>K</i><sub>i</sub> = 53 nM) and thereby served as a suitable starting point for our SAR studies, despite its low mTOR activity (<i>K</i><sub>i</sub> > 25 μM). To guide these efforts, we solved the crystal structure of <b>1</b> bound to PI3Kγ, whose structure is likely to closely mimic that of PI3Kα.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> As illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, the <i>N</i>-acetylbenzothiazole moiety forms two hydrogen bonds with the PI3Kγ residue Val882 of the hinge region. In addition, the pyrimidine ring forms a hydrogen bond with Lys833 and is adjacent to Asp841 and Tyr867 in the “affinity pocket”. We postulated that changes to the pyrimidine moiety to engage these three residues might improve potency. Finally, the thiomethyl group extends toward the “ribose pocket”, the region of the kinase that is occupied by the ribose moiety of ATP. The crystal structure suggests that this pocket could accommodate significantly larger groups, which may also serve to improve potency.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0022.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray cocrystal of <b>1</b> bound to PI3Kγ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54112" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54112" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our first objective was the synthesis of pyrimidine chloride <b>5</b>, which was required to make analogues of <b>1</b>. The synthesis of <b>5</b> began with the acylation of commercially available 2-amino-6-bromobenzothiazole <b>2</b> to provide <b>3</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Conversion of <b>3</b> to boronate <b>4a</b>, followed by Suzuki coupling with 2,4-dichloropyrimidine, afforded <b>5</b> in three high-yielding steps.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> In addition, boronic ester <b>4a</b> was converted into Molander salt <b>4b</b>, which was used for subsequent Suzuki couplings.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37-39)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0021.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Ac<sub>2</sub>O, DMAP, DCM, 0 °C to room temperature, 88%; (ii) bis(pinacolato)diboron, Pd(dppf)Cl<sub>2</sub>/DCM, KOAc, DMSO, 100 °C, 91%; (iii) TFE, EtOH, 45 °C; KHF<sub>2</sub>, room temperature, 69%; (iv) 2,4-dichloropyrimidine, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 95 °C, 85%.</p></p></figure><div class="NLM_p">Compound <b>5</b> served as a versatile intermediate for the preparation of several analogues, many of which were made via S<sub>N</sub>Ar displacement of the pyrimidine chloride. As outlined in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the sulfur-, oxygen-, and nitrogen-linked phenyl and benzyl analogues (<b>6</b>−<b>11</b>) were made by base-mediated or microwave-mediated chloride displacement with the corresponding thiols, alcohols, and amines. Carbon-linked analogues <b>12</b> and <b>13</b> were prepared via Negishi coupling of <b>5</b> with benzylzinc bromide and phenethylzinc bromide, respectively.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Thiophenyl analogues <b>14</b>−<b>22</b> were prepared by the reaction of the corresponding sodium thiophenoxides with <b>5</b>. Oxygen-linked analogues <b>23</b>−<b>35</b> were prepared by the reaction of the corresponding alcohols with <b>5</b>, again with either base-mediated or microwave-mediated pyrimidine chloride displacement. Finally, nitrogen-linked analogues <b>36</b>−<b>45</b> were obtained in a similar manner by the reaction of <b>5</b> with the corresponding sulfonamides or, in the case of <b>36</b>, with cumylamine (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The specific methods used for the synthesis of analogues <b>14</b>−<b>45</b> are summarized in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Synthesis of Carbon, Sulfur, Oxygen, and Nitrogen-Linked Analogues</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0001.gif" alt="" id="fx1" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">reagent</th><th class="colsep0 rowsep0" align="center">method<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">compd</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PhSH</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">SPh</td><td class="colsep0 rowsep0" align="left"><b>6</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BnSH</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">SBn</td><td class="colsep0 rowsep0" align="left"><b>7</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PhOH</td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">OPh</td><td class="colsep0 rowsep0" align="left"><b>8</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BnOH</td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">OBn</td><td class="colsep0 rowsep0" align="left"><b>9</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PhNH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">NHPh</td><td class="colsep0 rowsep0" align="left"><b>10</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BnNH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">NHBn</td><td class="colsep0 rowsep0" align="left"><b>11</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PhCH<sub>2</sub>ZnBr</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left"><b>12</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PhCH<sub>2</sub>CH<sub>2</sub>ZnBr</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left"><b>13</b></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Method A: NaH, DMF or DMSO, <b>5</b>, 13−25%. Method B: <b>5</b>, pyridine, 120 °C, microwave irradiation, 300 W, 6−22%. Method C: <b>5</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, THF, 80 °C, 8−11%.</p></div></div></div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaH, DMF or DMSO, 12−69%; (ii) pyridine, 120 °C, microwave irradiation, 300 W, 5−22%; (iii) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 180 °C, microwave irradiation, 180 W, 2%; (iv) NaH, DMF, <b>5</b>, Pd(OAc)<sub>2</sub>, Xantphos, 100 °C, microwave irradiation, 100 W, 16−36%.</p></p></figure><div class="NLM_p">The syntheses of amide <b>48</b> and central ring analogues <b>51</b>, <b>54</b>, <b>57</b>, <b>60</b>, and <b>63</b> are shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Commercially available 2-amino-4-chloropyrimidine <b>46</b> was converted to amide <b>47</b>, and subsequent Suzuki coupling with boronic ester <b>4a</b> provided <b>48</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>A). Sulfonamide <b>51</b> was prepared from commercially available 2-chloro-4-iodopyridine <b>49</b> via a two-step Suzuki coupling/S<sub>N</sub>Ar chloride displacement process (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>B). By contrast, sulfonamide <b>54</b> was obtained from commercially available bromide <b>52</b> using a two-step sequence in which the sulfonamide formation preceded the Suzuki coupling (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>C). Compounds <b>57</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>D) and <b>60</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>E) were prepared in a similar manner as <b>51</b>, with the routes differing only in the manner in which the sulfonamide was formed. Sulfonamide <b>57</b> was prepared via S<sub>N</sub>Ar chloride displacement of pyrazine <b>56</b>, while compound <b>60</b> was made by sulfonylation of amine <b>59</b> with 4-methoxybenzenesulfonyl chloride. Finally, analogue <b>63</b> was prepared from bromide <b>61</b> using the sulfonamamide formation/Suzuki coupling sequence that was used to prepare <b>54</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>F).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 4-anisoyl chloride, Et<sub>3</sub>N, DCM, 5%; (ii) <b>4a</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 90 °C, 18−32%; (iii) 4-methoxybenzenesulfonamide, NaH, Pd(OAc)<sub>2</sub>, Xantphos, DMF, 120 °C, microwave irradiation, 100 W, 12%; (iv) 4-methoxybenzenesulfonyl chloride, EtOH, 21%; (v) <b>4a</b>, Fibercat, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 100 °C, microwave irradiation, 100 W, 16%; (vi) <b>4a</b>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DME, 90 °C, 62%; (vii) 4-methoxybenzenesulfonamide, NaH, DMSO, 125 °C, 4%; (viii) 4-methoxybenzenesulfonyl chloride, pyridine, pyrrolidine, DCM, 73% (ix) 4-methoxybenzenesulfonyl chloride, LiHMDS, THF, −40 °C to room temperature, 8%; (x) <b>4a</b>, Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DME, 100 °C, 4%.</p></p></figure><div class="NLM_p">The preparation of analogue <b>68</b> required a longer synthetic sequence, as shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Commercially available chloropyridine <b>64</b> was treated with diethyl malonate in the presence of sodium hydride to introduce carbon functionality at the 2-position of the pyridine ring. Subsequent decarboxylation under acidic conditions provided methylpyridine <b>65</b>.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Reduction of the nitro group afforded amine <b>66</b>, and then Suzuki coupling with boronic ester <b>4a</b> and subsequent sulfonamide formation completed the synthesis of <b>68</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) diethyl malonate, NaH, DMF, 40 °C; (ii) HCl, H<sub>2</sub>O, 110 °C; (iii) Fe, HOAc, H<sub>2</sub>O, 52%; (iv) <b>4a</b>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DME, 100 °C, 50%; (v) 4-methoxybenzenesulfonyl chloride, DMAP, pyridine, THF, 65 °C, 53%.</p></p></figure><div class="NLM_p">Finally, sulfonamide analogues <b>70</b>−<b>82</b> were all prepared from commercially available bromide <b>69</b> in two steps (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). These syntheses involved Suzuki couplings, either with boronic ester <b>4a</b> or with Molander salt <b>4b</b>, and a sulfonamide formation step, with the sequence of these steps varying from compound to compound. This route provided facile access to compounds in this series, facilitating both the initial SAR studies and subsequent scale-up efforts of larger amounts of material for In Vivo studies.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Synthesis of Sulfonamide Analogues</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0005.gif" alt="" id="fx2" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">method<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">compd</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left"><b>70</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><b>71</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><b>72</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><b>73</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><b>74</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left"><b>75</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left"><b>76</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left"><b>77</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">3-<sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left"><b>78</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-<sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left"><b>79</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left"><b>80</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left"><b>81</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left"><b>82</b></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Method A: (i) 4-methoxybenzenesulfonyl chloride, pyridine, 110 °C, 49%; (ii) <b>4a</b>, Fibercat, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 100 °C, 41%. Method B: (i) <b>69</b>, LiHMDS, THF, −78 °C; ArSO<sub>2</sub>Cl, −78 °C to room temp, 45−99%; (ii) <b>4b</b>, Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 100 °C, 18−62%. Method C: (i) <b>4a</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 100 °C, 33%; (ii) ArSO<sub>2</sub>Cl, DMAP, THF, pyridine, 8−69%.</p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65060" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65060" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> SAR and Lead Generation</h3><div class="NLM_p">On the basis of the X-ray cocrystal structure of <b>1</b>, we replaced the thiomethyl group with thiophenyl (<b>6</b>) and thiobenzyl (<b>7</b>) groups to see how larger substituents would affect enzyme potency (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). These changes had a negligible effect on PI3Kα potency, suggesting that larger thioaryl groups could be tolerated in the ribose pocket. Benzyloxy analogue <b>9</b> and benzylamine analogue <b>11</b> were approximately 2 times less potent than <b>7</b>, suggesting that changing the linker atom from sulfur to oxygen or nitrogen had minimal impact on enzyme potency with a benzyl group attached. However, with a phenyl group, the effect of changing the linker atom was more pronounced. While the phenyloxy analogue <b>8</b> was about 2 times less potent than <b>6</b>, the aniline analogue <b>10</b> was over 100 times less potent. Finally, carbon-linked analogues <b>12</b> and <b>13</b> were at least 10 times less potent than <b>1</b>.</div><div class="NLM_p">Overall, these results reflect the impact of the linking atom on enzyme potency. The sulfur and oxygen atoms would position the benzyl and phenyl groups in the ribose pocket in a manner that would minimize lone-pair interactions between the linking atom and the pyrimidine ring. The comparable potencies of analogues <b>6</b>−<b>9</b> suggest that all of these analogues adopt similar conformations. However, the nitrogen linking atom of compound <b>10</b> would likely adopt a planar conformation relative to the pyrimidine ring and would thereby position the aryl group differently in the ribose pocket.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> On the basis of the micromolar potency of <b>10</b>, this change results in significant steric interference between the aryl group and the ribose pocket. However, the addition of the extra methylene unit in benzyl derivative <b>11</b> alleviates this steric encumbrance by extending the aryl group further into the ribose pocket, resulting in a significant increase in potency. Finally, the carbon linking atom would orient the aryl groups to minimize steric interactions with the pyrimidine ring. On the basis of the potencies of <b>12</b> and <b>13</b>, this results in conformations that do not bind well to PI3Kα.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Linker Atom SAR<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0006.gif" alt="" id="fx3" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">PI3Kα <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">mTOR IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">-SMe</td><td class="colsep0 rowsep0" align="left">53 ± 1</td><td class="colsep0 rowsep0" align="left">>6000<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">-SPh</td><td class="colsep0 rowsep0" align="left">40 ± 0.4</td><td class="colsep0 rowsep0" align="left">>6000<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">-SBn</td><td class="colsep0 rowsep0" align="left">47 ± 3</td><td class="colsep0 rowsep0" align="left">>6000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">-OPh</td><td class="colsep0 rowsep0" align="left">102 ± 4</td><td class="colsep0 rowsep0" align="left">>6000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">-OBn</td><td class="colsep0 rowsep0" align="left">105 ± 19</td><td class="colsep0 rowsep0" align="left">>6000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">-NHPh</td><td class="colsep0 rowsep0" align="left">6100<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">>6000<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">-NHBn</td><td class="colsep0 rowsep0" align="left">85 ± 0.2</td><td class="colsep0 rowsep0" align="left">>6000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">605 ± 102</td><td class="colsep0 rowsep0" align="left">>6000<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>CH<sub>2</sub>Ph</td><td class="colsep0 rowsep0" align="left">1010<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">>6000<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec3" aria-label="Experimental Methods">Experimental Methods</a> for assay details.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Average of two experiments.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Single experiment.</p></div></div></div><div class="NLM_p">On the basis of the enzyme activity of <b>6</b>, we conducted further SAR studies on the thiophenyl moiety of this compound (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). In particular, we examined the effect of fluoro, methyl, and methoxy groups at the 2, 3, and 4 positions. The fluoro and methyl groups had negligible impact on enzyme potency, regardless of their positions (<b>14</b>−<b>16</b> and <b>17</b>−<b>19</b>, respectively). However, the larger methoxy group decreased potency at the 2-position (<b>20</b>), maintained potency at the 3-position (<b>21</b>), and slightly improved potency at the 4-position (<b>22</b>). Overall, these results suggest that the phenyl group is surrounded by enough space to tolerate small substituents such as the fluoro or methyl group. However, with the larger methoxy group, the relative potencies of <b>20</b> and <b>22</b> suggest that there is more room for larger substituents at the 4-position than at the 2-position. In addition, lone pair interactions between the sulfur atom and methoxy group of <b>20</b> could change the orientation of the phenyl group in the ribose pocket just enough to result in decreased potency. We also evaluated the compounds listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> for their ability to inhibit Akt phosphorylation in U-87 MG cells. However, none of the compounds were potent, as the IC<sub>50</sub> for all of these compounds was over 1 μM. Given the similar enzyme potencies of <b>6</b> and <b>7</b>, we did not expect that extensive SAR studies of <b>7</b> would lead to dramatically improved enzyme or cellular activities. For this reason, further SAR studies on sulfur-linked analogues were not pursued.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Sulfur-Linker SAR<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0007.gif" alt="" id="fx4" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">PI3Kα <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">mTOR IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">40 ± 0.4</td><td class="colsep0 rowsep0" align="left">>6000<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">46 ± 5</td><td class="colsep0 rowsep0" align="left">>6000<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">31 ± 5</td><td class="colsep0 rowsep0" align="left">>6000<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">44 ± 4</td><td class="colsep0 rowsep0" align="left">>6000<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">2-Me</td><td class="colsep0 rowsep0" align="left">31 ± 7</td><td class="colsep0 rowsep0" align="left">>6000<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">3-Me</td><td class="colsep0 rowsep0" align="left">53 ± 7</td><td class="colsep0 rowsep0" align="left">>6000<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">4-Me</td><td class="colsep0 rowsep0" align="left">59 ± 6</td><td class="colsep0 rowsep0" align="left">>6000<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">2-OMe</td><td class="colsep0 rowsep0" align="left">144 ± 19</td><td class="colsep0 rowsep0" align="left">>6000<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">48 ± 3</td><td class="colsep0 rowsep0" align="left">>6000<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left">18 ± 1</td><td class="colsep0 rowsep0" align="left">3010 ± 1100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec3" aria-label="Experimental Methods">Experimental Methods</a> for assay details.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Average of two experiments.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Single experiment.</p></div></div></div><div class="NLM_p">We next examined the optimization of benzyloxypyrimidine <b>9</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Like the sulfur-linked series, we initially examined the effect of a fluoro, methyl, and methoxy group on potency (<b>23</b>−<b>28</b>). These analogues had enzyme potencies similar to <b>9</b> except for <b>25</b>, which was about 5 times more potent. However, the cellular activity of all of these compounds in the pAKT cellular assay was also over 1 μM. At this point, it became clear that simple phenyl substituents were unlikely to significantly affect enzyme or cellular potencies and that more significant structural changes would be required.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Oxygen-Linker SAR<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0008.gif" alt="" id="fx5" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0009.gif" alt="" id="fx6" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec3" aria-label="Experimental Methods">Experimental Methods</a> for assay details.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Average of two experiments.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Single experiment.</p></div></div></div><div class="NLM_p">We replaced the phenyl ring of <b>9</b> with a pyridine ring (<b>29</b>), a change that had a negligible impact on potency. Likewise, extending the pyridine further out into the ribose pocket (<b>30</b>) and subsequently shifting the pyridine nitrogen to the 3-position (<b>31</b>) had no effect. Interestingly, replacing the pyridine ring with a phenyl ring (<b>32</b>) improved potency, albeit only by a factor of 3. However, replacing the pyridine or phenyl ring with a morpholine group (<b>33</b>) had no significant impact on potency relative to <b>9</b>. Shortening the carbon tether by one unit (<b>34</b>) significantly reduced enzyme potency to above 1 μM. Likewise, replacing the aryl or morpholine group of <b>30</b>−<b>33</b> with a methoxy group (<b>35</b>) also reduced potency. The differing potencies of <b>30</b>−<b>35</b> suggest that both a three-carbon tether and an aryl group (or a similar-shaped substituent like a morpholine group) at the end of this tether are necessary for preserving enzyme potency relative to <b>9</b>. This could be the result of π−π stacking or van der Waals interactions at the edge of the ribose pocket. These data do not support the presence of a hydrogen bond in this region, as pyridine <b>30</b> and morpholine <b>33</b> have similar potencies (100−150 nM) as <b>9</b> while <b>32</b>, whose phenyl group would not be considered a hydrogen bond donor or acceptor, is more potent. Overall, while these oxygen-linked analogues enabled us to gain a better understanding of the SAR of this series in the ribose pocket, they did not result in any significant improvement in potency relative to <b>9</b> (outside of compound <b>32</b>) or in any cellular activities with IC<sub>50</sub> values of less than 1 μM. As a result of these findings and the similar enzyme potencies of oxygen linked analogues <b>8</b> and <b>9</b>, further SAR studies within the oxygen linked series were not pursued.</div><div class="NLM_p">We began our optimization of the nitrogen-linked series from benzylamine <b>11</b>, the more potent of the two initial nitrogen analogues. Our SAR studies on the sulfur series indicated that aryl substituents were unlikely to significantly improve enzyme potency. Likewise, the data from the oxygen series indicated that extending aryl groups further out into the ribose pocket would not improve potency. Therefore, within this series, we focused initially on the region around the nitrogen atom. Along these lines, we introduced a gem-dimethyl moiety at the benzyl position of <b>11</b>, resulting in an improvement in potency of over 3-fold (<b>36</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Introducing a carbonyl at the benzyl position (<b>48</b>) resulted in a compound with weak activity (<i>K</i><sub>i</sub> = 3.1 μM). However, replacing this amide group with a sulfonamide (<b>37</b>) restored PI3Kα enzyme potency to a similar level compared with <b>11</b>. The aryl groups of <b>11</b>, <b>36</b>, and <b>37</b> all have similar spatial orientations in the ribose pocket because of the sp<sup>3</sup> hybridization of the benzyl carbon for compounds <b>11</b> and <b>36</b> and the sulfonamide sulfur for compound <b>37</b>. These similar orientations may account for their similar PI3Kα enzyme potencies. However, the amide functionality of <b>48</b> (with an sp<sup>2</sup> hybridized carbon) positions the aryl group differently, a change the data suggest is not well tolerated. In fact, a molecular modeling overlay of <b>48</b> with the X-ray cocrystal of <b>1</b> showed significant steric interactions between the aryl group and the ribose pocket, which could account for the drop in potency.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Nitrogen-Linker SAR<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0010.gif" alt="" id="fx7" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0011.gif" alt="" id="fx8" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec3" aria-label="Experimental Methods">Experimental Methods</a> for assay details.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Average of two experiments.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Single experiment.</p></div></div></div><div class="NLM_p">The introduction of the sulfonamide group also resulted in a dramatic improvement in mTOR potency, as <b>37</b> was the first compound in this paper with an mTOR IC<sub>50</sub> below 100 nM. In fact, replacing the gem-dimethyl group of <b>36</b> with a sulfonamide had a much greater impact on mTOR potency than on PI3Kα potency. The change in mTOR potency between these two compounds is most likely explained by the formation of a hydrogen bond between the mTOR protein and one or both of the sulfonamide oxygens. The similar PI3Kα enzyme potencies of <b>36</b> and <b>37</b> suggest that such a hydrogen bond is not formed in PI3Kα nor is it necessary for enzyme activity.</div><div class="NLM_p">While dimethylbenzylamine <b>36</b> was more potent than sulfonamide <b>37</b> in the PI3Kα enzyme assay, its enzyme-to-cell shift was over 100-fold. By contrast, the enzyme-to-cell shift for <b>37</b> was just over 20-fold. For this reason, we sought to optimize <b>37</b>, beginning with the introduction of a methyl group (<b>38</b>) and an ethyl group (<b>39</b>) off the sulfonamide nitrogen. For both of these analogues, a modest increase in enzyme potency was observed. However, what was especially noteworthy among compounds <b>38</b> and <b>39</b> was the marked improvement in cell potency relative to <b>37</b>. The enzyme potency of compound <b>38</b> was virtually unchanged, while the cellular potency improved by almost 10-fold. A similar gain in cellular potency was also observed between 2-fluorophenylsulfonamides <b>40</b> and <b>41</b>, as well as with 4-methylphenylsulfonamides <b>44</b> and <b>45</b>. In fact, the cellular potency of <b>41</b> was over 5 times more potent than <b>40</b> despite the fact that the enzyme potencies of these compounds were similar. The improvement in cellular potency for <i>N</i>-methyl analogues <b>38</b>, <b>41</b>, and <b>45</b> relative to <b>37</b>, <b>40</b>, and <b>44</b> could be explained by the loss of a hydrogen bond donor, which could allow for better cell permeability.</div><div class="NLM_p">The incorporation of the sulfonamide moiety was a key discovery in our efforts to optimize the enzyme potency of <b>1</b>. This change afforded a number of compounds with enzyme potencies below 100 nM. In addition, the cellular potency and low enzyme to cell shift data for <b>38</b> and <b>45</b> were especially encouraging, as these were among the most potent compounds prepared thus far.</div><div class="NLM_p">Because of the improved cellular activity of <b>45</b>, we next examined its in vitro and In Vivo pharmacokinetic (PK) profile. Unfortunately, its in vitro clearance was high in both human and rat liver microsomes (579 and >399 (μL/min)/mg, respectively). This high in vitro clearance translated into high clearance (3.7 (L/h)/kg) In Vivo when <b>45</b> was administered intravenously (iv) to rats at a dose of 2 mg/kg. Similarly, compound <b>38</b> also exhibited high in vitro clearance (>399 (μL/min)/mg in both human and rat liver microsomes) and high In Vivo clearance (4.6 (L/h)/kg in rats). The high In Vivo clearance of <b>38</b> and <b>45</b> precluded further In Vivo studies with these molecules.</div><div class="NLM_p">To this point, our SAR studies produced compounds with enzyme potencies under 50 nM and cellular potencies under 400 nM. However, for further In Vivo studies to be pursued, the cellular potencies and In Vivo clearance would have to be improved. To address these issues, we investigated changes to the central pyrimidine ring. In particular, we examined the effect of removing and/or shifting the central ring nitrogens (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Changing the core from pyrimidine <b>37</b> to 2,4-disubstituted pyridine <b>51</b> dramatically improved both PI3Kα enzyme and cellular potency. Changing to the isomeric 3,5-disubstituted pyridine <b>54</b> improved enzyme potency to single digit nanomolar levels and lowered mTOR activity as well. One reason for the improved enzyme potency of <b>54</b> could be the formation of favorable hydrogen bond interactions between the pyridine nitrogen and the Asp841 and Tyr867 residues in the affinity pocket. The introduction of an additional nitrogen (i.e., pyrazine <b>57</b>) decreased the enzyme and cellular potencies relative to <b>54</b>, while removing all nitrogens from this central ring (<b>60</b>) resulted in a further loss of activity, especially against mTOR.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Central Ring SAR<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0012.gif" alt="" id="fx9" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0013.gif" alt="" id="fx10" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec3" aria-label="Experimental Methods">Experimental Methods</a> for assay details.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Average of two experiments.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Single experiment.</p></div></div></div><div class="NLM_p">The central ring modifications were key discoveries in our efforts to improve enzyme and cellular potencies. As a result of these changes, we obtained two compounds with single digit enzyme potencies and one compound with cellular activity below 50 nM. We also were able to improve mTOR activity. The PI3Kα and mTOR enzyme potencies of <b>54</b> led us to incorporate the 3,5-disubstituted pyridine ring into future analogues.</div><div class="NLM_p">The next phase of our SAR investigations involved the introduction of substituents at the 2-position of the central pyridine ring. On the basis of the X-ray crystal structure of <b>1</b>, we recognized that only small substituents would be tolerated, and this influenced our studies on this portion of the molecule (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). The introduction of cyano, methyl, and chloro groups had minimal effects on PI3Kα and mTOR enzyme potencies. However, the cyano substitution decreased cellular activity significantly while the methyl and chloro groups resulted in a 5- to 20-fold improvement in potency. The subnanomolar enzyme and single-digit nanomolar cellular potencies of <b>70</b> were the best for any compound studied in this series to this point. The use of the 2-chloro-3-sulfonamidopyridine moiety in PI3Kα inhibitors has been previously reported.<a onclick="showRef(event, 'ref33 ref44 ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref33 ref44 ref45 ref46 ref47">(33, 44-47)</a> However, the combination of this moiety with the benzothiazole hinge binder described in this work represents a novel scaffold for a PI3Kα inhibitor. Having optimized the in vitro enzyme and cellular activities, we focused on improving the PK properties of these molecules.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Central Ring Substitution SAR<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0014.gif" alt="" id="fx11" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">PI3Kα <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">pAKT IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">mTOR IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.6 ± 0.1</td><td class="colsep0 rowsep0" align="left">103 ± 54<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">11 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">1.4 ± 0.1</td><td class="colsep0 rowsep0" align="left">757<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1.6 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.1</td><td class="colsep0 rowsep0" align="left">18<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">6.0 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><1.0</td><td class="colsep0 rowsep0" align="left">5<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">2.1 ± 1.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec3" aria-label="Experimental Methods">Experimental Methods</a> for assay details.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Average of two experiments.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">Single experiment.</p></div></div></div><div class="NLM_p">We first evaluated the in vitro clearance of <b>70</b> in human and rat liver microsomes (HLM and RLM) and found the latter to be high, precluding further studies with this molecule (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>). The RLM data for phenylsulfonamide <b>71</b> were high as well. Therefore, we pursued SAR studies on the phenylsulfonamide portion of the molecule, with the goal of achieving HLM and RLM clearances below 50 (μL/min)/mg.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Phenylsulfonamide SAR<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0015.gif" alt="" id="fx12" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">PI3Kα <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">pAKT IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">HLM/RLM ((μL/min)/mg)<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">mTOR IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="left"><1.0</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">42/>399</td><td class="colsep0 rowsep0" align="left">2.1 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.4 ± 0.1</td><td class="colsep0 rowsep0" align="left">5 ± 1<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><14/>399</td><td class="colsep0 rowsep0" align="left"><1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><1.0</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left"><14/500</td><td class="colsep0 rowsep0" align="left"><1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><1.0</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">17/36</td><td class="colsep0 rowsep0" align="left"><1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left"><1.0</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left"><14/<14</td><td class="colsep0 rowsep0" align="left">1.6 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left"><1.0</td><td class="colsep0 rowsep0" align="left">4.9 ± 0.3<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><14/>399</td><td class="colsep0 rowsep0" align="left"><1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left"><1.0</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">16/>399</td><td class="colsep0 rowsep0" align="left"><1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left"><1.0</td><td class="colsep0 rowsep0" align="left">8.7 ± 0.9<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><14/<14</td><td class="colsep0 rowsep0" align="left"><1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="left">3-<sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left"><1.0</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">83/610</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="left">4-<sup><i>t</i></sup>Bu</td><td class="colsep0 rowsep0" align="left"><1.0</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">135/460</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left"><1.0</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left"><14/320</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">1.1 ± 0.5</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left"><14/>399</td><td class="colsep0 rowsep0" align="left">2.3 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>82</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.9</td><td class="colsep0 rowsep0" align="left">6.3 ± 6.5<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><14/<20</td><td class="colsep0 rowsep0" align="left">2.0 ± 4.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec3" aria-label="Experimental Methods">Experimental Methods</a> for assay details.</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last">Average of at least two experiments.</p></div><div class="footnote" id="t9fn3"><sup>c</sup><p class="last">Single experiment except where noted.</p></div></div></div><div class="NLM_p">All of the analogues shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a> exhibited similar enzyme and cellular potencies, indicating that there is enough room in the ribose pocket to accommodate small groups, regardless of their position on the phenyl ring (not unlike the sulfur- and oxygen-linked analogues discussed earlier). In addition, these analogues were all potent mTOR inhibitors. However, the HLM and RLM data indicated that metabolic stability differed significantly. Compounds substituted at the 4-position with electron withdrawing substituents exhibited low in vitro clearance (values below 20 (μL/min)/mg), while the corresponding 2- and 3-substituted derivatives exhibited higher clearance values, as evidenced by the chloro, fluoro, and trifluoromethyl compounds. These data suggested that the phenyl 4-position was readily metabolized and that substitution at this position with an electron withdrawing group was critical for obtaining metabolic stability. We identified <b>73</b>, <b>74</b>, <b>77</b>, and <b>82</b> as the only compounds with HLM and RLM values below 50 (μL/min)/mg.</div><div class="NLM_p">In order to better understand the potency of the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>, we next examined an X-ray cocrystal of compound <b>82</b> bound to PI3Kγ (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The X-ray cocrystal structure of <b>82</b> overlaps quite closely with <b>1</b>, with little movement of the protein observed. As observed with compound <b>1</b>, the <i>N</i>-acetylbenzothiazole forms two hydrogen bonds with Val882 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). However, the hydrogen bond with the Lys833 residue was not retained, despite the proximity of the sulfonamide nitrogen (3.6 Å) and oxygen atoms (3.3 Å).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The loss of this hydrogen bond was offset with the gain of two hydrogen bonds formed via an ordered water molecule located between the central chloropyridine ring nitrogen and the Tyr867 and Asp841 residues. These additional hydrogen bonds help explain the gain in enzyme potency achieved with the chloropyridine central ring. In addition, the space-filling model indicates that the arylsulfonamide portion in the ribose pocket has enough space around it to accommodate various substituents (e.g., trifluoromethyl, chloro, and <i>tert</i>-butyl) at the 2-, 3-, and 4-positions (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). This explains the relatively flat SAR exhibited by the arylsulfonamides (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>), as well as by the sulfur analogues (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) and oxygen analogues (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). It also confirms our earlier hypothesis that the ribose pocket would be able to accommodate groups significantly larger than the thiomethyl moiety of <b>1</b>. By contrast, the pyridine chloro group of <b>82</b> fits into a narrow pocket, confirming (based on the X-ray cocrystal structure of <b>1</b>) that only small groups would be tolerated at this position (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C).</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0016.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal of <b>82</b> bound to PI3Kγ. Parts A and B are from a similar vantage point, while part C views the molecule down the C−Cl bond of the chloropyridine central ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to be being a potent dual PI3Kα/mTOR inhibitor, compound <b>82</b> was also a potent inhibitor of the other class I PI3K isoforms PI3Kβ (<i>K</i><sub>i</sub> = 2.0 nM), PI3Kγ (<i>K</i><sub>i</sub> = 4.7 nM), and PI3Kδ (<i>K</i><sub>i</sub> = 1.2 nM). The inhibition of cell proliferation by this compound was determined using an ATP-based cell viability assay in PTEN-null U-87 MG glioblastoma and PTEN-null PC-3 prostate carcinoma cell lines. Sulfonamide <b>82</b> potently inhibited cell proliferation in both cell lines, exhibiting IC<sub>50</sub> values of 68 nM (U-87 MG) and 47 nM (PC-3).</div><div class="NLM_p last">Its selectivity against selected members of phosphatidylinositol kinase-related kinases (PIKK) was also examined. Compound <b>82</b> was a potent inhibitor of the class III PI3K, hVPS34 (<i>K</i><sub>i</sub> = 31 nM), and DNA-PK (IC<sub>50</sub> = 3 nM), suggesting that <b>82</b> could be considered a pan inhibitor of class I PI3K’s with limited selectivity over closely related PIKK’s. The selectivity of compound <b>82</b> against a panel of over 350 protein and lipid kinases, including class I PI3Ks, was examined using the AMBIT KINOMEscan platform.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> In this panel, the competitive binding of <b>82</b> was measured as a percentage of control (POC) at 1 μM. This compound demonstrated affinity against class I PI3Ks (POC = 0−1%), a finding consistent with the enzyme data mentioned above. However, it exhibited moderate activity (POC = 25−30%) against only two other kinases (CDKL2 and MLCK). For all other kinases assayed, no competitive binding by <b>82</b> was observed.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Studies</h3><div class="NLM_p">We also evaluated the In Vivo PK profile of this compound. When <b>82</b> was administered intravenously (iv) to rats, it exhibited a low clearance (0.007 (L/h)/kg), a low volume of distribution (0.17 L/kg), and a long half-life (19 h). The AUC exposure was 0.32 mg·h/mL. When given orally to rats, it exhibited a bioavailability of 103%.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The ability of this compound to inhibit HGF-stimulated PI3K signaling was evaluated in a mouse liver pharmacodynamic (PD) assay. Compound <b>82</b> was administered to mice at dosages ranging from 0.03 to 3 mg/kg. Human HGF was injected iv 3 h postdose to induce PI3K-dependent Akt phosphorylation in the liver. Compound <b>82</b> induced significant suppression of PI3K signaling, as indicated by a dose-dependent decrease in phosphorylated Akt (p-Akt) at Ser473 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). The EC<sub>50</sub> was found to be 399 ng/mL.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> In addition, in a time course liver study at 3 mg/kg, <b>82</b> maximally inhibited Akt phosphorylation 1 h after dosing and demonstrated significant inhibition for 24 h (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). Compound <b>82</b> appeared rapidly in plasma with a <i>C</i><sub>1h</sub> of 2000 ng/mL and reached a <i>C</i><sub>max</sub> of ∼3000 ng/mL at 3−8 h.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0017.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of compound <b>82</b> on HGF-mediated AKT phosphorylation (A) at 3 h postdose and (B) in a time course study at 3 mg/kg. Bars represent the mean ± standard deviation (<i>n</i> = 3). Diamonds represent mean plasma concentration. Asterisk denotes (A) <i>p</i> < 0.05 and (B) <i>p</i> < 0.001 compared with the vehicle (HGF) group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next evaluated whether <b>82</b> could inhibit tumor growth in established mouse xenograft models. In mice bearing U87-MG (PTEN null) glioblastoma xenografts,<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53, 54)</a> treatment with this compound, administered orally QD, caused a dose-dependent reduction in tumor growth with an ED<sub>50</sub> of 0.26 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). A similar dose dependency was observed in nude mice bearing A549 (KRAS mutant) lung adenocarcinoma<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> and HCT116<a onclick="showRef(event, 'ref18 ref57'); return false;" href="javascript:void(0);" class="ref ref18 ref57">(18, 57)</a> (KRAS and PI3Kα mutant) colon adenocarcinoma xenograft models (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B and Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C). In all tumor xenograft studies, sulfonamide <b>82</b> was well tolerated in terms of its effect on body weight. In only one instance (the 10 mg/kg arm of the HCT116 xenograft study) did the body weight drop below 90% of the starting body weight over the course of the study. These data suggest that compound <b>82</b> could potentially inhibit tumor growth against a wide range of tumors with different genetic backgrounds and that its efficacy may not be restricted to those tumors that are caused by a specific pathway mutation or mechanism of activation.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0018.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Daily dosing with <b>82</b> induced tumor stasis and growth delay in established xenograft models (A) U-87 MG glioblastoma, (B) A549 lung adenocarcinoma, and (C) HCT116 colon adenocarcinoma. Arrow denotes the first day of dosing. The 10 mpk arm had to be stopped on day 32 in the HCT116 model because of a drop in body weight to 85% of the initial body weight. (D) Summary of ED<sub>50</sub> and AUC (at ED<sub>50</sub>) values for the three studies. Asterisk denotes <i>p</i> < 0.0001 compared with the vehicle group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In conclusion, we have discovered and developed a novel series of potent PI3K/mTOR inhibitors from an initial hit, compound <b>1</b>. Extensive SAR studies resulted in the discovery of sulfonamide <b>45</b>. However, high in vitro and In Vivo clearance necessitated changes to the central pyrimidine ring. This led to the discovery of chloropyridine <b>70</b> and, after aryl sulfonamide SAR studies focused on optimizing in vitro clearance, compound <b>82</b>. This compound was the most potent analogue prepared in this series in terms of enzyme and cellular potencies. In addition, it also proved to be efficacious when tested in a liver PD assay and three distinct xenograft models. The biological profile of this molecule validated the benzothiazole series as a means of inhibiting tumor growth In Vivo by targeting PI3Kα and mTOR.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55037" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55037" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p">All reactions were conducted in a well-ventilated fume hood under N<sub>2</sub> using a Teflon-coated magnetic stirbar at the temperature indicated. Reactions run at elevated temperature were run in an oil bath at the temperature indicated. Microwave reactions were run in a CEM Discover microwave equipped with PowerMAX feature using the settings described below. All solvents and reagents obtained from commercial sources were used without further purification. Removal of solvents was conducted by using a rotary evaporator, and residual solvent was removed from nonvolatile compounds using a vacuum manifold maintained at approximately 1 Torr. All yields reported are isolated yields.</div><div class="NLM_p">Analytical TLC was performed with EMD 0.25 mm silica gel 60 plates with a 254 nm fluorescent indicator. Plates were developed in a covered chamber and visualized with ultraviolet light. Flash chromatography refers to column chromatography as described by Still using EMD silica gel 60, 230−400 mesh, as the stationary phase.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Where noted, ISCO purification refers to a Teledyne ISCO purification system using RediSep columns in the size noted as well as the solvent system and gradients noted.</div><div class="NLM_p"><sup>1</sup>H NMR spectra were obtained on a Bruker BioSpin GmbH magnetic resonance spectrometer. <sup>1</sup>H NMR spectra are reported as chemical shifts in parts per million (ppm) relative to an internal solvent reference. Peak multiplicity abbreviations are as follows: s (singlet), br s (broad singlet), d (doublet), dd (doublet of doublets), t (triplet), q (quartet), quin (quintet), and m (multiplet).</div><div class="NLM_p last">Analytical HPLC and mass spectrometry were conducted using a reverse-phase Agilent 1100 series HPLC−mass spectrometer. Purities for final compounds were measured using UV detection at 254 nm and are ≥95.0% unless otherwise noted. A detailed description of the HPLC methods that were used for analyzing final compounds is included in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Elemental analyses (% C, % H, % N) were obtained from Atlantic Microlab, Inc. in Norcross, GA.</div></div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> <i>N</i>-(6-Bromobenzo[<i>d</i>]thiazol-2-yl)acetamide (<b>3</b>)</h3><div class="NLM_p last">6-Bromobenzo[<i>d</i>]thiazol-2-amine (51.08 g, 223 mmol) was suspended in DCM (800 mL), and DMAP (30.71 g, 251 mmol) was added. The mixture was cooled in an ice−water bath under N<sub>2</sub>, and acetic anhydride (23.0 mL, 244 mmol) was added. The mixture was allowed to slowly warm to room temperature while being stirred overnight under N<sub>2</sub>. The mixture was treated with 10% HCl (375 mL), and the layers were separated. The organic phase was filtered, and the solid was washed with DCM. The aqueous phase was filtered separately, and the solid collected from this filtration was washed with water and then collected and combined with the solid collected from the filtration of the organic phase. The aqueous phase was extracted with 10:1 DCM/MeOH (300 mL, 200 mL, 150 mL). These organic extracts were combined with the filtrate from the filtration of the organic phase and concentrated. The concentrate was treated with Et<sub>2</sub>O and filtered. This solid was washed with Et<sub>2</sub>O and set aside. The first batch of solid collected (from the separate filtrations of the organic phase and aqueous phase above) was also treated with Et<sub>2</sub>O and filtered. This solid was washed with Et<sub>2</sub>O, DCM, and Et<sub>2</sub>O and then combined with the other batch of solid. The filtrate from this last filtration was concentrated, treated with Et<sub>2</sub>O, and filtered. The solid from this last filtration was washed with Et<sub>2</sub>O and then combined with all of the other collected solids to afford <b>3</b> (59.97 g, 89% purity, 88% yield). MS (ESI pos ion) <i>m</i>/<i>z</i>: 271 (M + H<sup>+</sup>, <sup>79</sup>Br), 273 (M + H<sup>+</sup>, <sup>81</sup>Br). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): 12.41 (s, 1H), 8.23 (d, <i>J</i> = 2.0 Hz, 1H), 7.66 (d, <i>J</i> = 8.5 Hz, 1H), 7.56 (m, 1H), 2.21 (s, 3H).</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>N</i>-(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>4a</b>)</h3><div class="NLM_p last"><i>N</i>-(6-Bromobenzo[<i>d</i>]thiazol-2-yl)acetamide (59.97 g, 221 mmol) and 4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane (76.58 g, 302 mmol) were suspended in DMSO. KOAc (55.8 mL, 893 mmol) was added, followed by more DMSO. The total amount of DMSO used was 650 mL. Then 1,1′-bis(diphenylphosphino)ferrocenepalladium(II) dichloride dichloromethane complex (12.34 g, 16.9 mmol) was added, followed by a DMSO (6 mL) rinse. The flask was placed in a preheated oil bath (90 °C), and the mixture was stirred under argon. After 2 h and 20 min, the mixture was allowed to cool to room temperature and filtered through a pad of Celite, which was then washed with MeOH. The filtrate was partially concentrated and partitioned between H<sub>2</sub>O (1000 mL) and DCM (550 mL). The layers were separated, and the aqueous phase was extracted with DCM (3 × 450 mL). The organic extracts were combined and divided into two portions of approximately 1 L each. The first portion was washed with brine (400 mL). The layers were separated, and the aqueous phase was extracted with DCM (2 × 400 mL). These organic phases were combined and set aside. The second portion was combined with these organic extracts. These combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The resultant solid was treated with Et<sub>2</sub>O and filtered. The solid was washed with Et<sub>2</sub>O and EtOAc, and the filtrate was set aside. The solid was also washed with MeOH and again with EtOAc. The filtrates from both filtrations were combined, concentrated, and purified on silica gel (DCM → 50:1 → 20:1 DCM/MeOH). The fractions with product were collected, concentrated, treated with Et<sub>2</sub>O, and filtered. The solid was collected and set aside. The filtrate was concentrated and treated with Et<sub>2</sub>O and filtered, and the resulting solid was washed with Et<sub>2</sub>O and hexanes. This solid was combined with the solid from the first filtration. The filtrate from this second filtration was concentrated again. This was treated with 1:1 hexanes/Et<sub>2</sub>O and filtered. The solid was washed with 1:1 hexanes/Et<sub>2</sub>O. This time, the filtrate was concentrated while the solid from this filtration was discarded. This filtrate was combined with the solid collected from the first two filtrations, concentrated, washed with hexanes, and dried to afford <b>4a</b> (73.2 g, 88% purity, 91% yield). MS (ESI pos ion) <i>m</i>/<i>z</i>: 319 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 10.44 (br s, 1H), 8.32 (s, 1H), 7.90 (d, <i>J =</i> 8.02 Hz, 1H), 7.76 (d, <i>J =</i> 8.22 Hz, 1H), 2.31 (s, 3H), 1.38 (s, 12H).</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Potassium <i>N</i>-(6-(Trifluoroboryl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>4b</b>)</h3><div class="NLM_p last">A 125 mL polytetrafluoroethylene (PTFE) beaker was charged with <b>4a</b> (4.00 g, 12.6 mmol), 75 mL of EtOH, 25 mL of TFEm and a stir bar. The slurry was sonicated and heated using a 45 °C H<sub>2</sub>O bath until a clear solution was apparent. The solution was treated with potassium fluoride hydrofluoride (2.45 g, 31.4 mmol) and stirred at room temperature for 24 h. The precipitate that formed was collected using a 0.22 μm PTFE membrane. The solids were washed with EtOH (2 × 25 mL), H<sub>2</sub>O (2 × 25 mL), and EtOH (1 × 25 mL). The solids were dried under a stream of N<sub>2</sub> and then at 60 °C and <1 mmHg for 48 h to afford <b>4b</b> (2.60 g, 69.4% yield). <sup>1</sup>H NMR (400 MHz, DMF, δ): 2.28 (s, 3 H), 7.50 (d, <i>J =</i> 7.43 Hz, 1H), 7.58 (d, <i>J =</i> 8.02 Hz, 1H), 7.94 (s, 1H), 11.99 (br s, 1H). <sup>13</sup>C NMR (101 MHz, DMF, δ): 22.66, 118.97, 123.6, 130.21, 130.85, 147.24, 156.21, 162.58, 169.17. <sup>19</sup>F NMR (376 MHz, DMF, ref = CFCl<sub>3</sub> = 0.00, δ): −140.19 (s, 3 F). Anal. Calcd for (C<sub>9</sub>H<sub>7</sub>BF<sub>3</sub>KN<sub>2</sub>OS·0.7H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>N</i>-(6-(2-Chloropyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>5</b>)</h3><div class="NLM_p last">2,4-Dichloropyrimidine (10.31 g, 69.20 mmol), <i>N</i>-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (28.52 g, 89.63 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (6.052 g, 5.237 mmol) were suspended in 1,4-dioxane (300 mL), and aqueous Na<sub>2</sub>CO<sub>3</sub> (2.0 M, 70 mL, 140 mmol) was added. Argon was bubbled through the solution for about 1 min, and then the flask was fitted with a reflux condenser and placed in a preheated oil bath (∼95 °C) and stirred under argon overnight. The mixture was cooled to room temperature, and the liquid was decanted. The residual solid was treated with 1:1 DCM/MeOH and filtered through a pad of Celite. This pad was washed with 1:1 DCM/MeOH as well as with some DMF. This filtrate was concentrated, combined with the decanted material, and concentrated again. The concentrated material was treated with DCM and filtered. The solid was washed with DCM, collected, and dried under high vacuum to afford <b>5</b> (17.89 g, 85% yield). MS (ESI pos ion) <i>m</i>/<i>z</i>: 305 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.58 (s, 1H), 8.87 (s, 1H), 8.82 (d, <i>J =</i> 5.02 Hz, 1H), 8.28 (d, <i>J =</i> 8.53 Hz, 1H), 8.19 (d, <i>J =</i> 5.52 Hz, 1H), 7.87 (d, <i>J =</i> 8.53 Hz, 1H), 2.23 (s, 3H).</div></div><div id="sec3_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Procedure for the Synthesis of <b>6</b>−<b>8</b>, <b>10</b>, <b>14</b>−<b>22</b>, <b>24</b>−<b>30</b>, and <b>37</b>−<b>39</b>. <i>N</i>-(6-(2-(Phenylthio)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>6</b>)</h3><div class="NLM_p last">Thiophenol (106.1 mg, 0.963 mmol) was dissolved in DMF (1.0 mL), and sodium hydride (67 mg, 60% in mineral oil, 1.7 mmol) was added. The mixture was stirred under N<sub>2</sub> at room temperature for 1 h, and then <b>5</b> (50.4 mg, 0.165 mmol) was added. The mixture was stirred at room temperature for 2.5 h and then was treated with H<sub>2</sub>O and saturated NaHCO<sub>3</sub>. The aqueous phase was extracted with DCM, and the organic extracts were combined, concentrated, treated with MeOH and DCM, and filtered. The filtrate was concentrated and the crude material was purified on HPLC (10% → 95% MeCN/H<sub>2</sub>O with 0.1% TFA over 28 min) to afford <b>6</b> (16.0 mg, 25% yield). MS (ESI pos ion) <i>m</i>/<i>z</i>: 379 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.55 (s, 1H), 8.67−8.62 (m, 2H), 8.10 (d, <i>J =</i> 8.53 Hz, 1H), 7.84 (d, <i>J =</i> 5.02 Hz, 1H), 7.79 (d, <i>J =</i> 8.53 Hz, 1H), 7.69 (dd, <i>J =</i> 6.02, 2.51 Hz, 2H), 7.56−7.51 (m, 3H), 2.23 (s, 3H).</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-(6-(2-(Benzylthio)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>7</b>)</h3><div class="NLM_p last">Using benzylthiol and following the procedure used to prepare <b>6</b> gave <b>7</b> in 13% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 393 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.50 (s, 1H), 8.85 (s, 1H), 8.68 (d, <i>J</i> = 5.0 Hz, 1H), 8.26 (d, <i>J</i> = 8.5 Hz, 1H), 7.84 (m, 2H), 7.49 (d, <i>J</i> = 7.0 Hz, 2H), 7.32 (t, <i>J</i> = 7.3 Hz, 2H), 7.25 (t, <i>J</i> = 7.3 Hz, 1H), 4.54 (s, 2H), 2.23 (s, 3H).</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-(6-(2-Phenoxypyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>8</b>)</h3><div class="NLM_p last">Using phenol and following the procedure used to prepare <b>6</b> gave <b>8</b> in 13% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 363 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.54 (s, 1H), 8.79 (s, 1H), 8.67 (d, <i>J =</i> 5.52 Hz, 1H), 8.19 (d, <i>J =</i> 8.53 Hz, 1H), 7.88 (d, <i>J =</i> 5.02 Hz, 1H), 7.84 (d, <i>J =</i> 8.53 Hz, 1H), 7.50−7.44 (m, 2H), 7.32−7.26 (m, 3H), 2.23 (s, 3H).</div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-(6-(2-(Phenylamino)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>10</b>)</h3><div class="NLM_p last">Using aniline and DMSO and following the procedure used to prepare <b>6</b> gave <b>10</b> in 21% yield. This analogue was purified by washing the crude material with Et<sub>2</sub>O and DCM. MS (ESI pos ion) <i>m</i>/<i>z</i>: 362 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 2.17 (s, 3H), 7.35 (d, <i>J</i> = 5.28 Hz, 1H), 7.54−7.66 (m, 5H), 7.74 (d, <i>J</i> = 8.61 Hz, 1H), 8.20 (d, <i>J =</i> 6.85 Hz, 1H), 8.25 (d, <i>J =</i> 8.61 Hz, 1H), 8.78 (s, 1H).</div></div><div id="sec3_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-(6-(2-(2-Fluorophenylthio)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>14</b>)</h3><div class="NLM_p last">Using 2-fluorothiophenol and following the procedure used to prepare <b>6</b> gave <b>14</b> in 25% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 397 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.52 (br s, 1H), 8.66−8.59 (m, 2H), 8.06 (d, <i>J =</i> 8.53 Hz, 1H), 7.86 (d, <i>J =</i> 5.02 Hz, 1H), 7.82−7.80 (m, 2H), 7.65 (q, <i>J =</i> 6.86 Hz, 1H), 7.45 (t, <i>J =</i> 8.53 Hz, 1H), 7.36 (t, <i>J =</i> 7.28 Hz, 1H), 2.23 (s, 3 H).</div></div><div id="sec3_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-(6-(2-(3-Fluorophenylthio)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>15</b>)</h3><div class="NLM_p last">Using 3-fluorothiophenol and following the procedure used to prepare <b>6</b> gave <b>15</b> in 42% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 397 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.53 (s, 1H), 8.70−8.64 (m, 2H), 8.11 (d, <i>J =</i> 8.53 Hz, 1H), 7.87 (d, <i>J =</i> 5.02 Hz, 1H), 7.81 (d, <i>J =</i> 8.53 Hz, 1H), 7.64−7.51 (m, 3H), 7.39 (t, <i>J =</i> 8.28 Hz, 1H), 2.23 (s, 3H).</div></div><div id="sec3_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-(6-(2-(4-Fluorophenylthio)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>16</b>)</h3><div class="NLM_p last">Using 4-fluorothiophenol and following the procedure used to prepare <b>6</b> gave <b>16</b> in 34% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 397 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.50 (br s, 1H), 8.68−8.61 (m, 2H), 8.09 (d, <i>J =</i> 8.53 Hz, 1H), 7.84 (d, <i>J =</i> 5.52 Hz, 1H), 7.80 (d, <i>J =</i> 8.53 Hz, 1H), 7.76−7.69 (m, 2H), 7.38 (t, <i>J =</i> 8.78 Hz, 2H), 2.23 (s, 3H).</div></div><div id="sec3_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-(6-(2-(2-Methylphenylthio)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>17</b>)</h3><div class="NLM_p last">Using 2-methylthiophenol and following the procedure used to prepare <b>6</b> gave <b>17</b> in 25% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 393 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.53 (s, 1H), 8.64−8.60 (m, 2H), 8.07 (dd, <i>J =</i> 8.61, 1.76 Hz, 1H), 7.82 (d, <i>J =</i> 5.48 Hz, 1H), 7.78 (d, <i>J =</i> 8.61 Hz, 1H), 7.64 (d, <i>J =</i> 7.43 Hz, 1H), 7.48−7.44 (m, 2H), 7.35−7.29 (m, 1H), 2.38 (s, 3H), 2.23 (s, 3H).</div></div><div id="sec3_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-(6-(2-(3-Methylphenylthio)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>18</b>)</h3><div class="NLM_p last">Using 3-methylthiophenol and following the procedure used to prepare <b>6</b> gave <b>18</b> in 29% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 393 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.53 (s, 1H), 8.67 (s, 1H), 8.64 (d, <i>J =</i> 5.52 Hz, 1H), 8.11 (d, <i>J =</i> 8.53 Hz, 1H), 7.84 (d, <i>J =</i> 5.52 Hz, 1H), 7.80 (d, <i>J =</i> 9.03 Hz, 1H), 7.54 (s, 1H), 7.49−7.45 (m, 1H), 7.41 (t, <i>J =</i> 7.53 Hz, 1H), 7.36−7.31 (m, 1H), 2.39 (s, 3H), 2.23 (s, 3H).</div></div><div id="sec3_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-(6-(2-(4-Methylphenylthio)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>19</b>)</h3><div class="NLM_p last">Using 4-methylthiophenol and following the procedure used to prepare <b>6</b> gave <b>19</b> in 40% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 393 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.52 (s, 1H), 8.65 (s, 1H), 8.62 (d, <i>J =</i> 5.02 Hz, 1H), 8.11 (d, <i>J =</i> 8.53 Hz, 1H), 7.84−7.78 (m, 2H), 7.55 (d, <i>J =</i> 7.53 Hz, 2H), 7.34 (d, <i>J =</i> 8.03 Hz, 2H), 2.41 (s, 3H), 2.23 (s, 3H).</div></div><div id="sec3_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(6-(2-(2-Methoxyphenylthio)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>20</b>)</h3><div class="NLM_p last">Using 2-methoxythiophenol and following the procedure used to prepare <b>6</b> gave <b>20</b> in 46% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 409 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.52 (s, 1H), 8.62 (s, 1H), 8.59 (d, <i>J =</i> 5.52 Hz, 1H), 8.07 (d, <i>J =</i> 8.53 Hz, 1H), 7.81−7.76 (m, 2H), 7.61 (d, <i>J =</i> 7.53 Hz, 1H), 7.55 (t, <i>J =</i> 7.78 Hz, 1H), 7.20 (d, <i>J =</i> 8.03 Hz, 1H), 7.07 (t, <i>J =</i> 7.53 Hz, 1H), 3.75 (s, 3H), 2.23 (s, 3H).</div></div><div id="sec3_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(6-(2-(3-Methoxyphenylthio)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>21</b>)</h3><div class="NLM_p last">Using 3-methoxythiophenol and following the procedure used to prepare <b>6</b> gave <b>21</b> in 34% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 409 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.41 (br s, 1H), 8.64−8.58 (m, 2H), 8.10 (d, <i>J =</i> 8.03 Hz, 1H), 7.83 (d, <i>J =</i> 5.02 Hz, 1H), 7.76 (d, <i>J =</i> 8.53 Hz, 1H), 7.44 (t, <i>J =</i> 8.03 Hz, 1H), 7.29−7.22 (m, 2H), 7.10 (d, <i>J =</i> 7.53 Hz, 1H), 3.81 (s, 3H), 2.20 (s, 3H).</div></div><div id="sec3_2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(6-(2-(4-Methoxyphenylthio)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>22</b>)</h3><div class="NLM_p last">Using 3-methoxythiophenol and following the procedure used to prepare <b>6</b> gave <b>22</b> in 38% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 409 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.52 (s, 1H), 8.65 (s, 1H), 8.61 (d, <i>J =</i> 5.52 Hz, 1H), 8.11 (d, <i>J =</i> 8.53 Hz, 1H), 7.83−7.78 (m, 2H), 7.58 (d, <i>J =</i> 8.53 Hz, 2H), 7.09 (d, <i>J =</i> 8.53 Hz, 2H), 3.85 (s, 3H), 2.23 (s, 3H).</div></div><div id="sec3_2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(6-(2-(3-Methylbenzyloxy)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>24</b>)</h3><div class="NLM_p last">Using (3-methylphenyl)methanol and following the procedure used to prepare <b>6</b> gave <b>24</b> in 47% yield. This compound was purified by washing with Et<sub>2</sub>O instead of by HPLC. MS (ESI pos ion) <i>m</i>/<i>z</i>: 391 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.55 (br s, 1H), 8.82 (s, 1H), 8.65 (d, <i>J =</i> 5.52 Hz, 1H), 8.24 (d, <i>J =</i> 8.53 Hz, 1H), 7.79 (d, <i>J =</i> 8.53 Hz, 1H), 7.76 (d, <i>J =</i> 5.02 Hz, 1H), 7.35 (s, 1H), 7.33−7.25 (m, 2H), 7.15 (d, <i>J =</i> 6.02 Hz, 1H), 5.47 (s, 2H), 2.33 (s, 3H), 2.20 (s, 3H).</div></div><div id="sec3_2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-(6-(2-(3-Methoxybenzyloxy)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>25</b>)</h3><div class="NLM_p last">Using (3-methoxyphenyl)methanol and following the procedure used to prepare <b>6</b> gave <b>25</b> in 69% yield. This compound was purified by washing with Et<sub>2</sub>O instead of by HPLC. MS (ESI pos ion) <i>m</i>/<i>z</i>: 407 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.45 (br s, 1H), 8.77 (br s, 1H), 8.63 (d, <i>J =</i> 5.02 Hz, 1H), 8.21 (d, <i>J =</i> 8.03 Hz, 1H), 7.77−7.69 (m, 2H), 7.31 (t, <i>J =</i> 7.78 Hz, 1H), 7.11−7.06 (m, 2H), 6.90 (d, <i>J =</i> 9.54 Hz, 1H), 5.48 (s, 2H), 3.76 (s, 3H), 2.16 (s, 3H).</div></div><div id="sec3_2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-(6-(2-(4-Fluorobenzyloxy)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>26</b>)</h3><div class="NLM_p last">Using (4-fluorophenyl)methanol and following the procedure used to prepare <b>6</b> gave <b>26</b> in 37% yield. This compound was purified by washing with Et<sub>2</sub>O, MeOH, and Et<sub>2</sub>O instead of by HPLC. MS (ESI pos ion) <i>m</i>/<i>z</i>: 395 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.51 (s, 1H), 8.88 (s, 1H), 8.68 (d, <i>J =</i> 5.02 Hz, 1H), 8.28 (d, <i>J =</i> 8.53 Hz, 1H), 7.85 (d, <i>J =</i> 8.53 Hz, 1H), 7.78 (d, <i>J =</i> 5.02 Hz, 1H), 7.58 (dd, <i>J =</i> 7.78, 5.77 Hz, 2H), 7.23 (t, <i>J =</i> 8.78 Hz, 2H), 5.50 (s, 2H), 2.23 (s, 3H).</div></div><div id="sec3_2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-(6-(2-(4-Methylbenzyloxy)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>27</b>)</h3><div class="NLM_p last">Using (4-methylphenyl)methanol and following the procedure used to prepare <b>6</b> gave <b>27</b> in 54% yield. This compound was purified by washing with Et<sub>2</sub>O instead of by HPLC. MS (ESI pos ion) <i>m</i>/<i>z</i>: 391 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.50 (br s, 1H), 8.81 (br s, 1H), 8.64 (d, <i>J =</i> 5.02 Hz, 1H), 8.24 (d, <i>J =</i> 9.03 Hz, 1H), 7.83−7.73 (m, 2H), 7.41 (d, <i>J =</i> 8.03 Hz, 2H), 7.21 (d, <i>J =</i> 7.53 Hz, 2H), 5.46 (s, 2H), 2.31 (s, 3H), 2.19 (s, 3H).</div></div><div id="sec3_2_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-(6-(2-(4-Methoxybenzyloxy)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>28</b>)</h3><div class="NLM_p last">Using (4-methoxyphenyl)methanol and following the procedure used to prepare <b>6</b> gave <b>28</b> in 31% yield. This compound was purified by washing with Et<sub>2</sub>O, MeOH, and Et<sub>2</sub>O instead of by HPLC. MS (ESI pos ion) <i>m</i>/<i>z</i>: 407 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.50 (br s, 1H), 8.77 (br s, 1H), 8.63 (d, <i>J =</i> 5.02 Hz, 1H), 8.22 (d, <i>J =</i> 8.53 Hz, 1H), 7.73 (d, <i>J =</i> 5.02 Hz, 2H), 7.46 (d, <i>J =</i> 8.03 Hz, 2H), 6.96 (d, <i>J =</i> 8.53 Hz, 2H), 5.43 (s, 2H), 3.76 (s, 3H), 2.16 (s, 3H).</div></div><div id="sec3_2_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-(6-(2-(Pyridin-4-ylmethoxy)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>29</b>)</h3><div class="NLM_p last">Using 4-(hydroxymethyl)pyridine and following the procedure used to prepare <b>6</b> gave <b>29</b> in 51% yield. This compound was purified by washing with Et<sub>2</sub>O instead of by HPLC. MS (ESI pos ion) <i>m</i>/<i>z</i>: 378 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 8.81 (s, 1H) 8.67 (d, <i>J =</i> 5.02 Hz, 1H), 8.59 (d, <i>J =</i> 5.52 Hz, 2H), 8.23 (d, <i>J =</i> 8.53 Hz, 1H), 7.81−7.76 (m, 2H), 7.49 (d, <i>J =</i> 5.52 Hz, 2H), 5.57 (s, 2H), 2.20 (s, 3H).</div></div><div id="sec3_2_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-(6-(2-(3-(Pyridin-4-yl)propoxy)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>30</b>)</h3><div class="NLM_p last">Using 3-(pyridin-4-yl)propan-1-ol and following the procedure used to prepare <b>6</b> gave <b>30</b> in 18% yield. This compound was purified by washing with Et<sub>2</sub>O instead of by HPLC. MS (ESI pos ion) <i>m</i>/<i>z</i>: 406 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.48 (br s, 1H), 8.83 (s, 1H), 8.64 (d, <i>J =</i> 5.52 Hz, 1H), 8.47 (d, <i>J =</i> 5.52 Hz, 2H), 8.24 (d, <i>J =</i> 8.53 Hz, 1H), 7.84 (d, <i>J =</i> 8.53 Hz, 1H), 7.74 (d, <i>J =</i> 5.02 Hz, 1H), 7.30 (d, <i>J =</i> 5.52 Hz, 2H), 4.43 (t, <i>J =</i> 6.53 Hz, 2H), 2.80 (t, <i>J =</i> 7.78 Hz, 2H), 2.23 (s, 3H), 2.16−2.08 (m, 2H).</div></div><div id="sec3_2_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-(6-(2-(4-Methoxyphenylsulfonamido)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>37</b>)</h3><div class="NLM_p last">Using 4-methoxybenzenesulfonamide and DMSO and following the procedure used to prepare <b>6</b> gave <b>37</b> in 29% yield. The reaction was run at 125 °C overnight, and following HPLC purification, the material was washed with Et<sub>2</sub>O, MeOH, and Et<sub>2</sub>O to afford the product. MS (ESI pos ion) <i>m</i>/<i>z</i>: 456 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.53 (s, 1H), 11.66 (br s, 1H), 8.59−8.52 (m, 2H), 8.15 (d, <i>J =</i> 8.53 Hz, 1H), 7.98 (d, <i>J =</i> 8.53 Hz, 2H), 7.85 (d, <i>J =</i> 8.53 Hz, 1H), 7.65 (d, <i>J =</i> 4.52 Hz, 1H), 7.10 (d, <i>J =</i> 9.03 Hz, 2H), 3.81 (s, 3H), 2.24 (s, 3H).</div></div><div id="sec3_2_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-(6-(2-(4-Methoxy-<i>N</i>-methylphenylsulfonamido)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>38</b>)</h3><div class="NLM_p last">Using 4-methoxy-<i>N</i>-methylbenzenesulfonamide and DMSO and following the procedure used to prepare <b>6</b> gave <b>38</b> in 25% yield. The reaction was run at 125 °C overnight. MS (ESI pos ion) <i>m</i>/<i>z</i>: 470 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.52 (br s, 1H), 8.64 (d, <i>J =</i> 5.02 Hz, 1H), 8.56 (s, 1H), 8.14 (d, <i>J =</i> 8.53 Hz, 1H), 7.99 (d, <i>J =</i> 8.53 Hz, 2H), 7.84 (d, <i>J =</i> 8.53 Hz, 1H), 7.71 (d, <i>J =</i> 5.02 Hz, 1H), 7.10 (d, <i>J =</i> 9.03 Hz, 2H), 3.82 (s, 3H), 3.69 (s, 3H), 2.23 (s, 3H).</div></div><div id="sec3_2_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(6-(2-(<i>N</i>-Ethyl-4-methoxyphenylsulfonamido)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>39</b>)</h3><div class="NLM_p last">Using 4-methoxy-<i>N</i>-ethylbenzenesulfonamide and DMSO and following the procedure used to prepare <b>6</b> gave <b>39</b> in 12% yield. The reaction was run at 125 °C overnight. MS (ESI pos ion) <i>m</i>/<i>z</i>: 484 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.51 (br s, 1H), 8.63 (d, <i>J =</i> 5.02 Hz, 1H), 8.48 (s, 1H), 8.08 (d, <i>J =</i> 8.53 Hz, 1H), 7.98 (d, <i>J =</i> 8.53 Hz, 2H), 7.83 (d, <i>J =</i> 8.53 Hz, 1H), 7.68 (d, <i>J =</i> 5.02 Hz, 1H), 7.10 (d, <i>J =</i> 8.53 Hz, 2H), 4.37−4.26 (m, 2H), 3.82 (s, 3H), 2.23 (s, 3H), 1.42 (t, <i>J =</i> 6.53 Hz, 3H).</div></div><div id="sec3_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Procedure for the Synthesis of <b>9</b>, <b>11</b>, <b>23</b>, <b>31</b>−<b>35</b>, <b>40</b>, and <b>42</b>−<b>44</b>. <i>N</i>-(6-(2-(Benzyloxy)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>9</b>)</h3><div class="NLM_p last">Compound <b>5</b> (60.8 mg, 0.200 mmol) and benzyl alcohol (0.20 mL, 1.9 mmol) were suspended in pyridine (0.84 mL) and sealed in a microwave vial. The vial was heated in the CEM microwave at 120 °C and 300 W with a 5 min ramp time and 20 min run time. The mixture was cooled to room temperature, concentrated, and purified on HPLC (10% → 95% MeCN/H<sub>2</sub>O with 0.1% TFA over 28−40 min) to afford <b>9</b> (4.4 mg, 6% yield). MS (ESI pos ion) <i>m</i>/<i>z</i>: 377 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.51 (br s, 1H), 8.87 (s, 1H), 8.67 (s, 1H), 8.27 (d, <i>J =</i> 6.53 Hz, 1H), 7.84 (d, <i>J =</i> 7.03 Hz, 1H), 7.77 (s, 1H), 7.60−7.29 (m, 5H), 5.51 (s, 2H), 2.23 (s, 3H).</div></div><div id="sec3_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-(6-(2-(Benzylamino)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>11</b>)</h3><div class="NLM_p last">Using benzylamine and following the procedure used to prepare <b>9</b> gave <b>11</b> in 22% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 376 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.48 (s, 1H), 8.73 (s, 1H), 8.36 (d, <i>J =</i> 5.52 Hz, 1H), 8.19 (d, <i>J =</i> 8.53 Hz, 1H), 7.93 (br s, 1H), 7.81 (d, <i>J =</i> 9.03 Hz, 1H), 7.44−7.36 (m, 2H), 7.32 (d, <i>J =</i> 14.56 Hz, 2H), 7.29−7.18 (m, 2H), 4.63 (br s, 2H), 2.23 (s, 3H).</div></div><div id="sec3_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-(6-(2-(3-Fluorobenzyloxy)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>23</b>)</h3><div class="NLM_p last">Using (3-fluorophenyl)methanol and following the procedure used to prepare <b>9</b> gave <b>23</b> in 22% yield. The mixture was reheated a second time in the microwave at 120 °C and 300 W with a 5 min ramp time and 10 min run time. MS (ESI pos ion) <i>m</i>/<i>z</i>: 395 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.51 (br s, 1H), 8.87 (s, 1H), 8.68 (d, <i>J =</i> 3.51 Hz, 1H), 8.27 (d, <i>J =</i> 8.03 Hz, 1H), 7.84 (d, <i>J =</i> 8.03 Hz, 1H), 7.78 (d, <i>J =</i> 3.51 Hz, 1H), 7.52−7.29 (m, 3H), 7.22−7.11 (m, 1H), 5.53 (s, 2H), 2.23 (s, 3H).</div></div><div id="sec3_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i>-(6-(2-(3-(Pyridin-3-yl)propoxy)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>31</b>)</h3><div class="NLM_p last">Using 3-pyridinepropanol and following the procedure used to prepare <b>9</b> gave <b>31</b> in 18% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 406 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.51 (s, 1H), 8.86−8.80 (m, 2H), 8.72 (d, <i>J =</i> 5.02 Hz, 1H), 8.64 (d, <i>J =</i> 5.52 Hz, 1H), 8.39 (d, <i>J =</i> 8.03 Hz, 1H), 8.25 (dd, <i>J =</i> 8.53, 1.51 Hz, 1H), 7.91−7.82 (m, 2H), 7.75 (d, <i>J =</i> 5.02 Hz, 1H), 4.47 (t, <i>J =</i> 6.27 Hz, 2H), 2.98 (t, <i>J =</i> 7.53 Hz, 2H), 2.23 (s, 3H), 2.22−2.14 (m, 2H).</div></div><div id="sec3_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i>-(6-(2-(3-Phenylpropoxy)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>32</b>)</h3><div class="NLM_p last">Using 3-phenylpropan-1-ol and following the procedure used to prepare <b>9</b> gave <b>32</b> in 6% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 405 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.50 (s, 1H), 8.83 (s, 1H), 8.64 (d, <i>J =</i> 5.02 Hz, 1H), 8.25 (d, <i>J =</i> 8.53 Hz, 1H), 7.84 (d, <i>J =</i> 8.53 Hz, 1H), 7.74 (d, <i>J =</i> 5.52 Hz, 1H), 7.34−7.24 (m, 4H), 7.23−7.16 (m, 1H), 4.42 (t, <i>J =</i> 6.53 Hz, 2H), 2.78 (t, <i>J =</i> 7.53 Hz, 2H), 2.23 (s, 3H), 2.14−2.04 (m, 2H).</div></div><div id="sec3_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-(6-(2-(3-Morpholinopropoxy)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>33</b>)</h3><div class="NLM_p last">Using 4-(3-hydroxypropyl)morpholine and following the procedure used to prepare <b>9</b> gave <b>33</b> in 5% yield as a TFA salt. Before HPLC purification, the crude material was filtered through silica gel (15:1 DCM/MeOH → 5:1 DCM/2 N ammonia in MeOH). MS (ESI pos ion) <i>m</i>/<i>z</i>: 414 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.52 (br s, 1H), 9.83 (br s, 1H), 8.85 (s, 1H), 8.67 (d, <i>J =</i> 5.52 Hz, 1H), 8.27 (d, <i>J =</i> 8.03 Hz, 1H), 7.86 (d, <i>J =</i> 8.53 Hz, 1H), 7.78 (d, <i>J =</i> 5.02 Hz, 1H), 4.51 (t, <i>J =</i> 5.77 Hz, 2H), 4.05−3.95 (m, 2H), 3.71−3.61 (m, 2H), 3.51 (d, <i>J =</i> 11.04 Hz, 2H), 3.40−3.29 (m, 2H), 3.16−3.05 (m, 2H), 2.30−2.16 (m, 5H).</div></div><div id="sec3_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i>-(6-(2-(2-Morpholinoethoxy)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>34</b>)</h3><div class="NLM_p last">Using 4-(2-hydroxyethyl)morpholine and following the procedure used to prepare <b>9</b> gave <b>34</b> in 5% yield as a TFA salt. MS (ESI pos ion) <i>m</i>/<i>z</i>: 400 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.53 (br s, 1H), 9.74 (br s, 1H), 8.87 (s, 1H), 8.71 (d, <i>J =</i> 5.52 Hz, 1H), 8.29 (d, <i>J =</i> 8.53 Hz, 1H), 7.89−7.82 (m, 2H), 4.80 (br s, 2H), 3.99−3.89 (m, 2H), 3.76−3.71 (m, 2H), 3.69−3.64 (m, 2H), 3.23−3.18 (m, 2H), 2.24 (s, 3H). (The additional two methylene protons could be buried under the H<sub>2</sub>O peak, which ranges from 3.64−3.35.)</div></div><div id="sec3_3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>N</i>-(6-(2-(3-Methoxypropoxy)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>35</b>)</h3><div class="NLM_p last">Using 3-methoxypropan-1-ol and following the procedure used to prepare <b>9</b> gave <b>35</b> in 7% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 359 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.50 (s, 1H), 8.85 (s, 1H), 8.64 (d, <i>J =</i> 5.02 Hz, 1H), 8.27 (d, <i>J =</i> 9.03 Hz, 1H), 7.85 (d, <i>J =</i> 8.53 Hz, 1H), 7.74 (d, <i>J =</i> 5.02 Hz, 1H), 4.46 (t, <i>J =</i> 6.27 Hz, 2H), 3.51 (t, <i>J =</i> 6.27 Hz, 2H), 3.27 (s, 3H), 2.23 (s, 3H), 2.02 (quin, <i>J =</i> 6.40 Hz, 2H).</div></div><div id="sec3_3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>N</i>-(6-(2-(2-Fluorophenylsulfonamido)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>40</b>)</h3><div class="NLM_p last">Using 2-fluorobenzenesulfonamide and following the procedure used to prepare <b>9</b> gave <b>40</b> in 17% yield. Before HPLC purification, the crude material was filtered through silica gel (10:1 DCM/MeOH). After HPLC purification, the material was washed with Et<sub>2</sub>O to afford <b>40</b>. MS (ESI pos ion) <i>m</i>/<i>z</i>: 444 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.54 (br s, 1H), 8.57−8.43 (m, 2H), 8.18 (t, <i>J =</i> 8.28 Hz, 1H), 7.99 (d, <i>J =</i> 7.53 Hz, 1H), 7.80 (d, <i>J =</i> 8.53 Hz, 1H), 7.72−7.57 (m, 2H), 7.49−7.42 (m, 1H), 7.37 (t, <i>J =</i> 9.03 Hz, 1H), 2.24 (s, 3H).</div></div><div id="sec3_3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-(6-(2-(3-Fluorophenylsulfonamido)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>42</b>)</h3><div class="NLM_p last">Using 3-fluorobenzenesulfonamide and following the procedure used to prepare <b>9</b> gave <b>42</b> in 6% yield. Before HPLC purification, the crude material was filtered through silica gel (10:1 DCM/MeOH). MS (ESI pos ion) <i>m</i>/<i>z</i>: 444 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.54 (s, 1H), 8.59−8.53 (m, 2H), 8.10 (d, <i>J =</i> 9.03 Hz, 1H), 7.88−7.80 (m, 3H), 7.69−7.61 (m, 2H), 7.53−7.45 (m, 1H), 2.24 (s, 3H).</div></div><div id="sec3_3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>N</i>-(6-(2-(4-Fluorophenylsulfonamido)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>43</b>)</h3><div class="NLM_p last">Using 4-fluorobenzenesulfonamide and following the procedure used to prepare <b>9</b> gave <b>43</b> in 7% yield. Before HPLC purification, the crude material was filtered through silica gel (10:1 DCM/MeOH). MS (ESI pos ion) <i>m</i>/<i>z</i>: 444 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.54 (s, 1H), 8.58 (s, 1H), 8.55 (d, <i>J =</i> 5.02 Hz, 1H), 8.14−8.07 (m, 3H), 7.85 (d, <i>J =</i> 8.53 Hz, 1H), 7.66 (d, <i>J =</i> 6.02 Hz, 1H), 7.43 (t, <i>J =</i> 8.78 Hz, 2H), 2.24 (s, 3H).</div></div><div id="sec3_3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>-(6-(2-(4-Methylphenylsulfonamido)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>44)</b></h3><div class="NLM_p last">Using 4-methylbenzenesulfonamide and following the procedure used to prepare <b>9</b> gave <b>44</b> in 13% yield. Instead of HPLC purification, the crude material was filtered through silica gel (10:1 DCM/MeOH). This filtrate was concentrated, treated with Et<sub>2</sub>O, and filtered. The solid was washed with Et<sub>2</sub>O, MeOH, and Et<sub>2</sub>O to afford <b>44</b>. MS (ESI pos ion) <i>m</i>/<i>z</i>: 440 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.53 (s, 1H), 11.77 (br s, 1H), 8.55 (d, <i>J =</i> 4.52 Hz, 1H), 8.52 (br s, 1H), 8.13 (d, <i>J =</i> 7.53 Hz, 1H), 7.93 (d, <i>J =</i> 8.03 Hz, 2H), 7.84 (d, <i>J =</i> 8.53 Hz, 1H), 7.66−7.60 (m, 1H), 7.39 (d, <i>J =</i> 8.03 Hz, 2H), 2.35 (s, 3H), 2.24 (s, 3H).</div></div><div id="sec3_3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>-(6-(2-Benzylpyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>12</b>)</h3><div class="NLM_p last"><i>N</i>-(6-(2-Chloropyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>5</b>, 59.0 mg, 0.194 mmol) was suspended in THF (1.8 mL) to which Pd(PPh<sub>3</sub>)<sub>4</sub> (25.6 mg, 0.022 mmol) and benzylzinc bromide (0.5 M solution in THF, 0.55 mL, 0.275 mmol) were added under argon. The reaction solution was stirred at room temperature. After 2 h, the mixture was heated to 80 °C, and stirring was continued under argon. After 100 min, additional Pd(PPh<sub>3</sub>)<sub>4</sub> (21 mg, 0.018 mmol) and benzylzinc bromide (0.5 M solution in THF, 0.57 mL, 0.285 mmol) were added, and the mixture was stirred. After another hour, additional benzylzinc bromide (0.5 M solution in THF, 0.73 mL, 0.365 mmol) was added, and stirring was continued at 80 °C. The mixture was stirred overnight and quenched with saturated ammonium chloride (1.5 mL) and 0.5 M EDTA (2.5 mL), extracted with 10:1 DCM/MeOH, and the organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered through Celite, and concentrated. The crude concentrate was purified on a silica gel column (20:1 → 5:1 DCM/MeOH), and the product-containing fractions were collected, concentrated, treated with Et<sub>2</sub>O and MeOH, and filtered. The solid was collected and purified on HPLC (10% 95% MeCN/H<sub>2</sub>O with 0.1% TFA over 40 min) to provide <b>12</b> (8 mg, 11% yield). MS (ESI pos ion) <i>m</i>/<i>z</i>: 361 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.50 (s, 1H), 8.85 (s, 1H), 8.78 (d, <i>J</i> = 5.5 Hz, 1H), 8.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.95 (d, <i>J</i> = 5.5 Hz, 1H), 7.85 (d, <i>J</i> = 8.5 Hz, 1H), 7.38 (m, 2H), 7.31 (m, 2H), 7.21 (m, 1H), 4.28 (s, 2H), 2.23 (s, 3H).</div></div><div id="sec3_3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>N</i>-(6-(2-Phenethylpyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>13</b>)</h3><div class="NLM_p last">Compound <b>5</b> (277 mg, 0.909 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (160 mg, 0.138 mmol) were suspended in THF (5.0 mL), and phenethylzinc(II) bromide (0.5 M in THF, 8.3 mL, 4.2 mmol) was added. The flask was fitted with a reflux condenser and was put in a preheated oil bath (80 °C) and stirred for 1 h. The mixture was cooled to room temperature and was treated with saturated ammonium chloride (5 mL) and 0.5 M aqueous EDTA (8 mL). The mixture was stirred at room temperature for 5 min and then was filtered through a Celite pad, which was washed with H<sub>2</sub>O, MeOH, DCM, and EtOAc. The layers of the filtrate were separated, and the aqueous phase was extracted with DCM. The organic phases were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and purified on silica gel (30:1 → 20:1 DCM/MeOH). The fractions with product were collected, concentrated, treated with MeOH, and filtered. The solid was washed with MeOH, Et<sub>2</sub>O, and MeOH. The filtrate and solid were combined, concentrated, treated with DCM, and filtered. The solid was washed with DCM and MeOH and was found to be less than 95% pure by HPLC. The filtrate and solid were combined, concentrated, and purified on HPLC (10% → 100% MeCN/H<sub>2</sub>O with 0.1% TFA over 28 min) to afford <b>13</b> (26.7 mg, 8% yield). MS (ESI pos ion) <i>m</i>/<i>z</i>: 375 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.80 (d, <i>J =</i> 5.48 Hz, 1H), 8.64 (d, <i>J =</i> 1.37 Hz, 1H), 8.23 (dd, <i>J =</i> 8.61, 1.56 Hz, 1H), 7.91 (d, <i>J =</i> 8.80 Hz, 1H), 7.68 (d, <i>J =</i> 5.48 Hz, 1H), 7.34−7.19 (m, 5H), 3.37−3.53 (m, 2H), 3.19−3.34 (m, 2H), 2.46 (s, 3H).</div></div><div id="sec3_3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>N</i>-(6-(2-(2-Phenylpropan-2-ylamino)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>36</b>)</h3><div class="NLM_p last">A solution of <b>5</b> (0.100 g, 0.328 mmol), cumylamine (0.05 mL, 0.4 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.2 g, 0.6 mmol) in DMF (1 mL) was heated in the CEM microwave at 180 °C and 180 W for 20 min. The mixture was diluted with DCM, washed with H<sub>2</sub>O three times, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by HPLC (5% → 100% MeCN/H<sub>2</sub>O with 0.05% TFA) to give <b>36</b> as an off-white solid (2.5 mg, 2% yield). MS (ESI pos ion) <i>m</i>/<i>z</i>: 404 (M + H<sup>+</sup>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 10.40 (br s, 1H), 8.85 (d, <i>J =</i> 4.82 Hz, 1H), 8.05 (d, <i>J =</i> 6.43 Hz, 1H), 7.78 (dd, <i>J =</i> 7.82, 6.36 Hz, 1H), 7.73−7.70 (m, 2H), 7.57−7.52 (m, 2H), 7.43 (t, <i>J =</i> 7.67 Hz, 2H), 7.32−7.26 (m, 1H), 7.08 (d, <i>J =</i> 6.58 Hz, 1H), 2.42 (s, 3H), 1.88 (s, 6H).</div></div><div id="sec3_3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Procedure for the Synthesis of <b>41</b> and <b>45</b>. <i>N</i>-(6-(2-(2-Fluoro-<i>N</i>-methylphenylsulfonamido)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>41</b>)</h3><div class="NLM_p last">A microwave vial equipped with a stir bar was charged with 2-fluoro-<i>N</i>-methylbenzenesulfonamide (0.23 g, 1.2 mmol) in DMF (3 mL). Then NaH (0.12 g, 4.9 mmol) was added to the mixture and the mixture was allowed to stir for 30 min. Then Pd(OAc)<sub>2</sub> (11 mg, 0.049 mmol), <b>5</b> (150 mg, 0.492 mmol), and Xantphos (10 mg, 0.017 mmol) were added to the mixture. The vial was capped and placed into a CEM microwave for 10 min at 100 °C, while 100 W of energy was supplied via Powermax. The mixture was added to a round-bottomed flask and diluted with H<sub>2</sub>O (150 mL). The mixture was allowed to stir overnight. The resulting precipitate was collected by filtration and washed with hexanes (3 × 50 mL) and 1:1 hexanes/Et<sub>2</sub>O (50 mL). Then the crude material was recrystallized from 1:1 MeOH/DCM and then from hexanes to give <b>41</b> (35 mg, 16% yield) as a brown solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 458 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.50 (s, 1H), 8.64 (d, <i>J =</i> 5.02 Hz, 1H), 8.48 (s, 1H), 8.22 (t, <i>J =</i> 7.53 Hz, 1H), 7.99 (d, <i>J =</i> 8.53 Hz, 1H), 7.79 (d, <i>J =</i> 8.53 Hz, 1H), 7.76−7.69 (m, 2H), 7.52−7.39 (m, 2H), 3.70 (s, 3H), 2.23 (s, 3H).</div></div><div id="sec3_3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>-(6-(2-(4-Methyl-<i>N</i>-methylphenylsulfonamido)pyrimidin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>45</b>)</h3><div class="NLM_p last">Using <i>N</i>-methyl-4-toluenesulfonamide and following the procedure used to prepare <b>41</b> gave <b>45</b> in 36% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 454 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.52 (s, 1H), 8.64 (s, 1H), 8.48 (s, 1H), 8.10 (d, <i>J</i> = 5.0 Hz, 1H), 7.93 (s, 2H), 7.83 (s, 1H), 7.71 (s, 1H), 7.40 (s, 2H), 3.70 (s, 3H), 2.37 (s, 3H), 2.24 (s, 3H).</div></div><div id="sec3_3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i>-(4-Chloropyrimidin-2-yl)-4-methoxybenzamide (<b>47</b>)</h3><div class="NLM_p last">A mixture of 4-chloropyrimidin-2-amine (<b>46</b>, 0.65 g, 5.0 mmol), triethylamine (1.4 mL, 10 mmol), and 4-anisoyl chloride (0.66 mL, 5.0 mmol) in DCM (20 mL) was stirred for 16 h at room temperature. Then the mixture was concentrated and the residue was purified on silica gel (0% → 8% MeOH in DCM) to afford <b>47</b> (70 mg, 5%) as a white solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 264 (M + H<sup>+</sup>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 8.56 (s, 1H), 8.54 (s, 1H), 8.29 (d, <i>J =</i> 5.70 Hz, 1H), 7.91−7.86 (m, 2H), 7.04−7.00 (m, 2H), 3.91 (s, 3H).</div></div><div id="sec3_3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i>-(4-(2-Acetamidobenzo[d]thiazol-6-yl)pyrimidin-2-yl)-4-methoxybenzamide (<b>48</b>)</h3><div class="NLM_p last">To a mixture of <b>47</b> (70 mg, 0.27 mmol), <b>4</b> (130 mg, 0.40 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (31 mg, 0.027 mmol) under N<sub>2</sub> was added aqueous 2 M Na<sub>2</sub>CO<sub>3</sub> (0.5 mL, 1 mmol) and 1,4-dioxane (3 mL). The flask was placed into a preheated (90 °C) bath, and the mixture was allowed to stir under an inert atmosphere overnight. The resulting mixture was concentrated and diluted with DMSO (2 mL) and purified by HPLC (5% → 95% MeCN in H<sub>2</sub>O). The fractions with pure product were concentrated, diluted with DCM, and washed with aqueous Na<sub>2</sub>CO<sub>3</sub> solution. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to give <b>48</b> (35 mg, 31%) as a white solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 420 (M + H<sup>+</sup>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, δ): 10.95 (br s, 1H), 8.85 (s, 1H), 8.72 (d, <i>J =</i> 5.26 Hz, 1H), 8.61 (d, <i>J =</i> 1.61 Hz, 1H), 8.16 (dd, <i>J =</i> 8.62, 1.75 Hz, 1H), 7.99−7.92 (m, 2H), 7.84 (d, <i>J =</i> 8.48 Hz, 1H), 7.50 (d, <i>J =</i> 5.41 Hz, 1H), 7.00 (d, <i>J =</i> 8.92 Hz, 2H), 3.90 (s, 3H), 2.33 (s, 3H).</div></div><div id="sec3_3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>N</i>-(6-(2-Chloropyridin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>50</b>)</h3><div class="NLM_p last">2-Chloro-4-iodopyridine (<b>49</b>, 500 mg, 2.09 mmol) was dissolved in 1,4-dioxane (15 mL). Then <b>4a</b> (0.8 g, 3 mmol), Ph(PPh<sub>3</sub>)<sub>4</sub> (0.3 g, 0.3 mmol), and aqueous 2 M Na<sub>2</sub>CO<sub>3</sub> (2 mL, 4 mmol) were added to the mixture. The flask was fitted with a reflux condenser, placed into a preheated (90 °C) bath, and stirred under inert atmosphere for 3 h. The mixture was allowed to cool to ambient temperature and was diluted with DCM and saturated NaHCO<sub>3</sub>. The organic layer was collected by extracting with DCM (3 × 20 mL). The organics were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was diluted with Et<sub>2</sub>O (50 mL) and allowed to stir for 10 min. The precipitate was collected by filtration and washed with Et<sub>2</sub>O to afford <b>50</b> (0.200 g, 32% yield) as a tan crystalline solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 304 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.49 (br s, 1H), 8.53 (s, 1H), 8.47 (d, <i>J =</i> 5.09 Hz, 1H), 7.94−7.89 (m, 2H), 7.86−7.79 (m, 2H), 2.22 (s, 3H).</div></div><div id="sec3_3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>N</i>-(6-(2-(4-Methoxyphenylsulfonamido)pyridin-4-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>51</b>)</h3><div class="NLM_p last">A microwave vial with a magnetic stir bar was charged with 4-methoxybenzenesulfonamide (0.25 g, 1.3 mmol) in DMF (3 mL). Sodium hydride (63 mg, 2.6 mmol) was added, and the mixture was allowed to stir for 15 min. Then <b>50</b> (160 mg, 0.528 mmol), Pd(OAc)<sub>2</sub> (12 mg, 0.053 mmol), and Xantphos (10 mg, 0.017 mmol) were added to the mixture. The vial was capped and placed into a CEM microwave for 20 min at 120 °C, while 100 W of energy was supplied via Powermax. The reaction mixture was then transferred to a round-bottomed flask and diluted with EtOAc (20 mL) while stirring. After 20 min, the mixture was filtered and the resulting precipitate was collected. The precipitate was diluted with DMSO and purified by HPLC to afford <b>51</b> (28 mg, 12% yield) as a tan crystalline solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 455 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 7.92 (d, <i>J =</i> 10.04 Hz, 2H), 7.85−7.68 (m, 3H), 7.65−7.54 (m, 2H), 7.46 (s, 1H), 6.96−6.84 (m, 3H), 6.70 (br s, 1H), 3.74 (s, 3H), 2.09 (s, 3H).</div></div><div id="sec3_3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>N</i>-(5-Bromopyridin-3-yl)-4-methoxybenzenesulfonamide (<b>53</b>)</h3><div class="NLM_p last">To a round-bottomed flask was added 5-bromopyridin-3-amine, <b>52</b> (400 mg, 2.31 mmol), EtOH (10 mL), and 4-methoxybenzene-1-sulfonyl chloride (0.96 g, 4.6 mmol). The resulting mixture was allowed to stir at ambient temperature overnight while under inert atmosphere. The mixture was diluted with DCM and saturated NaHCO<sub>3</sub> and extracted with DCM (3 × 25 mL). The organics were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and purified by ISCO silica gel chromatography in a gradient of 10% → 30% EtOAc/DCM over 30 min to afford <b>53</b> (0.165 g, 21% yield) as a white crystalline solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 343 (M + H<sup>+</sup>, <sup>79</sup>Br), 345 (M + H<sup>+</sup>, <sup>81</sup>Br). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 10.73 (s, 1H), 8.38 (s, 1H), 8.28 (s, 1H), 7.74 (d, <i>J =</i> 8.53 Hz, 2H), 7.67 (s, 1H), 7.11 (d, <i>J =</i> 8.53 Hz, 2H), 3.81 (s, 3H).</div></div><div id="sec3_3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>N</i>-(6-(5-(4-Methoxyphenylsulfonamido)pyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>54</b>)</h3><div class="NLM_p last">To a microwave vial charged with <b>53</b> (165 mg, 0.481 mmol) in 1,4-dioxane (3 mL) was added <b>4a</b> (223 mg, 0.701 mmol), Fibercat (24 mg, 20% Pd), and aqueous 2 M Na<sub>2</sub>CO<sub>3</sub> (0.6 mL, 1.2 mmol). A stir bar was added to the vial, and then the vial was capped and placed into CEM microwave for 10 min at 100 °C, while 100 W of energy was supplied via Powermax. The mixture was allowed to cool to ambient temperature and diluted with DCM and saturated NaHCO<sub>3</sub>. The organic layer was collected by extracting with DCM (3 × 20 mL). The organic extracts were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The mixture was allowed to stand for 2 h, and the precipitate was collected by filtration. The solid was washed with 1:1 EtOAc/Et<sub>2</sub>O and then with Et<sub>2</sub>O to afford <b>54</b> (35 mg, 16% yield) as a tan solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 455 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.42 (s, 1H), 8.59 (s, 1H), 8.24 (s, 2H), 7.86−7.70 (m, 4H), 7.63 (s, 1H), 7.08 (d, <i>J =</i> 5.52 Hz, 2H), 3.79 (s, 3H), 2.22 (s, 3H).</div></div><div id="sec3_3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>N</i>-(6-(6-Chloropyrazin-2-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>56</b>)</h3><div class="NLM_p last">2,6-Dichloropyrazine (<b>55</b>, 1.119 g, 7.511 mmol), <b>4a</b> (3.07 g, 9.65 mmol), Pd(dppf)<sub>2</sub>Cl<sub>2</sub>/DCM complex (519.9 mg, 0.637 mmol), and K<sub>2</sub>CO<sub>3</sub> (2.992 g, 21.65 mmol) were suspended in 1,2-dimethoxyethane (50 mL), and H<sub>2</sub>O (15 mL) was added. The flask was fitted with a reflux condenser and placed in a preheated oil bath (90 °C) and stirred under N<sub>2</sub>. After 1.5 h, the mixture was cooled to room temperature and filtered, and the solid was washed with 1,2-dimethoxyethane. The solid was set aside, and the filtrate was concentrated, treated with Et<sub>2</sub>O, and filtered. The solid from this filtration was washed with Et<sub>2</sub>O, H<sub>2</sub>O, and three cycles of MeOH and Et<sub>2</sub>O. The solid was collected and dried to afford <b>56</b> (1.954 g, 73% purity, 62% yield). For characterization purposes, a portion (∼100 mg) was purified on HPLC (10% → 95% MeCN/H<sub>2</sub>O with 0.1% TFA over 30 min). The fractions with product were collected, concentrated, and washed with Et<sub>2</sub>O, MeOH, and Et<sub>2</sub>O. The solid was collected and dried under high vacuum in a H<sub>2</sub>O bath (50 °C). MS (ESI pos ion) <i>m</i>/<i>z</i>: 305 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.50 (s, 1H), 9.32 (s, 1H), 8.77 (s, 1H), 8.72 (s, 1H), 8.20 (d, <i>J =</i> 8.53 Hz, 1H), 7.86 (d, <i>J =</i> 8.53 Hz, 1H), 2.23 (s, 3H).</div></div><div id="sec3_3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>N</i>-(6-(6-(4-Methoxyphenylsulfonamido)pyrazin-2-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>57</b>)</h3><div class="NLM_p last">4-Methoxybenzenesulfonamide (185.6 mg, 0.9913 mmol) was dissolved in DMSO (2.0 mL), and NaH (60% in mineral oil, 54.6 mg, 1.37 mmol) was added. The mixture was stirred under N<sub>2</sub> at room temperature for 1 h, and then <b>56</b> (84.8 mg, 0.278 mmol) was added. The flask was put in a preheated oil bath (125 °C) and was stirred under N<sub>2</sub> for 22 h. The mixture was cooled to room temperature, treated with MeOH, and filtered. The filtrate was concentrated and purified on HPLC (10% → 95% MeCN/H<sub>2</sub>O with 0.1% TFA over 40 min) to afford <b>57</b> (5.0 mg, 4% yield). MS (ESI pos ion) <i>m</i>/<i>z</i>: 456 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.51 (s, 1H), 11.54 (s, 1H), 8.87 (s, 1H), 8.47 (s, 1H), 8.22 (s, 1H), 8.05 (d, <i>J =</i> 8.53 Hz, 1H), 7.97 (d, <i>J =</i> 8.53 Hz, 2H), 7.85 (d, <i>J =</i> 8.53 Hz, 1H), 7.13 (d, <i>J =</i> 8.53 Hz, 2H), 3.81 (s, 3H), 2.23 (s, 3H).</div></div><div id="sec3_3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i>-(6-(3-Aminophenyl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>59</b>)</h3><div class="NLM_p last">A mixture of <b>4a</b> (319 mg, 1.00 mmol), 3-bromobenzenamine (<b>58</b>, 0.17 g, 1.0 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (1.2 g, 1.0 mmol) in dioxane (2 mL), and aqueous Na<sub>2</sub>CO<sub>3</sub> solution (2.0 M, 1.0 mL, 2.0 mmol) was heated in the microwave at 130 W and 100 °C for 20 min. Then the mixture was diluted with DCM and H<sub>2</sub>O. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was recrystallized to give <b>59</b> (0.050 g, 18%) as a brown solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 284 (M + H<sup>+</sup>).</div></div><div id="sec3_3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>N</i>-(6-(3-(4-Methoxyphenylsulfonamido)phenyl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>60</b>)</h3><div class="NLM_p last">To a mixture of <b>59</b> (0.030 g, 0.11 mmol) and pyridine (0.03 g, 0.3 mmol) in DCM (2 g) was added 4-methoxybenzene-1-sulfonyl chloride (0.05 g, 0.2 mmol) at room temperature. The mixture was stirred for 4 h, and then pyrrolidine (0.02 g, 0.3 mmol) was added. The resulting mixture was concentrated, diluted with DMSO (2 mL), and purified by HPLC (5% → 95% MeCN/H<sub>2</sub>O). The fractions with pure product were collected, concentrated, diluted with DCM, and washed with aqueous Na<sub>2</sub>CO<sub>3</sub> solution. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to give <b>60</b> (0.035 g, 73%) as a white solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 454 (M + H<sup>+</sup>). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.39 (s, 1H), 10.26 (s, 1H), 8.12 (d, <i>J =</i> 1.61 Hz, 1H), 7.80 (d, <i>J =</i> 8.62 Hz, 1H), 7.75 (d, <i>J =</i> 8.92 Hz, 2H), 7.55 (dd, <i>J =</i> 8.55, 1.53 Hz, 1H), 7.41−7.31 (m, 3H), 7.10−7.04 (m, 3H), 3.79 (s, 3H), 2.22 (s, 3H).</div></div><div id="sec3_3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>N</i>-(5-Bromo-2-cyanopyridin-3-yl)-4-methoxybenzenesulfonamide (<b>62</b>)</h3><div class="NLM_p last">To a 100 mL round-bottomed flask was added 3-amino-5-bromopicolinonitrile <b>61</b> (0.7 g, 4 mmol) in 20 mL of THF. The solution was cooled to −40 °C and treated with LiHMDS (1.0 M in hexanes, 1 mL, 1 mmol) dropwise. The mixture was stirred for 10 min at the same temperature, and then 4-methoxybenzenesulfonyl chloride (0.9 g, 4 mmol) was added. The ice bath was removed, and the mixture was stirred at room temperature for 2 h. The mixture was then treated with brine and EtOAc, and the aqueous phase was extracted with EtOAc (2×). The combined organic phases were washed with brine, dried over MgSO<sub>4</sub>, and concentrated. Purification by ISCO chromatography provided <b>62</b> (0.1 g, 8% yield) as a white solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 368 (M + H<sup>+</sup>, <sup>79</sup>Br), 370 (M + H<sup>+</sup>, <sup>81</sup>Br). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ): 8.45 (d, <i>J =</i> 1.76 Hz, 1H), 8.30 (d, <i>J =</i> 1.76 Hz, 1H), 7.80 (d, <i>J =</i> 8.80 Hz, 2H), 7.06 (s, 1H), 7.00 (d, <i>J =</i> 8.80 Hz, 2H), 3.88 (s, 3H).</div></div><div id="sec3_3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <i>N</i>-(6-(6-Cyano-5-(4-methoxyphenylsulfonamido)pyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>63</b>)</h3><div class="NLM_p last">To a 100 mL round-bottomed flask were added <b>62</b> (100 mg, 0.272 mmol) and <b>4a</b> (108 mg, 0.339 mmol) in DME (10 mL). Argon was bubbled in for 2 min, and then aqueous Na<sub>2</sub>CO<sub>3</sub> (2 M, 5 mL, 10 mmol) was added, followed by Pd(dppf)Cl<sub>2</sub> (80 mg, 0.11 mmol). The mixture was heated at 100 °C for 2 h and then was cooled to room temperature. The mixture was diluted with EtOAc (200 mL), causing precipitation. The suspension was filtered, and the filtrate was concentrated and purified via ISCO chromatographic purification (5% → 20% MeOH/DCM) to afford <b>63</b> (5 mg, 4% yield) as a brown solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 478 (M − H). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 8.11 (d, <i>J =</i> 1.56 Hz, 1H), 8.05 (d, <i>J =</i> 1.96 Hz, 1H), 7.81 (d, <i>J =</i> 8.41 Hz, 1H), 7.78 (d, <i>J =</i> 1.96 Hz, 1H), 7.71 (d, <i>J =</i> 8.80 Hz, 2H), 7.48 (dd, <i>J =</i> 8.31, 1.66 Hz, 1H), 6.95 (d, <i>J =</i> 8.80 Hz, 2H), 3.75 (s, 3H), 2.22 (s, 3H).</div></div><div id="sec3_3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 5-Bromo-2-methylpyridin-3-amine (<b>66</b>)</h3><div class="NLM_p last">5-Bromo-2-methyl-3-nitropyridine<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (1.808 g, 8.331 mmol) was suspended in glacial acetic acid (16 mL) and H<sub>2</sub>O (4 mL), and iron powder (1.411 g, 25.27 mmol) was added in portions over 5 min. The mixture was stirred under N<sub>2</sub> at room temperature for 70 min, using a water bath to cool the reaction flask. Then the mixture was diluted with EtOAc (20 mL) and the suspension was poured into 5 N NaOH (50 mL). The resulting emulsion was filtered through a pad of Celite, which was washed with H<sub>2</sub>O and EtOAc. The layers were separated, and the aqueous phase was extracted with EtOAc (2 × 50 mL). The organic extracts and phases were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and dried under high vacuum to afford <b>66</b> (1.86 g, 95% pure at 254 nm; 44% pure at 215 nm). Yield (based on purity at 215 nm): 52%. MS (ESI pos ion) <i>m</i>/<i>z</i>: 187 (M + H<sup>+</sup>, <sup>79</sup>Br), 189 (M + H<sup>+</sup>, <sup>81</sup>Br).</div></div><div id="sec3_3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>N</i>-(6-(5-Amino-6-methylpyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>67</b>)</h3><div class="NLM_p last">Compound <b>66</b> (224.9 mg, 1.202 mmol), compound <b>4a</b> (413.7 mg, 1.300 mmol), K<sub>2</sub>CO<sub>3</sub> (549.4 mg, 3.975 mmol), and Pd(dppf)Cl<sub>2</sub>/DCM complex (108.7 mg, 0.133 mmol) were suspended in DME (5.0 mL) and H<sub>2</sub>O (1.25 mL). The flask was fitted with a reflux condenser, and argon was bubbled through for about 15 s. The flask was placed in a preheated oil bath (100 °C) and stirred under argon for 80 min. The mixture was cooled to room temperature, and the aqueous phase was removed via pipet. The mixture was then concentrated, treated with MeOH, and filtered. The solid was washed with MeOH, H<sub>2</sub>O, MeOH, and Et<sub>2</sub>O. The solid was collected and dried under high vacuum to afford <b>67</b> (179.7 mg, 50% yield). MS (ESI pos ion) <i>m</i>/<i>z</i>: 299 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.37 (br s, 1H), 8.18 (d, <i>J =</i> 1.00 Hz, 1H), 8.01 (d, <i>J =</i> 2.01 Hz, 1H), 7.79 (d, <i>J =</i> 8.53 Hz, 1H), 7.62 (dd, <i>J =</i> 8.28, 1.76 Hz, 1H), 7.21 (d, <i>J =</i> 1.51 Hz, 1H), 5.14 (s, 2H), 2.31 (s, 3H), 2.21 (s, 3H).</div></div><div id="sec3_3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>N</i>-(6-(5-(4-Methoxyphenylsulfonamido)-6-methylpyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>68</b>)</h3><div class="NLM_p last">Compound <b>67</b> (76.5 mg, 0.256 mmol), DMAP (31.4 mg, 0.257 mmol), and 4-methoxybenzene-1-sulfonyl chloride (224.7 mg, 1.087 mmol) were suspended in THF (1.5 mL) and pyridine (1.5 mL). The flask was fitted with reflux condenser and was placed in a preheated oil bath (65 °C) and stirred under N<sub>2</sub> for 90 min. More DMAP (33.2 mg, 0.272 mmol) and 4-methoxybenzene-1-sulfonyl chloride (163 mg, 0.789 mmol) were added, and stirring continued. After 4 h, more DMAP (20 mg) and 4-methoxybenzenesulfonyl chloride (85 mg, 0.41 mmol) were added. Stirring was continued for 30 min, and then the mixture was cooled to room temperature, concentrated, and purified on silica gel (20:1 → 10:1 DCM/MeOH). The fractions with product were collected, concentrated, treated with DCM, and filtered. The solid was washed with DCM and Et<sub>2</sub>O, collected, and dried under high vacuum to afford <b>68</b> (64.0 mg, 53%). MS (ESI pos ion) <i>m</i>/<i>z</i>: 469 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.43 (s, 1H), 9.82 (s, 1H), 8.64 (d, <i>J =</i> 1.96 Hz, 1H), 8.18 (d, <i>J =</i> 1.56 Hz, 1H), 7.81 (d, <i>J =</i> 8.41 Hz, 1H), 7.63 (d, <i>J =</i> 6.65 Hz, 2H), 7.62−7.56 (m, 2H), 7.11 (d, <i>J =</i> 8.80 Hz, 2H), 3.83 (s, 3H), 2.22 (s, 3H), 2.19 (s, 3H).</div></div><div id="sec3_3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>N</i>-(6-(6-Chloro-5-(4-methoxyphenylsulfonamido)pyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>70</b>)</h3><div class="NLM_p">A solution of 4-methoxybenzene-1-sulfonyl chloride (1 g, 5 mmol) and 3-amino-5-bromo-2-chloropyridine, <b>69</b> (0.45 g, 2.2 mmol), in pyridine (15 mL) was heated in a microwave vial at 100 °C for 20 min. The mixture was then concentrated and the residue was purified by silica gel column chromatography to afford the intermediate <i>N</i>-(5-bromo-2-chloropyridin-3-yl)-4-methoxybenzenesulfonamide (0.4 g, 49%).</div><div class="NLM_p last">Then <i>N</i>-(5-bromo-2-chloropyridin-3-yl)-4-methoxybenzenesulfonamide (0.15 g, 0.4 mmol), <b>4a</b> (0.18 g, 0.57 mmol), and Fibercat were mixed with 10% Na<sub>2</sub>CO<sub>3</sub> (1 mL) and 1,4-dioxane (3 mL). The mixture was heated at 100 °C for 12 min. The mixture was filtered, and the filtrate was concentrated and washed with EtOAc. The collected solid was recrystallized in MeOH to afford <b>70</b> (0.08 g, 41% yield) as a white solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 489 (M + H<sup>+</sup>). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD, δ): 8.44 (d, <i>J =</i> 2.34 Hz, 1H), 8.17 (d, <i>J =</i> 2.34 Hz, 1H), 8.11 (d, <i>J =</i> 1.61 Hz, 1H), 7.90−7.81 (m, 1H), 7.78−7.70 (m, 2H), 7.66 (dd, <i>J =</i> 8.48, 1.90 Hz, 1H), 7.07−6.97 (m, 2H), 3.85 (s, 3H), 2.29 (s, 3H). Anal. Calcd for (C<sub>21</sub>H<sub>17</sub>ClN<sub>4</sub>O<sub>4</sub>S<sub>2</sub>·0.1DCM) C, H, N.</div></div><div id="sec3_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Procedure for the Synthesis of <b>72</b>, <b>73</b>, <b>75</b>, <b>78</b>, and <b>80</b>. <i>N</i>-(6-(6-Chloro-5-(2-chlorophenylsulfonamido)pyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>75</b>)</h3><div class="NLM_p">In a 20 mL sealed tube, compound <b>69</b> (200 mg, 0.964 mmol) was dissolved in THF (2.0 mL). The solution was cooled to −78 °C, and LiHMDS (1.0 M in THF, 2.9 mL, 2.9 mmol) was added via syringe. The mixture was stirred at −78 °C for 10 min, and then 2-chlorobenzenesulfonyl chloride (203 mg, 0.964 mmol) was added. The dry ice bath was removed, and the mixture was allowed to warm to room temperature and was stirred for 17 h. Then the mixture was treated with ammonium chloride. To the mixture was added 2 N HCl to bring the aqueous phase to neutral pH. The mixture was extracted with ethyl acetate, and the organic phase was washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified via ISCO silica gel chromatography (0−50% A/B, where A = DCM/MeOH (90:10) and B = DCM). This afforded the intermediate <i>N</i>-(5-bromo-2-chloropyridin-3-yl)-2-chlorobenzenesulfonamide (200 mg, 54% yield) as a tan solid.</div><div class="NLM_p last">In a 20 mL sealed tube, dioxane (0.500 mL) was added, the solvent was purged with N<sub>2</sub> for 5 min, and the tube was sealed. Then <i>N</i>-(5-bromo-2-chloropyridin-3-yl)-2-chlorobenzenesulfonamide (75 mg, 0.196 mmol), <b>4b</b> (64 mg, 0.22 mmol), and Na<sub>2</sub>CO<sub>3</sub> (42 mg, 0.39 mmol) were added, and the flask was again purged with N<sub>2</sub> and sealed. Finally, Pd(dppf)Cl<sub>2</sub> (7.2 mg, 0.0098 mmol) was added, and the flask was purged with N<sub>2</sub>, sealed, and heated to 100 °C while the mixture was stirred for 1 h. The mixture was cooled to room temperature, concentrated, and extracted with DCM. A few drops of 2 N HCl were added, and the organic phase was washed with H<sub>2</sub>O (2×), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified via ISCO silica gel chromatography (0% → 100% A/B, where A = DCM/MeOH (90:10) and B = DCM) to afford <b>75</b> (23 mg, 93% purity, 24% yield) as a red solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 493 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.44 (s, 1H), 10.68 (br s, 1H), 8.62 (d, <i>J =</i> 2.15 Hz, 1H), 8.32 (d, <i>J =</i> 1.56 Hz, 1H), 8.02 (d, <i>J =</i> 2.35 Hz, 1H), 7.95 (dd, <i>J =</i> 7.92, 1.27 Hz, 1H), 7.83 (d, <i>J =</i> 8.41 Hz, 1H), 7.72−7.64 (m, 3H), 7.52−7.48 (m, 1H), 2.22 (s, 3H). Analytical HPLC: 94.5%.</div></div><div id="sec3_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> <i>N</i>-(6-(6-Chloro-5-(2-(trifluoromethyl)phenylsulfonamido)pyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>72</b>)</h3><div class="NLM_p last">Using 2-(trifluoromethyl)benzene-1-sulfonyl chloride and following the procedure used to prepare <b>75</b> gave <b>72</b> in 45% yield for the sulfonylation step and 62% yield for the Suzuki step. In addition, for the Suzuki coupling, microwave irradiation at 140 °C for 5 min was used. The final compound was purified by MPLC (Teledine ISCO Combiflash Companion). The crude residue was taken up in minimal DCM/MeOH and absorbed onto a minimal amount of silica gel, which was then packed into a 25 g custom loading cartridge and passed through a Redi-Sep prepacked silica gel column (80 g) using 99:1 DCM/MeOH → 95:5 DCM/MeOH. The resulting solid was triturated from MeOH and collected by vacuum filtration to afford <b>72</b> (72 mg, 62% yield) as a colorless amorphous solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 527 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.45 (s, 1H), 10.60 (br s, 1H), 8.66 (d, <i>J</i> = 2.25 Hz, 1H), 8.07 (d, <i>J</i> = 2.35 Hz, 1H), 8.05−7.98 (m, 2H), 7.81−7.92 (m, 3H), 7.71 (dd, <i>J</i> = 8.46, 1.91 Hz, 1H), 2.22 (s, 3H).</div></div><div id="sec3_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> <i>N</i>-(6-(6-Chloro-5-(3-(trifluoromethyl)phenylsulfonamido)pyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>73</b>)</h3><div class="NLM_p last">This material was prepared using an analogous procedure as was used for the preparation of <b>75</b>. For the Suzuki step, microwave heating at 100 °C with 100 W of power was used for 10 min. In addition, Cs<sub>2</sub>CO<sub>3</sub> was used instead of Na<sub>2</sub>CO<sub>3</sub>. MS (ESI pos ion) <i>m</i>/<i>z</i>: 527 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.39 (s, 1H), 8.08−7.99 (m, 3H), 7.91−7.62 (m, 5H), 7.46 (d, <i>J =</i> 7.53 Hz, 1H), 2.21 (s, 3H).</div></div><div id="sec3_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> <i>N</i>-(6-(5-(3-<i>tert</i>-Butylphenylsulfonamido)-6-chloropyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>78</b>)</h3><div class="NLM_p last">Using 3-(<i>tert</i>-butyl)benzene-1-sulfonyl chloride and following the procedure used to prepare <b>75</b> gave <b>78</b> in 99% yield for the sulfonylation step and 18% yield for the Suzuki step. For the Suzuki step, microwave heating at 100 °C with 100 W of power was used for 10 min. In addition, Cs<sub>2</sub>CO<sub>3</sub> was used instead of Na<sub>2</sub>CO<sub>3</sub>. MS (ESI pos ion) <i>m</i>/<i>z</i>: 515 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.46 (s, 1H), 10.37 (br s, 1H), 8.58 (s, 1H), 8.27 (s, 1H), 7.92 (s, 1H), 7.82 (d, <i>J =</i> 8.03 Hz, 1H), 7.74−7.67 (m, 2H), 7.64 (d, <i>J =</i> 8.03 Hz, 1H), 7.59 (d, <i>J =</i> 7.03 Hz, 1H), 7.54−7.46 (m, 1H), 2.22 (s, 3H), 1.22 (s, 9H).</div></div><div id="sec3_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>N</i>-(6-(6-Chloro-5-(2-fluorophenylsulfonamido)pyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>80</b>)</h3><div class="NLM_p last">Using 2-fluorobenzene-1-sulfonyl chloride and following the procedure used to prepare <b>75</b> gave <b>80</b> in 87% yield for the sulfonylation step and 61% yield for the Suzuki step. For the Suzuki coupling, microwave irradiation at 140 °C for 5 min was used. The crude material from the Suzuki step was purified by MPLC (Teledine ISCO Combiflash Companion) following the procedure outlined for compound <b>72</b>. The final compound was purified via trituration from DCM and filtration. MS (ESI pos ion) <i>m</i>/<i>z</i>: 477 (M + H<sup>+</sup>). 1H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.45 (s, 1H), 10.79 (br s, 1H), 8.65 (d, <i>J =</i> 2.05 Hz, 1H), 8.36 (d, <i>J =</i> 1.66 Hz, 1H), 8.09 (s, 1H), 7.85 (d, <i>J =</i> 8.41 Hz, 1H), 7.81−7.69 (m, 3H), 7.47 (dd, <i>J =</i> 10.03, 8.46 Hz, 1H), 7.40−7.32 (m, 1H), 2.24 (s, 3H).</div></div><div id="sec3_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Procedure for the Synthesis of <b>71</b>, <b>74</b>, <b>76</b>, <b>77</b>, <b>79</b>, <b>81</b>, and <b>82</b>. <i>N</i>-(6-(6-Chloro-5-(phenylsulfonamido)pyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>71</b>)</h3><div class="NLM_p">Compound <b>69</b> (1.00 g, 4.82 mmol), compound <b>4a</b> (1.73 g, 5.45 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (0.836 g, 0.723 mmol), and K<sub>2</sub>CO<sub>3</sub> (2.20 g, 15.9 mmol) were suspended in 1,4-dioxane (25 mL), and H<sub>2</sub>O (2.5 mL) was added. Argon was bubbled through the suspension for 30 s, and the flask was fitted with a reflux condenser and was placed in a preheated oil bath (100 °C). The mixture was stirred under an inert atmosphere. The mixture was cooled to room temperature after 3 h and then was diluted with DCM and saturated NaHCO<sub>3</sub>. The organic layer was extracted with DCM (3 × 30 mL), and the organic phases were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was diluted with EtOAc and the precipitate was collected by filtration and washed with hexanes to give the intermediate <i>N</i>-(6-(5-amino-6-chloropyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (0.500 g, 32.5% yield) as a brown crystalline solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 319 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.41 (br s, 1H), 8.24 (s, 1H), 7.94 (s, 1H), 7.81 (d, <i>J =</i> 8.53 Hz, 1H), 7.65 (d, <i>J =</i> 8.03 Hz, 1H), 7.42 (s, 1H), 5.66 (s, 2H), 2.22 (s, 3H).</div><div class="NLM_p last">Then a 50 mL round-bottomed flask equipped with stir bar was charged with <i>N</i>-(6-(5-amino-6-chloropyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (50 mg, 0.16 mmol) and THF (1.5 mL). Benzenesulfonyl chloride (0.30 mL, 2.4 mmol), DMAP (1.1 mg, 0.0094 mmol), and pyridine (1.0 mL, 13 mmol) were added. The mixture was allowed to stir under an inert atmosphere at ambient temperature until LCMS analysis indicated that the product was present. The mixture was diluted with DCM and saturated NaHCO<sub>3</sub> and then was extracted with DCM (3 × 25 mL). The organics were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and purified by ISCO silica gel chromatography in a gradient of 10% → 50% EtOAc/DCM over 35 min to afford <b>71</b> (50 mg, 69% yield) as a white crystalline solid. MS (ESI pos ion) <i>m</i>/<i>z</i>: 459 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.46 (s, 1H), 10.44 (br s, 1H), 8.61 (d, <i>J =</i> 2.01 Hz, 1H), 8.32 (d, <i>J =</i> 1.51 Hz, 1H), 7.99 (d, <i>J =</i> 2.51 Hz, 1H), 7.84 (d, <i>J =</i> 8.53 Hz, 1H), 7.79−7.74 (m, 2H), 7.70−7.64 (m, 2H), 7.62−7.56 (m, 2H), 2.23 (s, 3H).</div></div><div id="sec3_5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>N</i>-(6-(6-Chloro-5-(4-(trifluoromethyl)phenylsulfonamido)pyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>74</b>)</h3><div class="NLM_p last">Using 4-(trifluoromethyl)benzenesulfonyl chloride and following the procedure used to prepare <b>71</b> gave <b>74</b> in 8% yield. To isolate the crude material, H<sub>2</sub>O was added, and the mixture was stirred at room temperature for 1 h. The resultant precipitate was collected by filtration and purified by ISCO silica gel chromatography in a gradient of 1% → 10% MeOH/DCM over 35 min. MS (ESI pos ion) <i>m</i>/<i>z</i>: 527 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.42 (br s, 1H), 8.54 (d, <i>J =</i> 1.51 Hz, 1H), 8.24 (d, <i>J =</i> 1.51 Hz, 1H), 8.01−7.99 (m, 5H), 7.81 (d, <i>J =</i> 8.53 Hz, 1H), 7.65 (dd, <i>J =</i> 8.53, 1.51 Hz, 1H), 2.22 (s, 3H).</div></div><div id="sec3_5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> <i>N</i>-(6-(6-Chloro-5-(3-chlorophenylsulfonamido)pyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>76</b>)</h3><div class="NLM_p last">Using 3-chlorobenzenesulfonyl chloride and following the procedure used to prepare <b>71</b> gave <b>76</b> in 19% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 493 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.46 (s, 1H), 10.64 (br s, 1H), 8.34 (s, 1H), 8.02 (d, <i>J =</i> 2.01 Hz, 1H), 7.84 (d, <i>J =</i> 8.53 Hz, 1H), 7.81−7.75 (m, 2H), 7.74−7.67 (m, 2H), 7.65−7.59 (m, 1H), 2.23 (s, 3H).</div></div><div id="sec3_5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> <i>N</i>-(6-(6-Chloro-5-(4-chlorophenylsulfonamido)pyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>77</b>)</h3><div class="NLM_p last">Using 4-chlorobenzenesulfonyl chloride and following the procedure used to prepare <b>71</b> gave <b>77</b> in 24% yield. The following modifications were made: The sulfonylation reaction was run using only pyridine as the solvent, and the final compound was purified by ISCO silica gel chromatography using a gradient of 0% → 10% MeOH/DCM over 30 min. MS (ESI pos ion) <i>m</i>/<i>z</i>: 493 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.46 (s, 1H), 10.57 (br s, 1H), 8.63 (s, 1H), 8.33 (s, 1H), 8.02 (s, 1H), 7.84 (d, <i>J =</i> 8.03 Hz, 1H), 7.79−7.64 (m, 5H), 2.23 (s, 3H).</div></div><div id="sec3_5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> <i>N</i>-(6-(6-Chloro-5-(4-<i>tert</i>-butylphenylsulfonamido)pyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>79</b>)</h3><div class="NLM_p last">Using 4-<i>tert</i>-butylbenzenesulfonyl chloride and following the procedure used to prepare <b>71</b> gave <b>79</b> in 16% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 515 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.39 (s, 1H), 7.94 (br s, 1H), 7.78−7.70 (m, 2H), 7.68 (d, <i>J =</i> 8.53 Hz, 2H), 7.63 (br s, 1H), 7.45−7.37 (m, 3H), 2.21 (s, 3H), 1.26 (s, 9H).</div></div><div id="sec3_5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> <i>N</i>-(6-(6-Chloro-5-(3-fluorophenylsulfonamido)pyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>81</b>)</h3><div class="NLM_p last">Using 3-fluorobenzenesulfonyl chloride and following the procedure used to prepare <b>71</b> gave <b>81</b> in 40% yield. MS (ESI pos ion) <i>m</i>/<i>z</i>: 477 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.46 (s, 1H), 10.62 (br s, 1H), 8.62 (d, <i>J =</i> 1.51 Hz, 1H), 8.34 (s, 1H), 8.02 (d, <i>J =</i> 1.51 Hz, 1H), 7.84 (d, <i>J =</i> 8.53 Hz, 1H), 7.71 (d, <i>J =</i> 8.03 Hz, 1H), 7.67−7.57 (m, 4H), 2.22 (s, 3H).</div></div><div id="sec3_5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> <i>N</i>-(6-(6-Chloro-5-(4-fluorophenylsulfonamido)pyridin-3-yl)benzo[<i>d</i>]thiazol-2-yl)acetamide (<b>82</b>)</h3><div class="NLM_p last">Using 4-fluorobenzenesulfonyl chloride and following the procedure used to prepare <b>71</b> gave <b>82</b> in 57% yield. The following modifications were made: The sulfonylation reaction was run using only pyridine as the solvent, and crude product was collected by treating the mixture with H<sub>2</sub>O and filtering the resulting suspension. The solid was washed with H<sub>2</sub>O and EtOAc and recrystallized from MeOH to afford <b>82</b> as a white powder. MS (ESI pos ion) <i>m</i>/<i>z</i>: 477 (M + H<sup>+</sup>). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ): 12.47 (s, 1H), 10.50 (br s, 1H), 8.64 (d, <i>J =</i> 2.34 Hz, 1H), 8.35 (d, <i>J =</i> 1.61 Hz, 1H), 8.04 (d, <i>J =</i> 2.34 Hz, 1H), 7.88−7.78 (m, 3H), 7.72 (dd, <i>J =</i> 8.48, 1.90 Hz, 1H), 7.48−7.40 (m, 2H), 2.23 (s, 3H).</div></div><div id="sec3_6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> In Vitro Assays. PI3K Enzyme Assay</h3><div class="NLM_p">Human p110-α, -β, and -δ with N-terminal poly-His tags were coexpressed with p85-α in a Sf9 baculovirus expression system. p110-δ/p85 heterodimers were purified by sequential Ni-NTA, Q-HP, Superdex-100 chromatography. A truncated form of PI3Kγ encompassing residues 114−1102, N-terminally labeled with poly-His tag, was expressed with baculovirus in Hi5 insect cells and purified by sequential Ni-NTA, Superdex-200, Q-HP chromatography.</div><div class="NLM_p">The inhibition of PI3K activity was determined using a modified in vitro AlphaScreen assay.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> From a starting concentration of 5 mM, test compounds were serially diluted 1:2 across 384-well Greiner clear polypropylene plates (supplier) to yield 22 test concentrations. Columns 23 and 24 contained only DMSO and were designated for positive and negative controls. Source plates were replicated into 384-well Optiplates (PerkinElmer, Waltham, MA), 0.5 μL/well, to make assay-ready plates. PI3K enzyme was diluted in enzyme reaction buffer (50 mM Tris-HCl, pH 7, 14 mM MgCl<sub>2</sub>, 2 mM sodium cholate, 100 mM NaCl, and 2 mM DTT) to give 2× working solutions. PI3Kα and PI3Kδ were diluted to 1.6 nM. PI3Kβ was diluted to 0.8 nM, and PI3Kγ was diluted to a final concentration of 15 nM. 2× substrate solutions containing 10 μM PI(4,5)P2 (Echelon Biosciences, Salt Lake City, UT) were generated containing either 20 μM ATP, used in the assays testing PI3Kα and PI3Kβ, or 8 μM ATP used in the assays testing PI3Kγ and PI3Kδ. By use of a 384-well dispensing Multidrop (Titertek, Huntsville, AL), 10 μL of 2× enzyme reaction mixture and 10 μL of the appropriate substrate solution were then added to columns 1−24 of the 384-well containing serially diluted test compound. Plates were then incubated at room temperature for 20 min.</div><div class="NLM_p last">The reaction was subsequently terminated by the addition of 10 μL/well of the donor bead solution composed of 40 nM biotinylated-IP<sub>4</sub> (Echelon Biosciences, Salt Lake City, UT), 80 μg/mL streptavadin-donor beads diluted in AlphaScreen reaction buffer (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.10% Tween 20, and 30 mM EDTA). The plates were incubated at room temperature in the dark for 30 min. Then 10 μL of the acceptor bead solution, containing 40 nM PIP<sub>3</sub>-binding protein (Echelon Biosciences, Salt Lake City, UT) and 80 μg/mL anti-GST-acceptor beads diluted in α screen reaction buffer, was then added to each well. The plates were then incubated in the dark for an additional 1.5 h prior to being read on an Envision multimode plate reader (PerkinElmer, Waltham, MA) with a 680 nm excitation filter and a 520−620 nm emission filter. IC<sub>50</sub> determinations were analyzed using the Genedata Screener (ALDI) high content data analysis program nonlinear regression Hill equations.</div></div><div id="sec3_6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> mTOR LanthaScreen Assay</h3><div class="NLM_p">The mTOR LanthaScreen is a TR-FRET assay measuring the phosphorylation of mTOR’s substrate 4EBP1. The 384-well compound plates were prepared by Amgen’s sample bank containing 1 μL of compound per well starting at 5 mM and diluted 1:2 across the row, resulting in a 22-well serial dilution. Then 24 μL of assay buffer (Invitrogen, PV4794) with 2 mM DTT was added to the compound plate in rows 1−24 using the VELOCITY11 VPREP 384 ST, resulting in a DMSO concentration of 4%. The compound plate was mixed, and 2.5 μL of serially diluted compound or controls was added to the assay plate (Costar, 3658).</div><div class="NLM_p">The assay was conducted on the PerkinElmer FlexDrop PLUS. A 5 μL mix of 800 nM GFP-4E-BP1 (Invitrogen, PV4759) and 20 μM ATP (Amgen) was added to rows 1−24. Then 2.5 μL of 0.6 μg/mL of recombinant mTOR (Amgen, N-terminal GST-tagged mTOR fragment spanning amino acids 1360−2549) was added to rows 1−23. An amount of 2.5 μL of assay buffer was added to row 24 for the low control. The final concentration of the compounds was 50 μM serially diluted to 23.84 pM in 1% DMSO. The final high control had 1% DMSO, and the low control was a no enzyme control with a concentration of 1% DMSO. The final concentrations of the assay reagents were 400 nM GFP-4E-BP1, 10 μM of ATP, and 0.15 μg/mL mTOR enzyme. Compound, enzyme, and substrate were incubated for 90 min. At this point, 10 μL of stop solution was added (20 mM Tris, pH 7.5 (Invitrogen, 15567-027), 0.02% sodium azide (Teknova, S0208), 0.01% NP-40 (Roche, 11754599001), 20 mM EDTA (Invitrogen, 15575-038), and 4 nM Tb-anti-p4E-BP1 (Invitrogen, PV4758)) for a final concentration of 2 nM Tb-anti-p4E-BP1. The mixtures were then incubated for 60 min.</div><div class="NLM_p last">The plates were read on the PerkinElmer EnVision 2103 multilable reader using the excitation filter 340 nm and the emission filters 520 and 495 nm. The ratio of 520 nm/495 nm was calculated, and the POC data were analyzed to report the IC<sub>50</sub> IP for the phosphorylation of 4EBP1. IC<sub>50</sub> values were determined by Genedata Screener software using an Amgen designed fit strategy.</div></div><div id="sec3_6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> DNA-PK LanthaScreen Enzyme Assay</h3><div class="NLM_p last">IC<sub>50</sub> values for the inhibition of the DNA-PK were measured using a LanthaScreen TR-FRET enzyme assay. The enzyme assay was carried out in 384-well polystyrene low volume plates. All reagents were diluted in kinase buffer (50 mM HEPES (pH 7.5), 10 mM MgCl<sub>2</sub>, 1 mM EGTA, 0.01% Brij-35, and 1 mM DTT). The 3-fold, 10-point serial compound dilutions (4×) were prepared in kinase buffer (20% DMSO) with a top concentration of 12 μM and aliquoted into assay plates in 2.5 μL/well volumes. A 4× substrate working stock solution containing 44 μM ATP, 1600 nM fluorescein-p53 [Ser15] peptide (Invitrogen, PV5132), and 10 μg/mL sheared calf thymus DNA (Invitrogen, 15633-019) was prepared in kinase buffer and aliquoted into the assay plate in 2.5 μL/well volumes. The reaction was initiated by adding 5 μL/well of a 2× enzyme working stock solution containing 2 U/μL of DNA-PK enzyme (Promega, 9PIV581) prepared in kinase buffer. The enzyme reaction was carried out for 30 min before being terminated by adding 10 μL/well of a 2× termination solution containing 20 mM EDTA and 4 nM Tb-anti-phospho-p53(S15) Ab (Invitrogen, PV5130) solution. The assay plate was then incubated at room temperature for 1 h and read on a Tecan Safire II. IC<sub>50</sub> values were determined by Genedata Screener software using an Amgen designed fit strategy.</div></div><div id="sec3_6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> hVPS34 LanthaScreen Enzyme Assay</h3><div class="NLM_p last">IC<sub>50</sub> values for the inhibition of hVPS34 were measured using a fluorescence-based immunoassay for the detection of ADP (Adapta universal kinase assay kit, Invitrogen, PV5099). The enzyme assay was carried out in 384-well polystyrene low volume plates. All reagents were diluted in kinase buffer (50 mM HEPES (pH 7.5), 0.1% CHAPS, 1 mM EGTA, 2 mM MnCl<sub>2,</sub> 2 mM DTT). The 3-fold, 10-point serial compound dilutions (4×) were prepared in kinase buffer (4% DMSO) with a top concentration of 36 μM and aliquoted into assay plates in 2.5 μL/well volumes. A 4× enzyme working solution was prepared by diluting hVPS34 (Invitrogen, PV5126) in kinase buffer to 650 μg/mL and aliquoted into assay plates in 2.5 μL/well volumes. The reaction was initiated by adding 5 μL/well of a 2× substrate working stock solution containing 200 μM phosphatidylinositol/phosphatidylserine (Invitrogen, PV5122) and 20 μM ATP. The enzyme reaction was carried out at room temperature for 30 min before being terminated with 5 μL/well of kinase quench buffer containing 30 mM EDTA, 6 nM ADP-Ab, and 15 nM ADP-tracer. The assay plate was then incubated at room temperature for 30 min and read on a Tecan Safire II. IC<sub>50</sub> values were determined by Genedata Screener software using an Amgen designed fit strategy.</div></div><div id="sec3_6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Akt (Ser 473) Phosphorylation Cell Based Assay</h3><div class="NLM_p">U-87 MG cells diluted to 0.25 million cells/mL were plated at 20 μL per well in 384-well white tissue culture plates. The plates were then incubated overnight at 37 °C at 5% CO<sub>2</sub> in MEM supplemented with 10% FBS, nonessential amino acids, and <span class="smallcaps smallerCapital">l</span>-glutamine (all purchased from Gibco, Carlsbad, CA).</div><div class="NLM_p">The 384-well compound plates were prepared containing 1 μL of compound per well at a starting concentration of 5 mM and diluted 1:2 to produce a 22-well serial dilution. Then 39 μL of growth medium was added to the compound plate in rows 1−22 using the PerkinElmer FlexDrop PLUS, resulting in a DMSO concentration of 2.5%. The cell plates and diluted compound plates were put onto the VELOCITY11 VPREP 384 ST where the compound plate was mixed, and 5 μL of serially diluted compound or controls was added to the cell plate. The final concentration of the compounds was 25 μM serially diluted to 11.9 pM in 0.5% DMSO. The cell plates were then incubated with compound for 2 h at 37 °C, 5% CO<sub>2</sub>. After 2 h, the medium in the cell plates was aspirated using the BioTek ELx405HT plate washer (Winooski, VT), removing most of the medium and compound without disturbing the adherent U-87 MG cells.</div><div class="NLM_p last">Akt (Ser 473) phosphorylation was determined using a SureFire Akt (Ser 473) phosphorylation (TGR BioSciences, Adelaide, Austalia) and IgG detection kits (PerkinElmer, Waltham, MA). An amount of 5 μL of 1× lysis buffer was added to each well using the PerkinElmer FlexDrop PLUS. The plates were then incubated at room temperature on a shaker for 10 min. The AlphaScreen reaction was then prepared under low light conditions (subdued or green light) containing p-Akt(Ser 473) reaction buffer, dilution buffer, activation buffer, acceptor beads, and donor beads at a ratio of 40:20:10:1:1, respectively. The AlphaScreen reaction was added to the cell lysate at 6 μL per well using the PerkinElmer FlexDrop PLUS. The plates were placed in a humid environment to reduce edge effects and incubated overnight at room temperature with restricted air flow in the dark. The plates were read on the PerkinElmer EnVision 2103 multilable reader using the standard AlphaScreen readout. IC<sub>50</sub> values were then determined by Genedata Screener software using an Amgen designed fit strategy.</div></div><div id="sec3_6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> U-87 MG and PC3 Cell Viability Assay</h3><div class="NLM_p last">U-87 MG and PC-3 tumor cells were seeded at a density of 3000 cells/well (U-87 MG-growth medium containing MEM supplemented with 10% FBS, 1× nonessential amino acids, and 1× <span class="smallcaps smallerCapital">l</span>-glutamine (all purchased from Invitrogen); PC-3 growth medium containing RPMI supplemented with 10% FBS and 1× <span class="smallcaps smallerCapital">l</span>-glutamine (all purchased from Invitrogen)) in 96-well tissue culture plates and subsequently incubated overnight at 37 °C and 5% CO<sub>2</sub> to allow cells to adhere to the plate. Ten-point 1:3 serial dilutions of compound <b>82</b> were prepared in DMSO and added to cells, covering a dose range of 10 μM to 500 pM. ATPlite one-step viability assays (Perkin-Elmer, 6016731) were carried out following 72 h of compound treatment. IC<sub>50</sub> IP values were calculated with XLfit (IDBS software), applying a four-parameter logistic model for curve fitting. Mean IC<sub>50</sub> IP values are reported from a minimum of two experiments.</div></div><div id="sec3_7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> In Vivo Assays. PD Assay</h3><div class="NLM_p">Four- to five-week old female CD1 nude mice (Charles Rivers Laboratories) were used in all In Vivo studies. For the liver PD assay, mice were dosed orally (via gavage) with compound <b>82</b> at different doses as indicated. Three hours after dosing, 0.2 mL of recombinant human HGF (0.06 mg/mL) was administrated through the tail of each mouse (12 μg/mouse). After 5 min, animals were anesthetized and sacrificed and blood samples were collected and placed in heparinized tubes. Blood samples were then centrifuged to obtain the plasma for PK analysis. Liver tissues were harvested and fast-frozen in liquid nitrogen for analysis of Akt (Ser 473) phosphorylation.</div><div class="NLM_p">For Akt (Ser 473) phosphorylation analysis, each liver was homogenized in 1 mL of ice-cold MSD lysis buffer (containing 150 mM NaCl, 20 mM Tris, pH 7.5, 1 mM EDTA, 1 mM EGTA, 1% Triton-X-100, 1/10 protease inhibitor tablet (Roche, catalog no. 1836170), 20 μL of phosphatase inhibitor I (Sigma-Aldrich, Inc., catalog no. P-2850), 20 μL of phosphatase inhibitor II (Sigma-Aldrich, Inc., catalog no. P-5726) and 40 mM NaF) with GenoGrinder 2000 (BT&C Inc., product no. SP2100-115) at 350 strokes/min for 2 min at room temperature. The lysate was centrifuged (2×) in a 1.5 mL Eppendorf microcentrifuge tube at 14 000 rpm for 15 min at 4 °C. The supernatant was precleared with Protein A/G beads (PIERCE, product no. 20421) in an Eppendorf microcentrifuge tube at 4 °C for 1 h. The beads were centrifuged at 14 000 rpm for 15 min at 4 °C, and the supernatant was transferred to a clean Eppendorf microcentrifuge tube. The protein concentration of each sample was determined using Bio-Rad DC protein assay (Bio-Rad, catalog no. 500-0116) and normalized to a final concentration of 1 mg/mL. The level of phosphorylated Akt(S473) and total Akt in mouse liver lysates were detected using Meso Scale Discovery phospho-Akt(S473) (catalog no. K151CAD-2) and total Akt (catalog no. K151CBD-2) whole cell lysate kits. pAkt(S473) MSD plate and total Akt MSD plate were blocked with 150 μL of MSD blocking solution (containing 3% bovine serum albumin, 50 mM Tris, pH 7.5, 150 mM NaCl, and 0.02% Tween-20) and incubated at room temperature for 1 h. The plates were then washed (4×) with 300 μL of MSD Tris wash buffer (containing 50 mM Tris, pH 7.5, 150 mM NaCl, and 0.02% Tween-20). An amount of 25 μL (1mg / mL) of liver lysate was dispensed to each well of the MSD plate. The plate was incubated with shaking in Eppendorf thermonixer R (Eppendorf, product no. 22670107) at 600 rpm at room temperature for 2 h. The plate was then washed four times with 300 μL of MSD Tris wash buffer. An amount of 25 μL (1.5 μg/mL) of anti-pAkt(S473) or antitotal Akt detection antibody solution was added to each well of the MSD plate. The plate was incubated with shaking in Eppendorf Thermomixer R at 600 rpm at room temperature for 1 h. The plate was then washed (4×) with 300 μL of MSD Tris wash buffer. An amount of 150 μL of 1× MSD read buffer was added to each well of the MSD plate. The intensity of pAkt(S473) or total Akt signal was measured using MSD sector imager 6000.</div><div class="NLM_p last">The raw phosphorylated Akt(S473) values were divided by the ratio of the mean of total Akt in each group in order to adjust the values for phosphorylated Akt(S473) data to account for varying total Akt levels in individual tissue samples. All results were expressed as the mean ± standard error. Statistical analysis was performed by analysis of variance (ANOVA) followed by Bonferroni−Dunn post hoc test.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Xenograft Studies</h3><div class="NLM_p last">Mice were injected subcutaneously with 0.2 mL of tumor cell suspension in medium mixed with 1:1 ratio of matrigel (BD Bioscience), which contains 5 × 10<sup>6</sup> U-87 MG cells (ATCC), 5 × 10<sup>6</sup> A549 cells (ATCC), or 2 × 10<sup>6</sup> HCT116 cells (ATCC). Subconfluent cells were harvested prior to injection. Ten to thirteen days after tumor cell inoculation, when the tumor volume had reached ∼200 mm<sup>3</sup>, animals were divided randomly into test groups (each with 10 mice), and the daily oral administration of <b>82</b> at indicated doses began and continued to the end of each study. Tumor volumes and body weights were recorded at intervals of 3 or 4 days. Tumor volume was calculated as length × width × width/2 and is in mm<sup>3</sup>. Results are expressed as the mean ± standard error. The data were statistically analyzed with ANOVA or ANOVA followed by RM-ANOVA for repeated measurements (JMP 7). Mice were euthanized with CO<sub>2</sub> asphyxiation, and final plasma samples were harvested for PK analysis. All experiments were conducted in accordance with institutional guidelines, which include mandates for sacrificing mice when tumors exceed size thresholds.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Crystallography: Determination of p110γ Crystal Structures</h3><div class="NLM_p last">Human p110γ(144−1102) was expressed, purified, and crystallized according to published procedures.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Inhibitor complexes were obtained by soaking apo crystals overnight in cryo solutions (mother liquor plus 20% glycerol) containing 1 mM compound. Crystals were then flash-frozen in liquid nitrogen prior to data collection. Diffraction data for p110γ + <b>1</b> were collected at the Advanced Photon Source, beamline 31-ID using λ = 0.9793 Å and a MAR 165 mm CCD detector. Diffraction data for p110γ + <b>82</b> were collected on a FR-E rotating anode X-ray source equipped with an RAXIS IV++ detector. Data were reduced using the HKL software suite,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> and the structures were solved by molecular replacement using apo human p110γ as a search model (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E8Y">1E8Y</a>). Structures were refined using REFMAC,<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a> and model building was performed with COOT.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i100"><a href="/doi/suppl/10.1021/jm1014605">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36577" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36577" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic methods used for analogues <b>14</b>−<b>45</b>, X-ray data for <b>1</b> and <b>82</b>, enzyme selectivity data for <b>82</b>, analytical HPLC methods, and PD data for compound <b>73</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm1014605/suppl_file/jm1014605_si_001.pdf">jm1014605_si_001.pdf (182.05 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm1014605" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25512" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25512" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Noel D. D’Angelo</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e185808f86848d8ea1808c86848fcf828e8c"><span class="__cf_email__" data-cfemail="8febeee1e8eae3e0cfeee2e8eae1a1ece0e2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tae-Seong Kim</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristin Andrews</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shon K. Booker</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean Caenepeel</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kui Chen</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Derin D’Amico</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Freeman</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Jiang</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Longbin Liu</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John D. McCarter</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tisha San Miguel</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erin L. Mullady</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Schrag</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raju Subramanian</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin Tang</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert C. Wahl</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ling Wang</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas A. Whittington</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tian Wu</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ning Xi</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang Xu</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Yakowec</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Yang</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leeanne P. Zalameda</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nancy Zhang</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Hughes</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark H. Norman</span> - <span class="hlFld-Affiliation affiliation">Departments of ⊥High-Throughput Screening/Molecular Pharmacology, †Medicinal Chemistry, ‡Molecular Structure, §Oncology Research, ∥Pharmaceutics, and #Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departments of ¶High-Throughput Screening/Molecular Pharmacology and ○Molecular Structure, Amgen Inc., 360 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i99">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Teresa Burgess, Randall Hungate, Richard Kendall, Robert Radinsky, and Terry Rosen for their support and direction of this work. We also thank Yunxin Bo, Derin D’Amico, Lillian Liao, Philip Olivieri, and Emily Peterson for their contributions of specific compounds and intermediates to this manuscript. Finally, we thank Paul Andrews for his support with the cellular assay.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56120" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56120" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">After this paper was published online February 18, 2011, three authors were added to the author list (Derin D'Amico, Longbin Liu, and Kevin Yang). The revised version was published March 1, 2011.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i101" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i101"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i102" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i102"> Abbreviations Used</h2><tr><td class="NLM_term">Ac</td><td class="NLM_def"><p class="first last">acetyl</p></td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">serine−threonine kinase Akt</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">1,2-dimethoxyethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">EC</td><td class="NLM_def"><p class="first last">effective concentration</p></td></tr><tr><td class="NLM_term">ED</td><td class="NLM_def"><p class="first last">effective dose</p></td></tr><tr><td class="NLM_term">HGF</td><td class="NLM_def"><p class="first last">hepatocyte growth factor</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamic</p></td></tr><tr><td class="NLM_term">PIP2</td><td class="NLM_def"><p class="first last">phosphatidylinositol 4,5-biphosphate</p></td></tr><tr><td class="NLM_term">PIP3</td><td class="NLM_def"><p class="first last">phosphatidylinositol 3,4,5-triphosphate</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PTEN</td><td class="NLM_def"><p class="first last">phosphatase and tensin homologue gene</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsomes</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure−activity relationship</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TFE</td><td class="NLM_def"><p class="first last">trifluoroethanol</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">Xantphos</td><td class="NLM_def"><p class="first last">4,5-bis(diphenylphosphino)-9,9-dimethylxanthene</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i103">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57304" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57304" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 64 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Engleman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">The Evolution of Phosphatidylinositol 3-Kinases as Regulators of Growth and Metabolism</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1038%2Fnrg1879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=16847462" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=606-619&author=J.+A.+Englemanauthor=J.+Luoauthor=L.+C.+Cantley&title=The+Evolution+of+Phosphatidylinositol+3-Kinases+as+Regulators+of+Growth+and+Metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrg1879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg1879%26sid%3Dliteratum%253Aachs%26aulast%3DEngleman%26aufirst%3DJ.%2BA.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520Evolution%2520of%2520Phosphatidylinositol%25203-Kinases%2520as%2520Regulators%2520of%2520Growth%2520and%2520Metabolism%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2006%26volume%3D7%26spage%3D606%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Marone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cmiljanovic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span> </span><span class="NLM_article-title">Targeting Phosphoinositide 3-Kinase: Moving towards Therapy</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=159-185&author=R.+Maroneauthor=V.+Cmiljanovicauthor=B.+Gieseauthor=M.+P.+Wymann&title=Targeting+Phosphoinositide+3-Kinase%3A+Moving+towards+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarone%26aufirst%3DR.%26aulast%3DCmiljanovic%26aufirst%3DV.%26aulast%3DGiese%26aufirst%3DB.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3DTargeting%2520Phosphoinositide%25203-Kinase%253A%2520Moving%2520towards%2520Therapy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26spage%3D159%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. J.</span><span> </span><span class="NLM_article-title">Targeting the Phosphoinositide 3-Kinase Pathway in Cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1038%2Fnrd2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=19644473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627-644&author=P.+Liuauthor=H.+Chengauthor=T.+M.+Robertsauthor=J.+J.+Zhao&title=Targeting+the+Phosphoinositide+3-Kinase+Pathway+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span></div><div class="casAuthors">Liu, Pixu; Cheng, Hailing; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system that links oncogenes and multiple receptor classes to many essential cellular functions, and is perhaps the most commonly activated signalling pathway in human cancer.  This pathway therefore presents both an opportunity and a challenge for cancer therapy.  Even as inhibitors that target PI3K isoforms and other major nodes in the pathway, including AKT and mammalian target of rapamycin (mTOR), reach clin. trials, major issues remain.  Here, we highlight recent progress that has been made in our understanding of the PI3K pathway and discuss the potential of and challenges for the development of therapeutic agents that target this pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk9T-ZoNDtLVg90H21EOLACvtfcHk0lidrwOlVDWXvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D&md5=fdc94abd15178a9dbe7c56dafbfb7787</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2926%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520the%2520Phosphoinositide%25203-Kinase%2520Pathway%2520in%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D627%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Franke, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">PI3K: Downstream AKTion Blocks Apoptosis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1997&pages=435-437&author=T.+F.+Frankeauthor=D.+R.+Kaplanauthor=L.+C.+Cantley&title=PI3K%3A+Downstream+AKTion+Blocks+Apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFranke%26aufirst%3DT.%2BF.%26aulast%3DKaplan%26aufirst%3DD.%2BR.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DPI3K%253A%2520Downstream%2520AKTion%2520Blocks%2520Apoptosis%26jtitle%3DCell%26date%3D1997%26volume%3D88%26spage%3D435%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Shepherd, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withers, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddle, K.</span><span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase: The Key Switch Mechanism in Insulin Signaling</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x"> (</span><span class="NLM_issue">Part 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=1998&pages=471-490&issue=Part+3&author=P.+R.+Shepherdauthor=D.+J.+Withersauthor=K.+Siddle&title=Phosphoinositide+3-Kinase%3A+The+Key+Switch+Mechanism+in+Insulin+Signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShepherd%26aufirst%3DP.%2BR.%26aulast%3DWithers%26aufirst%3DD.%2BJ.%26aulast%3DSiddle%26aufirst%3DK.%26atitle%3DPhosphoinositide%25203-Kinase%253A%2520The%2520Key%2520Switch%2520Mechanism%2520in%2520Insulin%2520Signaling%26jtitle%3DBiochem.%2520J.%26date%3D1998%26volume%3D333%26issue%3DPart%25203%26spage%3D471%26epage%3D490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Maehama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. E.</span><span> </span><span class="NLM_article-title">The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Triphosphate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">13375</span><span class="NLM_x">–</span> <span class="NLM_lpage">13378</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=13375-13378&author=T.+Maehamaauthor=J.+E.+Dixon&title=The+Tumor+Suppressor%2C+PTEN%2FMMAC1%2C+Dephosphorylates+the+Lipid+Second+Messenger%2C+Phosphatidylinositol+3%2C4%2C5-Triphosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaehama%26aufirst%3DT.%26aulast%3DDixon%26aufirst%3DJ.%2BE.%26atitle%3DThe%2520Tumor%2520Suppressor%252C%2520PTEN%252FMMAC1%252C%2520Dephosphorylates%2520the%2520Lipid%2520Second%2520Messenger%252C%2520Phosphatidylinositol%25203%252C4%252C5-Triphosphate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D13375%26epage%3D13378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Maehama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. E.</span><span> </span><span class="NLM_article-title">PTEN and Myotubularin: Novel Phosphoinositide Phosphatases</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1146%2Fannurev.biochem.70.1.247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=11395408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=247-279&author=T.+Maehamaauthor=G.+S.+Taylorauthor=J.+E.+Dixon&title=PTEN+and+Myotubularin%3A+Novel+Phosphoinositide+Phosphatases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN and Myotubularin: novel phosphoinositide phosphatases</span></div><div class="casAuthors">Maehama, Tomohiko; Taylor, Gregory S.; Dixon, Jack E.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247-279</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with 161 refs.  Protein tyrosine phosphatases (PTPs) are a diverse group of enzymes that contain a highly conserved active site motif, Cys-x5-Arg (Cx5R).  The PTP superfamily enzymes, which include tyrosine-specific, dual specificity, low-mol.-wt., and Cdc25 phosphatases, are key mediators of a wide variety of cellular processes, including growth, metab., differentiation, motility, and programmed cell death.  The PTEN/MMAC1/TEP1 gene was originally identified as a candidate tumor suppressor gene located on human chromosome 10q23; it encodes a protein with sequence similarity to PTPs and tensin.  Recent studies have demonstrated that PTEN plays an essential role in regulating signaling pathways involved in cell growth and apoptosis, and mutations in the PTEN gene are now known to cause tumorigenesis in a no. of human tissues.  In addn., germ line mutations in the PTEN gene also play a major role in the development of Cowden and Bannayan-Zonana syndromes, in which patients often suffer from increased risk of breast and thyroid cancers.  Biochem. studies of the PTEN phosphatase have revealed a mol. mechanism by which tumorigenesis may be caused in individuals with PTEN mutations.  Unlike most members of the PTP superfamily, PTEN utilizes the phosphoinositide second messenger, phosphatidylinositol 3,4,5-trisphosphate (PIP3), as its physiol. substrate.  This inositol lipid is an important regulator of cell growth and survival signaling through the Ser/Thr protein kinases PDK1 and Akt.  By specifically dephosphorylating the D3 position of PIP3, the PTEN tumor suppressor functions as a neg. regulator of signaling processes downstream of this lipid second messenger.  Mutations that impair PTEN function result in a marked increase in cellular levels of PIP3 and constitutive activation of Akt survival signaling pathways, leading to inhibition of apoptosis, hyperplasia, and tumor formation.  Certain structural features of PTEN contribute to its specificity for PIP3, as well as its role(s) in regulating cellular proliferation and apoptosis.  Recently, myotubularin, a second PTP superfamily enzyme assocd. with human disease, has also been shown to utilize a phosphoinositide as its physiol. substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTw3shS-h3J7Vg90H21EOLACvtfcHk0lidrwOlVDWXvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7o%253D&md5=ef23ea23449834941d7ba4d712cf5029</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.70.1.247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.70.1.247%26sid%3Dliteratum%253Aachs%26aulast%3DMaehama%26aufirst%3DT.%26aulast%3DTaylor%26aufirst%3DG.%2BS.%26aulast%3DDixon%26aufirst%3DJ.%2BE.%26atitle%3DPTEN%2520and%2520Myotubularin%253A%2520Novel%2520Phosphoinositide%2520Phosphatases%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2001%26volume%3D70%26spage%3D247%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Vivanco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">The Phosphatidylinositol 3-Kinase-AKT Pathway in Human Cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1038%2Fnrc839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=12094235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=489-501&author=I.+Vivancoauthor=C.+L.+Sawyers&title=The+Phosphatidylinositol+3-Kinase-AKT+Pathway+in+Human+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol 3-Kinase-AKT pathway in human cancer</span></div><div class="casAuthors">Vivanco, Igor; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-501</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One signal that is overactivated in a wide range of tumor types is the prodn. of a phospholipid, phosphatidylinositol (3,4,5) trisphosphate, by phosphatidylinositol 3-kinase (PI3K).  This lipid and the protein kinase that is activated by it, AKT, trigger a cascade of responses, from cell growth and proliferation to survival and motility, that drive tumor progression.  Small-mol. therapeutics that block PI3K signaling might deal a severe blow to cancer cells by blocking many aspects of the tumor-cell phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAQ-0qeD7pLVg90H21EOLACvtfcHk0lgBCc_-TeMY0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D&md5=c6762d32f9f1281632f4ccdbcd29268c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrc839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc839%26sid%3Dliteratum%253Aachs%26aulast%3DVivanco%26aufirst%3DI.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DThe%2520Phosphatidylinositol%25203-Kinase-AKT%2520Pathway%2520in%2520Human%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D489%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Wishart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. E.</span><span> </span><span class="NLM_article-title">PTEN and Myotubularin Phosphatases: From 3-Phosphoinositide Dephosphorylation to Disease</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">585</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1016%2FS0962-8924%2802%2902412-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=12495846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsV2msbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=579-585&author=M.+J.+Wishartauthor=J.+E.+Dixon&title=PTEN+and+Myotubularin+Phosphatases%3A+From+3-Phosphoinositide+Dephosphorylation+to+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease</span></div><div class="casAuthors">Wishart, Matthew J.; Dixon, Jack E.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">579-585</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The phosphatase and tensin homolog deleted on chromosome ten (PTEN) and myotubularin (MTM1) represent subfamilies of protein tyrosine phosphatases whose principal physiol. substrates are D3-phosphorylated inositol phospholipids.  As lipid phosphatases, PTEN- and MTM1-related (MTMR) proteins dephosphorylate the products of phosphoinositide 3-kinases and antagonize downstream effectors that utilize 3-phosphoinositides as ligands for protein targeting domains or allosteric activation.  Here, the authors describe the cellular mechanisms of PTEN and MTMR function and their role in the etiol. of cancer and other human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWnHPFC-ifGLVg90H21EOLACvtfcHk0lgBCc_-TeMY0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsV2msbk%253D&md5=b330162845ad4a2b62071cd2e5db1d60</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2802%2902412-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252802%252902412-1%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DM.%2BJ.%26aulast%3DDixon%26aufirst%3DJ.%2BE.%26atitle%3DPTEN%2520and%2520Myotubularin%2520Phosphatases%253A%2520From%25203-Phosphoinositide%2520Dephosphorylation%2520to%2520Disease%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2002%26volume%3D12%26spage%3D579%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Bader, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P. K.</span><span> </span><span class="NLM_article-title">Oncogenic PI3K Deregulates Transcription and Translation</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1038%2Fnrc1753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=16341083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ykurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=921-929&author=A.+G.+Baderauthor=S.+Kangauthor=L.+Zhaoauthor=P.+K.+Vogt&title=Oncogenic+PI3K+Deregulates+Transcription+and+Translation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic PI3K deregulates transcription and translation</span></div><div class="casAuthors">Bader, Andreas G.; Kang, Sohye; Zhao, Li; Vogt, Peter K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">921-929</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There have long been indications of a role for PI3K (phosphatidylinositol 3-kinase) in cancer pathogenesis.  Exptl. data document a requirement for deregulation of both transcription and translation in PI3K-mediated oncogenic transformation.  The recent discoveries of cancer-specific mutations in PIK3CA, the gene that encodes the catalytic subunit p110α of PI3K, have heightened the interest in the oncogenic potential of this lipid kinase and have made p110α an ideal drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq61EnpTquPh7Vg90H21EOLACvtfcHk0lgBCc_-TeMY0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ykurbF&md5=11cf0cec31b8e6c6af2b46b020db6241</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrc1753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1753%26sid%3Dliteratum%253Aachs%26aulast%3DBader%26aufirst%3DA.%2BG.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DVogt%26aufirst%3DP.%2BK.%26atitle%3DOncogenic%2520PI3K%2520Deregulates%2520Transcription%2520and%2520Translation%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D921%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Manning, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">AKT/PKB Signaling: Navigating Downstream</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=1261-1274&author=B.+D.+Manningauthor=L.+C.+Cantley&title=AKT%2FPKB+Signaling%3A+Navigating+Downstream"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DAKT%252FPKB%2520Signaling%253A%2520Navigating%2520Downstream%26jtitle%3DCell%26date%3D2007%26volume%3D129%26spage%3D1261%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Janssen, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleithoff, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartram, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, A. S.</span><span> </span><span class="NLM_article-title">An Oncogenic Fusion Product of the Phosphatidylinositol 3-Kinase p85β Subunit and HUMORF8, a Putative Deubiquitinating Enzyme</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1767</span><span class="NLM_x">–</span> <span class="NLM_lpage">1772</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=1767-1772&author=J.+W.+Janssenauthor=L.+Schleithoffauthor=C.+R.+Bartramauthor=A.+S.+Schulz&title=An+Oncogenic+Fusion+Product+of+the+Phosphatidylinositol+3-Kinase+p85%CE%B2+Subunit+and+HUMORF8%2C+a+Putative+Deubiquitinating+Enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJanssen%26aufirst%3DJ.%2BW.%26aulast%3DSchleithoff%26aufirst%3DL.%26aulast%3DBartram%26aufirst%3DC.%2BR.%26aulast%3DSchulz%26aufirst%3DA.%2BS.%26atitle%3DAn%2520Oncogenic%2520Fusion%2520Product%2520of%2520the%2520Phosphatidylinositol%25203-Kinase%2520p85%25CE%25B2%2520Subunit%2520and%2520HUMORF8%252C%2520a%2520Putative%2520Deubiquitinating%2520Enzyme%26jtitle%3DOncogene%26date%3D1998%26volume%3D16%26spage%3D1767%26epage%3D1772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Jimenez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Viciana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennstrom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kobbe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toran, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">R.-Borlado, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albar, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcos, M. A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downward, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-A., C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merida, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrera, A. C.</span><span> </span><span class="NLM_article-title">Identification and Characterization of a New Oncogene Derived from the Regulatory Subunit of Phosphoinositide 3-Kinase</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=743-753&author=C.+Jimenezauthor=D.+R.+Jonesauthor=P.+Rodriguez-Vicianaauthor=A.+Gonzalez-Garciaauthor=E.+Leonardoauthor=S.+Wennstromauthor=C.+von+Kobbeauthor=J.+L.+Toranauthor=L.+R.-Borladoauthor=V.+Calvoauthor=S.+G.+Copinauthor=J.+P.+Albarauthor=M.+L.+Gasparauthor=E.+Diezauthor=M.+A.+R.+Marcosauthor=J.+Downwardauthor=C.+Martinez-A.author=I.+Meridaauthor=A.+C.+Carrera&title=Identification+and+Characterization+of+a+New+Oncogene+Derived+from+the+Regulatory+Subunit+of+Phosphoinositide+3-Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJimenez%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DD.%2BR.%26aulast%3DRodriguez-Viciana%26aufirst%3DP.%26aulast%3DGonzalez-Garcia%26aufirst%3DA.%26aulast%3DLeonardo%26aufirst%3DE.%26aulast%3DWennstrom%26aufirst%3DS.%26aulast%3Dvon%2BKobbe%26aufirst%3DC.%26aulast%3DToran%26aufirst%3DJ.%2BL.%26aulast%3DR.-Borlado%26aufirst%3DL.%26aulast%3DCalvo%26aufirst%3DV.%26aulast%3DCopin%26aufirst%3DS.%2BG.%26aulast%3DAlbar%26aufirst%3DJ.%2BP.%26aulast%3DGaspar%26aufirst%3DM.%2BL.%26aulast%3DDiez%26aufirst%3DE.%26aulast%3DMarcos%26aufirst%3DM.%2BA.%2BR.%26aulast%3DDownward%26aufirst%3DJ.%26aulast%3DMartinez-A.%26aufirst%3DC.%26aulast%3DMerida%26aufirst%3DI.%26aulast%3DCarrera%26aufirst%3DA.%2BC.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%2520New%2520Oncogene%2520Derived%2520from%2520the%2520Regulatory%2520Subunit%2520of%2520Phosphoinositide%25203-Kinase%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D743%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Jucker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiedler, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, R. A.</span><span> </span><span class="NLM_article-title">Expression of a Mutated Form of the p85α Regulatory Subunit of Phosphatidylinositol 3-Kinase in a Hodgkin’s Lymphona-Derived Cell Line (CO)</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">894</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=894-901&author=M.+Juckerauthor=K.+Sudelauthor=S.+Hornauthor=M.+Sickelauthor=W.+Wegnerauthor=W.+Fiedlerauthor=R.+A.+Feldman&title=Expression+of+a+Mutated+Form+of+the+p85%CE%B1+Regulatory+Subunit+of+Phosphatidylinositol+3-Kinase+in+a+Hodgkin%E2%80%99s+Lymphona-Derived+Cell+Line+%28CO%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DSudel%26aufirst%3DK.%26aulast%3DHorn%26aufirst%3DS.%26aulast%3DSickel%26aufirst%3DM.%26aulast%3DWegner%26aufirst%3DW.%26aulast%3DFiedler%26aufirst%3DW.%26aulast%3DFeldman%26aufirst%3DR.%2BA.%26atitle%3DExpression%2520of%2520a%2520Mutated%2520Form%2520of%2520the%2520p85%25CE%25B1%2520Regulatory%2520Subunit%2520of%2520Phosphatidylinositol%25203-Kinase%2520in%2520a%2520Hodgkin%25E2%2580%2599s%2520Lymphona-Derived%2520Cell%2520Line%2520%2528CO%2529%26jtitle%3DLeukemia%26date%3D2002%26volume%3D16%26spage%3D894%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">High Frequency of Mutations of the PIK3CA Gene in Human Cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1126%2Fscience.1096502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=15016963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVGmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=554&author=Y.+Samuelsauthor=Z.+Wangauthor=A.+Bardelliauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=H.+Yanauthor=A.+Gazdarauthor=S.+M.+Powellauthor=G.+J.+Rigginsauthor=J.+K.+V.+Willsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=V.+E.+Velculescu&title=High+Frequency+of+Mutations+of+the+PIK3CA+Gene+in+Human+Cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Brevia: High frequency of mutations of the PIK3Ca gene in human cancers</span></div><div class="casAuthors">Samuels, Yardena; Wang, Zhenghe; Bardelli, Alberto; Silliman, Natalie; Ptak, Janine; Szabo, Steve; Yan, Hai; Gazdar, Adi; Powell, Steven M.; Riggins, Gregory J.; Willson, James K. V.; Markowitz, Sanford; Kinzler, Kenneth W.; Vogelstein, Bert; Velculescu, Victor E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">5670</span>),
    <span class="NLM_cas:pages">554</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr74Tv7Oo80NbVg90H21EOLACvtfcHk0liD3KzsT-trzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVGmsbk%253D&md5=be8d63bf0c909971c3b7a5f475ce8fab</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1126%2Fscience.1096502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1096502%26sid%3Dliteratum%253Aachs%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DS.%2BM.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%2BV.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DHigh%2520Frequency%2520of%2520Mutations%2520of%2520the%2520PIK3CA%2520Gene%2520in%2520Human%2520Cancers%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Isakoff, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearline, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugge, J. S.</span><span> </span><span class="NLM_article-title">Breast Cancer-Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial Cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">10992</span><span class="NLM_x">–</span> <span class="NLM_lpage">11000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=10992-11000&author=S.+J.+Isakoffauthor=J.+A.+Engelmanauthor=H.+Y.+Irieauthor=J.+Luoauthor=S.+M.+Brachmannauthor=R.+V.+Pearlineauthor=L.+C.+Cantleyauthor=J.+S.+Brugge&title=Breast+Cancer-Associated+PIK3CA+Mutations+Are+Oncogenic+in+Mammary+Epithelial+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsakoff%26aufirst%3DS.%2BJ.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DIrie%26aufirst%3DH.%2BY.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DBrachmann%26aufirst%3DS.%2BM.%26aulast%3DPearline%26aufirst%3DR.%2BV.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DBrugge%26aufirst%3DJ.%2BS.%26atitle%3DBreast%2520Cancer-Associated%2520PIK3CA%2520Mutations%2520Are%2520Oncogenic%2520in%2520Mammary%2520Epithelial%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D10992%26epage%3D11000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P. K.</span><span> </span><span class="NLM_article-title">Phosphatidylinositol 3-Kinase Mutations Identified in Human Cancer Are Oncogenic</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=802-807&author=S.+Kangauthor=A.+G.+Baderauthor=P.+K.+Vogt&title=Phosphatidylinositol+3-Kinase+Mutations+Identified+in+Human+Cancer+Are+Oncogenic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DS.%26aulast%3DBader%26aufirst%3DA.%2BG.%26aulast%3DVogt%26aufirst%3DP.%2BK.%26atitle%3DPhosphatidylinositol%25203-Kinase%2520Mutations%2520Identified%2520in%2520Human%2520Cancer%2520Are%2520Oncogenic%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D802%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt-Kittler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rago, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huso, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">Mutant PIK3CA Promotes Cell Growth and Invasion of Human Cancer Cells</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=561-573&author=Y.+Samuelsauthor=L.+A.+Diazauthor=O.+Schmidt-Kittlerauthor=J.+M.+Cumminsauthor=L.+DeLongauthor=I.+Cheongauthor=C.+Ragoauthor=D.+L.+Husoauthor=C.+Lengauerauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=V.+E.+Velculescu&title=Mutant+PIK3CA+Promotes+Cell+Growth+and+Invasion+of+Human+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DDiaz%26aufirst%3DL.%2BA.%26aulast%3DSchmidt-Kittler%26aufirst%3DO.%26aulast%3DCummins%26aufirst%3DJ.%2BM.%26aulast%3DDeLong%26aufirst%3DL.%26aulast%3DCheong%26aufirst%3DI.%26aulast%3DRago%26aufirst%3DC.%26aulast%3DHuso%26aufirst%3DD.%2BL.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DMutant%2520PIK3CA%2520Promotes%2520Cell%2520Growth%2520and%2520Invasion%2520of%2520Human%2520Cancer%2520Cells%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D561%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Shayesteh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldocchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. W.</span><span> </span><span class="NLM_article-title">PIK3CA Is Implicated as an Oncogene in Ovarian Cancer</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1038%2F5042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=9916799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=99-102&author=L.+Shayestehauthor=Y.+Luauthor=W.+L.+Kuoauthor=R.+Baldocchiauthor=T.+Godfreyauthor=C.+Collinsauthor=D.+Pinkelauthor=B.+Powellauthor=G.+B.+Millsauthor=J.+W.+Gray&title=PIK3CA+Is+Implicated+as+an+Oncogene+in+Ovarian+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">PIK3CA is implicated as an oncogene in ovarian cancer</span></div><div class="casAuthors">Shayesteh, Laleh; Lu, Yiling; Kuo, Wen-Lin; Baldocchi, Russell; Godfrey, Tony; Collins, Colin; Pinkel, Daniel; Powell, Bethan; Mills, Gordon B.; Gray, Joe W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-102</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Ovarian cancer is the leading cause of death from gynecol. malignancy and the 4th leading cause of cancer death among American women, yet little is known about its mol. etiol.  Studies using comparative genomic hybridization (CGH) have revealed several regions of recurrent, abnormal, DNA sequence copy no. that may encode genes involved in the genesis or progression of the disease.  A region at 3q26 was increased in copy no. in 40% of ovarian and other cancers contains PIK3CA, which encodes the p110α catalytic subunit of phosphatidylinositol 3-kinase (PI3-kinase).  The assocn. between PIK3CA copy no. and PI3-kinase activity makes PIK3CA a candidate oncogene because a broad range of cancer-related functions were assocd. with PI3-kinase mediated signalling.  These include proliferation, glucose transport and catabolism, cell adhesion, apoptosis, RAS signalling6 and oncogenic transformation.  Downstream effectors of PI3-kinase, AKT1 and AKT2, were amplified or activated in human tumors, including ovarian cancer.  We show that PIK3CA is frequently increased in copy no. in ovarian cancers, that the increased copy no. is assocd. with increased PIK3CA transcription, p110α protein expression, and PI3-kinase activity and that treatment with the PI3-kinase inhibitor LY294002 decreases proliferation and increases apoptosis.  These observations suggest PIK3CA is an oncogene that has an important role in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYnLbYYzMTtrVg90H21EOLACvtfcHk0liQ1JEWbd-Xxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D&md5=e46ad55fb14c5465bf7ce86fb5a9cca0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2F5042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F5042%26sid%3Dliteratum%253Aachs%26aulast%3DShayesteh%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DW.%2BL.%26aulast%3DBaldocchi%26aufirst%3DR.%26aulast%3DGodfrey%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DPinkel%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26atitle%3DPIK3CA%2520Is%2520Implicated%2520as%2520an%2520Oncogene%2520in%2520Ovarian%2520Cancer%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D21%26spage%3D99%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Borlado, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redondo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criado, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcos, M. A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-A, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balomenos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrera, A. C.</span><span> </span><span class="NLM_article-title">Increased Phosphoinositide 3-Kinase Activity Induces a Lymphoproliferative Disorder and Contributes to Tumor Generation In Vivo</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">895</span><span class="NLM_x">–</span> <span class="NLM_lpage">903</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=895-903&author=L.+R.+Borladoauthor=C.+Redondoauthor=B.+Alvarezauthor=C.+Jimenezauthor=L.+M.+Criadoauthor=J.+Floresauthor=M.+A.+R.+Marcosauthor=C.+Martinez-Aauthor=D.+Balomenosauthor=A.+C.+Carrera&title=Increased+Phosphoinositide+3-Kinase+Activity+Induces+a+Lymphoproliferative+Disorder+and+Contributes+to+Tumor+Generation+In+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorlado%26aufirst%3DL.%2BR.%26aulast%3DRedondo%26aufirst%3DC.%26aulast%3DAlvarez%26aufirst%3DB.%26aulast%3DJimenez%26aufirst%3DC.%26aulast%3DCriado%26aufirst%3DL.%2BM.%26aulast%3DFlores%26aufirst%3DJ.%26aulast%3DMarcos%26aufirst%3DM.%2BA.%2BR.%26aulast%3DMartinez-A%26aufirst%3DC.%26aulast%3DBalomenos%26aufirst%3DD.%26aulast%3DCarrera%26aufirst%3DA.%2BC.%26atitle%3DIncreased%2520Phosphoinositide%25203-Kinase%2520Activity%2520Induces%2520a%2520Lymphoproliferative%2520Disorder%2520and%2520Contributes%2520to%2520Tumor%2520Generation%2520In%2520Vivo%26jtitle%3DFASEB%2520J.%26date%3D2000%26volume%3D14%26spage%3D895%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ma, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lung, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whang-Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, C. Y.</span><span> </span><span class="NLM_article-title">PIK3CA as an Oncogene in Cervical Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2739</span><span class="NLM_x">–</span> <span class="NLM_lpage">2744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=2739-2744&author=Y.+T.+Maauthor=S.+J.+Weiauthor=Y.+C.+Linauthor=J.+C.+Lungauthor=T.+C.+Changauthor=J.+Whang-Pengauthor=J.+M.+Liuauthor=D.+M.+Yangauthor=W.+K.+Yangauthor=C.+Y.+Shen&title=PIK3CA+as+an+Oncogene+in+Cervical+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%2BT.%26aulast%3DWei%26aufirst%3DS.%2BJ.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DLung%26aufirst%3DJ.%2BC.%26aulast%3DChang%26aufirst%3DT.%2BC.%26aulast%3DWhang-Peng%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%2BM.%26aulast%3DYang%26aufirst%3DD.%2BM.%26aulast%3DYang%26aufirst%3DW.%2BK.%26aulast%3DShen%26aufirst%3DC.%2BY.%26atitle%3DPIK3CA%2520as%2520an%2520Oncogene%2520in%2520Cervical%2520Cancer%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D2739%26epage%3D2744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Trotman, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotan, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koutcher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cristofano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoo, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy-Burman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenbert, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyke, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordon-Cardo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span> </span><span class="NLM_article-title">PTEN Dose Dictates Cancer Progression in the Prostate</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=385-396&issue=3&author=L.+C.+Trotmanauthor=M.+Nikiauthor=Z.+A.+Dotanauthor=J.+A.+Koutcherauthor=A.+Di+Cristofanoauthor=A.+Xiaoauthor=A.+S.+Khooauthor=P.+Roy-Burmanauthor=N.+M.+Greenbertauthor=T.+V.+Dykeauthor=C.+Cordon-Cardoauthor=P.+P.+Pandolfi&title=PTEN+Dose+Dictates+Cancer+Progression+in+the+Prostate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrotman%26aufirst%3DL.%2BC.%26aulast%3DNiki%26aufirst%3DM.%26aulast%3DDotan%26aufirst%3DZ.%2BA.%26aulast%3DKoutcher%26aufirst%3DJ.%2BA.%26aulast%3DDi%2BCristofano%26aufirst%3DA.%26aulast%3DXiao%26aufirst%3DA.%26aulast%3DKhoo%26aufirst%3DA.%2BS.%26aulast%3DRoy-Burman%26aufirst%3DP.%26aulast%3DGreenbert%26aufirst%3DN.%2BM.%26aulast%3DDyke%26aufirst%3DT.%2BV.%26aulast%3DCordon-Cardo%26aufirst%3DC.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26atitle%3DPTEN%2520Dose%2520Dictates%2520Cancer%2520Progression%2520in%2520the%2520Prostate%26jtitle%3DPLoS%2520Biol.%26date%3D2003%26volume%3D1%26issue%3D3%26spage%3D385%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Leslie, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downes, C. P.</span><span> </span><span class="NLM_article-title">PTEN Function: How Normal Cells Control It and Tumour Cells Lose It</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">382</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2004&pages=1-11&author=N.+R.+Leslieauthor=C.+P.+Downes&title=PTEN+Function%3A+How+Normal+Cells+Control+It+and+Tumour+Cells+Lose+It"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DN.%2BR.%26aulast%3DDownes%26aufirst%3DC.%2BP.%26atitle%3DPTEN%2520Function%253A%2520How%2520Normal%2520Cells%2520Control%2520It%2520and%2520Tumour%2520Cells%2520Lose%2520It%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D382%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Parsons, R.</span><span> </span><span class="NLM_article-title">Human Cancer, PTEN, and the PI-3 Kinase Pathway</span> <span class="citation_source-journal">Semin. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=171-176&author=R.+Parsons&title=Human+Cancer%2C+PTEN%2C+and+the+PI-3+Kinase+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DR.%26atitle%3DHuman%2520Cancer%252C%2520PTEN%252C%2520and%2520the%2520PI-3%2520Kinase%2520Pathway%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2004%26volume%3D15%26spage%3D171%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Cully, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Beyond PTEN Mutations: The PI3K Pathway as an Integrator of Multiple Inputs During Tumorigenesis</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1038%2Fnrc1819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=16453012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslelt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=184-192&author=M.+Cullyauthor=H.+Youauthor=A.+J.+Levineauthor=T.+W.+Mak&title=Beyond+PTEN+Mutations%3A+The+PI3K+Pathway+as+an+Integrator+of+Multiple+Inputs+During+Tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis</span></div><div class="casAuthors">Cully, Megan; You, Han; Levine, Arnold J.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-192</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  The tumor-suppressor phosphatase with tensin homol. (PTEN) is the most important neg. regulator of the cell-survival signaling pathway initiated by phosphatidylinositol 3-kinase (PI3K).  Although PTEN is mutated or deleted in many tumors, deregulation of the PI3K-PTEN network also occurs through other mechanisms.  Crosstalk between the PI3K pathways and other tumorigenic signaling pathways, such as those that involve Ras, p53, TOR (target of rapamycin) or DJ1, can contribute to this deregulation.  How does the PI3K pathway integrate signals from numerous sources, and how can this information be used in the rational design of cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7UxMKOlX7X7Vg90H21EOLACvtfcHk0lgwzA8zZt6baQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslelt78%253D&md5=8769e7e349cc58f5c618cdce886186d2</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrc1819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1819%26sid%3Dliteratum%253Aachs%26aulast%3DCully%26aufirst%3DM.%26aulast%3DYou%26aufirst%3DH.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DBeyond%2520PTEN%2520Mutations%253A%2520The%2520PI3K%2520Pathway%2520as%2520an%2520Integrator%2520of%2520Multiple%2520Inputs%2520During%2520Tumorigenesis%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D184%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the Role of mTOR in Cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+Role+of+mTOR+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520Role%2520of%2520mTOR%2520in%2520Cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Karakas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B. H.</span><span> </span><span class="NLM_article-title">Mutation of the PIK3CA Oncogene in Human Cancers</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1038%2Fsj.bjc.6602970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=16449998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1ers70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=455-459&author=B.+Karakasauthor=K.+E.+Bachmanauthor=B.+H.+Park&title=Mutation+of+the+PIK3CA+Oncogene+in+Human+Cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Mutation of the PIK3CA oncogene in human cancers</span></div><div class="casAuthors">Karakas, B.; Bachman, K. E.; Park, B. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">455-459</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  It is now well established that cancer is a genetic disease and that somatic mutations of oncogenes and tumor suppressor genes are the initiators of the carcinogenic process.  The phosphatidylinositol 3-kinase signaling pathway has previously been implicated in tumorigenesis, and evidence over the past year suggests a pivotal role for the phosphatidylinositol 3-kinase catalytic subunit, PIK3CA, in human cancers.  In this review, we analyze recent reports describing PIK3CA mutations in a variety of human malignancies, and discuss their possible implications for diagnosis and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3GosToKQSIbVg90H21EOLACvtfcHk0libNWQjENPurg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1ers70%253D&md5=c109aaf6e660f6299d4db185be8a97ea</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6602970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6602970%26sid%3Dliteratum%253Aachs%26aulast%3DKarakas%26aufirst%3DB.%26aulast%3DBachman%26aufirst%3DK.%2BE.%26aulast%3DPark%26aufirst%3DB.%2BH.%26atitle%3DMutation%2520of%2520the%2520PIK3CA%2520Oncogene%2520in%2520Human%2520Cancers%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26spage%3D455%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Vogt, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsliger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gymnopoulos, M.</span><span> </span><span class="NLM_article-title">Cancer-Specific Mutations in Phosphatidylinositol 3-Kinase</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=342-349&author=P.+K.+Vogtauthor=S.+Kangauthor=M.+A.+Elsligerauthor=M.+Gymnopoulos&title=Cancer-Specific+Mutations+in+Phosphatidylinositol+3-Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVogt%26aufirst%3DP.%2BK.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DElsliger%26aufirst%3DM.%2BA.%26aulast%3DGymnopoulos%26aufirst%3DM.%26atitle%3DCancer-Specific%2520Mutations%2520in%2520Phosphatidylinositol%25203-Kinase%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2007%26volume%3D32%26spage%3D342%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Yap, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Targeting the PI3K-AKT-mTOR Pathway: Progress, Pitfalls, and Promises</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1016%2Fj.coph.2008.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=18721898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=393-412&author=T.+A.+Yapauthor=M.+D.+Garrettauthor=M.+I.+Waltonauthor=F.+Raynaudauthor=J.+S.+De+Bonoauthor=P.+Workman&title=Targeting+the+PI3K-AKT-mTOR+Pathway%3A+Progress%2C+Pitfalls%2C+and+Promises"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises</span></div><div class="casAuthors">Yap, Timothy A.; Garrett, Michelle D.; Walton, Mike I.; Raynaud, Florence; de Bono, Johann S.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">393-412</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The strategy of drugging the cancer kinome' has led to the successful development and regulatory approval of several novel mol. targeted agents.  The spotlight is now shifting to the phosphatidylinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway as a key potential target.  This review details the role of the pathway in oncogenesis and the rationale for inhibiting its vital components.  The focus will be on the progress made in the development of novel therapies for cancer treatment, with emphasis placed on agents that have entered clin. development.  Strategies involving horizontal and vertical blockade of the pathway, as well as the use of biomarkers to select appropriate patients and to provide proof of target modulation will also be highlighted.  Finally, we discuss the issues and limitations involved with targeting the PI3K-AKT-mTOR pathway, and predict what the future may hold for these novel anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnmwezNSKUfbVg90H21EOLACvtfcHk0libNWQjENPurg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E&md5=b6a4f3c01a6776977d61cde8222d7201</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DWalton%26aufirst%3DM.%2BI.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DDe%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520PI3K-AKT-mTOR%2520Pathway%253A%2520Progress%252C%2520Pitfalls%252C%2520and%2520Promises%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D393%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Kong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">Advances in Development of Phosphatidylinositol 3-Kinase Inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2839</span><span class="NLM_x">–</span> <span class="NLM_lpage">2854</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.2174%2F092986709788803222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=19689267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvVynt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=2839-2854&author=D.+Kongauthor=T.+Yamori&title=Advances+in+Development+of+Phosphatidylinositol+3-Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in development of phosphatidylinositol 3-kinase inhibitors</span></div><div class="casAuthors">Kong, Dexin; Yamori, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2839-2854</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Phosphatidylinositol 3-kinases (P13Ks) are a class of lipid kinases that phosphorylate phosphatidylinositol 4,5-bisphosphate (PIP2) at the 3-OH of the inositol ring to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3), which in turn activates Akt and the downstream effectors like mTOR, and therefore play important roles in cell growth, survival, etc.  The phosphatase and tensin homolog deleted in chromosome ten (PTEN), acts as the catalytic antagonist of PI3K by dephosphorylating PIP3 to PIP2.  PI3K has become an important drug target for cancer therapy, since gain-of-function mutations of PIK3CA encoding PI3Kα, as well as loss-of-function mutations of PTEN, have been frequently found in human cancers.  The pharmaceutical development of PI3K inhibitors has made a great leap forward during the last 3 years.  While PI3Kβ, δ and γ isoform-specific PI3K inhibitors (TGX-221, IC87114 and AS-605240) have been developed for therapy of coronary heart disease, asthma, and glomerulonephritis, resp., a promising PI3Kα specific inhibitor is not yet available.  Correspondingly, almost all of the promising PI3K inhibitors under development for cancer therapy, such as NVP-BEZ235, GDC-0941 and ZSTK474, are pan-PI3K isoform inhibitors.  Each of these pan-PI3K inhibitors seems to induce a common G1 phase arrest.  All have shown favorable in vivo anticancer efficacies and low toxicities, and therefore most have entered evaluation in clin. trials.  P-Akt and p-S6 have been reported to be feasible pharmacodynamic biomarkers for monitoring the efficacy of these agents.  In the process of discovery of these and other PI3K inhibitors, detailed structure-activity relation studies were carried out.  This review summarizes key advances in the development of PI3K inhibitors, which is preceded by an introduction of PI3K family and their functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo34auL80q6urVg90H21EOLACvtfcHk0libNWQjENPurg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvVynt7c%253D&md5=7bcedc62a6b1a0b570143d49ba861fee</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F092986709788803222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709788803222%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DD.%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DAdvances%2520in%2520Development%2520of%2520Phosphatidylinositol%25203-Kinase%2520Inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D2839%26epage%3D2854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Fan, Q. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mostov, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span> </span><span class="NLM_article-title">A Dual PI3 Kinase/mTOR Inhibitor Reveals Emergent Efficacy in Glioma</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=341-349&author=Q.+W.+Fanauthor=Z.+A.+Knightauthor=D.+D.+Goldenbergauthor=W.+Yuauthor=K.+E.+Mostovauthor=D.+Stokoeauthor=K.+M.+Shokatauthor=W.+A.+Weiss&title=A+Dual+PI3+Kinase%2FmTOR+Inhibitor+Reveals+Emergent+Efficacy+in+Glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DQ.%2BW.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DMostov%26aufirst%3DK.%2BE.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26atitle%3DA%2520Dual%2520PI3%2520Kinase%252FmTOR%2520Inhibitor%2520Reveals%2520Emergent%2520Efficacy%2520in%2520Glioma%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D341%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Ihle, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powis, G.</span><span> </span><span class="NLM_article-title">Inhibitors of Phosphatidylinositol-3-kinase in Cancer Therapy</span> <span class="citation_source-journal">Mol. Aspects. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1016%2Fj.mam.2010.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=20176047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFGqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=135-144&author=N.+T.+Ihleauthor=G.+Powis&title=Inhibitors+of+Phosphatidylinositol-3-kinase+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of phosphatidylinositol-3-kinase in cancer therapy</span></div><div class="casAuthors">Ihle, Nathan T.; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-144</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The phosphatidylinositol-3-kinase (PI3K) signaling pathway is implicated in multiple aspects of tumorigenesis and tumor maintenance, and recent years have seen significant efforts towards developing agents to inhibit the pathway.  However, the development of such agents raises issues such as what specific member or members in the PI3K family should be inhibited to achieve maximal therapeutic benefit, and can specific inhibitors be developed with the necessary pharmacol. properties to allow them to proceed to clin. trials.  The no. of PI3K inhibitors has gone from a handful of archetypal inhibitors which largely detd. how the pathway was initially defined through their inhibition of PI3K, but also due to their off target properties, to a much larger no. of inhibitors of not only PI3K but also other members of the PI3K family.  The question remains to be answered whether greater therapeutic efficacy will be obtained through the use of inhibitors with increased specificity, or through inhibitors that target a spectrum of targets within the pathway.  This review will cover the development of agents targeting the pathway, and will discuss current issues surrounding the development of such agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Qmn3244-87Vg90H21EOLACvtfcHk0liFxZE2xYT2zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFGqurg%253D&md5=f32d46e1b410ba190d393553a088468b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2010.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2010.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DIhle%26aufirst%3DN.%2BT.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DInhibitors%2520of%2520Phosphatidylinositol-3-kinase%2520in%2520Cancer%2520Therapy%26jtitle%3DMol.%2520Aspects.%2520Med.%26date%3D2010%26volume%3D31%26spage%3D135%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donatelli, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgers, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarpong, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garver, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gontarek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershner, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raha, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherk, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegrzyn, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span> </span><span class="NLM_article-title">Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml900028r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=39-43&author=S.+D.+Knightauthor=N.+D.+Adamsauthor=J.+L.+Burgessauthor=A.+M.+Chaudhariauthor=M.+G.+Darcyauthor=C.+A.+Donatelliauthor=J.+I.+Luengoauthor=K.+A.+Newlanderauthor=C.+A.+Parrishauthor=L.+H.+Ridgersauthor=M.+A.+Sarpongauthor=S.+J.+Schmidtauthor=G.+S.+Van+Allerauthor=J.+D.+Carsonauthor=M.+A.+Diamondauthor=P.+A.+Elkinsauthor=C.+M.+Gardinerauthor=E.+Garverauthor=S.+A.+Gilbertauthor=R.+R.+Gontarekauthor=J.+R.+Jacksonauthor=K.+L.+Kershnerauthor=L.+Luoauthor=K.+Rahaauthor=C.+S.+Sherkauthor=C.+M.+Sungauthor=D.+Suttonauthor=P.+J.+Tumminoauthor=R.+J.+Wegrzynauthor=K.+R.+Augerauthor=D.+Dhanak&title=Discovery+of+GSK2126458%2C+a+Highly+Potent+Inhibitor+of+PI3K+and+the+Mammalian+Target+of+Rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin</span></div><div class="casAuthors">Knight, Steven D.; Adams, Nicholas D.; Burgess, Joelle L.; Chaudhari, Amita M.; Darcy, Michael G.; Donatelli, Carla A.; Luengo, Juan I.; Newlander, Ken A.; Parrish, Cynthia A.; Ridgers, Lance H.; Sarpong, Martha A.; Schmidt, Stanley J.; Van Aller, Glenn S.; Carson, Jeffrey D.; Diamond, Melody A.; Elkins, Patricia A.; Gardiner, Christine M.; Garver, Eric; Gilbert, Seth A.; Gontarek, Richard R.; Jackson, Jeffrey R.; Kershner, Kevin L.; Luo, Lusong; Raha, Kaushik; Sherk, Christian S.; Sung, Chiu-Mei; Sutton, David; Tummino, Peter J.; Wegrzyn, Ronald J.; Auger, Kurt R.; Dhanak, Dashyant</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-43</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinase α (PI3Kα) is a crit. regulator of cell growth and transformation, and its signaling pathway is the most commonly mutated pathway in human cancers.  The mammalian target of rapamycin (mTOR), a class IV PI3K protein kinase, is also a central regulator of cell growth, and mTOR inhibitors are believed to augment the antiproliferative efficacy of PI3K/AKT pathway inhibition. 2,4-Difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide (GSK2126458, 1 (I)) has been identified as a highly potent, orally bioavailable inhibitor of PI3Kα and mTOR with in vivo activity in both pharmacodynamic and tumor growth efficacy models.  Compd. 1 is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBH6_ywCnjCrVg90H21EOLACvtfcHk0liFxZE2xYT2zQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D&md5=72fcca85702dba95529ac03281e0bdbc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fml900028r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml900028r%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DAdams%26aufirst%3DN.%2BD.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DChaudhari%26aufirst%3DA.%2BM.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DDonatelli%26aufirst%3DC.%2BA.%26aulast%3DLuengo%26aufirst%3DJ.%2BI.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DParrish%26aufirst%3DC.%2BA.%26aulast%3DRidgers%26aufirst%3DL.%2BH.%26aulast%3DSarpong%26aufirst%3DM.%2BA.%26aulast%3DSchmidt%26aufirst%3DS.%2BJ.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DCarson%26aufirst%3DJ.%2BD.%26aulast%3DDiamond%26aufirst%3DM.%2BA.%26aulast%3DElkins%26aufirst%3DP.%2BA.%26aulast%3DGardiner%26aufirst%3DC.%2BM.%26aulast%3DGarver%26aufirst%3DE.%26aulast%3DGilbert%26aufirst%3DS.%2BA.%26aulast%3DGontarek%26aufirst%3DR.%2BR.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DKershner%26aufirst%3DK.%2BL.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DRaha%26aufirst%3DK.%26aulast%3DSherk%26aufirst%3DC.%2BS.%26aulast%3DSung%26aufirst%3DC.%2BM.%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DWegrzyn%26aufirst%3DR.%2BJ.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DDhanak%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520GSK2126458%252C%2520a%2520Highly%2520Potent%2520Inhibitor%2520of%2520PI3K%2520and%2520the%2520Mammalian%2520Target%2520of%2520Rapamycin%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D39%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunder, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">A Pharmacological Map of the PI3-K Family Defines a Role of p110α in Insulin Signaling</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">747</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=733-747&author=Z.+A.+Knightauthor=B.+Gonzalezauthor=M.+E.+Feldmanauthor=E.+R.+Zunderauthor=D.+D.+Goldenbergauthor=O.+Williamsauthor=R.+Loewithauthor=D.+Stokoeauthor=A.+Ballaauthor=B.+Tothauthor=T.+Ballaauthor=W.+A.+Weissauthor=R.+L.+Williamsauthor=K.+M.+Shokat&title=A+Pharmacological+Map+of+the+PI3-K+Family+Defines+a+Role+of+p110%CE%B1+in+Insulin+Signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DZunder%26aufirst%3DE.%2BR.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBalla%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DB.%26aulast%3DBalla%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520Pharmacological%2520Map%2520of%2520the%2520PI3-K%2520Family%2520Defines%2520a%2520Role%2520of%2520p110%25CE%25B1%2520in%2520Insulin%2520Signaling%26jtitle%3DCell%26date%3D2006%26volume%3D125%26spage%3D733%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><div class="note"><p class="first last">At the time of these studies, the X-ray crystal structure of PI3Kα had yet to be realized, though it has since been reported: </p></div><span class="NLM_contrib-group">Huang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt-Kittler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabelli, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amzel, M.</span><span> </span><span class="NLM_article-title">The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1744</span><span class="NLM_x">–</span> <span class="NLM_lpage">1748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1744-1748&author=C.+H.+Huangauthor=D.+Mandelkerauthor=O.+Schmidt-Kittlerauthor=Y.+Samuelsauthor=V.+E.+Velculescuauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=S.+B.+Gabelliauthor=M.+Amzel&title=The+Structure+of+a+Human+p110%CE%B1%2Fp85%CE%B1+Complex+Elucidates+the+Effects+of+Oncogenic+PI3K%CE%B1+Mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%2BH.%26aulast%3DMandelker%26aufirst%3DD.%26aulast%3DSchmidt-Kittler%26aufirst%3DO.%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DGabelli%26aufirst%3DS.%2BB.%26aulast%3DAmzel%26aufirst%3DM.%26atitle%3DThe%2520Structure%2520of%2520a%2520Human%2520p110%25CE%25B1%252Fp85%25CE%25B1%2520Complex%2520Elucidates%2520the%2520Effects%2520of%2520Oncogenic%2520PI3K%25CE%25B1%2520Mutations%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1744%26epage%3D1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Recent Advances in the Cross-Coupling Reactions of Organoboron Derivatives with Organic Electrophiles, 1995−1998</span> <span class="citation_source-journal">J. Organomet. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">576</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><div class="note"><p class="first last"> and references therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1016%2FS0022-328X%2898%2901055-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADyaK1MXivFOlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=576&publication_year=1999&pages=147-168&author=A.+Suzuki&title=Recent+Advances+in+the+Cross-Coupling+Reactions+of+Organoboron+Derivatives+with+Organic+Electrophiles%2C+1995%E2%88%921998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the cross-coupling reactions of organoboron derivatives with organic electrophiles, 1995-1998</span></div><div class="casAuthors">Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">576</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">147-168</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">The Pd-catalyzed cross-coupling reaction between organoboron compds. and org. halides or triflates provides a powerful and general methodol. for the formation of C-C bonds.  Recently, this reaction was called the Suzuki coupling, Suzuki reaction, or Suzuki-Miyaura coupling, although the authors never referred to it as such previously.  In this review, this name will be used with hesitation, simply to express the coupling reaction.  The availability of the reagents and the mild reaction conditions all contribute to the versatility of this reaction.  The coupling reaction offers several addnl. advantages, such as being largely unaffected by the presence of H2O, tolerating a broad range of functional groups, and proceeding generally regio- and stereoselectively.  Also, the inorg. byproduct of the reaction is nontoxic and easily removed from the reaction mixt. thereby making the Suzuki coupling suitable not only for labs. but also for industrial processes.  The authors published previously a comprehensive review of the reaction which covered mainly the refs. until the end of 1994.  Thereafter, a large no. of papers related to the coupling reaction are reported.  Consequently, such new results presented from 1995 to May 1998 are summarized in this review, with 139 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooCbrdm1cvkLVg90H21EOLACvtfcHk0ljIhhsynCuc1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFOlsr0%253D&md5=be2fdd114211afa4abdf106008dd9845</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0022-328X%2898%2901055-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-328X%252898%252901055-9%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Derivatives%2520with%2520Organic%2520Electrophiles%252C%25201995%25E2%2588%25921998%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D1999%26volume%3D576%26spage%3D147%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Molander, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biolatto, B.</span><span> </span><span class="NLM_article-title">Efficient Ligandless Palladium-Catalyzed Suzuki Reactions of Potassium Aryltrifluoroborates</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1867</span><span class="NLM_x">–</span> <span class="NLM_lpage">1870</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol025845p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=1867-1870&issue=11&author=G.+A.+Molanderauthor=B.+Biolatto&title=Efficient+Ligandless+Palladium-Catalyzed+Suzuki+Reactions+of+Potassium+Aryltrifluoroborates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fol025845p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol025845p%26sid%3Dliteratum%253Aachs%26aulast%3DMolander%26aufirst%3DG.%2BA.%26aulast%3DBiolatto%26aufirst%3DB.%26atitle%3DEfficient%2520Ligandless%2520Palladium-Catalyzed%2520Suzuki%2520Reactions%2520of%2520Potassium%2520Aryltrifluoroborates%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26issue%3D11%26spage%3D1867%26epage%3D1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Molander, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biolatto, B.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Suzuki−Miyaura Cross-Coupling Reactions of Potassium Aryl- and Heteroaryltrifluoroborates</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">4302</span><span class="NLM_x">–</span> <span class="NLM_lpage">4314</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0342368" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=4302-4314&issue=11&author=G.+A.+Molanderauthor=B.+Biolatto&title=Palladium-Catalyzed+Suzuki%E2%88%92Miyaura+Cross-Coupling+Reactions+of+Potassium+Aryl-+and+Heteroaryltrifluoroborates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo0342368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0342368%26sid%3Dliteratum%253Aachs%26aulast%3DMolander%26aufirst%3DG.%2BA.%26aulast%3DBiolatto%26aufirst%3DB.%26atitle%3DPalladium-Catalyzed%2520Suzuki%25E2%2588%2592Miyaura%2520Cross-Coupling%2520Reactions%2520of%2520Potassium%2520Aryl-%2520and%2520Heteroaryltrifluoroborates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26issue%3D11%26spage%3D4302%26epage%3D4314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Darses, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genet, J. P.</span><span> </span><span class="NLM_article-title">Potassium Organotrifluoroborates: New Perspectives in Organic Synthesis</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr0509758" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCrsLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=288-325&author=S.+Darsesauthor=J.+P.+Genet&title=Potassium+Organotrifluoroborates%3A+New+Perspectives+in+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Potassium Organotrifluoroborates: New Perspectives in Organic Synthesis</span></div><div class="casAuthors">Darses, Sylvain; Genet, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">288-325</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The purpose of this article is to present an exhaustive review on potassium organotrifluoroborates in org. synthesis.  Prepn. of these boron ate complexes are included.  Interest in the compds. is certainly due to the exceptional stability of these boron ate complexes toward oxygen and moisture as compared to all other described organoboron derivs.  Another interesting aspect of organotrifluoroborate is their ease of prepn. and purifn. compared to boronic acids, and higher yields are generally achieved in their prepn.  It has also been demonstrated that contrary to trivalent organoboranes, these reagents can easily be functionalized using a great variety of reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrZcSx_cnQIrVg90H21EOLACvtfcHk0ljIhhsynCuc1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCrsLnJ&md5=06b1f8556b14f8c636292c510f95805a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcr0509758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0509758%26sid%3Dliteratum%253Aachs%26aulast%3DDarses%26aufirst%3DS.%26aulast%3DGenet%26aufirst%3DJ.%2BP.%26atitle%3DPotassium%2520Organotrifluoroborates%253A%2520New%2520Perspectives%2520in%2520Organic%2520Synthesis%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D288%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Negishi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okukado, N. J.</span><span> </span><span class="NLM_article-title">Selective Carbon−Carbon Bond Formation via Transition Metal Catalysis. 3. A Highly Selective Synthesis of Unsymmetrical Biaryls and Diarylmethanes by the Nickel- or Palladium-Catalyzed Reaction of Aryl- and Benzylzinc Derivatives with Aryl Halides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1821</span><span class="NLM_x">–</span> <span class="NLM_lpage">1823</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00430a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1977&pages=1821-1823&author=E.+Negishiauthor=A.+O.+Kingauthor=N.+J.+Okukado&title=Selective+Carbon%E2%88%92Carbon+Bond+Formation+via+Transition+Metal+Catalysis.+3.+A+Highly+Selective+Synthesis+of+Unsymmetrical+Biaryls+and+Diarylmethanes+by+the+Nickel-+or+Palladium-Catalyzed+Reaction+of+Aryl-+and+Benzylzinc+Derivatives+with+Aryl+Halides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjo00430a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00430a041%26sid%3Dliteratum%253Aachs%26aulast%3DNegishi%26aufirst%3DE.%26aulast%3DKing%26aufirst%3DA.%2BO.%26aulast%3DOkukado%26aufirst%3DN.%2BJ.%26atitle%3DSelective%2520Carbon%25E2%2588%2592Carbon%2520Bond%2520Formation%2520via%2520Transition%2520Metal%2520Catalysis.%25203.%2520A%2520Highly%2520Selective%2520Synthesis%2520of%2520Unsymmetrical%2520Biaryls%2520and%2520Diarylmethanes%2520by%2520the%2520Nickel-%2520or%2520Palladium-Catalyzed%2520Reaction%2520of%2520Aryl-%2520and%2520Benzylzinc%2520Derivatives%2520with%2520Aryl%2520Halides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1977%26volume%3D42%26spage%3D1821%26epage%3D1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><div class="note"><p class="first last">For preparation of <i>N</i>-ethyl-4-methoxybenzenesulfonamide (used to prepare <b>39</b>) and 2-fluoro-<i>N</i>-methylbenzenesulfonamide (used to prepare <b>41</b>), the following reference should be consulted:</p></div><span class="NLM_contrib-group">Booker, S. K.; D’Angelo, N. D.; D’Amico, D. C.; Kim, T. S.; Liu, L.; Meagher, K.; Norman, M. H.; Panter, K.; Schenkel, L. B.; Smith, A. L.; Tamayo, N. A.; Whittington, D. A.; Xi, N.; Yang, K.</span><span> </span><span class="NLM_article-title">Preparation of 2-Aminobenzothiazole Derivatives as Phosphoinositide 3-Kinase (PI3 Kinase) Modulators</span>. PCT Int. Appl. WO2009017822A2,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+K.+Booker&author=N.+D.+D%E2%80%99Angelo&author=D.+C.+D%E2%80%99Amico&author=T.+S.+Kim&author=L.+Liu&author=K.+Meagher&author=M.+H.+Norman&author=K.+Panter&author=L.+B.+Schenkel&author=A.+L.+Smith&author=N.+A.+Tamayo&author=D.+A.+Whittington&author=N.+Xi&author=K.+Yang&title=Preparation+of+2-Aminobenzothiazole+Derivatives+as+Phosphoinositide+3-Kinase+%28PI3+Kinase%29+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBooker%26aufirst%3DS.%2BK.%26atitle%3DPreparation%2520of%25202-Aminobenzothiazole%2520Derivatives%2520as%2520Phosphoinositide%25203-Kinase%2520%2528PI3%2520Kinase%2529%2520Modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Jones, C. D.; Luke, R. W. A.; Mccoull, W.</span><span> </span><span class="NLM_article-title">Preparation of Ethynylpyrimidine Derivatives as Tie2 Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer</span>. PCT Int. Appl. WO2006103449A2,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=C.+D.+Jones&author=R.+W.+A.+Luke&author=W.+Mccoull&title=Preparation+of+Ethynylpyrimidine+Derivatives+as+Tie2+Receptor+Tyrosine+Kinase+Inhibitors+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BD.%26atitle%3DPreparation%2520of%2520Ethynylpyrimidine%2520Derivatives%2520as%2520Tie2%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Cancer%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="note"><p class="first last">An X-ray structure of 2-phenoxypyrimidine (analogous to <b>8</b>) revealed a dihedral angle of 76−79° between the two ring planes (</p></div><div class="NLM_citation" id="cit43a"><span><span class="NLM_contrib-group">Bakhtiar, N. S.; Abdullah, Z.; Ng, S. W.</span><span> </span><span class="NLM_article-title">2-Phenoxypyrimidine</span>.  <span class="citation_source-journal">Acta Crystallogr., Sect. E</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">o114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=o114&author=N.+S.+Bakhtiar&author=Z.+Abdullah&author=S.+W.+Ng&title=2-Phenoxypyrimidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBakhtiar%26aufirst%3DN.%2BS.%26atitle%3D2-Phenoxypyrimidine%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520E%26date%3D2009%26volume%3D65%26spage%3Do114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">), while an X-ray structure of <i>N</i>-(pyrimidine-2-yl)aniline (analogous to <b>10</b>) showed a dihedral angle of 31−35° (</p></div><div class="NLM_citation" id="cit43b"><span><span class="NLM_contrib-group">Badaruddin, E.; Bakhtiar, N. S.; Aiyub, Z.; Abdullah, Z.; Ng, S. W.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Pyrimidin-2-yl)aniline</span>.  <span class="citation_source-journal">Acta Crystallogr. Sect. E</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">o703</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=o703&author=E.+Badaruddin&author=N.+S.+Bakhtiar&author=Z.+Aiyub&author=Z.+Abdullah&author=S.+W.+Ng&title=N-%28Pyrimidin-2-yl%29aniline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBadaruddin%26aufirst%3DE.%26atitle%3DN-%2528Pyrimidin-2-yl%2529aniline%26jtitle%3DActa%2520Crystallogr.%2520Sect.%2520E%26date%3D2009%26volume%3D65%26spage%3Do703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Bengtsson, M.; Larsson, J.; Nikitidis, G.; Storm, P.; Bailey, J. P.; Griffen, E. J.; Arnould, J. C.; Bird, T. G. C.</span><span> </span><span class="NLM_article-title">5-Heteroaryl Thiazoles and Their Use as PI3K Inhibitors</span>. PCT Int. Appl. WO2006051270A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Bengtsson&author=J.+Larsson&author=G.+Nikitidis&author=P.+Storm&author=J.+P.+Bailey&author=E.+J.+Griffen&author=J.+C.+Arnould&author=T.+G.+C.+Bird&title=5-Heteroaryl+Thiazoles+and+Their+Use+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBengtsson%26aufirst%3DM.%26atitle%3D5-Heteroaryl%2520Thiazoles%2520and%2520Their%2520Use%2520as%2520PI3K%2520Inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Arnould, J. C.; Foote, K. M.; Griffen, E. J.</span><span> </span><span class="NLM_article-title">Thiazole Derivates and Their Use as Anti-Tumour Agents</span>. PCT Int. Appl. WO2007129044A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+C.+Arnould&author=K.+M.+Foote&author=E.+J.+Griffen&title=Thiazole+Derivates+and+Their+Use+as+Anti-Tumour+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArnould%26aufirst%3DJ.%2BC.%26atitle%3DThiazole%2520Derivates%2520and%2520Their%2520Use%2520as%2520Anti-Tumour%2520Agents%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Cosulich, S.; Griffen, E.</span><span> </span><span class="NLM_article-title">New Thiazole Pyridine Sulfonamides as Orally Bioavailable Highly Potent PI3 Kinase Inhibitors</span>. Presented at the 2007 Keystone Symposia, Santa Fe, NM, February 15−20,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=S.+Cosulich&author=E.+Griffen&title=New+Thiazole+Pyridine+Sulfonamides+as+Orally+Bioavailable+Highly+Potent+PI3+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DCosulich%26aufirst%3DS.%26atitle%3DNew%2520Thiazole%2520Pyridine%2520Sulfonamides%2520as%2520Orally%2520Bioavailable%2520Highly%2520Potent%2520PI3%2520Kinase%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Adams, N. D.; Darcy, M. G.; Johnson, N. W.; Kasparec, J.; Knight, S. D.; Newlander, K. A.; Peng, X.; Ridgers, L. H.</span><span> </span><span class="NLM_article-title">Preparation of <i>N</i>-Pyridinyl Benzenesulfonamide Derivatives as PI3 Kinase Inhibitors</span>. PCT Int. Appl. WO2009055418A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=N.+D.+Adams&author=M.+G.+Darcy&author=N.+W.+Johnson&author=J.+Kasparec&author=S.+D.+Knight&author=K.+A.+Newlander&author=X.+Peng&author=L.+H.+Ridgers&title=Preparation+of+N-Pyridinyl+Benzenesulfonamide+Derivatives+as+PI3+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DN.%2BD.%26atitle%3DPreparation%2520of%2520N-Pyridinyl%2520Benzenesulfonamide%2520Derivatives%2520as%2520PI3%2520Kinase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="note"><p class="first last">The suboptimal hydrogen bond angles between the Lys833 amino group and the sulfonamide oxygen (129°) and nitrogen (146°) atoms are the most likely explanation for this hydrogen bond not being observed.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A Small Molecule−Kinase Interaction Map for Clinical Kinase Inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&issue=3&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+Small+Molecule%E2%88%92Kinase+Interaction+Map+for+Clinical+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520Small%2520Molecule%25E2%2588%2592Kinase%2520Interaction%2520Map%2520for%2520Clinical%2520Kinase%2520Inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26issue%3D3%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="note"><p class="first last">A table of the studied kinases is presented in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="note"><p class="first last">Compound <b>82</b> exhibited a bioavailability of 103% when administered as a 1 mg/kg dose in 20% Captisol, 2% HPMC, and 1% Tween 80, with the compound being dissolved at a pH of 9.0, and then the pH was readjusted to 7.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="note"><p class="first last">Compound <b>73</b> was also evaluated in a a mouse liver (PD) assay, using dosages ranging from 0.01 to 0.3 mg/kg. Human HGF was injected iv 4 h postdose. The dose-response graph is included in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Ali, I. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schriml, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span> </span><span class="NLM_article-title">Mutational Spectra of PTEN/MMAC1 Gene: A Tumor Suppressor with Lipid Phosphatase Activity</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1922</span><span class="NLM_x">–</span> <span class="NLM_lpage">1932</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1093%2Fjnci%2F91.22.1922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=10564676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADyaK1MXotVaitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=1922-1932&author=I.+U.+Aliauthor=L.+M.+Schrimlauthor=M.+Dean&title=Mutational+Spectra+of+PTEN%2FMMAC1+Gene%3A+A+Tumor+Suppressor+with+Lipid+Phosphatase+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity</span></div><div class="casAuthors">Ali, Iqbal Unnisa; Schriml, Lynn M.; Dean, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1922-1932</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 120 refs.  PTEN/MMAC1 (phosphatase, tensin homolog/mutated in multiple advanced cancers) is a tumor suppressor protein that has sequence homol. with dual-specificity phosphatases, which are capable of dephosphorylating both tyrosine phosphate and serine/threonine phosphate residues on proteins.  The in vivo function of PTEN/MMAC1 appears to be dephosphorylation of phosphotidylinositol 3,4,5-triphosphate.  The PTEN/MMAC1 gene is mutated in the germline of patients with rare autosomal dominant cancer syndromes and in subsets of specific cancers.  Here we review the mutational spectra of the PTEN/MMAC1 gene in tumors from various tissues, esp. endometrium, brain, prostate, and ovary, in which the gene is inactivated very frequently.  Germline and somatic mutations in the PTEN/MMAC1 gene occur mostly in the protein coding region and involve the phosphatase domain and poly(A)6 stretches.  Compared with germline alterations found in the PTEN/MMAC1 gene, there is a substantially increased frequency of frameshift mutations in tumors.  Glioblastomas and endometrial carcinomas appear to have distinct mutational spectra, probably reflecting differences in the underlying mechanisms of inactivation of the PTEN/MMAC1 gene in the two tissue types.  Also, depending on the tissue type, the gene appears to be involved in the initiation or the progression of cancers.  Further understanding of PTEN/MMAC1 gene mutations in different tumors and the physiol. consequences of these mutations is likely to open up new therapeutic opportunities for targeting this crit. gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox1hhrBuiMKrVg90H21EOLACvtfcHk0liCjZtm7pC_PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotVaitr4%253D&md5=2b00e89439f512e96d9089d0f7312c28</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F91.22.1922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F91.22.1922%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DI.%2BU.%26aulast%3DSchriml%26aufirst%3DL.%2BM.%26aulast%3DDean%26aufirst%3DM.%26atitle%3DMutational%2520Spectra%2520of%2520PTEN%252FMMAC1%2520Gene%253A%2520A%2520Tumor%2520Suppressor%2520with%2520Lipid%2520Phosphatase%2520Activity%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1999%26volume%3D91%26spage%3D1922%26epage%3D1932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Eng, C.</span><span> </span><span class="NLM_article-title">PTEN: One Gene, Many Syndromes</span> <span class="citation_source-journal">Hum. Mutat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1002%2Fhumu.10257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=12938083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos12msLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=183-198&author=C.+Eng&title=PTEN%3A+One+Gene%2C+Many+Syndromes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN: one gene, many syndromes</span></div><div class="casAuthors">Eng, Charis</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">183-198</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  PTEN, on 10q23.3, encodes a major lipid phosphatase which signals down the phosphoinositol-3-kinase/Akt pathway and effects G1 cell cycle arrest and apoptosis.  Germline PTEN mutations have been found to occur in 80% of classic Cowden syndrome (CS), 60% of Bannayan-Riley-Ruvalcaba syndrome (BRRS), up to 20% of Proteus syndrome (PS), and approx. 50% of a Proteus-like syndrome (PSL).  CS is a heritable multiple hamartoma syndrome with a high risk of breast, thyroid, and endometrial carcinomas.  BRRS is a congenital autosomal dominant disorder characterized by megencephaly, developmental delay, lipomatosis, and speckled penis.  PS and PSL had never been assocd. with risk of malignancy.  Finding germline PTEN mutations in patients with BRRS, PS, and PSL suggests equiv. risks of developing malignancy as in CS with implications for medical management.  The mutational spectra of CS and BRRS overlap, with many of the mutations occurring in exons 5, 7, and 8.  Genotype-phenotype assocn. analyses have revealed that the presence of germline PTEN mutations is assocd. with breast tumor development, and that mutations occurring within and 5' of the phosphatase motif were assocd. with multi-organ involvement.  Pooled anal. of PTEN mutation series of CS and BRRS occurring in the last five years reveals that 65% of CS-assocd. mutations occur in the first five exons encoding the phosphatase domain and the promoter region, while 60% of BRRS-assocd. mutations occur in the 3' four exons encoding mainly the C2 domain.  Somatic PTEN mutations occur with a wide distribution of frequencies in sporadic primary tumors, with the highest frequencies in endometrial carcinomas and glioblastoma multiform.  Several mechanisms of PTEN inactivation occur in primary malignancies derived from different tissues, but a favored mechanism appears to occur in a tissue-specific manner.  Inappropriate subcellular compartmentalization and increased/decreased proteasome degrdn. may be two novel mechanisms of PTEN inactivation.  Further functional work could reveal more effective means of mol.-directed therapy and prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVqzT_tptFgbVg90H21EOLACvtfcHk0liCjZtm7pC_PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos12msLo%253D&md5=dbc551912f25f440d46da96431ca940d</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fhumu.10257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.10257%26sid%3Dliteratum%253Aachs%26aulast%3DEng%26aufirst%3DC.%26atitle%3DPTEN%253A%2520One%2520Gene%252C%2520Many%2520Syndromes%26jtitle%3DHum.%2520Mutat.%26date%3D2003%26volume%3D22%26spage%3D183%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Rodenhuis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Wetering, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Zandwijk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, J. L.</span><span> </span><span class="NLM_article-title">Mutational Activation of the K-ras Oncogene: A Possible Pathogenetic Factor in Adenocarcinoma of the Lung</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1056%2FNEJM198710083171504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=3041218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A280%3ADyaL2szhsFarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=1987&pages=929-935&author=S.+Rodenhuisauthor=M.+L.+van+de+Weteringauthor=W.+J.+Mooiauthor=S.+G.+Eversauthor=N.+Van+Zandwijkauthor=J.+L.+Bos&title=Mutational+Activation+of+the+K-ras+Oncogene%3A+A+Possible+Pathogenetic+Factor+in+Adenocarcinoma+of+the+Lung"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung</span></div><div class="casAuthors">Rodenhuis S; van de Wetering M L; Mooi W J; Evers S G; van Zandwijk N; Bos J L</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">929-35</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">To define the role of cellular oncogenes in human cancers, we studied the prevalence of mutational activation of ras oncogenes in untreated non-small-cell lung cancer.  Genomic DNA was extracted from 39 tumor specimens obtained by thoracotomy and was examined for activating point mutations in codons 12, 13, and 61 of the H-ras, K-ras, and N-ras genes.  A novel, highly sensitive assay based on oligonucleotide hybridization following an in vitro amplification step was employed.  The K-ras gene was found to be activated by point mutations in codon 12 in 5 of 10 adenocarcinomas.  Two of these tumors were less than 2 cm in size and had not metastasized.  No ras gene mutations were observed in 15 squamous-cell carcinomas, 10 large-cell carcinomas, 1 carcinoid, 2 metastatic adenocarcinomas from primary tumors outside the lung, and 1 small-cell carcinoma.  An approximately 20-fold amplification of the unmutated K-ras gene was observed in a tumor that proved to be a solitary lung metastasis of a rectal carcinoma.  We conclude that mutational K-ras activation may be an important early event in the pathogenesis of adenocarcinoma of the lung but that amplification of ras genes or mutational activation of H-ras or N-ras does not play a major part in non-small-cell lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3KA7iei6rnOvW160gIxP_fW6udTcc2eZzU-6gPRgajrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2szhsFarsw%253D%253D&md5=5e2688b0cb069f49f8f59ab32c8fce70</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1056%2FNEJM198710083171504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198710083171504%26sid%3Dliteratum%253Aachs%26aulast%3DRodenhuis%26aufirst%3DS.%26aulast%3Dvan%2Bde%2BWetering%26aufirst%3DM.%2BL.%26aulast%3DMooi%26aufirst%3DW.%2BJ.%26aulast%3DEvers%26aufirst%3DS.%2BG.%26aulast%3DVan%2BZandwijk%26aufirst%3DN.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DMutational%2520Activation%2520of%2520the%2520K-ras%2520Oncogene%253A%2520A%2520Possible%2520Pathogenetic%2520Factor%2520in%2520Adenocarcinoma%2520of%2520the%2520Lung%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1987%26volume%3D317%26spage%3D929%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Okudela, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakane, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">KeQin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, H.</span><span> </span><span class="NLM_article-title"><i>K-ras</i> Gene Mutation Enhances Motility of Immortalized Airway Cells and Lung Adenocarcinoma Cells via Akt Activation</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1016%2FS0002-9440%2810%2963100-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=14695323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVCgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2004&pages=91-100&issue=1&author=K.+Okudelaauthor=H.+Hayashiauthor=T.+Itoauthor=T.+Yazawaauthor=T.+Suzukiauthor=Y.+Nakaneauthor=H.+Satoauthor=H.+Ishiauthor=X.+KeQinauthor=A.+Masudaauthor=T.+Takahashiauthor=H.+Kitamura&title=K-ras+Gene+Mutation+Enhances+Motility+of+Immortalized+Airway+Cells+and+Lung+Adenocarcinoma+Cells+via+Akt+Activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma</span></div><div class="casAuthors">Okudela, Koji; Hayashi, Hiroyuki; Ito, Takaaki; Yazawa, Takuya; Suzuki, Takehisa; Nakane, Yuko; Sato, Hanako; Ishi, Haruhiko; KeQin, Xin; Masuda, Akira; Takahashi, Takashi; Kitamura, Hitoshi</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-100</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Point mutations of the K-ras gene, which are found in 10 to 30% of lung adenocarcinomas, are regarded as being an early event during the carcinogenesis.  Autonomous vigorous motility of neoplastic cells, as well as growth and survival advantages, are considered to be necessary for cancer development and progression.  The present study describes the contributions of the K-ras gene mutation and its downstream pathway via phosphatidylinositol 3-OH kinase (PI3K)-Akt to the cell motility in an immortalized human peripheral airway epithelial cell (HPL1D) and lung adenocarcinoma cells (A549, H820, TKB6, and TKB14).  We have also evaluated the relationship between pathol. events and the K-ras-Akt pathway using surgically resected lung tumors.  The HPL1D cells transfected with the mutated K-ras gene (HPL-V12) showed a significant increase in cell motility compared to those transfected with empty vector (HPL-E) or wild-type K-ras gene (HPL-K).  The enhanced motility in the HPL-V12 cells was markedly reduced by either treatment with inhibitors of ras, PI3K, and/or MEK, or by transfection with the dominant-neg. mutant Akt (dnAkt).  The lung adenocarcinoma cells bearing the K-ras gene mutation (A549 and H820) showed consistently higher levels of cell motilities than those without the mutation (TKB6 and TKB14), and the motility of A549 and H820 cells were significantly inhibited by dnAkt transfection.  These results suggest that the K-ras gene mutation could enhance the motility of neoplastic cells through a pathway involving PI3K-Akt.  Actually, among the surgically resected lung tumors, the adenocarcinomas with the K-ras gene mutation tended to show a higher frequency and intensity of immunoreactivity for phosphorylated Akt (p-ser473Akt) than those without the mutation, supporting the in vitro observation that the mutated K-ras can activate the PI3K-Akt pathway.  Immunoreactivity for p-ser473Akt was also seen in the pre-malignant and early lesions at a frequency similar to that in the advanced lung adenocarcinomas,.  No correlation was seen between p-ser473Akt immunoreactivity and lymphatic/organ metastasis or prognosis.  These results taken together suggest that the K-ras-Akt pathway might facilitate the motility of neoplastic cells during the early period of carcinogenesis in lung adenocarcinomas, and may contribute to their non-invasive expansion along the alveolar septa, rather than invasion or metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppxaDuQ3Y8IrVg90H21EOLACvtfcHk0lgZdTNPqXmcNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVCgsg%253D%253D&md5=f439b85b4835771a0a34cce7e72b37a5</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963100-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963100-8%26sid%3Dliteratum%253Aachs%26aulast%3DOkudela%26aufirst%3DK.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DYazawa%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DNakane%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DIshi%26aufirst%3DH.%26aulast%3DKeQin%26aufirst%3DX.%26aulast%3DMasuda%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DH.%26atitle%3DK-ras%2520Gene%2520Mutation%2520Enhances%2520Motility%2520of%2520Immortalized%2520Airway%2520Cells%2520and%2520Lung%2520Adenocarcinoma%2520Cells%2520via%2520Akt%2520Activation%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2004%26volume%3D164%26issue%3D1%26spage%3D91%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Velho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suriano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duval, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carneiro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machado, J. C.</span><span> </span><span class="NLM_article-title">The Prevalence of PIK3CA Mutations in Gastric and Colon Cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1649</span><span class="NLM_x">–</span> <span class="NLM_lpage">1654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=1649-1654&author=S.+Velhoauthor=C.+Oliveiraauthor=A.+Ferreiraauthor=A.+C.+Ferreiraauthor=G.+Surianoauthor=J.+Schwartzauthor=A.+Duvalauthor=F.+Carneiroauthor=J.+C.+Machado&title=The+Prevalence+of+PIK3CA+Mutations+in+Gastric+and+Colon+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVelho%26aufirst%3DS.%26aulast%3DOliveira%26aufirst%3DC.%26aulast%3DFerreira%26aufirst%3DA.%26aulast%3DFerreira%26aufirst%3DA.%2BC.%26aulast%3DSuriano%26aufirst%3DG.%26aulast%3DSchwartz%26aufirst%3DJ.%26aulast%3DDuval%26aufirst%3DA.%26aulast%3DCarneiro%26aufirst%3DF.%26aulast%3DMachado%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520Prevalence%2520of%2520PIK3CA%2520Mutations%2520in%2520Gastric%2520and%2520Colon%2520Cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2005%26volume%3D41%26spage%3D1649%26epage%3D1654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Still, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, A.</span><span> </span><span class="NLM_article-title">Rapid Chromatographic Technique for Preparative Separations with Moderate Resolution</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">2923</span><span class="NLM_x">–</span> <span class="NLM_lpage">2925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00408a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADyaE1cXksF2hu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1978&pages=2923-2925&issue=14&author=W.+C.+Stillauthor=M.+Kahnauthor=A.+Mitra&title=Rapid+Chromatographic+Technique+for+Preparative+Separations+with+Moderate+Resolution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid chromatographic technique for preparative separations with moderate resolution</span></div><div class="casAuthors">Still, W. Clark; Kahn, Michael; Mitra, Abhijit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2923-5</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A simple adsorption chromatog. technique has been developed for rapid (<15 min) sepns.  The technique uses a short (e.g., 5 in.) column of 40-63-μm silica gel and operates at high flow rates (2.0 vertical in./min) to allow the sepn. of multigram quantities of compds. which are resolved on anal. TLC by as little as ΔRf 0.15.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCsgCIAoC4VbVg90H21EOLACvtfcHk0lgZdTNPqXmcNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXksF2hu7s%253D&md5=34e721c237babee0665e2f9c6f6a3999</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjo00408a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00408a041%26sid%3Dliteratum%253Aachs%26aulast%3DStill%26aufirst%3DW.%2BC.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DMitra%26aufirst%3DA.%26atitle%3DRapid%2520Chromatographic%2520Technique%2520for%2520Preparative%2520Separations%2520with%2520Moderate%2520Resolution%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1978%26volume%3D43%26issue%3D14%26spage%3D2923%26epage%3D2925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batty, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priganica, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downes, P.</span><span> </span><span class="NLM_article-title">Nonradioactive Methods for the Assay of Phosphoinositide 3-Kinases and Phosphoinositide Phosphatases and Selective Detection of Signaling Lipids in Cell and Tissue Extracts</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2003&pages=234-245&issue=2&author=A.+Grayauthor=H.+Olssonauthor=I.+H.+Battyauthor=C.+Priganicaauthor=P.+Downes&title=Nonradioactive+Methods+for+the+Assay+of+Phosphoinositide+3-Kinases+and+Phosphoinositide+Phosphatases+and+Selective+Detection+of+Signaling+Lipids+in+Cell+and+Tissue+Extracts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DA.%26aulast%3DOlsson%26aufirst%3DH.%26aulast%3DBatty%26aufirst%3DI.%2BH.%26aulast%3DPriganica%26aufirst%3DC.%26aulast%3DDownes%26aufirst%3DP.%26atitle%3DNonradioactive%2520Methods%2520for%2520the%2520Assay%2520of%2520Phosphoinositide%25203-Kinases%2520and%2520Phosphoinositide%2520Phosphatases%2520and%2520Selective%2520Detection%2520of%2520Signaling%2520Lipids%2520in%2520Cell%2520and%2520Tissue%2520Extracts%26jtitle%3DAnal.%2520Biochem.%26date%3D2003%26volume%3D313%26issue%3D2%26spage%3D234%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Walker, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacold, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perisic, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span> </span><span class="NLM_article-title">Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">919</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1016%2FS1097-2765%2805%2900089-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=11090628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVegurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=909-919&author=E.+H.+Walkerauthor=M.+E.+Pacoldauthor=O.+Perisicauthor=L.+Stephensauthor=P.+T.+Hawkinsauthor=M.+P.+Wymannauthor=R.+L.+Williams&title=Structural+Determinants+of+Phosphoinositide+3-Kinase+Inhibition+by+Wortmannin%2C+LY294002%2C+Quercetin%2C+Myricetin%2C+and+Staurosporine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine</span></div><div class="casAuthors">Walker, Edward H.; Pacold, Michael E.; Perisic, Olga; Stephens, Len; Hawkins, Philip T.; Wymann, Matthias P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">909-919</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The specific phosphoinositide 3-kinase (P13K) inhibitors wortmannin and LY294002 have been invaluable tools for elucidating the roles of these enzymes in signal transduction pathways.  The X-ray crystallog. structures of P13K bound to these lipid kinase inhibitors and to the broad-spectrum protein kinase inhibitors quercetin, myricetin, and staurosporine reveal how these compds. fit into the ATP binding pocket.  With a nanomolar IC50, wortmannin most closely fits and fills the active site and induces a conformational change in the catalytic domain.  Surprisingly, LY294002 and the lead compd. on which it was designed, quercetin, as well as the closely related flavonoid myricetin bind P13K in remarkably different orientations that are related to each other by 1800 rotations.  Staurosporine/P13K interactions are reminiscent of low-affinity protein kinase/staurosporine complexes.  These results provide a rich basis for development of isoform-specific P13K inhibitors with therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgIbTky2xQmbVg90H21EOLACvtfcHk0liEMC3lu87nbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVegurY%253D&md5=5dd92f9b48c437e43c0023fdff10c1ac</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2805%2900089-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252805%252900089-4%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DE.%2BH.%26aulast%3DPacold%26aufirst%3DM.%2BE.%26aulast%3DPerisic%26aufirst%3DO.%26aulast%3DStephens%26aufirst%3DL.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DStructural%2520Determinants%2520of%2520Phosphoinositide%25203-Kinase%2520Inhibition%2520by%2520Wortmannin%252C%2520LY294002%252C%2520Quercetin%252C%2520Myricetin%252C%2520and%2520Staurosporine%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D6%26spage%3D909%26epage%3D919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray Diffraction Data Collected in Oscillation Mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-ray+Diffraction+Data+Collected+in+Oscillation+Mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0liEMC3lu87nbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520Diffraction%2520Data%2520Collected%2520in%2520Oscillation%2520Mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Navaza, J.</span><span> </span><span class="NLM_article-title">AMoRe: An Automated Package for Molecular Replacement</span> <span class="citation_source-journal">Acta Crystallogr., Sect. A: Found. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1107%2FS0108767393007597" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=157-163&author=J.+Navaza&title=AMoRe%3A+An+Automated+Package+for+Molecular+Replacement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1107%2FS0108767393007597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767393007597%26sid%3Dliteratum%253Aachs%26aulast%3DNavaza%26aufirst%3DJ.%26atitle%3DAMoRe%253A%2520An%2520Automated%2520Package%2520for%2520Molecular%2520Replacement%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D157%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of Macromolecular Structures by the Maximum-Likelihood Method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">Part 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&issue=Part+3&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+Macromolecular+Structures+by+the+Maximum-Likelihood+Method"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520Macromolecular%2520Structures%2520by%2520the%2520Maximum-Likelihood%2520Method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26issue%3DPart%25203%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: Model-Building Tools for Molecular Graphics</span> <span class="citation_source-journal">Acta Crystallogr. Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">Part 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2126-2132&issue=Part+1&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+Model-Building+Tools+for+Molecular+Graphics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520Model-Building%2520Tools%2520for%2520Molecular%2520Graphics%26jtitle%3DActa%2520Crystallogr.%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D12%26issue%3DPart%25201%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43a','cit43b'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':[],'ref49':['cit49'],'ref50':[],'ref51':[],'ref52':[],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 77 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jian Li, Xin-Er Yang, Shan-Le Wang, Long-Long Zhang, Xiao-Zhou Zhou, Shun-Yi Wang, <span class="NLM_string-name hlFld-ContribAuthor">Shun-Jun Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Visible-Light-Promoted Cross-Coupling Reactions of 4-Alkyl-1,4-dihydropyridines with Thiosulfonate or Selenium Sulfonate: A Unified Approach to Sulfides, Selenides, and Sulfoxides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (12)
                                     , 4908-4913. <a href="https://doi.org/10.1021/acs.orglett.0c01776" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c01776</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c01776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c01776%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DVisible-Light-Promoted%252BCross-Coupling%252BReactions%252Bof%252B4-Alkyl-1%25252C4-dihydropyridines%252Bwith%252BThiosulfonate%252Bor%252BSelenium%252BSulfonate%25253A%252BA%252BUnified%252BApproach%252Bto%252BSulfides%25252C%252BSelenides%25252C%252Band%252BSulfoxides%26aulast%3DLi%26aufirst%3DJian%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26052020%26date%3D10062020%26volume%3D22%26issue%3D12%26spage%3D4908%26epage%3D4913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Martina Durcik, Žan Toplak, Nace Zidar, Janez Ilaš, Anamarija Zega, Danijel Kikelj, Lucija Peterlin Mašič, <span class="NLM_string-name hlFld-ContribAuthor">Tihomir Tomašič</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Hydroxy-Substituted 2-Aminobenzo[d]thiazole-6-carboxylic Acid Derivatives as New Building Blocks in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (14)
                                     , 8305-8311. <a href="https://doi.org/10.1021/acsomega.0c00768" title="DOI URL">https://doi.org/10.1021/acsomega.0c00768</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c00768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c00768%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DEfficient%252BSynthesis%252Bof%252BHydroxy-Substituted%252B2-Aminobenzo%25255Bd%25255Dthiazole-6-carboxylic%252BAcid%252BDerivatives%252Bas%252BNew%252BBuilding%252BBlocks%252Bin%252BDrug%252BDiscovery%26aulast%3DDurcik%26aufirst%3DMartina%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21022020%26date%3D20032020%26date%3D31032020%26volume%3D5%26issue%3D14%26spage%3D8305%26epage%3D8311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Aimie
E. Garces, <span class="NLM_string-name hlFld-ContribAuthor">Michael J. Stocks</span>. </span><span class="cited-content_cbyCitation_article-title">Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (10)
                                     , 4815-4850. <a href="https://doi.org/10.1021/acs.jmedchem.8b01492" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01492</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01492%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DClass%252B1%252BPI3K%252BClinical%252BCandidates%252Band%252BRecent%252BInhibitor%252BDesign%252BStrategies%25253A%252BA%252BMedicinal%252BChemistry%252BPerspective%26aulast%3DGarces%26aufirst%3DAimie%2BE.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D25092018%26date%3D24122018%26volume%3D62%26issue%3D10%26spage%3D4815%26epage%3D4850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nick Barton, Máire Convery, Anthony W. J. Cooper, Kenneth Down, J. Nicole Hamblin, Graham Inglis, Simon Peace, James Rowedder, Paul Rowland, Jonathan A. Taylor, <span class="NLM_string-name hlFld-ContribAuthor">Natalie Wellaway</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent, Efficient, and Selective Inhibitors of Phosphoinositide 3-Kinase δ through a Deconstruction and Regrowth Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (24)
                                     , 11061-11073. <a href="https://doi.org/10.1021/acs.jmedchem.8b01556" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01556</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01556%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%25252C%252BEfficient%25252C%252Band%252BSelective%252BInhibitors%252Bof%252BPhosphoinositide%252B3-Kinase%252B%2525CE%2525B4%252Bthrough%252Ba%252BDeconstruction%252Band%252BRegrowth%252BApproach%26aulast%3DBarton%26aufirst%3DNick%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05102018%26date%3D21122018%26date%3D11122018%26volume%3D61%26issue%3D24%26spage%3D11061%26epage%3D11073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nils Pemberton, Mickael Mogemark, Susanne Arlbrandt, Peter Bold, Rhona J. Cox, Cristina Gardelli, Neil S. Holden, Kostas Karabelas, Johan Karlsson, Sarah Lever, Xueshan Li, Helena Lindmark, Monica Norberg, Matthew W. D. Perry, Jens Petersen, Sandra Rodrigo Blomqvist, Matthew Thomas, Christian Tyrchan, Annika Westin Eriksson, Pavol Zlatoidsky, <span class="NLM_string-name hlFld-ContribAuthor">Linda Öster</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (12)
                                     , 5435-5441. <a href="https://doi.org/10.1021/acs.jmedchem.8b00447" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00447</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00447%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BHighly%252BIsoform%252BSelective%252BOrally%252BBioavailable%252BPhosphoinositide%252B3-Kinase%252B%252528PI3K%252529-%2525CE%2525B3%252BInhibitors%26aulast%3DPemberton%26aufirst%3DNils%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21032018%26date%3D18062018%26date%3D31052018%26volume%3D61%26issue%3D12%26spage%3D5435%26epage%3D5441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tao Yu, Ning Li, Chengde Wu, Amy Guan, Yi Li, Zhengang Peng, Miao He, Jie Li, Zhen Gong, Lei Huang, Bo Gao, Dongling Hao, Jikui Sun, Yan Pan, Liang Shen, Chichung Chan, Xiulian Lu, Hongyu Yuan, Yongguo Li, Jian Li, <span class="NLM_string-name hlFld-ContribAuthor">Shuhui Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Pyridopyrimidinones as Potent and Orally Active Dual Inhibitors of PI3K/mTOR. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (3)
                                     , 256-261. <a href="https://doi.org/10.1021/acsmedchemlett.8b00002" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00002%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BPyridopyrimidinones%252Bas%252BPotent%252Band%252BOrally%252BActive%252BDual%252BInhibitors%252Bof%252BPI3K%25252FmTOR%26aulast%3DYu%26aufirst%3DTao%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03012018%26date%3D27022018%26date%3D28022018%26date%3D27022018%26volume%3D9%26issue%3D3%26spage%3D256%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chengbin  Yang</span>, <span class="hlFld-ContribAuthor ">Xi  Zhang</span>, <span class="hlFld-ContribAuthor ">Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Yongtai  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Liu</span>, <span class="hlFld-ContribAuthor ">Mingli  Deng</span>, <span class="hlFld-ContribAuthor ">Yu  Jia</span>, <span class="hlFld-ContribAuthor ">Yun  Ling</span>, <span class="hlFld-ContribAuthor ">Ling-hua  Meng</span>, and <span class="hlFld-ContribAuthor ">Yaming  Zhou</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Series of 7-Azaindole Scaffold Derivatives as PI3K Inhibitors with Potent Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (8)
                                     , 875-880. <a href="https://doi.org/10.1021/acsmedchemlett.7b00222" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00222%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BSeries%252Bof%252B7-Azaindole%252BScaffold%252BDerivatives%252Bas%252BPI3K%252BInhibitors%252Bwith%252BPotent%252BActivity%26aulast%3DYang%26aufirst%3DChengbin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D28052017%26date%3D26072017%26date%3D31072017%26date%3D10082017%26date%3D26072017%26volume%3D8%26issue%3D8%26spage%3D875%26epage%3D880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span> and <span class="hlFld-ContribAuthor ">Demetri T.  Moustakas</span>  . </span><span class="cited-content_cbyCitation_article-title">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 3552-3579. <a href="https://doi.org/10.1021/acs.jmedchem.6b01807" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BNecessary%252BNitrogen%252BAtom%25253A%252BA%252BVersatile%252BHigh-Impact%252BDesign%252BElement%252Bfor%252BMultiparameter%252BOptimization%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D09122016%26date%3D08022017%26date%3D11052017%26volume%3D60%26issue%3D9%26spage%3D3552%26epage%3D3579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiyue  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Jing Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Xuan  Gao</span>, <span class="hlFld-ContribAuthor ">Zun  Huang</span>, and <span class="hlFld-ContribAuthor ">Qi  Shen</span>  . </span><span class="cited-content_cbyCitation_article-title">Multifunctional Nanoparticles Loading with Docetaxel and GDC0941 for Reversing Multidrug Resistance Mediated by PI3K/Akt Signal Pathway. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2017,</strong> <em>14 </em>
                                    (4)
                                     , 1120-1132. <a href="https://doi.org/10.1021/acs.molpharmaceut.6b01045" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.6b01045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.6b01045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.6b01045%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DMultifunctional%252BNanoparticles%252BLoading%252Bwith%252BDocetaxel%252Band%252BGDC0941%252Bfor%252BReversing%252BMultidrug%252BResistance%252BMediated%252Bby%252BPI3K%25252FAkt%252BSignal%252BPathway%26aulast%3DWang%26aufirst%3DYiyue%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D2017%26date%3D17112016%26date%3D14032017%26date%3D09032017%26date%3D22032017%26date%3D03042017%26date%3D14032017%26volume%3D14%26issue%3D4%26spage%3D1120%26epage%3D1132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Felix  Gonzalez-Lopez de Turiso</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Hao</span>, <span class="hlFld-ContribAuthor ">Youngsook  Shin</span>, <span class="hlFld-ContribAuthor ">Minna  Bui</span>, <span class="hlFld-ContribAuthor ">Iain D. G.  Campuzano</span>, <span class="hlFld-ContribAuthor ">Mario  Cardozo</span>, <span class="hlFld-ContribAuthor ">Michelle C.  Dunn</span>, <span class="hlFld-ContribAuthor ">Jason  Duquette</span>, <span class="hlFld-ContribAuthor ">Benjamin  Fisher</span>, <span class="hlFld-ContribAuthor ">Robert S.  Foti</span>, <span class="hlFld-ContribAuthor ">Kirk  Henne</span>, <span class="hlFld-ContribAuthor ">Xiao  He</span>, <span class="hlFld-ContribAuthor ">Yi-Ling  Hu</span>, <span class="hlFld-ContribAuthor ">Ron C.  Kelly</span>, <span class="hlFld-ContribAuthor ">Michael G.  Johnson</span>, <span class="hlFld-ContribAuthor ">Brian S.  Lucas</span>, <span class="hlFld-ContribAuthor ">John  McCarter</span>, <span class="hlFld-ContribAuthor ">Lawrence R.  McGee</span>, <span class="hlFld-ContribAuthor ">Julio C.  Medina</span>, <span class="hlFld-ContribAuthor ">Daniela  Metz</span>, <span class="hlFld-ContribAuthor ">Tisha  San Miguel</span>, <span class="hlFld-ContribAuthor ">Deanna  Mohn</span>, <span class="hlFld-ContribAuthor ">Thuy  Tran</span>, <span class="hlFld-ContribAuthor ">Christine  Vissinga</span>, <span class="hlFld-ContribAuthor ">Sharon  Wannberg</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">John  Whoriskey</span>, <span class="hlFld-ContribAuthor ">Gang  Yu</span>, <span class="hlFld-ContribAuthor ">Leeanne  Zalameda</span>, <span class="hlFld-ContribAuthor ">Xuxia  Zhang</span>, and <span class="hlFld-ContribAuthor ">Timothy D.  Cushing</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (15)
                                     , 7252-7267. <a href="https://doi.org/10.1021/acs.jmedchem.6b00827" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00827</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00827&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00827%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252Bthe%252BPotent%252Band%252BSelective%252BPI3K%2525CE%2525B4%252BInhibitors%252B2-%252528%2525281S%252529-1-%252528%2525286-Amino-5-cyano-4-pyrimidinyl%252529amino%252529ethyl%252529-6-fluoro-N-methyl-3-%2525282-pyridinyl%252529-4-quinolinecarboxamide%252B%252528AM-0687%252529%252Band%252B2-%252528%2525281S%252529-1-%252528%2525286-Amino-5-cyano-4-pyrimidinyl%252529amino%252529ethyl%252529-5-fluoro-N-methyl-3-%2525282-pyridinyl%252529-4-quinolinecarboxamide%252B%252528AM-1430%252529%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DFelix%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01062016%26date%3D25072016%26date%3D11082016%26date%3D14072016%26volume%3D59%26issue%3D15%26spage%3D7252%26epage%3D7267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xianjin  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Xie</span>, <span class="hlFld-ContribAuthor ">Pinhua  Li</span>, <span class="hlFld-ContribAuthor ">Jianqi  Guo</span>, and <span class="hlFld-ContribAuthor ">Lei  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Visible-Light-Induced Direct Thiolation at α-C(sp3)–H of Ethers with Disulfides Using Acridine Red as Photocatalyst. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (7)
                                     , 1546-1549. <a href="https://doi.org/10.1021/acs.orglett.6b00304" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b00304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b00304%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DVisible-Light-Induced%252BDirect%252BThiolation%252Bat%252B%2525CE%2525B1-C%252528sp3%252529%2525E2%252580%252593H%252Bof%252BEthers%252Bwith%252BDisulfides%252BUsing%252BAcridine%252BRed%252Bas%252BPhotocatalyst%26aulast%3DZhu%26aufirst%3DXianjin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29012016%26date%3D22032016%26date%3D01042016%26volume%3D18%26issue%3D7%26spage%3D1546%26epage%3D1549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youngsook  Shin</span>, <span class="hlFld-ContribAuthor ">Julia  Suchomel</span>, <span class="hlFld-ContribAuthor ">Mario  Cardozo</span>, <span class="hlFld-ContribAuthor ">Jason  Duquette</span>, <span class="hlFld-ContribAuthor ">Xiao  He</span>, <span class="hlFld-ContribAuthor ">Kirk  Henne</span>, <span class="hlFld-ContribAuthor ">Yi-Ling  Hu</span>, <span class="hlFld-ContribAuthor ">Ron C.  Kelly</span>, <span class="hlFld-ContribAuthor ">John  McCarter</span>, <span class="hlFld-ContribAuthor ">Lawrence R.  McGee</span>, <span class="hlFld-ContribAuthor ">Julio C.  Medina</span>, <span class="hlFld-ContribAuthor ">Daniela  Metz</span>, <span class="hlFld-ContribAuthor ">Tisha  San Miguel</span>, <span class="hlFld-ContribAuthor ">Deanna  Mohn</span>, <span class="hlFld-ContribAuthor ">Thuy  Tran</span>, <span class="hlFld-ContribAuthor ">Christine  Vissinga</span>, <span class="hlFld-ContribAuthor ">Simon  Wong</span>, <span class="hlFld-ContribAuthor ">Sharon  Wannberg</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">John  Whoriskey</span>, <span class="hlFld-ContribAuthor ">Gang  Yu</span>, <span class="hlFld-ContribAuthor ">Leeanne  Zalameda</span>, <span class="hlFld-ContribAuthor ">Xuxia  Zhang</span>, and <span class="hlFld-ContribAuthor ">Timothy D.  Cushing</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (1)
                                     , 431-447. <a href="https://doi.org/10.1021/acs.jmedchem.5b01651" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01651</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01651%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252BOptimization%25252C%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252BBenzimidazole%252BDerivatives%252BAM-8508%252Band%252BAM-9635%252Bas%252BPotent%252Band%252BSelective%252BPI3K%2525CE%2525B4%252BInhibitors%26aulast%3DShin%26aufirst%3DYoungsook%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D21102015%26date%3D21122015%26date%3D14012016%26date%3D10122015%26volume%3D59%26issue%3D1%26spage%3D431%26epage%3D447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrian L.  Smith</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Holger  Beckmann</span>, <span class="hlFld-ContribAuthor ">Steven F.  Bellon</span>, <span class="hlFld-ContribAuthor ">Pedro J.  Beltran</span>, <span class="hlFld-ContribAuthor ">Shon  Booker</span>, <span class="hlFld-ContribAuthor ">Hao  Chen</span>, <span class="hlFld-ContribAuthor ">Young-Ah  Chung</span>, <span class="hlFld-ContribAuthor ">Noel D.  D’Angelo</span>, <span class="hlFld-ContribAuthor ">Jennifer  Dao</span>, <span class="hlFld-ContribAuthor ">Kenneth R.  Dellamaggiore</span>, <span class="hlFld-ContribAuthor ">Peter  Jaeckel</span>, <span class="hlFld-ContribAuthor ">Richard  Kendall</span>, <span class="hlFld-ContribAuthor ">Katja  Labitzke</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Long</span>, <span class="hlFld-ContribAuthor ">Silvia  Materna-Reichelt</span>, <span class="hlFld-ContribAuthor ">Petia  Mitchell</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>, <span class="hlFld-ContribAuthor ">David  Powers</span>, <span class="hlFld-ContribAuthor ">Mark  Rose</span>, <span class="hlFld-ContribAuthor ">Paul L.  Shaffer</span>, <span class="hlFld-ContribAuthor ">Michelle M.  Wu</span>, and <span class="hlFld-ContribAuthor ">J. Russell  Lipford</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 1H-Pyrazol-3(2H)-ones as Potent and Selective Inhibitors of Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (3)
                                     , 1426-1441. <a href="https://doi.org/10.1021/jm5017494" title="DOI URL">https://doi.org/10.1021/jm5017494</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5017494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5017494%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B1H-Pyrazol-3%2525282H%252529-ones%252Bas%252BPotent%252Band%252BSelective%252BInhibitors%252Bof%252BProtein%252BKinase%252BR-like%252BEndoplasmic%252BReticulum%252BKinase%252B%252528PERK%252529%26aulast%3DSmith%26aufirst%3DAdrian%2BL.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D11112014%26date%3D14012015%26date%3D12022015%26volume%3D58%26issue%3D3%26spage%3D1426%26epage%3D1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Andrs</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Daniel  Jun</span>, <span class="hlFld-ContribAuthor ">Zdenek  Hodny</span>, <span class="hlFld-ContribAuthor ">Jiri  Bartek</span>, and <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>  . </span><span class="cited-content_cbyCitation_article-title">Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 41-71. <a href="https://doi.org/10.1021/jm501026z" title="DOI URL">https://doi.org/10.1021/jm501026z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501026z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501026z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhosphatidylinositol%252B3-Kinase%252B%252528PI3K%252529%252Band%252BPhosphatidylinositol%252B3-Kinase-Related%252BKinase%252B%252528PIKK%252529%252BInhibitors%25253A%252BImportance%252Bof%252Bthe%252BMorpholine%252BRing%26aulast%3DAndrs%26aufirst%3DMartin%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D08072014%26date%3D05122014%26date%3D08012015%26date%3D11112014%26volume%3D58%26issue%3D1%26spage%3D41%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy D.  Cushing</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Hao</span>, <span class="hlFld-ContribAuthor ">Youngsook  Shin</span>, <span class="hlFld-ContribAuthor ">Kristin  Andrews</span>, <span class="hlFld-ContribAuthor ">Matthew  Brown</span>, <span class="hlFld-ContribAuthor ">Mario  Cardozo</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Jason  Duquette</span>, <span class="hlFld-ContribAuthor ">Ben  Fisher</span>, <span class="hlFld-ContribAuthor ">Felix  Gonzalez-Lopez de Turiso</span>, <span class="hlFld-ContribAuthor ">Xiao  He</span>, <span class="hlFld-ContribAuthor ">Kirk R.  Henne</span>, <span class="hlFld-ContribAuthor ">Yi-Ling  Hu</span>, <span class="hlFld-ContribAuthor ">Randall  Hungate</span>, <span class="hlFld-ContribAuthor ">Michael G.  Johnson</span>, <span class="hlFld-ContribAuthor ">Ron C.  Kelly</span>, <span class="hlFld-ContribAuthor ">Brian  Lucas</span>, <span class="hlFld-ContribAuthor ">John D.  McCarter</span>, <span class="hlFld-ContribAuthor ">Lawrence R.  McGee</span>, <span class="hlFld-ContribAuthor ">Julio C.  Medina</span>, <span class="hlFld-ContribAuthor ">Tisha  San Miguel</span>, <span class="hlFld-ContribAuthor ">Deanna  Mohn</span>, <span class="hlFld-ContribAuthor ">Vatee  Pattaropong</span>, <span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Andreas  Reichelt</span>, <span class="hlFld-ContribAuthor ">Robert M.  Rzasa</span>, <span class="hlFld-ContribAuthor ">Jennifer  Seganish</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>, <span class="hlFld-ContribAuthor ">Robert C.  Wahl</span>, <span class="hlFld-ContribAuthor ">Sharon  Wannberg</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">John  Whoriskey</span>, <span class="hlFld-ContribAuthor ">Gang  Yu</span>, <span class="hlFld-ContribAuthor ">Leeanne  Zalameda</span>, <span class="hlFld-ContribAuthor ">Dawei  Zhang</span>, and <span class="hlFld-ContribAuthor ">Daniela P.  Metz</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and in Vivo Evaluation of (S)-N-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 480-511. <a href="https://doi.org/10.1021/jm501624r" title="DOI URL">https://doi.org/10.1021/jm501624r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501624r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501624r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252B%252528S%252529-N-%2525281-%2525287-Fluoro-2-%252528pyridin-2-yl%252529quinolin-3-yl%252529ethyl%252529-9H-purin-6-amine%252B%252528AMG319%252529%252Band%252BRelated%252BPI3K%2525CE%2525B4%252BInhibitors%252Bfor%252BInflammation%252Band%252BAutoimmune%252BDisease%26aulast%3DCushing%26aufirst%3DTimothy%2BD.%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D20102014%26date%3D03122014%26date%3D08012015%26volume%3D58%26issue%3D1%26spage%3D480%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng-Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Qing  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Jun  Dai</span>, <span class="hlFld-ContribAuthor ">Yi-Si  Feng</span>, and <span class="hlFld-ContribAuthor ">Hua-Jian  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Silver-Mediated Decarboxylative C–S Cross-Coupling of Aliphatic Carboxylic Acids under Mild Conditions. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (17)
                                     , 4586-4589. <a href="https://doi.org/10.1021/ol502144c" title="DOI URL">https://doi.org/10.1021/ol502144c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol502144c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol502144c%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSilver-Mediated%252BDecarboxylative%252BC%2525E2%252580%252593S%252BCross-Coupling%252Bof%252BAliphatic%252BCarboxylic%252BAcids%252Bunder%252BMild%252BConditions%26aulast%3DWang%26aufirst%3DPeng-Fei%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D21072014%26date%3D25082014%26date%3D05092014%26volume%3D16%26issue%3D17%26spage%3D4586%26epage%3D4589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seul-Gi  Kim</span>, <span class="hlFld-ContribAuthor ">Se-Lin  Jung</span>, <span class="hlFld-ContribAuthor ">Gee-Hyung  Lee</span>, and <span class="hlFld-ContribAuthor ">Young-Dae  Gong</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Solid-Phase Parallel Synthesis of N-Substituted-2-aminobenzo [d]thiazole Derivatives via Cyclization Reactions of 2-Iodophenyl Thiourea Intermediate Resin. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2013,</strong> <em>15 </em>
                                    (1)
                                     , 29-40. <a href="https://doi.org/10.1021/co300112b" title="DOI URL">https://doi.org/10.1021/co300112b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/co300112b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fco300112b%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DNovel%252BSolid-Phase%252BParallel%252BSynthesis%252Bof%252BN-Substituted-2-aminobenzo%252B%25255Bd%25255Dthiazole%252BDerivatives%252Bvia%252BCyclization%252BReactions%252Bof%252B2-Iodophenyl%252BThiourea%252BIntermediate%252BResin%26aulast%3DKim%26aufirst%3DSeul-Gi%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D14092012%26date%3D20112012%26date%3D03122012%26date%3D14012013%26date%3D20112012%26volume%3D15%26issue%3D1%26spage%3D29%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Felix  Gonzalez-Lopez de Turiso</span>, <span class="hlFld-ContribAuthor ">Youngsook  Shin</span>, <span class="hlFld-ContribAuthor ">Matthew  Brown</span>, <span class="hlFld-ContribAuthor ">Mario  Cardozo</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">David  Fong</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Hao</span>, <span class="hlFld-ContribAuthor ">Xiao  He</span>, <span class="hlFld-ContribAuthor ">Kirk  Henne</span>, <span class="hlFld-ContribAuthor ">Yi-Ling  Hu</span>, <span class="hlFld-ContribAuthor ">Michael G.  Johnson</span>, <span class="hlFld-ContribAuthor ">Todd  Kohn</span>, <span class="hlFld-ContribAuthor ">Julia  Lohman</span>, <span class="hlFld-ContribAuthor ">Helen J.  McBride</span>, <span class="hlFld-ContribAuthor ">Lawrence R.  McGee</span>, <span class="hlFld-ContribAuthor ">Julio C.  Medina</span>, <span class="hlFld-ContribAuthor ">Daniela  Metz</span>, <span class="hlFld-ContribAuthor ">Kent  Miner</span>, <span class="hlFld-ContribAuthor ">Deanna  Mohn</span>, <span class="hlFld-ContribAuthor ">Vatee  Pattaropong</span>, <span class="hlFld-ContribAuthor ">Jennifer  Seganish</span>, <span class="hlFld-ContribAuthor ">Jillian L.  Simard</span>, <span class="hlFld-ContribAuthor ">Sharon  Wannberg</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Gang  Yu</span>, and <span class="hlFld-ContribAuthor ">Timothy D.  Cushing</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and in Vivo Evaluation of Dual PI3Kβ/δ Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7667-7685. <a href="https://doi.org/10.1021/jm300679u" title="DOI URL">https://doi.org/10.1021/jm300679u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300679u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300679u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252BDual%252BPI3K%2525CE%2525B2%25252F%2525CE%2525B4%252BInhibitors%26aulast%3DGonzalez-Lopez%2Bde%2BTuriso%26aufirst%3DFelix%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D15052012%26date%3D29082012%26date%3D13092012%26date%3D09082012%26volume%3D55%26issue%3D17%26spage%3D7667%26epage%3D7685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark H.  Norman</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Yunxin Y.  Bo</span>, <span class="hlFld-ContribAuthor ">Shon K.  Booker</span>, <span class="hlFld-ContribAuthor ">Sean  Caenepeel</span>, <span class="hlFld-ContribAuthor ">Victor J.  Cee</span>, <span class="hlFld-ContribAuthor ">Noel D.  D’Angelo</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Freeman</span>, <span class="hlFld-ContribAuthor ">Bradley J.  Herberich</span>, <span class="hlFld-ContribAuthor ">Fang-Tsao  Hong</span>, <span class="hlFld-ContribAuthor ">Claire L. M.  Jackson</span>, <span class="hlFld-ContribAuthor ">Jian  Jiang</span>, <span class="hlFld-ContribAuthor ">Brian A.  Lanman</span>, <span class="hlFld-ContribAuthor ">Longbin  Liu</span>, <span class="hlFld-ContribAuthor ">John D.  McCarter</span>, <span class="hlFld-ContribAuthor ">Erin L.  Mullady</span>, <span class="hlFld-ContribAuthor ">Nobuko  Nishimura</span>, <span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Anthony B.  Reed</span>, <span class="hlFld-ContribAuthor ">Tisha San  Miguel</span>, <span class="hlFld-ContribAuthor ">Adrian L.  Smith</span>, <span class="hlFld-ContribAuthor ">Markian M.  Stec</span>, <span class="hlFld-ContribAuthor ">Seifu  Tadesse</span>, <span class="hlFld-ContribAuthor ">Andrew  Tasker</span>, <span class="hlFld-ContribAuthor ">Divesh  Aidasani</span>, <span class="hlFld-ContribAuthor ">Xiaochun  Zhu</span>, <span class="hlFld-ContribAuthor ">Raju  Subramanian</span>, <span class="hlFld-ContribAuthor ">Nuria A.  Tamayo</span>, <span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Tian  Wu</span>, <span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Kevin  Yang</span>, <span class="hlFld-ContribAuthor ">Leeanne  Zalameda</span>, <span class="hlFld-ContribAuthor ">Nancy  Zhang</span>, and <span class="hlFld-ContribAuthor ">Paul E.  Hughes</span>  . </span><span class="cited-content_cbyCitation_article-title">Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7796-7816. <a href="https://doi.org/10.1021/jm300846z" title="DOI URL">https://doi.org/10.1021/jm300846z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300846z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300846z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSelective%252BClass%252BI%252BPhosphoinositide%252B3-Kinase%252BInhibitors%25253A%252BOptimization%252Bof%252Ba%252BSeries%252Bof%252BPyridyltriazines%252BLeading%252Bto%252Bthe%252BIdentification%252Bof%252Ba%252BClinical%252BCandidate%25252C%252BAMG%252B511%26aulast%3DNorman%26aufirst%3DMark%2BH.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D15062012%26date%3D30082012%26date%3D13092012%26date%3D16082012%26volume%3D55%26issue%3D17%26spage%3D7796%26epage%3D7816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrian L.  Smith</span>, <span class="hlFld-ContribAuthor ">Noel D.  D’Angelo</span>, <span class="hlFld-ContribAuthor ">Yunxin Y.  Bo</span>, <span class="hlFld-ContribAuthor ">Shon K.  Booker</span>, <span class="hlFld-ContribAuthor ">Victor J.  Cee</span>, <span class="hlFld-ContribAuthor ">Brad  Herberich</span>, <span class="hlFld-ContribAuthor ">Fang-Tsao  Hong</span>, <span class="hlFld-ContribAuthor ">Claire L. M.  Jackson</span>, <span class="hlFld-ContribAuthor ">Brian A.  Lanman</span>, <span class="hlFld-ContribAuthor ">Longbin  Liu</span>, <span class="hlFld-ContribAuthor ">Nobuko  Nishimura</span>, <span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Anthony B.  Reed</span>, <span class="hlFld-ContribAuthor ">Seifu  Tadesse</span>, <span class="hlFld-ContribAuthor ">Nuria A.  Tamayo</span>, <span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Kevin  Yang</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">John D.  McCarter</span>, <span class="hlFld-ContribAuthor ">Tisha San  Miguel</span>, <span class="hlFld-ContribAuthor ">Leeanne  Zalameda</span>, <span class="hlFld-ContribAuthor ">Jian  Jiang</span>, <span class="hlFld-ContribAuthor ">Raju  Subramanian</span>, <span class="hlFld-ContribAuthor ">Erin L.  Mullady</span>, <span class="hlFld-ContribAuthor ">Sean  Caenepeel</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Freeman</span>, <span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Nancy  Zhang</span>, <span class="hlFld-ContribAuthor ">Tian  Wu</span>, <span class="hlFld-ContribAuthor ">Paul E.  Hughes</span>, and <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of a Novel Series of Potent, Selective Inhibitors of the Class I Phosphatidylinositol 3-Kinases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (11)
                                     , 5188-5219. <a href="https://doi.org/10.1021/jm300184s" title="DOI URL">https://doi.org/10.1021/jm300184s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300184s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300184s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BPotent%25252C%252BSelective%252BInhibitors%252Bof%252Bthe%252BClass%252BI%252BPhosphatidylinositol%252B3-Kinases%26aulast%3DSmith%26aufirst%3DAdrian%2BL.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D09022012%26date%3D23052012%26date%3D14062012%26date%3D01052012%26volume%3D55%26issue%3D11%26spage%3D5188%26epage%3D5219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markian M.  Stec</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Shon K.  Booker</span>, <span class="hlFld-ContribAuthor ">Sean  Caenepeel</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Freeman</span>, <span class="hlFld-ContribAuthor ">Jian  Jiang</span>, <span class="hlFld-ContribAuthor ">Hongyu  Liao</span>, <span class="hlFld-ContribAuthor ">John  McCarter</span>, <span class="hlFld-ContribAuthor ">Erin L.  Mullady</span>, <span class="hlFld-ContribAuthor ">Tisha  San Miguel</span>, <span class="hlFld-ContribAuthor ">Raju  Subramanian</span>, <span class="hlFld-ContribAuthor ">Nuria  Tamayo</span>, <span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Kevin  Yang</span>, <span class="hlFld-ContribAuthor ">Leeanne P.  Zalameda</span>, <span class="hlFld-ContribAuthor ">Nancy  Zhang</span>, <span class="hlFld-ContribAuthor ">Paul E.  Hughes</span>, and <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships of Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors: Investigations of Various 6,5-Heterocycles to Improve Metabolic Stability. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (14)
                                     , 5174-5184. <a href="https://doi.org/10.1021/jm2004442" title="DOI URL">https://doi.org/10.1021/jm2004442</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2004442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2004442%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BPhosphoinositide%252B3-Kinase%252B%252528PI3K%252529%25252FMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%252BDual%252BInhibitors%25253A%252BInvestigations%252Bof%252BVarious%252B6%25252C5-Heterocycles%252Bto%252BImprove%252BMetabolic%252BStability%26aulast%3DStec%26aufirst%3DMarkian%2BM.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D13042011%26date%3D29062011%26date%3D28072011%26volume%3D54%26issue%3D14%26spage%3D5174%26epage%3D5184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nobuko  Nishimura</span>, <span class="hlFld-ContribAuthor ">Aaron  Siegmund</span>, <span class="hlFld-ContribAuthor ">Longbin  Liu</span>, <span class="hlFld-ContribAuthor ">Kevin  Yang</span>, <span class="hlFld-ContribAuthor ">Marian C.  Bryan</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Yunxin  Bo</span>, <span class="hlFld-ContribAuthor ">Shon K.  Booker</span>, <span class="hlFld-ContribAuthor ">Sean  Caenepeel</span>, <span class="hlFld-ContribAuthor ">Daniel  Freeman</span>, <span class="hlFld-ContribAuthor ">Hongyu  Liao</span>, <span class="hlFld-ContribAuthor ">John  McCarter</span>, <span class="hlFld-ContribAuthor ">Erin L.  Mullady</span>, <span class="hlFld-ContribAuthor ">Tisha  San Miguel</span>, <span class="hlFld-ContribAuthor ">Raju  Subramanian</span>, <span class="hlFld-ContribAuthor ">Nuria  Tamayo</span>, <span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Leeanne  Zalameda</span>, <span class="hlFld-ContribAuthor ">Nancy  Zhang</span>, <span class="hlFld-ContribAuthor ">Paul E.  Hughes</span>, and <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>  . </span><span class="cited-content_cbyCitation_article-title">Phospshoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors: Discovery and Structure–Activity Relationships of a Series of Quinoline and Quinoxaline Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (13)
                                     , 4735-4751. <a href="https://doi.org/10.1021/jm200386s" title="DOI URL">https://doi.org/10.1021/jm200386s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200386s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200386s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhospshoinositide%252B3-Kinase%252B%252528PI3K%252529%25252FMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%252BDual%252BInhibitors%25253A%252BDiscovery%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252Ba%252BSeries%252Bof%252BQuinoline%252Band%252BQuinoxaline%252BDerivatives%26aulast%3DNishimura%26aufirst%3DNobuko%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D01042011%26date%3D20062011%26date%3D14072011%26date%3D25052011%26volume%3D54%26issue%3D13%26spage%3D4735%26epage%3D4751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chengbin  Yang</span>, <span class="hlFld-ContribAuthor ">Chenyue  Xu</span>, <span class="hlFld-ContribAuthor ">Zhipeng  Li</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Tianze  Wu</span>, <span class="hlFld-ContribAuthor ">Hui  Hong</span>, <span class="hlFld-ContribAuthor ">Mingzhu  Lu</span>, <span class="hlFld-ContribAuthor ">Yu  Jia</span>, <span class="hlFld-ContribAuthor ">Yongtai  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Liu</span>, <span class="hlFld-ContribAuthor ">Mingli  Deng</span>, <span class="hlFld-ContribAuthor ">Zhenxia  Chen</span>, <span class="hlFld-ContribAuthor ">Qingquan  Li</span>, <span class="hlFld-ContribAuthor ">Yun  Ling</span>, <span class="hlFld-ContribAuthor ">Yaming  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Bioisosteric replacements of the indole moiety for the development of a potent and selective PI3Kδ inhibitor: Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113661. <a href="https://doi.org/10.1016/j.ejmech.2021.113661" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113661</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113661%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBioisosteric%252Breplacements%252Bof%252Bthe%252Bindole%252Bmoiety%252Bfor%252Bthe%252Bdevelopment%252Bof%252Ba%252Bpotent%252Band%252Bselective%252BPI3K%2525CE%2525B4%252Binhibitor%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DYang%26aufirst%3DChengbin%26date%3D2021%26volume%3D223%26spage%3D113661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silviana  Corrêa</span>, <span class="hlFld-ContribAuthor ">Isael Aparecido  Rosa</span>, <span class="hlFld-ContribAuthor ">Gustavo A.  Andolpho</span>, <span class="hlFld-ContribAuthor ">Letícia Cristina de  Assis</span>, <span class="hlFld-ContribAuthor ">Maíra dos S.  Pires</span>, <span class="hlFld-ContribAuthor ">Lívia C. T.  Lacerda</span>, <span class="hlFld-ContribAuthor ">Francisco G. E.  Nogueira</span>, <span class="hlFld-ContribAuthor ">Elaine F. F. da  Cunha</span>, <span class="hlFld-ContribAuthor ">Eugenie  Nepovimova</span>, <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>, <span class="hlFld-ContribAuthor ">Teodorico C.  Ramalho</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid Materials Based on Magnetic Iron Oxides with Benzothiazole Derivatives: A Plausible Potential Spectroscopy Probe. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (8)
                                     , 3980. <a href="https://doi.org/10.3390/ijms22083980" title="DOI URL">https://doi.org/10.3390/ijms22083980</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22083980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22083980%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DHybrid%252BMaterials%252BBased%252Bon%252BMagnetic%252BIron%252BOxides%252Bwith%252BBenzothiazole%252BDerivatives%25253A%252BA%252BPlausible%252BPotential%252BSpectroscopy%252BProbe%26aulast%3DCorr%25C3%25AAa%26aufirst%3DSilviana%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D8%26spage%3D3980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiu-zheng  Gao</span>, <span class="hlFld-ContribAuthor ">Xu-tao  Lv</span>, <span class="hlFld-ContribAuthor ">Rui-rui  Zhang</span>, <span class="hlFld-ContribAuthor ">Yang  Luo</span>, <span class="hlFld-ContribAuthor ">Mu-xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Jia-shu  Chen</span>, <span class="hlFld-ContribAuthor ">Yu-kai  Zhang</span>, <span class="hlFld-ContribAuthor ">Bin  Sun</span>, <span class="hlFld-ContribAuthor ">Jin-yue  Sun</span>, <span class="hlFld-ContribAuthor ">Yu-fa  Liu</span>, <span class="hlFld-ContribAuthor ">Chao  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>109 </em>, 104694. <a href="https://doi.org/10.1016/j.bioorg.2021.104694" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104694</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104694%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bin%252Bvitro%252Banticancer%252Bresearch%252Bof%252Bnovel%252Btetrandrine%252Band%252Bfangchinoline%252Bderivatives%26aulast%3DGao%26aufirst%3DXiu-zheng%26date%3D2021%26volume%3D109%26spage%3D104694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Avinash  Kumar</span>, <span class="hlFld-ContribAuthor ">Sudhanshu  Rai</span>, <span class="hlFld-ContribAuthor ">Ekta  Rathi</span>, <span class="hlFld-ContribAuthor ">Paridhi  Agarwal</span>, <span class="hlFld-ContribAuthor ">Suvarna G.  Kini</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore-guided fragment-based design of novel mammalian target of rapamycin inhibitors: extra precision docking, fingerprint-based 2D and atom-based 3D-QSAR modelling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (4)
                                     , 1155-1173. <a href="https://doi.org/10.1080/07391102.2020.1726816" title="DOI URL">https://doi.org/10.1080/07391102.2020.1726816</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1726816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1726816%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DPharmacophore-guided%252Bfragment-based%252Bdesign%252Bof%252Bnovel%252Bmammalian%252Btarget%252Bof%252Brapamycin%252Binhibitors%25253A%252Bextra%252Bprecision%252Bdocking%25252C%252Bfingerprint-based%252B2D%252Band%252Batom-based%252B3D-QSAR%252Bmodelling%26aulast%3DKumar%26aufirst%3DAvinash%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D4%26spage%3D1155%26epage%3D1173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip A.  Harris</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of RIP1 kinase: a patent review (2016–present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (2)
                                     , 137-151. <a href="https://doi.org/10.1080/13543776.2021.1854729" title="DOI URL">https://doi.org/10.1080/13543776.2021.1854729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1854729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1854729%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DInhibitors%252Bof%252BRIP1%252Bkinase%25253A%252Ba%252Bpatent%252Breview%252B%2525282016%2525E2%252580%252593present%252529%26aulast%3DHarris%26aufirst%3DPhilip%2BA.%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D2%26spage%3D137%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Drug Targets. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-96. <a href="https://doi.org/10.1002/9781119607311.ch1" title="DOI URL">https://doi.org/10.1002/9781119607311.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BTargets%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D96%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit  Bhowmik</span>, <span class="hlFld-ContribAuthor ">Mahesh  Yadav</span>, <span class="hlFld-ContribAuthor ">Rodney A.  Fernandes</span>. </span><span class="cited-content_cbyCitation_article-title">Room temperature nickel-catalyzed cross-coupling of aryl-boronic acids with thiophenols: synthesis of diarylsulfides. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (13)
                                     , 2447-2458. <a href="https://doi.org/10.1039/D0OB00244E" title="DOI URL">https://doi.org/10.1039/D0OB00244E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB00244E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB00244E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRoom%252Btemperature%252Bnickel-catalyzed%252Bcross-coupling%252Bof%252Baryl-boronic%252Bacids%252Bwith%252Bthiophenols%25253A%252Bsynthesis%252Bof%252Bdiarylsulfides%26aulast%3DBhowmik%26aufirst%3DAmit%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D13%26spage%3D2447%26epage%3D2458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruna T. L.  Pereira</span>, <span class="hlFld-ContribAuthor ">Mateus A.  Gonçalves</span>, <span class="hlFld-ContribAuthor ">Daiana T.  Mancini</span>, <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>, <span class="hlFld-ContribAuthor ">Teodorico C.  Ramalho</span>. </span><span class="cited-content_cbyCitation_article-title">First Attempts of the Use of 195Pt NMR of Phenylbenzothiazole Complexes as Spectroscopic Technique for the Cancer Diagnosis. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (21)
                                     , 3970. <a href="https://doi.org/10.3390/molecules24213970" title="DOI URL">https://doi.org/10.3390/molecules24213970</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24213970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24213970%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DFirst%252BAttempts%252Bof%252Bthe%252BUse%252Bof%252B195Pt%252BNMR%252Bof%252BPhenylbenzothiazole%252BComplexes%252Bas%252BSpectroscopic%252BTechnique%252Bfor%252Bthe%252BCancer%252BDiagnosis%26aulast%3DPereira%26aufirst%3DBruna%2BT.%2BL.%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D21%26spage%3D3970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Chunlan  Pu</span>, <span class="hlFld-ContribAuthor ">Suke  Lan</span>, <span class="hlFld-ContribAuthor ">Xinxin  Zhong</span>, <span class="hlFld-ContribAuthor ">Meng  Zhou</span>, <span class="hlFld-ContribAuthor ">Xueyan  Hou</span>, <span class="hlFld-ContribAuthor ">Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Huifang  Shan</span>, <span class="hlFld-ContribAuthor ">Lifeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Rui  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as potent and orally active PI3K/mTOR dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 667-686. <a href="https://doi.org/10.1016/j.ejmech.2019.06.021" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.021%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-phenyl-2H-benzo%25255Bb%25255D%25255B1%25252C4%25255Doxazin-3%2525284H%252529-one%252Bderivatives%252Bas%252Bpotent%252Band%252Borally%252Bactive%252BPI3K%25252FmTOR%252Bdual%252Binhibitors%26aulast%3DYan%26aufirst%3DGuoyi%26date%3D2019%26volume%3D178%26spage%3D667%26epage%3D686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Mubeen</span>, <span class="hlFld-ContribAuthor ">Suvarna Ganesh  Kini</span>, <span class="hlFld-ContribAuthor ">Avinash  Kumar</span>, <span class="hlFld-ContribAuthor ">Karkala Sreedhara Ranganath  Pai</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, Biological Evaluation and In Silico Studies of Few Novel 2-Substituted Benzothiazole Derivatives as Potential EGFR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Letters in Drug Design & Discovery</span><span> <strong>2019,</strong> <em>16 </em>
                                    (8)
                                     , 961-971. <a href="https://doi.org/10.2174/1570180816666181108112228" title="DOI URL">https://doi.org/10.2174/1570180816666181108112228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570180816666181108112228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570180816666181108112228%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520%2526%2520Discovery%26atitle%3DDesign%25252C%252BSynthesis%25252C%252BBiological%252BEvaluation%252Band%252BIn%252BSilico%252BStudies%252Bof%252BFew%252BNovel%252B2-Substituted%252BBenzothiazole%252BDerivatives%252Bas%252BPotential%252BEGFR%252BInhibitors%26aulast%3DMubeen%26aufirst%3DMuhammad%26date%3D2019%26volume%3D16%26issue%3D8%26spage%3D961%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manjula  Singh</span>, <span class="hlFld-ContribAuthor ">Lal Dhar S.  Yadav</span>, <span class="hlFld-ContribAuthor ">Rana Krishna Pal  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Direct radical sulfonylation at α-C(sp3)-H of THF with sodium sulfinates in aqueous medium. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (11)
                                     , 810-813. <a href="https://doi.org/10.1016/j.tetlet.2019.02.021" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.02.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.02.021%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DDirect%252Bradical%252Bsulfonylation%252Bat%252B%2525CE%2525B1-C%252528sp3%252529-H%252Bof%252BTHF%252Bwith%252Bsodium%252Bsulfinates%252Bin%252Baqueous%252Bmedium%26aulast%3DSingh%26aufirst%3DManjula%26date%3D2019%26volume%3D60%26issue%3D11%26spage%3D810%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen  Bruinsma</span>, <span class="hlFld-ContribAuthor ">Declan J.  James</span>, <span class="hlFld-ContribAuthor ">Melanie  Quintana Serrano</span>, <span class="hlFld-ContribAuthor ">Joseph  Esquibel</span>, <span class="hlFld-ContribAuthor ">Sang Su  Woo</span>, <span class="hlFld-ContribAuthor ">Elle  Kielar-Grevstad</span>, <span class="hlFld-ContribAuthor ">Ellen  Crummy</span>, <span class="hlFld-ContribAuthor ">Rehan  Qurashi</span>, <span class="hlFld-ContribAuthor ">Judy A.  Kowalchyk</span>, <span class="hlFld-ContribAuthor ">Thomas F.J.  Martin</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules that inhibit the late stage of Munc13-4–dependent secretory granule exocytosis in mast cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2018,</strong> <em>293 </em>
                                    (21)
                                     , 8217-8229. <a href="https://doi.org/10.1074/jbc.RA117.001547" title="DOI URL">https://doi.org/10.1074/jbc.RA117.001547</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA117.001547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA117.001547%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DSmall%252Bmolecules%252Bthat%252Binhibit%252Bthe%252Blate%252Bstage%252Bof%252BMunc13-4%2525E2%252580%252593dependent%252Bsecretory%252Bgranule%252Bexocytosis%252Bin%252Bmast%252Bcells%26aulast%3DBruinsma%26aufirst%3DStephen%26date%3D2018%26volume%3D293%26issue%3D21%26spage%3D8217%26epage%3D8229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunzhi  Yin</span>, <span class="hlFld-ContribAuthor ">Yiyue  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Jingjing  Chen</span>, <span class="hlFld-ContribAuthor ">Qi  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of PI3K/Akt signal pathway inhibitor on docetaxel nanoparticles in cell uptake, cell colony, caspase-3 & caspase-9 expression and pharmacokinetics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Drug Delivery Science and Technology</span><span> <strong>2018,</strong> <em>44 </em>, 298-304. <a href="https://doi.org/10.1016/j.jddst.2018.01.007" title="DOI URL">https://doi.org/10.1016/j.jddst.2018.01.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jddst.2018.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jddst.2018.01.007%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Drug%2520Delivery%2520Science%2520and%2520Technology%26atitle%3DEffect%252Bof%252BPI3K%25252FAkt%252Bsignal%252Bpathway%252Binhibitor%252Bon%252Bdocetaxel%252Bnanoparticles%252Bin%252Bcell%252Buptake%25252C%252Bcell%252Bcolony%25252C%252Bcaspase-3%252B%252526%252Bcaspase-9%252Bexpression%252Band%252Bpharmacokinetics%26aulast%3DYin%26aufirst%3DYunzhi%26date%3D2018%26volume%3D44%26spage%3D298%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>, <span class="hlFld-ContribAuthor ">Jiankang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 449-463. <a href="https://doi.org/10.1016/j.ejmech.2017.11.049" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.11.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.11.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.11.049%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploiting%252Bpolypharmacology%252Bfor%252Bimproving%252Btherapeutic%252Boutcome%252Bof%252Bkinase%252Binhibitors%252B%252528KIs%252529%25253A%252BAn%252Bupdate%252Bof%252Brecent%252Bmedicinal%252Bchemistry%252Befforts%26aulast%3DMa%26aufirst%3DXiaodong%26date%3D2018%26volume%3D143%26spage%3D449%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Milan  Jovanović</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolić</span>, <span class="hlFld-ContribAuthor ">Žarko  Gagić</span>, <span class="hlFld-ContribAuthor ">Danica  Agbaba</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular modeling and analysis of the 3D pharmacophore structure of the selective PI3K-α inhibitors as antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Arhiv za farmaciju</span><span> <strong>2018,</strong> <em>68 </em>
                                    (4)
                                     , 860-873. <a href="https://doi.org/10.5937/ArhFarm1804860J" title="DOI URL">https://doi.org/10.5937/ArhFarm1804860J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5937/ArhFarm1804860J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5937%2FArhFarm1804860J%26sid%3Dliteratum%253Aachs%26jtitle%3DArhiv%2520za%2520farmaciju%26atitle%3DMolecular%252Bmodeling%252Band%252Banalysis%252Bof%252Bthe%252B3D%252Bpharmacophore%252Bstructure%252Bof%252Bthe%252Bselective%252BPI3K-%2525CE%2525B1%252Binhibitors%252Bas%252Bantitumor%252Bagents%26aulast%3DJovanovi%25C4%2587%26aufirst%3DMilan%26date%3D2018%26volume%3D68%26issue%3D4%26spage%3D860%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stella  Cascioferro</span>, <span class="hlFld-ContribAuthor ">Barbara  Parrino</span>, <span class="hlFld-ContribAuthor ">Virginia  Spanò</span>, <span class="hlFld-ContribAuthor ">Anna  Carbone</span>, <span class="hlFld-ContribAuthor ">Alessandra  Montalbano</span>, <span class="hlFld-ContribAuthor ">Paola  Barraja</span>, <span class="hlFld-ContribAuthor ">Patrizia  Diana</span>, <span class="hlFld-ContribAuthor ">Girolamo  Cirrincione</span>. </span><span class="cited-content_cbyCitation_article-title">1,3,5-Triazines: A promising scaffold for anticancer drugs development. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>142 </em>, 523-549. <a href="https://doi.org/10.1016/j.ejmech.2017.09.035" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.09.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.09.035%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D1%25252C3%25252C5-Triazines%25253A%252BA%252Bpromising%252Bscaffold%252Bfor%252Banticancer%252Bdrugs%252Bdevelopment%26aulast%3DCascioferro%26aufirst%3DStella%26date%3D2017%26volume%3D142%26spage%3D523%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grace Q.  Gong</span>, <span class="hlFld-ContribAuthor ">Jackie D.  Kendall</span>, <span class="hlFld-ContribAuthor ">James M.J.  Dickson</span>, <span class="hlFld-ContribAuthor ">Gordon W.  Rewcastle</span>, <span class="hlFld-ContribAuthor ">Christina M.  Buchanan</span>, <span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Peter R.  Shepherd</span>, <span class="hlFld-ContribAuthor ">Jack U.  Flanagan</span>. </span><span class="cited-content_cbyCitation_article-title">Combining properties of different classes of PI3Kα inhibitors to understand the molecular features that confer selectivity. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2017,</strong> <em>474 </em>
                                    (13)
                                     , 2261-2276. <a href="https://doi.org/10.1042/BCJ20161098" title="DOI URL">https://doi.org/10.1042/BCJ20161098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20161098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20161098%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DCombining%252Bproperties%252Bof%252Bdifferent%252Bclasses%252Bof%252BPI3K%2525CE%2525B1%252Binhibitors%252Bto%252Bunderstand%252Bthe%252Bmolecular%252Bfeatures%252Bthat%252Bconfer%252Bselectivity%26aulast%3DGong%26aufirst%3DGrace%2BQ.%26date%3D2017%26date%3D2017%26volume%3D474%26issue%3D13%26spage%3D2261%26epage%3D2276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-zhu  Wan</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Guan-lian  Zhou</span>, <span class="hlFld-ContribAuthor ">Xin-guang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 7181-7200. <a href="https://doi.org/10.18632/oncotarget.12742" title="DOI URL">https://doi.org/10.18632/oncotarget.12742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.12742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.12742%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DRecent%252Bdevelopment%252Bof%252BATP-competitive%252Bsmall%252Bmolecule%252Bphosphatidylinostitol-3-kinase%252Binhibitors%252Bas%252Banticancer%252Bagents%26aulast%3DLiu%26aufirst%3DYu%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D4%26spage%3D7181%26epage%3D7200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinsong  Han</span>, <span class="hlFld-ContribAuthor ">Ying  Chen</span>, <span class="hlFld-ContribAuthor ">Chao  Yang</span>, <span class="hlFld-ContribAuthor ">Ting  Liu</span>, <span class="hlFld-ContribAuthor ">Mingping  Wang</span>, <span class="hlFld-ContribAuthor ">Haojie  Xu</span>, <span class="hlFld-ContribAuthor ">Ling  Zhang</span>, <span class="hlFld-ContribAuthor ">Canhui  Zheng</span>, <span class="hlFld-ContribAuthor ">Yunlong  Song</span>, <span class="hlFld-ContribAuthor ">Ju  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based optimization leads to the discovery of NSC765844, a highly potent, less toxic and orally efficacious dual PI3K/mTOR inhibitor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>122 </em>, 684-701. <a href="https://doi.org/10.1016/j.ejmech.2016.06.030" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.06.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.06.030%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Boptimization%252Bleads%252Bto%252Bthe%252Bdiscovery%252Bof%252BNSC765844%25252C%252Ba%252Bhighly%252Bpotent%25252C%252Bless%252Btoxic%252Band%252Borally%252Befficacious%252Bdual%252BPI3K%25252FmTOR%252Binhibitor%26aulast%3DHan%26aufirst%3DJinsong%26date%3D2016%26volume%3D122%26spage%3D684%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ninad V.  Puranik</span>, <span class="hlFld-ContribAuthor ">Hemalata M.  Puntambekar</span>, <span class="hlFld-ContribAuthor ">Pratibha  Srivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Antidiabetic potential and enzyme kinetics of benzothiazole derivatives and their non-bonded interactions with α-glucosidase and α-amylase. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2016,</strong> <em>25 </em>
                                    (4)
                                     , 805-816. <a href="https://doi.org/10.1007/s00044-016-1520-3" title="DOI URL">https://doi.org/10.1007/s00044-016-1520-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-016-1520-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-016-1520-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DAntidiabetic%252Bpotential%252Band%252Benzyme%252Bkinetics%252Bof%252Bbenzothiazole%252Bderivatives%252Band%252Btheir%252Bnon-bonded%252Binteractions%252Bwith%252B%2525CE%2525B1-glucosidase%252Band%252B%2525CE%2525B1-amylase%26aulast%3DPuranik%26aufirst%3DNinad%2BV.%26date%3D2016%26date%3D2016%26volume%3D25%26issue%3D4%26spage%3D805%26epage%3D816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhixu  Zhou</span>, <span class="hlFld-ContribAuthor ">Linwei  Li</span>, <span class="hlFld-ContribAuthor ">Ning  Yan</span>, <span class="hlFld-ContribAuthor ">Lei  Du</span>, <span class="hlFld-ContribAuthor ">Changshan  Sun</span>, <span class="hlFld-ContribAuthor ">Tiemin  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Crystal Structure, Absolute Configuration and Antitumor Activity of the Enantiomers of 5-Bromo-2-chloro-N-(1-phenylethyl)pyridine-3-sulfonamide. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (11)
                                     , 20926-20938. <a href="https://doi.org/10.3390/molecules201119740" title="DOI URL">https://doi.org/10.3390/molecules201119740</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules201119740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules201119740%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%25252C%252BCrystal%252BStructure%25252C%252BAbsolute%252BConfiguration%252Band%252BAntitumor%252BActivity%252Bof%252Bthe%252BEnantiomers%252Bof%252B5-Bromo-2-chloro-N-%2525281-phenylethyl%252529pyridine-3-sulfonamide%26aulast%3DZhou%26aufirst%3DZhixu%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D11%26spage%3D20926%26epage%3D20938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Xiao  Xie</span>, <span class="hlFld-ContribAuthor ">Huan  Li</span>, <span class="hlFld-ContribAuthor ">Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Shuai  Mao</span>, <span class="hlFld-ContribAuthor ">Min-Hang  Xin</span>, <span class="hlFld-ContribAuthor ">She-Min  Lu</span>, <span class="hlFld-ContribAuthor ">Qi-Bing  Mei</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer effects evaluation of 1-alkyl-3-(6-(2-methoxy-3-sulfonylaminopyridin-5-yl)benzo[d]thiazol-2-yl)urea as anticancer agents with low toxicity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (19)
                                     , 6477-6485. <a href="https://doi.org/10.1016/j.bmc.2015.08.013" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.08.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.08.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Beffects%252Bevaluation%252Bof%252B1-alkyl-3-%2525286-%2525282-methoxy-3-sulfonylaminopyridin-5-yl%252529benzo%25255Bd%25255Dthiazol-2-yl%252529urea%252Bas%252Banticancer%252Bagents%252Bwith%252Blow%252Btoxicity%26aulast%3DXie%26aufirst%3DXiao-Xiao%26date%3D2015%26volume%3D23%26issue%3D19%26spage%3D6477%26epage%3D6485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markian M.  Stec</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Yunxin  Bo</span>, <span class="hlFld-ContribAuthor ">Sean  Caenepeel</span>, <span class="hlFld-ContribAuthor ">Hongyu  Liao</span>, <span class="hlFld-ContribAuthor ">John  McCarter</span>, <span class="hlFld-ContribAuthor ">Erin L.  Mullady</span>, <span class="hlFld-ContribAuthor ">Tisha  San Miguel</span>, <span class="hlFld-ContribAuthor ">Raju  Subramanian</span>, <span class="hlFld-ContribAuthor ">Nuria  Tamayo</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Tian  Wu</span>, <span class="hlFld-ContribAuthor ">Leeanne P.  Zalameda</span>, <span class="hlFld-ContribAuthor ">Nancy  Zhang</span>, <span class="hlFld-ContribAuthor ">Paul E.  Hughes</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">The imidazo[1,2-a]pyridine ring system as a scaffold for potent dual phosphoinositide-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (19)
                                     , 4136-4142. <a href="https://doi.org/10.1016/j.bmcl.2015.08.016" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.08.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.08.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bimidazo%25255B1%25252C2-a%25255Dpyridine%252Bring%252Bsystem%252Bas%252Ba%252Bscaffold%252Bfor%252Bpotent%252Bdual%252Bphosphoinositide-3-kinase%252B%252528PI3K%252529%25252Fmammalian%252Btarget%252Bof%252Brapamycin%252B%252528mTOR%252529%252Binhibitors%26aulast%3DStec%26aufirst%3DMarkian%2BM.%26date%3D2015%26volume%3D25%26issue%3D19%26spage%3D4136%26epage%3D4142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T. A.  Kuz’menko</span>, <span class="hlFld-ContribAuthor ">L. N.  Divaeva</span>, <span class="hlFld-ContribAuthor ">A. S.  Morkovnik</span>. </span><span class="cited-content_cbyCitation_article-title">4-substituted 2-chloromethyl[1,2,4]triazolo[1,5-a]benzimidazoles and their transformations. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>51 </em>
                                    (10)
                                     , 1474-1480. <a href="https://doi.org/10.1134/S1070428015100218" title="DOI URL">https://doi.org/10.1134/S1070428015100218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428015100218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428015100218%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D4-substituted%252B2-chloromethyl%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dbenzimidazoles%252Band%252Btheir%252Btransformations%26aulast%3DKuz%25E2%2580%2599menko%26aufirst%3DT.%2BA.%26date%3D2015%26date%3D2015%26volume%3D51%26issue%3D10%26spage%3D1474%26epage%3D1480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Shuai  Mao</span>, <span class="hlFld-ContribAuthor ">Lei  Cao</span>, <span class="hlFld-ContribAuthor ">Xiao-Xiao  Xie</span>, <span class="hlFld-ContribAuthor ">Min-Hang  Xin</span>, <span class="hlFld-ContribAuthor ">Jia-Fang  Lian</span>, <span class="hlFld-ContribAuthor ">Yong-Xiao  Cao</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Modification of N -(6-(2-methoxy-3-(4-fluorophenylsulfonamido)pyridin-5-yl)-[1,2,4]triazolo[1,5- a ]pyridin-2-yl)acetamide as PI3Ks inhibitor by replacement of the acetamide group with alkylurea. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (17)
                                     , 5662-5671. <a href="https://doi.org/10.1016/j.bmc.2015.07.017" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.07.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.07.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DModification%252Bof%252BN%252B-%2525286-%2525282-methoxy-3-%2525284-fluorophenylsulfonamido%252529pyridin-5-yl%252529-%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-%252Ba%252B%25255Dpyridin-2-yl%252529acetamide%252Bas%252BPI3Ks%252Binhibitor%252Bby%252Breplacement%252Bof%252Bthe%252Bacetamide%252Bgroup%252Bwith%252Balkylurea%26aulast%3DWang%26aufirst%3DXiao-Meng%26date%3D2015%26volume%3D23%26issue%3D17%26spage%3D5662%26epage%3D5671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaohui  Yang</span>, <span class="hlFld-ContribAuthor ">Haikuo  Ma</span>, <span class="hlFld-ContribAuthor ">Zhijian  Sun</span>, <span class="hlFld-ContribAuthor ">Lusong  Luo</span>, <span class="hlFld-ContribAuthor ">Sheng  Tian</span>, <span class="hlFld-ContribAuthor ">Jiyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Xiaohu  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a 6-(pyridin-3-yl)benzo[d]thiazole template for optimization of hedgehog and PI3K/AKT/mTOR dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (17)
                                     , 3665-3670. <a href="https://doi.org/10.1016/j.bmcl.2015.06.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.06.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.06.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.06.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252B6-%252528pyridin-3-yl%252529benzo%25255Bd%25255Dthiazole%252Btemplate%252Bfor%252Boptimization%252Bof%252Bhedgehog%252Band%252BPI3K%25252FAKT%25252FmTOR%252Bdual%252Binhibitors%26aulast%3DYang%26aufirst%3DZhaohui%26date%3D2015%26volume%3D25%26issue%3D17%26spage%3D3665%26epage%3D3670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prinka  Singla</span>, <span class="hlFld-ContribAuthor ">Vijay  Luxami</span>, <span class="hlFld-ContribAuthor ">Kamaldeep  Paul</span>. </span><span class="cited-content_cbyCitation_article-title">Triazine as a promising scaffold for its versatile biological behavior. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>102 </em>, 39-57. <a href="https://doi.org/10.1016/j.ejmech.2015.07.037" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.07.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.07.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.07.037%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTriazine%252Bas%252Ba%252Bpromising%252Bscaffold%252Bfor%252Bits%252Bversatile%252Bbiological%252Bbehavior%26aulast%3DSingla%26aufirst%3DPrinka%26date%3D2015%26volume%3D102%26spage%3D39%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Xu</span>, <span class="hlFld-ContribAuthor ">Min-Hang  Xin</span>, <span class="hlFld-ContribAuthor ">She-Min  Lu</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and antiproliferative activity evaluation of m -(4-morpholinyl-1,3,5-triazin-2-yl)benzamides in vitro. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (8)
                                     , 1730-1735. <a href="https://doi.org/10.1016/j.bmcl.2015.02.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.02.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.02.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.02.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bantiproliferative%252Bactivity%252Bevaluation%252Bof%252Bm%252B-%2525284-morpholinyl-1%25252C3%25252C5-triazin-2-yl%252529benzamides%252Bin%252Bvitro%26aulast%3DWang%26aufirst%3DXiao-Meng%26date%3D2015%26volume%3D25%26issue%3D8%26spage%3D1730%26epage%3D1735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ch. Durga  Prasad</span>, <span class="hlFld-ContribAuthor ">Ajay  Verma</span>, <span class="hlFld-ContribAuthor ">Moh.  Sattar</span>, <span class="hlFld-ContribAuthor ">Sangit  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Silver-mediated thio-acetoxylation and TFA triggered cyclization of amino disulfides with unactivated alkenes: synthesis of 3-aryl/alkyl-1,4-benzothiazines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (93)
                                     , 75881-75888. <a href="https://doi.org/10.1039/C5RA12995H" title="DOI URL">https://doi.org/10.1039/C5RA12995H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA12995H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA12995H%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSilver-mediated%252Bthio-acetoxylation%252Band%252BTFA%252Btriggered%252Bcyclization%252Bof%252Bamino%252Bdisulfides%252Bwith%252Bunactivated%252Balkenes%25253A%252Bsynthesis%252Bof%252B3-aryl%25252Falkyl-1%25252C4-benzothiazines%26aulast%3DPrasad%26aufirst%3DCh.%2BDurga%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D93%26spage%3D75881%26epage%3D75888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kurosh  Rad-Moghadam</span>, <span class="hlFld-ContribAuthor ">Abbas Ali  Esmaeili</span>, <span class="hlFld-ContribAuthor ">Saeid Amini  Ghalandarabad</span>, <span class="hlFld-ContribAuthor ">Fereshteh  Hoseininejad</span>, <span class="hlFld-ContribAuthor ">Seyyed Adel  Fallah-Rasoulinejad</span>, <span class="hlFld-ContribAuthor ">Samaneh  Kiani</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Novel 1-(Benzo[
              d
              ]thiazol-2-yl)-1
              H
              -pyrrol-2(5
              H
              )-ones. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2014,</strong> <em>51 </em>
                                    (6)
                                     , 1791-1796. <a href="https://doi.org/10.1002/jhet.1885" title="DOI URL">https://doi.org/10.1002/jhet.1885</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.1885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.1885%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BNovel%252B1-%252528Benzo%25255B%252Bd%252B%25255Dthiazol-2-yl%252529-1%252BH%252B-pyrrol-2%2525285%252BH%252B%252529-ones%26aulast%3DRad-Moghadam%26aufirst%3DKurosh%26date%3D2014%26date%3D2014%26volume%3D51%26issue%3D6%26spage%3D1791%26epage%3D1796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raju  Subramanian</span>, <span class="hlFld-ContribAuthor ">Divesh  Aidasani</span>, <span class="hlFld-ContribAuthor ">Keith  Bailey</span>, <span class="hlFld-ContribAuthor ">Dan  Branstetter</span>, <span class="hlFld-ContribAuthor ">Nancy  Everds</span>, <span class="hlFld-ContribAuthor ">Jian  Jiang</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>, <span class="hlFld-ContribAuthor ">Ronya  Primack</span>, <span class="hlFld-ContribAuthor ">Gary L.  Skiles</span>, <span class="hlFld-ContribAuthor ">Irene  Soto</span>, <span class="hlFld-ContribAuthor ">Markian M.  Stec</span>, <span class="hlFld-ContribAuthor ">Mylo  Wagner</span>, <span class="hlFld-ContribAuthor ">Tian  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaochun  Zhu</span>, <span class="hlFld-ContribAuthor ">Hervé  Lebrec</span>. </span><span class="cited-content_cbyCitation_article-title">P450-Mediated O-Demethylated Metabolite Is Responsible for Rat Hepatobiliary Toxicity of Pyridyltriazine-Containing PI3K Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Toxicological Sciences</span><span> <strong>2014,</strong> <em>142 </em>
                                    (1)
                                     , 298-310. <a href="https://doi.org/10.1093/toxsci/kfu178" title="DOI URL">https://doi.org/10.1093/toxsci/kfu178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/toxsci/kfu178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Ftoxsci%2Fkfu178%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicological%2520Sciences%26atitle%3DP450-Mediated%252BO-Demethylated%252BMetabolite%252BIs%252BResponsible%252Bfor%252BRat%252BHepatobiliary%252BToxicity%252Bof%252BPyridyltriazine-Containing%252BPI3K%252BInhibitors%26aulast%3DSubramanian%26aufirst%3DRaju%26date%3D2014%26date%3D2014%26volume%3D142%26issue%3D1%26spage%3D298%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangbin  Han</span>, <span class="hlFld-ContribAuthor ">Songwen  Lin</span>, <span class="hlFld-ContribAuthor ">Peng  Liu</span>, <span class="hlFld-ContribAuthor ">Jing  Tao</span>, <span class="hlFld-ContribAuthor ">Chongqin  Yi</span>, <span class="hlFld-ContribAuthor ">Heng  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationships of PI3K/mTOR dual inhibitors from a series of 2-amino-4-methylpyrido[2,3- d ]pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (18)
                                     , 4538-4541. <a href="https://doi.org/10.1016/j.bmcl.2014.07.073" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.07.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.07.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.07.073%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252BPI3K%25252FmTOR%252Bdual%252Binhibitors%252Bfrom%252Ba%252Bseries%252Bof%252B2-amino-4-methylpyrido%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine%252Bderivatives%26aulast%3DHan%26aufirst%3DFangbin%26date%3D2014%26volume%3D24%26issue%3D18%26spage%3D4538%26epage%3D4541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng Jun  Wang</span>, <span class="hlFld-ContribAuthor ">De Yun  Zeng</span>, <span class="hlFld-ContribAuthor ">Shan Shan  Gong</span>, <span class="hlFld-ContribAuthor ">Qi  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">An Unexpected Synthesis of 2H-Benzimidazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Advanced Materials Research</span><span> <strong>2014,</strong> <em>1023 </em>, 43-46. <a href="https://doi.org/10.4028/www.scientific.net/AMR.1023.43" title="DOI URL">https://doi.org/10.4028/www.scientific.net/AMR.1023.43</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4028/www.scientific.net/AMR.1023.43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4028%2Fwww.scientific.net%2FAMR.1023.43%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Materials%2520Research%26atitle%3DAn%252BUnexpected%252BSynthesis%252Bof%252B2H-Benzimidazole%252BDerivatives%26aulast%3DWang%26aufirst%3DCheng%2BJun%26date%3D2014%26date%3D2014%26volume%3D1023%26spage%3D43%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huan  Li</span>, <span class="hlFld-ContribAuthor ">Xiao-Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Teng  Shao</span>, <span class="hlFld-ContribAuthor ">Yi-Ping  Li</span>, <span class="hlFld-ContribAuthor ">Qi-Bing  Mei</span>, <span class="hlFld-ContribAuthor ">She-Min  Lu</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Combination of 2-methoxy-3-phenylsulfonylaminobenzamide and 2-aminobenzothiazole to discover novel anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (14)
                                     , 3739-3748. <a href="https://doi.org/10.1016/j.bmc.2014.04.064" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.04.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.04.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.04.064%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DCombination%252Bof%252B2-methoxy-3-phenylsulfonylaminobenzamide%252Band%252B2-aminobenzothiazole%252Bto%252Bdiscover%252Bnovel%252Banticancer%252Bagents%26aulast%3DLi%26aufirst%3DHuan%26date%3D2014%26volume%3D22%26issue%3D14%26spage%3D3739%26epage%3D3748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L. M.  Sinegovskaya</span>, <span class="hlFld-ContribAuthor ">V. A.  Shagun</span>, <span class="hlFld-ContribAuthor ">E. P.  Levanova</span>, <span class="hlFld-ContribAuthor ">N. A.  Korchevin</span>, <span class="hlFld-ContribAuthor ">I. B.  Rozentsveig</span>, <span class="hlFld-ContribAuthor ">V. I.  Smirnov</span>. </span><span class="cited-content_cbyCitation_article-title">Spectral and Quantum-Chemical Study of Acid-Catalyzed Heterocyclization of S-(2-Chloroprop-2-EN-1-YL)Isothiuronium Chloride with Acetylacetone. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2014,</strong> <em>50 </em>
                                    (3)
                                     , 404-414. <a href="https://doi.org/10.1007/s10593-014-1488-1" title="DOI URL">https://doi.org/10.1007/s10593-014-1488-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-014-1488-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-014-1488-1%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSpectral%252Band%252BQuantum-Chemical%252BStudy%252Bof%252BAcid-Catalyzed%252BHeterocyclization%252Bof%252BS-%2525282-Chloroprop-2-EN-1-YL%252529Isothiuronium%252BChloride%252Bwith%252BAcetylacetone%26aulast%3DSinegovskaya%26aufirst%3DL.%2BM.%26date%3D2014%26date%3D2014%26volume%3D50%26issue%3D3%26spage%3D404%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujeong  Jeong</span>, <span class="hlFld-ContribAuthor ">Daeil  Kwon</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Selective and potent small-molecule inhibitors of PI3Ks. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (7)
                                     , 737-756. <a href="https://doi.org/10.4155/fmc.14.28" title="DOI URL">https://doi.org/10.4155/fmc.14.28</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.28%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSelective%252Band%252Bpotent%252Bsmall-molecule%252Binhibitors%252Bof%252BPI3Ks%26aulast%3DJeong%26aufirst%3DYujeong%26date%3D2014%26volume%3D6%26issue%3D7%26spage%3D737%26epage%3D756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daiana T.  Mancini</span>, <span class="hlFld-ContribAuthor ">Eugenio F.  Souza</span>, <span class="hlFld-ContribAuthor ">Melissa S.  Caetano</span>, <span class="hlFld-ContribAuthor ">Teodorico C.  Ramalho</span>. </span><span class="cited-content_cbyCitation_article-title">99
              Tc NMR as a promising technique for structural investigation of biomolecules: theoretical studies on the solvent and thermal effects of phenylbenzothiazole complex. </span><span class="cited-content_cbyCitation_journal-name">Magnetic Resonance in Chemistry</span><span> <strong>2014,</strong> <em>52 </em>
                                    (4)
                                     , 129-137. <a href="https://doi.org/10.1002/mrc.4043" title="DOI URL">https://doi.org/10.1002/mrc.4043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mrc.4043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmrc.4043%26sid%3Dliteratum%253Aachs%26jtitle%3DMagnetic%2520Resonance%2520in%2520Chemistry%26atitle%3D99%252BTc%252BNMR%252Bas%252Ba%252Bpromising%252Btechnique%252Bfor%252Bstructural%252Binvestigation%252Bof%252Bbiomolecules%25253A%252Btheoretical%252Bstudies%252Bon%252Bthe%252Bsolvent%252Band%252Bthermal%252Beffects%252Bof%252Bphenylbenzothiazole%252Bcomplex%26aulast%3DMancini%26aufirst%3DDaiana%2BT.%26date%3D2014%26date%3D2014%26volume%3D52%26issue%3D4%26spage%3D129%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xilei  Xie</span>, <span class="hlFld-ContribAuthor ">Yu  Yan</span>, <span class="hlFld-ContribAuthor ">Ning  Zhu</span>, <span class="hlFld-ContribAuthor ">Gang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Benzothiazoles exhibit broad-spectrum antitumor activity: Their potency, structure–activity and structure–metabolism relationships. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>76 </em>, 67-78. <a href="https://doi.org/10.1016/j.ejmech.2014.02.007" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzothiazoles%252Bexhibit%252Bbroad-spectrum%252Bantitumor%252Bactivity%25253A%252BTheir%252Bpotency%25252C%252Bstructure%2525E2%252580%252593activity%252Band%252Bstructure%2525E2%252580%252593metabolism%252Brelationships%26aulast%3DXie%26aufirst%3DXilei%26date%3D2014%26volume%3D76%26spage%3D67%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo-Rui  Kang</span>, <span class="hlFld-ContribAuthor ">Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Huan  Li</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Qi-Bing  Mei</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antitumor activity evaluation of 2-arylisoquinoline-1,3(2H,4H)-diones in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2014,</strong> <em>23 </em>
                                    (3)
                                     , 1340-1349. <a href="https://doi.org/10.1007/s00044-013-0734-x" title="DOI URL">https://doi.org/10.1007/s00044-013-0734-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-013-0734-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-013-0734-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Band%252Bantitumor%252Bactivity%252Bevaluation%252Bof%252B2-arylisoquinoline-1%25252C3%2525282H%25252C4H%252529-diones%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DKang%26aufirst%3DBo-Rui%26date%3D2014%26date%3D2013%26volume%3D23%26issue%3D3%26spage%3D1340%26epage%3D1349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teng  Shao</span>, <span class="hlFld-ContribAuthor ">Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Gang  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao-Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Huan  Li</span>, <span class="hlFld-ContribAuthor ">Yi-Ping  Li</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Guang-De  Yang</span>, <span class="hlFld-ContribAuthor ">Qi-Bing  Mei</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-methoxy-3-phenylsulfonamino-5-(quinazolin-6-yl or quinolin-6-yl)benzamides as novel PI3K inhibitors and anticancer agents by bioisostere. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>75 </em>, 96-105. <a href="https://doi.org/10.1016/j.ejmech.2014.01.053" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.01.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.01.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.01.053%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-methoxy-3-phenylsulfonamino-5-%252528quinazolin-6-yl%252Bor%252Bquinolin-6-yl%252529benzamides%252Bas%252Bnovel%252BPI3K%252Binhibitors%252Band%252Banticancer%252Bagents%252Bby%252Bbioisostere%26aulast%3DShao%26aufirst%3DTeng%26date%3D2014%26volume%3D75%26spage%3D96%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. P.  Levanova</span>, <span class="hlFld-ContribAuthor ">V. A.  Grabel’nykh</span>, <span class="hlFld-ContribAuthor ">V. S.  Vakhrina</span>, <span class="hlFld-ContribAuthor ">N. V.  Russavskaya</span>, <span class="hlFld-ContribAuthor ">A. I.  Albanov</span>, <span class="hlFld-ContribAuthor ">N. A.  Korchevin</span>, <span class="hlFld-ContribAuthor ">I. B.  Rozentsveig</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new 2-(alkenylsulfanyl)pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>50 </em>
                                    (3)
                                     , 429-433. <a href="https://doi.org/10.1134/S1070428014030221" title="DOI URL">https://doi.org/10.1134/S1070428014030221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428014030221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428014030221%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bnew%252B2-%252528alkenylsulfanyl%252529pyrimidine%252Bderivatives%26aulast%3DLevanova%26aufirst%3DE.%2BP.%26date%3D2014%26date%3D2014%26volume%3D50%26issue%3D3%26spage%3D429%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Gordon W.  Rewcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of the Phosphatidylinositol 3-Kinase Pathway. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 449-478. <a href="https://doi.org/10.1016/B978-0-12-396521-9.00015-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-396521-9.00015-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396521-9.00015-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396521-9.00015-2%26sid%3Dliteratum%253Aachs%26atitle%3DInhibitors%252Bof%252Bthe%252BPhosphatidylinositol%252B3-Kinase%252BPathway%26aulast%3DDenny%26aufirst%3DWilliam%2BA.%26date%3D2014%26spage%3D449%26epage%3D478%26pub%3DElsevier%26atitle%3DCancer%252BDrug%252BDesign%252Band%252BDiscovery%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenjuan  Yang</span>, <span class="hlFld-ContribAuthor ">Mao  Shu</span>, <span class="hlFld-ContribAuthor ">Yuanqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  Hu</span>, <span class="hlFld-ContribAuthor ">Lingxin  Meng</span>, <span class="hlFld-ContribAuthor ">Zhihua  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR and docking studies of 3-Pyridine heterocyclic derivatives as potent PI3K/mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2013,</strong> <em>1054-1055 </em>, 107-116. <a href="https://doi.org/10.1016/j.molstruc.2013.09.049" title="DOI URL">https://doi.org/10.1016/j.molstruc.2013.09.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2013.09.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2013.09.049%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3D3D-QSAR%252Band%252Bdocking%252Bstudies%252Bof%252B3-Pyridine%252Bheterocyclic%252Bderivatives%252Bas%252Bpotent%252BPI3K%25252FmTOR%252Binhibitors%26aulast%3DYang%26aufirst%3DWenjuan%26date%3D2013%26volume%3D1054-1055%26spage%3D107%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiqing  Xu</span>, <span class="hlFld-ContribAuthor ">Hirofumi  Kamada</span>, <span class="hlFld-ContribAuthor ">Eun Hoo  Kim</span>, <span class="hlFld-ContribAuthor ">Akimichi  Oda</span>, <span class="hlFld-ContribAuthor ">Ei-ichi  Negishi</span>. </span><span class="cited-content_cbyCitation_article-title">Pd-Catalyzed Cross-Coupling with Organometals Containing Zn, Al, Zr, and so on - The Negishi Coupling and Its Recent Advances. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 133-278. <a href="https://doi.org/10.1002/9783527655588.ch3" title="DOI URL">https://doi.org/10.1002/9783527655588.ch3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527655588.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527655588.ch3%26sid%3Dliteratum%253Aachs%26atitle%3DPd-Catalyzed%252BCross-Coupling%252Bwith%252BOrganometals%252BContaining%252BZn%25252C%252BAl%25252C%252BZr%25252C%252Band%252Bso%252Bon%252B-%252BThe%252BNegishi%252BCoupling%252Band%252BIts%252BRecent%252BAdvances%26aulast%3DXu%26aufirst%3DShiqing%26date%3D2013%26date%3D2013%26spage%3D133%26epage%3D278%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DMetal-Catalyzed%252BCross-Coupling%252BReactions%252Band%252BMore%26aulast%3Dde%2BMeijere%26aufirst%3DArmin%26date%3D2014%26volume%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Furthering the design and the discovery of small molecule ATP-competitive mTOR inhibitors as an effective cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2013,</strong> <em>8 </em>
                                    (8)
                                     , 991-1012. <a href="https://doi.org/10.1517/17460441.2013.800479" title="DOI URL">https://doi.org/10.1517/17460441.2013.800479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2013.800479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2013.800479%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DFurthering%252Bthe%252Bdesign%252Band%252Bthe%252Bdiscovery%252Bof%252Bsmall%252Bmolecule%252BATP-competitive%252BmTOR%252Binhibitors%252Bas%252Ban%252Beffective%252Bcancer%252Btreatment%26aulast%3DLv%26aufirst%3DXiaoqing%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D8%26spage%3D991%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Xu</span>, <span class="hlFld-ContribAuthor ">Yi-Ping  Li</span>, <span class="hlFld-ContribAuthor ">Huan  Li</span>, <span class="hlFld-ContribAuthor ">Cong-Shan  Jiang</span>, <span class="hlFld-ContribAuthor ">Guang-De  Yang</span>, <span class="hlFld-ContribAuthor ">She-Min  Lu</span>, <span class="hlFld-ContribAuthor ">San-Qi  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer activity evaluation of a series of [1,2,4]triazolo[1,5-a]pyridinylpyridines in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>67 </em>, 243-251. <a href="https://doi.org/10.1016/j.ejmech.2013.06.052" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.06.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.06.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.06.052%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Bactivity%252Bevaluation%252Bof%252Ba%252Bseries%252Bof%252B%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dpyridinylpyridines%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%26aulast%3DWang%26aufirst%3DXiao-Meng%26date%3D2013%26volume%3D67%26spage%3D243%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E.  Welker</span>, <span class="hlFld-ContribAuthor ">George  Kulik</span>. </span><span class="cited-content_cbyCitation_article-title">Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (14)
                                     , 4063-4091. <a href="https://doi.org/10.1016/j.bmc.2013.04.083" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.04.083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.04.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.04.083%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bsyntheses%252Bof%252BPI3K%25252FAkt%25252FmTOR%252Bsignaling%252Bpathway%252Binhibitors%26aulast%3DWelker%26aufirst%3DMark%2BE.%26date%3D2013%26volume%3D21%26issue%3D14%26spage%3D4063%26epage%3D4091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandip B.  Bharate</span>, <span class="hlFld-ContribAuthor ">Baljinder  Singh</span>, <span class="hlFld-ContribAuthor ">Jaideep B.  Bharate</span>, <span class="hlFld-ContribAuthor ">Shreyans K.  Jain</span>, <span class="hlFld-ContribAuthor ">Samdarshi  Meena</span>, <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR and pharmacophore modeling of N-acetyl-2-aminobenzothiazole class of phosphoinositide-3-kinase-α inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2013,</strong> <em>22 </em>
                                    (2)
                                     , 890-899. <a href="https://doi.org/10.1007/s00044-012-0081-3" title="DOI URL">https://doi.org/10.1007/s00044-012-0081-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-012-0081-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-012-0081-3%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DQSAR%252Band%252Bpharmacophore%252Bmodeling%252Bof%252BN-acetyl-2-aminobenzothiazole%252Bclass%252Bof%252Bphosphoinositide-3-kinase-%2525CE%2525B1%252Binhibitors%26aulast%3DBharate%26aufirst%3DSandip%2BB.%26date%3D2013%26date%3D2012%26volume%3D22%26issue%3D2%26spage%3D890%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Se Hun  Kwak</span>, <span class="hlFld-ContribAuthor ">Gee-Hyung  Lee</span>, <span class="hlFld-ContribAuthor ">Young-Dae  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of N-Substituted-2-Aminothiazolo[4,5-b]pyrazines by Tandem Reaction of o-Aminohalopyrazines with Isothiocyanates. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2012,</strong> <em>33 </em>
                                    (12)
                                     , 4271-4274. <a href="https://doi.org/10.5012/bkcs.2012.33.12.4271" title="DOI URL">https://doi.org/10.5012/bkcs.2012.33.12.4271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5012/bkcs.2012.33.12.4271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5012%2Fbkcs.2012.33.12.4271%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DSynthesis%252Bof%252BN-Substituted-2-Aminothiazolo%25255B4%25252C5-b%25255Dpyrazines%252Bby%252BTandem%252BReaction%252Bof%252Bo-Aminohalopyrazines%252Bwith%252BIsothiocyanates%26aulast%3DKwak%26aufirst%3DSe%2BHun%26date%3D2012%26volume%3D33%26issue%3D12%26spage%3D4271%26epage%3D4274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Longbin  Liu</span>, <span class="hlFld-ContribAuthor ">Kevin  Yang</span>, <span class="hlFld-ContribAuthor ">Nobuko  Nishimura</span>, <span class="hlFld-ContribAuthor ">Yunxin  Bo</span>, <span class="hlFld-ContribAuthor ">Liping H.  Pettus</span>, <span class="hlFld-ContribAuthor ">Sean  Caenepeel</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Freeman</span>, <span class="hlFld-ContribAuthor ">John D.  McCarter</span>, <span class="hlFld-ContribAuthor ">Erin L.  Mullady</span>, <span class="hlFld-ContribAuthor ">Tisha San  Miguel</span>, <span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Nancy  Zhang</span>, <span class="hlFld-ContribAuthor ">Kristin L.  Andrews</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Jian  Jiang</span>, <span class="hlFld-ContribAuthor ">Raju  Subramanian</span>, <span class="hlFld-ContribAuthor ">Paul E.  Hughes</span>, <span class="hlFld-ContribAuthor ">Mark H.  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (17)
                                     , 5714-5720. <a href="https://doi.org/10.1016/j.bmcl.2012.06.078" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.06.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.06.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.06.078%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bdual%252BPI3K%25252FmTOR%252Binhibitors%252Bbased%252Bon%252Ba%252B4-amino-6-methyl-1%25252C3%25252C5-triazine%252Bsulfonamide%252Bscaffold%26aulast%3DWurz%26aufirst%3DRyan%2BP.%26date%3D2012%26volume%3D22%26issue%3D17%26spage%3D5714%26epage%3D5720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinan  Wang</span>, <span class="hlFld-ContribAuthor ">Fangfang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhengtao  Xiao</span>, <span class="hlFld-ContribAuthor ">Guowen  Sheng</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Yonghua  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular simulation of a series of benzothiazole PI3Kα inhibitors: probing the relationship between structural features, anti-tumor potency and selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2012,</strong> <em>18 </em>
                                    (7)
                                     , 2943-2958. <a href="https://doi.org/10.1007/s00894-011-1299-6" title="DOI URL">https://doi.org/10.1007/s00894-011-1299-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-011-1299-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-011-1299-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DMolecular%252Bsimulation%252Bof%252Ba%252Bseries%252Bof%252Bbenzothiazole%252BPI3K%2525CE%2525B1%252Binhibitors%25253A%252Bprobing%252Bthe%252Brelationship%252Bbetween%252Bstructural%252Bfeatures%25252C%252Banti-tumor%252Bpotency%252Band%252Bselectivity%26aulast%3DWang%26aufirst%3DJinan%26date%3D2012%26date%3D2011%26volume%3D18%26issue%3D7%26spage%3D2943%26epage%3D2958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Wang</span>, <span class="hlFld-ContribAuthor ">Xiang  Wang</span>, <span class="hlFld-ContribAuthor ">Yanhong  Chen</span>, <span class="hlFld-ContribAuthor ">Simeng  Chen</span>, <span class="hlFld-ContribAuthor ">Guang  Chen</span>, <span class="hlFld-ContribAuthor ">Linjiang  Tong</span>, <span class="hlFld-ContribAuthor ">Linghua  Meng</span>, <span class="hlFld-ContribAuthor ">Yuyuan  Xie</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Chunhao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and bioactivity of 4-(2-arylpyrido[3′,2′:3,4]pyrrolo[1,2-f][1,2,4]triazin-4-yl) morpholine derivatives as novel PI3K inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (1)
                                     , 339-342. <a href="https://doi.org/10.1016/j.bmcl.2011.11.003" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.11.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.11.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Bbioactivity%252Bof%252B4-%2525282-arylpyrido%25255B3%2525E2%252580%2525B2%25252C2%2525E2%252580%2525B2%25253A3%25252C4%25255Dpyrrolo%25255B1%25252C2-f%25255D%25255B1%25252C2%25252C4%25255Dtriazin-4-yl%252529%252Bmorpholine%252Bderivatives%252Bas%252Bnovel%252BPI3K%252Binhibitors%26aulast%3DWang%26aufirst%3DJia%26date%3D2012%26volume%3D22%26issue%3D1%26spage%3D339%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Wu</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules targeting phosphoinositide 3-kinases. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2012,</strong> <em>3 </em>
                                    (11)
                                     , 1337. <a href="https://doi.org/10.1039/c2md20044a" title="DOI URL">https://doi.org/10.1039/c2md20044a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2md20044a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2md20044a%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSmall%252Bmolecules%252Btargeting%252Bphosphoinositide%252B3-kinases%26aulast%3DWu%26aufirst%3DPeng%26date%3D2012%26volume%3D3%26issue%3D11%26spage%3D1337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinhee  Kim</span>, <span class="hlFld-ContribAuthor ">Seunghee  Hong</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new aminopyrimidine-based phosphoinositide 3-kinase beta (PI3Kβ) inhibitors with selectivity over PI3Kα. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (23)
                                     , 6977-6981. <a href="https://doi.org/10.1016/j.bmcl.2011.09.118" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.09.118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.09.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.09.118%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnew%252Baminopyrimidine-based%252Bphosphoinositide%252B3-kinase%252Bbeta%252B%252528PI3K%2525CE%2525B2%252529%252Binhibitors%252Bwith%252Bselectivity%252Bover%252BPI3K%2525CE%2525B1%26aulast%3DKim%26aufirst%3DJinhee%26date%3D2011%26volume%3D21%26issue%3D23%26spage%3D6977%26epage%3D6981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph M.  Dehnhardt</span>, <span class="hlFld-ContribAuthor ">Aranapakam M.  Venkatesan</span>, <span class="hlFld-ContribAuthor ">Zecheng  Chen</span>, <span class="hlFld-ContribAuthor ">Efren  Delos-Santos</span>, <span class="hlFld-ContribAuthor ">Semiramis  Ayral-Kaloustian</span>, <span class="hlFld-ContribAuthor ">Natasja  Brooijmans</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Larry  Feldberg</span>, <span class="hlFld-ContribAuthor ">Judy  Lucas</span>, <span class="hlFld-ContribAuthor ">Robert  Mallon</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of 2-oxatriazines as highly potent pan-PI3K/mTOR dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (16)
                                     , 4773-4778. <a href="https://doi.org/10.1016/j.bmcl.2011.06.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.06.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.06.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252B2-oxatriazines%252Bas%252Bhighly%252Bpotent%252Bpan-PI3K%25252FmTOR%252Bdual%252Binhibitors%26aulast%3DDehnhardt%26aufirst%3DChristoph%2BM.%26date%3D2011%26volume%3D21%26issue%3D16%26spage%3D4773%26epage%3D4778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0022.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray cocrystal of <b>1</b> bound to PI3Kγ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0021.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) Ac<sub>2</sub>O, DMAP, DCM, 0 °C to room temperature, 88%; (ii) bis(pinacolato)diboron, Pd(dppf)Cl<sub>2</sub>/DCM, KOAc, DMSO, 100 °C, 91%; (iii) TFE, EtOH, 45 °C; KHF<sub>2</sub>, room temperature, 69%; (iv) 2,4-dichloropyrimidine, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 95 °C, 85%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaH, DMF or DMSO, 12−69%; (ii) pyridine, 120 °C, microwave irradiation, 300 W, 5−22%; (iii) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 180 °C, microwave irradiation, 180 W, 2%; (iv) NaH, DMF, <b>5</b>, Pd(OAc)<sub>2</sub>, Xantphos, 100 °C, microwave irradiation, 100 W, 16−36%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 4-anisoyl chloride, Et<sub>3</sub>N, DCM, 5%; (ii) <b>4a</b>, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 90 °C, 18−32%; (iii) 4-methoxybenzenesulfonamide, NaH, Pd(OAc)<sub>2</sub>, Xantphos, DMF, 120 °C, microwave irradiation, 100 W, 12%; (iv) 4-methoxybenzenesulfonyl chloride, EtOH, 21%; (v) <b>4a</b>, Fibercat, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 100 °C, microwave irradiation, 100 W, 16%; (vi) <b>4a</b>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DME, 90 °C, 62%; (vii) 4-methoxybenzenesulfonamide, NaH, DMSO, 125 °C, 4%; (viii) 4-methoxybenzenesulfonyl chloride, pyridine, pyrrolidine, DCM, 73% (ix) 4-methoxybenzenesulfonyl chloride, LiHMDS, THF, −40 °C to room temperature, 8%; (x) <b>4a</b>, Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DME, 100 °C, 4%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) diethyl malonate, NaH, DMF, 40 °C; (ii) HCl, H<sub>2</sub>O, 110 °C; (iii) Fe, HOAc, H<sub>2</sub>O, 52%; (iv) <b>4a</b>, Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, H<sub>2</sub>O, DME, 100 °C, 50%; (v) 4-methoxybenzenesulfonyl chloride, DMAP, pyridine, THF, 65 °C, 53%.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0016.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray cocrystal of <b>82</b> bound to PI3Kγ. Parts A and B are from a similar vantage point, while part C views the molecule down the C−Cl bond of the chloropyridine central ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0017.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of compound <b>82</b> on HGF-mediated AKT phosphorylation (A) at 3 h postdose and (B) in a time course study at 3 mg/kg. Bars represent the mean ± standard deviation (<i>n</i> = 3). Diamonds represent mean plasma concentration. Asterisk denotes (A) <i>p</i> < 0.05 and (B) <i>p</i> < 0.001 compared with the vehicle (HGF) group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/medium/jm-2010-014605_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0018.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Daily dosing with <b>82</b> induced tumor stasis and growth delay in established xenograft models (A) U-87 MG glioblastoma, (B) A549 lung adenocarcinoma, and (C) HCT116 colon adenocarcinoma. Arrow denotes the first day of dosing. The 10 mpk arm had to be stopped on day 32 in the HCT116 model because of a drop in body weight to 85% of the initial body weight. (D) Summary of ED<sub>50</sub> and AUC (at ED<sub>50</sub>) values for the three studies. Asterisk denotes <i>p</i> < 0.0001 compared with the vehicle group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm1014605/production/images/large/jm-2010-014605_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm1014605&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i103">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18430" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18430" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 64 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Engleman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">The Evolution of Phosphatidylinositol 3-Kinases as Regulators of Growth and Metabolism</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1038%2Fnrg1879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=16847462" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=606-619&author=J.+A.+Englemanauthor=J.+Luoauthor=L.+C.+Cantley&title=The+Evolution+of+Phosphatidylinositol+3-Kinases+as+Regulators+of+Growth+and+Metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrg1879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg1879%26sid%3Dliteratum%253Aachs%26aulast%3DEngleman%26aufirst%3DJ.%2BA.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520Evolution%2520of%2520Phosphatidylinositol%25203-Kinases%2520as%2520Regulators%2520of%2520Growth%2520and%2520Metabolism%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2006%26volume%3D7%26spage%3D606%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Marone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cmiljanovic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giese, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span> </span><span class="NLM_article-title">Targeting Phosphoinositide 3-Kinase: Moving towards Therapy</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=159-185&author=R.+Maroneauthor=V.+Cmiljanovicauthor=B.+Gieseauthor=M.+P.+Wymann&title=Targeting+Phosphoinositide+3-Kinase%3A+Moving+towards+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarone%26aufirst%3DR.%26aulast%3DCmiljanovic%26aufirst%3DV.%26aulast%3DGiese%26aufirst%3DB.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3DTargeting%2520Phosphoinositide%25203-Kinase%253A%2520Moving%2520towards%2520Therapy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26spage%3D159%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. J.</span><span> </span><span class="NLM_article-title">Targeting the Phosphoinositide 3-Kinase Pathway in Cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1038%2Fnrd2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=19644473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627-644&author=P.+Liuauthor=H.+Chengauthor=T.+M.+Robertsauthor=J.+J.+Zhao&title=Targeting+the+Phosphoinositide+3-Kinase+Pathway+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span></div><div class="casAuthors">Liu, Pixu; Cheng, Hailing; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system that links oncogenes and multiple receptor classes to many essential cellular functions, and is perhaps the most commonly activated signalling pathway in human cancer.  This pathway therefore presents both an opportunity and a challenge for cancer therapy.  Even as inhibitors that target PI3K isoforms and other major nodes in the pathway, including AKT and mammalian target of rapamycin (mTOR), reach clin. trials, major issues remain.  Here, we highlight recent progress that has been made in our understanding of the PI3K pathway and discuss the potential of and challenges for the development of therapeutic agents that target this pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk9T-ZoNDtLVg90H21EOLACvtfcHk0lhY7uod9gdSkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D&md5=fdc94abd15178a9dbe7c56dafbfb7787</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrd2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2926%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520the%2520Phosphoinositide%25203-Kinase%2520Pathway%2520in%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D627%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Franke, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">PI3K: Downstream AKTion Blocks Apoptosis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1997&pages=435-437&author=T.+F.+Frankeauthor=D.+R.+Kaplanauthor=L.+C.+Cantley&title=PI3K%3A+Downstream+AKTion+Blocks+Apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFranke%26aufirst%3DT.%2BF.%26aulast%3DKaplan%26aufirst%3DD.%2BR.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DPI3K%253A%2520Downstream%2520AKTion%2520Blocks%2520Apoptosis%26jtitle%3DCell%26date%3D1997%26volume%3D88%26spage%3D435%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Shepherd, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withers, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddle, K.</span><span> </span><span class="NLM_article-title">Phosphoinositide 3-Kinase: The Key Switch Mechanism in Insulin Signaling</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x"> (</span><span class="NLM_issue">Part 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=1998&pages=471-490&issue=Part+3&author=P.+R.+Shepherdauthor=D.+J.+Withersauthor=K.+Siddle&title=Phosphoinositide+3-Kinase%3A+The+Key+Switch+Mechanism+in+Insulin+Signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShepherd%26aufirst%3DP.%2BR.%26aulast%3DWithers%26aufirst%3DD.%2BJ.%26aulast%3DSiddle%26aufirst%3DK.%26atitle%3DPhosphoinositide%25203-Kinase%253A%2520The%2520Key%2520Switch%2520Mechanism%2520in%2520Insulin%2520Signaling%26jtitle%3DBiochem.%2520J.%26date%3D1998%26volume%3D333%26issue%3DPart%25203%26spage%3D471%26epage%3D490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Maehama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. E.</span><span> </span><span class="NLM_article-title">The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Triphosphate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">13375</span><span class="NLM_x">–</span> <span class="NLM_lpage">13378</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=13375-13378&author=T.+Maehamaauthor=J.+E.+Dixon&title=The+Tumor+Suppressor%2C+PTEN%2FMMAC1%2C+Dephosphorylates+the+Lipid+Second+Messenger%2C+Phosphatidylinositol+3%2C4%2C5-Triphosphate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaehama%26aufirst%3DT.%26aulast%3DDixon%26aufirst%3DJ.%2BE.%26atitle%3DThe%2520Tumor%2520Suppressor%252C%2520PTEN%252FMMAC1%252C%2520Dephosphorylates%2520the%2520Lipid%2520Second%2520Messenger%252C%2520Phosphatidylinositol%25203%252C4%252C5-Triphosphate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D13375%26epage%3D13378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Maehama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. E.</span><span> </span><span class="NLM_article-title">PTEN and Myotubularin: Novel Phosphoinositide Phosphatases</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1146%2Fannurev.biochem.70.1.247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=11395408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=247-279&author=T.+Maehamaauthor=G.+S.+Taylorauthor=J.+E.+Dixon&title=PTEN+and+Myotubularin%3A+Novel+Phosphoinositide+Phosphatases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN and Myotubularin: novel phosphoinositide phosphatases</span></div><div class="casAuthors">Maehama, Tomohiko; Taylor, Gregory S.; Dixon, Jack E.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">247-279</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review, with 161 refs.  Protein tyrosine phosphatases (PTPs) are a diverse group of enzymes that contain a highly conserved active site motif, Cys-x5-Arg (Cx5R).  The PTP superfamily enzymes, which include tyrosine-specific, dual specificity, low-mol.-wt., and Cdc25 phosphatases, are key mediators of a wide variety of cellular processes, including growth, metab., differentiation, motility, and programmed cell death.  The PTEN/MMAC1/TEP1 gene was originally identified as a candidate tumor suppressor gene located on human chromosome 10q23; it encodes a protein with sequence similarity to PTPs and tensin.  Recent studies have demonstrated that PTEN plays an essential role in regulating signaling pathways involved in cell growth and apoptosis, and mutations in the PTEN gene are now known to cause tumorigenesis in a no. of human tissues.  In addn., germ line mutations in the PTEN gene also play a major role in the development of Cowden and Bannayan-Zonana syndromes, in which patients often suffer from increased risk of breast and thyroid cancers.  Biochem. studies of the PTEN phosphatase have revealed a mol. mechanism by which tumorigenesis may be caused in individuals with PTEN mutations.  Unlike most members of the PTP superfamily, PTEN utilizes the phosphoinositide second messenger, phosphatidylinositol 3,4,5-trisphosphate (PIP3), as its physiol. substrate.  This inositol lipid is an important regulator of cell growth and survival signaling through the Ser/Thr protein kinases PDK1 and Akt.  By specifically dephosphorylating the D3 position of PIP3, the PTEN tumor suppressor functions as a neg. regulator of signaling processes downstream of this lipid second messenger.  Mutations that impair PTEN function result in a marked increase in cellular levels of PIP3 and constitutive activation of Akt survival signaling pathways, leading to inhibition of apoptosis, hyperplasia, and tumor formation.  Certain structural features of PTEN contribute to its specificity for PIP3, as well as its role(s) in regulating cellular proliferation and apoptosis.  Recently, myotubularin, a second PTP superfamily enzyme assocd. with human disease, has also been shown to utilize a phosphoinositide as its physiol. substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTw3shS-h3J7Vg90H21EOLACvtfcHk0lg0arCR1InmhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVeht7o%253D&md5=ef23ea23449834941d7ba4d712cf5029</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.70.1.247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.70.1.247%26sid%3Dliteratum%253Aachs%26aulast%3DMaehama%26aufirst%3DT.%26aulast%3DTaylor%26aufirst%3DG.%2BS.%26aulast%3DDixon%26aufirst%3DJ.%2BE.%26atitle%3DPTEN%2520and%2520Myotubularin%253A%2520Novel%2520Phosphoinositide%2520Phosphatases%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2001%26volume%3D70%26spage%3D247%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Vivanco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">The Phosphatidylinositol 3-Kinase-AKT Pathway in Human Cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1038%2Fnrc839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=12094235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=489-501&author=I.+Vivancoauthor=C.+L.+Sawyers&title=The+Phosphatidylinositol+3-Kinase-AKT+Pathway+in+Human+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphatidylinositol 3-Kinase-AKT pathway in human cancer</span></div><div class="casAuthors">Vivanco, Igor; Sawyers, Charles L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-501</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  One signal that is overactivated in a wide range of tumor types is the prodn. of a phospholipid, phosphatidylinositol (3,4,5) trisphosphate, by phosphatidylinositol 3-kinase (PI3K).  This lipid and the protein kinase that is activated by it, AKT, trigger a cascade of responses, from cell growth and proliferation to survival and motility, that drive tumor progression.  Small-mol. therapeutics that block PI3K signaling might deal a severe blow to cancer cells by blocking many aspects of the tumor-cell phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzAQ-0qeD7pLVg90H21EOLACvtfcHk0lg0arCR1InmhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFKltLs%253D&md5=c6762d32f9f1281632f4ccdbcd29268c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrc839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc839%26sid%3Dliteratum%253Aachs%26aulast%3DVivanco%26aufirst%3DI.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DThe%2520Phosphatidylinositol%25203-Kinase-AKT%2520Pathway%2520in%2520Human%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D489%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Wishart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. E.</span><span> </span><span class="NLM_article-title">PTEN and Myotubularin Phosphatases: From 3-Phosphoinositide Dephosphorylation to Disease</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">585</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1016%2FS0962-8924%2802%2902412-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=12495846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsV2msbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=579-585&author=M.+J.+Wishartauthor=J.+E.+Dixon&title=PTEN+and+Myotubularin+Phosphatases%3A+From+3-Phosphoinositide+Dephosphorylation+to+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease</span></div><div class="casAuthors">Wishart, Matthew J.; Dixon, Jack E.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">579-585</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The phosphatase and tensin homolog deleted on chromosome ten (PTEN) and myotubularin (MTM1) represent subfamilies of protein tyrosine phosphatases whose principal physiol. substrates are D3-phosphorylated inositol phospholipids.  As lipid phosphatases, PTEN- and MTM1-related (MTMR) proteins dephosphorylate the products of phosphoinositide 3-kinases and antagonize downstream effectors that utilize 3-phosphoinositides as ligands for protein targeting domains or allosteric activation.  Here, the authors describe the cellular mechanisms of PTEN and MTMR function and their role in the etiol. of cancer and other human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWnHPFC-ifGLVg90H21EOLACvtfcHk0lg0arCR1InmhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsV2msbk%253D&md5=b330162845ad4a2b62071cd2e5db1d60</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0962-8924%2802%2902412-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0962-8924%252802%252902412-1%26sid%3Dliteratum%253Aachs%26aulast%3DWishart%26aufirst%3DM.%2BJ.%26aulast%3DDixon%26aufirst%3DJ.%2BE.%26atitle%3DPTEN%2520and%2520Myotubularin%2520Phosphatases%253A%2520From%25203-Phosphoinositide%2520Dephosphorylation%2520to%2520Disease%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2002%26volume%3D12%26spage%3D579%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Bader, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P. K.</span><span> </span><span class="NLM_article-title">Oncogenic PI3K Deregulates Transcription and Translation</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1038%2Fnrc1753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=16341083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ykurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=921-929&author=A.+G.+Baderauthor=S.+Kangauthor=L.+Zhaoauthor=P.+K.+Vogt&title=Oncogenic+PI3K+Deregulates+Transcription+and+Translation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic PI3K deregulates transcription and translation</span></div><div class="casAuthors">Bader, Andreas G.; Kang, Sohye; Zhao, Li; Vogt, Peter K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">921-929</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There have long been indications of a role for PI3K (phosphatidylinositol 3-kinase) in cancer pathogenesis.  Exptl. data document a requirement for deregulation of both transcription and translation in PI3K-mediated oncogenic transformation.  The recent discoveries of cancer-specific mutations in PIK3CA, the gene that encodes the catalytic subunit p110α of PI3K, have heightened the interest in the oncogenic potential of this lipid kinase and have made p110α an ideal drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq61EnpTquPh7Vg90H21EOLACvtfcHk0lhNtMzLCFOe7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ykurbF&md5=11cf0cec31b8e6c6af2b46b020db6241</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrc1753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1753%26sid%3Dliteratum%253Aachs%26aulast%3DBader%26aufirst%3DA.%2BG.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DVogt%26aufirst%3DP.%2BK.%26atitle%3DOncogenic%2520PI3K%2520Deregulates%2520Transcription%2520and%2520Translation%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D921%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Manning, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">AKT/PKB Signaling: Navigating Downstream</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=1261-1274&author=B.+D.+Manningauthor=L.+C.+Cantley&title=AKT%2FPKB+Signaling%3A+Navigating+Downstream"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DAKT%252FPKB%2520Signaling%253A%2520Navigating%2520Downstream%26jtitle%3DCell%26date%3D2007%26volume%3D129%26spage%3D1261%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Janssen, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleithoff, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartram, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, A. S.</span><span> </span><span class="NLM_article-title">An Oncogenic Fusion Product of the Phosphatidylinositol 3-Kinase p85β Subunit and HUMORF8, a Putative Deubiquitinating Enzyme</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1767</span><span class="NLM_x">–</span> <span class="NLM_lpage">1772</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1998&pages=1767-1772&author=J.+W.+Janssenauthor=L.+Schleithoffauthor=C.+R.+Bartramauthor=A.+S.+Schulz&title=An+Oncogenic+Fusion+Product+of+the+Phosphatidylinositol+3-Kinase+p85%CE%B2+Subunit+and+HUMORF8%2C+a+Putative+Deubiquitinating+Enzyme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJanssen%26aufirst%3DJ.%2BW.%26aulast%3DSchleithoff%26aufirst%3DL.%26aulast%3DBartram%26aufirst%3DC.%2BR.%26aulast%3DSchulz%26aufirst%3DA.%2BS.%26atitle%3DAn%2520Oncogenic%2520Fusion%2520Product%2520of%2520the%2520Phosphatidylinositol%25203-Kinase%2520p85%25CE%25B2%2520Subunit%2520and%2520HUMORF8%252C%2520a%2520Putative%2520Deubiquitinating%2520Enzyme%26jtitle%3DOncogene%26date%3D1998%26volume%3D16%26spage%3D1767%26epage%3D1772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Jimenez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Viciana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennstrom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kobbe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toran, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">R.-Borlado, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albar, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcos, M. A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downward, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-A., C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merida, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrera, A. C.</span><span> </span><span class="NLM_article-title">Identification and Characterization of a New Oncogene Derived from the Regulatory Subunit of Phosphoinositide 3-Kinase</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=743-753&author=C.+Jimenezauthor=D.+R.+Jonesauthor=P.+Rodriguez-Vicianaauthor=A.+Gonzalez-Garciaauthor=E.+Leonardoauthor=S.+Wennstromauthor=C.+von+Kobbeauthor=J.+L.+Toranauthor=L.+R.-Borladoauthor=V.+Calvoauthor=S.+G.+Copinauthor=J.+P.+Albarauthor=M.+L.+Gasparauthor=E.+Diezauthor=M.+A.+R.+Marcosauthor=J.+Downwardauthor=C.+Martinez-A.author=I.+Meridaauthor=A.+C.+Carrera&title=Identification+and+Characterization+of+a+New+Oncogene+Derived+from+the+Regulatory+Subunit+of+Phosphoinositide+3-Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJimenez%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DD.%2BR.%26aulast%3DRodriguez-Viciana%26aufirst%3DP.%26aulast%3DGonzalez-Garcia%26aufirst%3DA.%26aulast%3DLeonardo%26aufirst%3DE.%26aulast%3DWennstrom%26aufirst%3DS.%26aulast%3Dvon%2BKobbe%26aufirst%3DC.%26aulast%3DToran%26aufirst%3DJ.%2BL.%26aulast%3DR.-Borlado%26aufirst%3DL.%26aulast%3DCalvo%26aufirst%3DV.%26aulast%3DCopin%26aufirst%3DS.%2BG.%26aulast%3DAlbar%26aufirst%3DJ.%2BP.%26aulast%3DGaspar%26aufirst%3DM.%2BL.%26aulast%3DDiez%26aufirst%3DE.%26aulast%3DMarcos%26aufirst%3DM.%2BA.%2BR.%26aulast%3DDownward%26aufirst%3DJ.%26aulast%3DMartinez-A.%26aufirst%3DC.%26aulast%3DMerida%26aufirst%3DI.%26aulast%3DCarrera%26aufirst%3DA.%2BC.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520a%2520New%2520Oncogene%2520Derived%2520from%2520the%2520Regulatory%2520Subunit%2520of%2520Phosphoinositide%25203-Kinase%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D743%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Jucker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiedler, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, R. A.</span><span> </span><span class="NLM_article-title">Expression of a Mutated Form of the p85α Regulatory Subunit of Phosphatidylinositol 3-Kinase in a Hodgkin’s Lymphona-Derived Cell Line (CO)</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">894</span><span class="NLM_x">–</span> <span class="NLM_lpage">901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=894-901&author=M.+Juckerauthor=K.+Sudelauthor=S.+Hornauthor=M.+Sickelauthor=W.+Wegnerauthor=W.+Fiedlerauthor=R.+A.+Feldman&title=Expression+of+a+Mutated+Form+of+the+p85%CE%B1+Regulatory+Subunit+of+Phosphatidylinositol+3-Kinase+in+a+Hodgkin%E2%80%99s+Lymphona-Derived+Cell+Line+%28CO%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DSudel%26aufirst%3DK.%26aulast%3DHorn%26aufirst%3DS.%26aulast%3DSickel%26aufirst%3DM.%26aulast%3DWegner%26aufirst%3DW.%26aulast%3DFiedler%26aufirst%3DW.%26aulast%3DFeldman%26aufirst%3DR.%2BA.%26atitle%3DExpression%2520of%2520a%2520Mutated%2520Form%2520of%2520the%2520p85%25CE%25B1%2520Regulatory%2520Subunit%2520of%2520Phosphatidylinositol%25203-Kinase%2520in%2520a%2520Hodgkin%25E2%2580%2599s%2520Lymphona-Derived%2520Cell%2520Line%2520%2528CO%2529%26jtitle%3DLeukemia%26date%3D2002%26volume%3D16%26spage%3D894%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silliman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ptak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, J. K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markowitz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">High Frequency of Mutations of the PIK3CA Gene in Human Cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1126%2Fscience.1096502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=15016963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsVGmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=554&author=Y.+Samuelsauthor=Z.+Wangauthor=A.+Bardelliauthor=N.+Sillimanauthor=J.+Ptakauthor=S.+Szaboauthor=H.+Yanauthor=A.+Gazdarauthor=S.+M.+Powellauthor=G.+J.+Rigginsauthor=J.+K.+V.+Willsonauthor=S.+Markowitzauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=V.+E.+Velculescu&title=High+Frequency+of+Mutations+of+the+PIK3CA+Gene+in+Human+Cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Brevia: High frequency of mutations of the PIK3Ca gene in human cancers</span></div><div class="casAuthors">Samuels, Yardena; Wang, Zhenghe; Bardelli, Alberto; Silliman, Natalie; Ptak, Janine; Szabo, Steve; Yan, Hai; Gazdar, Adi; Powell, Steven M.; Riggins, Gregory J.; Willson, James K. V.; Markowitz, Sanford; Kinzler, Kenneth W.; Vogelstein, Bert; Velculescu, Victor E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">5670</span>),
    <span class="NLM_cas:pages">554</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr74Tv7Oo80NbVg90H21EOLACvtfcHk0lhNtMzLCFOe7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsVGmsbk%253D&md5=be8d63bf0c909971c3b7a5f475ce8fab</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1126%2Fscience.1096502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1096502%26sid%3Dliteratum%253Aachs%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSilliman%26aufirst%3DN.%26aulast%3DPtak%26aufirst%3DJ.%26aulast%3DSzabo%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DS.%2BM.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DWillson%26aufirst%3DJ.%2BK.%2BV.%26aulast%3DMarkowitz%26aufirst%3DS.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DHigh%2520Frequency%2520of%2520Mutations%2520of%2520the%2520PIK3CA%2520Gene%2520in%2520Human%2520Cancers%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Isakoff, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearline, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugge, J. S.</span><span> </span><span class="NLM_article-title">Breast Cancer-Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial Cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">10992</span><span class="NLM_x">–</span> <span class="NLM_lpage">11000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=10992-11000&author=S.+J.+Isakoffauthor=J.+A.+Engelmanauthor=H.+Y.+Irieauthor=J.+Luoauthor=S.+M.+Brachmannauthor=R.+V.+Pearlineauthor=L.+C.+Cantleyauthor=J.+S.+Brugge&title=Breast+Cancer-Associated+PIK3CA+Mutations+Are+Oncogenic+in+Mammary+Epithelial+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsakoff%26aufirst%3DS.%2BJ.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DIrie%26aufirst%3DH.%2BY.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DBrachmann%26aufirst%3DS.%2BM.%26aulast%3DPearline%26aufirst%3DR.%2BV.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DBrugge%26aufirst%3DJ.%2BS.%26atitle%3DBreast%2520Cancer-Associated%2520PIK3CA%2520Mutations%2520Are%2520Oncogenic%2520in%2520Mammary%2520Epithelial%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D10992%26epage%3D11000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogt, P. K.</span><span> </span><span class="NLM_article-title">Phosphatidylinositol 3-Kinase Mutations Identified in Human Cancer Are Oncogenic</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">802</span><span class="NLM_x">–</span> <span class="NLM_lpage">807</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=802-807&author=S.+Kangauthor=A.+G.+Baderauthor=P.+K.+Vogt&title=Phosphatidylinositol+3-Kinase+Mutations+Identified+in+Human+Cancer+Are+Oncogenic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DS.%26aulast%3DBader%26aufirst%3DA.%2BG.%26aulast%3DVogt%26aufirst%3DP.%2BK.%26atitle%3DPhosphatidylinositol%25203-Kinase%2520Mutations%2520Identified%2520in%2520Human%2520Cancer%2520Are%2520Oncogenic%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D802%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt-Kittler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rago, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huso, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span> </span><span class="NLM_article-title">Mutant PIK3CA Promotes Cell Growth and Invasion of Human Cancer Cells</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=561-573&author=Y.+Samuelsauthor=L.+A.+Diazauthor=O.+Schmidt-Kittlerauthor=J.+M.+Cumminsauthor=L.+DeLongauthor=I.+Cheongauthor=C.+Ragoauthor=D.+L.+Husoauthor=C.+Lengauerauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=V.+E.+Velculescu&title=Mutant+PIK3CA+Promotes+Cell+Growth+and+Invasion+of+Human+Cancer+Cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DDiaz%26aufirst%3DL.%2BA.%26aulast%3DSchmidt-Kittler%26aufirst%3DO.%26aulast%3DCummins%26aufirst%3DJ.%2BM.%26aulast%3DDeLong%26aufirst%3DL.%26aulast%3DCheong%26aufirst%3DI.%26aulast%3DRago%26aufirst%3DC.%26aulast%3DHuso%26aufirst%3DD.%2BL.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26atitle%3DMutant%2520PIK3CA%2520Promotes%2520Cell%2520Growth%2520and%2520Invasion%2520of%2520Human%2520Cancer%2520Cells%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D7%26spage%3D561%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Shayesteh, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldocchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godfrey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. W.</span><span> </span><span class="NLM_article-title">PIK3CA Is Implicated as an Oncogene in Ovarian Cancer</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1038%2F5042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=9916799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=99-102&author=L.+Shayestehauthor=Y.+Luauthor=W.+L.+Kuoauthor=R.+Baldocchiauthor=T.+Godfreyauthor=C.+Collinsauthor=D.+Pinkelauthor=B.+Powellauthor=G.+B.+Millsauthor=J.+W.+Gray&title=PIK3CA+Is+Implicated+as+an+Oncogene+in+Ovarian+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">PIK3CA is implicated as an oncogene in ovarian cancer</span></div><div class="casAuthors">Shayesteh, Laleh; Lu, Yiling; Kuo, Wen-Lin; Baldocchi, Russell; Godfrey, Tony; Collins, Colin; Pinkel, Daniel; Powell, Bethan; Mills, Gordon B.; Gray, Joe W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-102</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Ovarian cancer is the leading cause of death from gynecol. malignancy and the 4th leading cause of cancer death among American women, yet little is known about its mol. etiol.  Studies using comparative genomic hybridization (CGH) have revealed several regions of recurrent, abnormal, DNA sequence copy no. that may encode genes involved in the genesis or progression of the disease.  A region at 3q26 was increased in copy no. in 40% of ovarian and other cancers contains PIK3CA, which encodes the p110α catalytic subunit of phosphatidylinositol 3-kinase (PI3-kinase).  The assocn. between PIK3CA copy no. and PI3-kinase activity makes PIK3CA a candidate oncogene because a broad range of cancer-related functions were assocd. with PI3-kinase mediated signalling.  These include proliferation, glucose transport and catabolism, cell adhesion, apoptosis, RAS signalling6 and oncogenic transformation.  Downstream effectors of PI3-kinase, AKT1 and AKT2, were amplified or activated in human tumors, including ovarian cancer.  We show that PIK3CA is frequently increased in copy no. in ovarian cancers, that the increased copy no. is assocd. with increased PIK3CA transcription, p110α protein expression, and PI3-kinase activity and that treatment with the PI3-kinase inhibitor LY294002 decreases proliferation and increases apoptosis.  These observations suggest PIK3CA is an oncogene that has an important role in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYnLbYYzMTtrVg90H21EOLACvtfcHk0lgPsZ3oHYIKwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltlWjtw%253D%253D&md5=e46ad55fb14c5465bf7ce86fb5a9cca0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2F5042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F5042%26sid%3Dliteratum%253Aachs%26aulast%3DShayesteh%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DKuo%26aufirst%3DW.%2BL.%26aulast%3DBaldocchi%26aufirst%3DR.%26aulast%3DGodfrey%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DC.%26aulast%3DPinkel%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26atitle%3DPIK3CA%2520Is%2520Implicated%2520as%2520an%2520Oncogene%2520in%2520Ovarian%2520Cancer%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D21%26spage%3D99%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Borlado, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redondo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Criado, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcos, M. A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-A, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balomenos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrera, A. C.</span><span> </span><span class="NLM_article-title">Increased Phosphoinositide 3-Kinase Activity Induces a Lymphoproliferative Disorder and Contributes to Tumor Generation In Vivo</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">895</span><span class="NLM_x">–</span> <span class="NLM_lpage">903</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=895-903&author=L.+R.+Borladoauthor=C.+Redondoauthor=B.+Alvarezauthor=C.+Jimenezauthor=L.+M.+Criadoauthor=J.+Floresauthor=M.+A.+R.+Marcosauthor=C.+Martinez-Aauthor=D.+Balomenosauthor=A.+C.+Carrera&title=Increased+Phosphoinositide+3-Kinase+Activity+Induces+a+Lymphoproliferative+Disorder+and+Contributes+to+Tumor+Generation+In+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorlado%26aufirst%3DL.%2BR.%26aulast%3DRedondo%26aufirst%3DC.%26aulast%3DAlvarez%26aufirst%3DB.%26aulast%3DJimenez%26aufirst%3DC.%26aulast%3DCriado%26aufirst%3DL.%2BM.%26aulast%3DFlores%26aufirst%3DJ.%26aulast%3DMarcos%26aufirst%3DM.%2BA.%2BR.%26aulast%3DMartinez-A%26aufirst%3DC.%26aulast%3DBalomenos%26aufirst%3DD.%26aulast%3DCarrera%26aufirst%3DA.%2BC.%26atitle%3DIncreased%2520Phosphoinositide%25203-Kinase%2520Activity%2520Induces%2520a%2520Lymphoproliferative%2520Disorder%2520and%2520Contributes%2520to%2520Tumor%2520Generation%2520In%2520Vivo%26jtitle%3DFASEB%2520J.%26date%3D2000%26volume%3D14%26spage%3D895%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ma, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lung, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whang-Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, C. Y.</span><span> </span><span class="NLM_article-title">PIK3CA as an Oncogene in Cervical Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2739</span><span class="NLM_x">–</span> <span class="NLM_lpage">2744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=2739-2744&author=Y.+T.+Maauthor=S.+J.+Weiauthor=Y.+C.+Linauthor=J.+C.+Lungauthor=T.+C.+Changauthor=J.+Whang-Pengauthor=J.+M.+Liuauthor=D.+M.+Yangauthor=W.+K.+Yangauthor=C.+Y.+Shen&title=PIK3CA+as+an+Oncogene+in+Cervical+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%2BT.%26aulast%3DWei%26aufirst%3DS.%2BJ.%26aulast%3DLin%26aufirst%3DY.%2BC.%26aulast%3DLung%26aufirst%3DJ.%2BC.%26aulast%3DChang%26aufirst%3DT.%2BC.%26aulast%3DWhang-Peng%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%2BM.%26aulast%3DYang%26aufirst%3DD.%2BM.%26aulast%3DYang%26aufirst%3DW.%2BK.%26aulast%3DShen%26aufirst%3DC.%2BY.%26atitle%3DPIK3CA%2520as%2520an%2520Oncogene%2520in%2520Cervical%2520Cancer%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D2739%26epage%3D2744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Trotman, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotan, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koutcher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cristofano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khoo, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy-Burman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenbert, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyke, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordon-Cardo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span> </span><span class="NLM_article-title">PTEN Dose Dictates Cancer Progression in the Prostate</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">396</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=385-396&issue=3&author=L.+C.+Trotmanauthor=M.+Nikiauthor=Z.+A.+Dotanauthor=J.+A.+Koutcherauthor=A.+Di+Cristofanoauthor=A.+Xiaoauthor=A.+S.+Khooauthor=P.+Roy-Burmanauthor=N.+M.+Greenbertauthor=T.+V.+Dykeauthor=C.+Cordon-Cardoauthor=P.+P.+Pandolfi&title=PTEN+Dose+Dictates+Cancer+Progression+in+the+Prostate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrotman%26aufirst%3DL.%2BC.%26aulast%3DNiki%26aufirst%3DM.%26aulast%3DDotan%26aufirst%3DZ.%2BA.%26aulast%3DKoutcher%26aufirst%3DJ.%2BA.%26aulast%3DDi%2BCristofano%26aufirst%3DA.%26aulast%3DXiao%26aufirst%3DA.%26aulast%3DKhoo%26aufirst%3DA.%2BS.%26aulast%3DRoy-Burman%26aufirst%3DP.%26aulast%3DGreenbert%26aufirst%3DN.%2BM.%26aulast%3DDyke%26aufirst%3DT.%2BV.%26aulast%3DCordon-Cardo%26aufirst%3DC.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26atitle%3DPTEN%2520Dose%2520Dictates%2520Cancer%2520Progression%2520in%2520the%2520Prostate%26jtitle%3DPLoS%2520Biol.%26date%3D2003%26volume%3D1%26issue%3D3%26spage%3D385%26epage%3D396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Leslie, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downes, C. P.</span><span> </span><span class="NLM_article-title">PTEN Function: How Normal Cells Control It and Tumour Cells Lose It</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">382</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2004&pages=1-11&author=N.+R.+Leslieauthor=C.+P.+Downes&title=PTEN+Function%3A+How+Normal+Cells+Control+It+and+Tumour+Cells+Lose+It"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeslie%26aufirst%3DN.%2BR.%26aulast%3DDownes%26aufirst%3DC.%2BP.%26atitle%3DPTEN%2520Function%253A%2520How%2520Normal%2520Cells%2520Control%2520It%2520and%2520Tumour%2520Cells%2520Lose%2520It%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D382%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Parsons, R.</span><span> </span><span class="NLM_article-title">Human Cancer, PTEN, and the PI-3 Kinase Pathway</span> <span class="citation_source-journal">Semin. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=171-176&author=R.+Parsons&title=Human+Cancer%2C+PTEN%2C+and+the+PI-3+Kinase+Pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DR.%26atitle%3DHuman%2520Cancer%252C%2520PTEN%252C%2520and%2520the%2520PI-3%2520Kinase%2520Pathway%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2004%26volume%3D15%26spage%3D171%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Cully, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Beyond PTEN Mutations: The PI3K Pathway as an Integrator of Multiple Inputs During Tumorigenesis</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1038%2Fnrc1819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=16453012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslelt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=184-192&author=M.+Cullyauthor=H.+Youauthor=A.+J.+Levineauthor=T.+W.+Mak&title=Beyond+PTEN+Mutations%3A+The+PI3K+Pathway+as+an+Integrator+of+Multiple+Inputs+During+Tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis</span></div><div class="casAuthors">Cully, Megan; You, Han; Levine, Arnold J.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">184-192</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  The tumor-suppressor phosphatase with tensin homol. (PTEN) is the most important neg. regulator of the cell-survival signaling pathway initiated by phosphatidylinositol 3-kinase (PI3K).  Although PTEN is mutated or deleted in many tumors, deregulation of the PI3K-PTEN network also occurs through other mechanisms.  Crosstalk between the PI3K pathways and other tumorigenic signaling pathways, such as those that involve Ras, p53, TOR (target of rapamycin) or DJ1, can contribute to this deregulation.  How does the PI3K pathway integrate signals from numerous sources, and how can this information be used in the rational design of cancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7UxMKOlX7X7Vg90H21EOLACvtfcHk0ljht3WzMv3j9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslelt78%253D&md5=8769e7e349cc58f5c618cdce886186d2</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrc1819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1819%26sid%3Dliteratum%253Aachs%26aulast%3DCully%26aufirst%3DM.%26aulast%3DYou%26aufirst%3DH.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DBeyond%2520PTEN%2520Mutations%253A%2520The%2520PI3K%2520Pathway%2520as%2520an%2520Integrator%2520of%2520Multiple%2520Inputs%2520During%2520Tumorigenesis%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D184%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the Role of mTOR in Cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+Role+of+mTOR+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520Role%2520of%2520mTOR%2520in%2520Cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Karakas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachman, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B. H.</span><span> </span><span class="NLM_article-title">Mutation of the PIK3CA Oncogene in Human Cancers</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1038%2Fsj.bjc.6602970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=16449998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhs1ers70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2006&pages=455-459&author=B.+Karakasauthor=K.+E.+Bachmanauthor=B.+H.+Park&title=Mutation+of+the+PIK3CA+Oncogene+in+Human+Cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Mutation of the PIK3CA oncogene in human cancers</span></div><div class="casAuthors">Karakas, B.; Bachman, K. E.; Park, B. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">455-459</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  It is now well established that cancer is a genetic disease and that somatic mutations of oncogenes and tumor suppressor genes are the initiators of the carcinogenic process.  The phosphatidylinositol 3-kinase signaling pathway has previously been implicated in tumorigenesis, and evidence over the past year suggests a pivotal role for the phosphatidylinositol 3-kinase catalytic subunit, PIK3CA, in human cancers.  In this review, we analyze recent reports describing PIK3CA mutations in a variety of human malignancies, and discuss their possible implications for diagnosis and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3GosToKQSIbVg90H21EOLACvtfcHk0ljht3WzMv3j9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhs1ers70%253D&md5=c109aaf6e660f6299d4db185be8a97ea</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6602970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6602970%26sid%3Dliteratum%253Aachs%26aulast%3DKarakas%26aufirst%3DB.%26aulast%3DBachman%26aufirst%3DK.%2BE.%26aulast%3DPark%26aufirst%3DB.%2BH.%26atitle%3DMutation%2520of%2520the%2520PIK3CA%2520Oncogene%2520in%2520Human%2520Cancers%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2006%26volume%3D94%26spage%3D455%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Vogt, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsliger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gymnopoulos, M.</span><span> </span><span class="NLM_article-title">Cancer-Specific Mutations in Phosphatidylinositol 3-Kinase</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=342-349&author=P.+K.+Vogtauthor=S.+Kangauthor=M.+A.+Elsligerauthor=M.+Gymnopoulos&title=Cancer-Specific+Mutations+in+Phosphatidylinositol+3-Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVogt%26aufirst%3DP.%2BK.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DElsliger%26aufirst%3DM.%2BA.%26aulast%3DGymnopoulos%26aufirst%3DM.%26atitle%3DCancer-Specific%2520Mutations%2520in%2520Phosphatidylinositol%25203-Kinase%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2007%26volume%3D32%26spage%3D342%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Yap, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Targeting the PI3K-AKT-mTOR Pathway: Progress, Pitfalls, and Promises</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1016%2Fj.coph.2008.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=18721898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=393-412&author=T.+A.+Yapauthor=M.+D.+Garrettauthor=M.+I.+Waltonauthor=F.+Raynaudauthor=J.+S.+De+Bonoauthor=P.+Workman&title=Targeting+the+PI3K-AKT-mTOR+Pathway%3A+Progress%2C+Pitfalls%2C+and+Promises"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises</span></div><div class="casAuthors">Yap, Timothy A.; Garrett, Michelle D.; Walton, Mike I.; Raynaud, Florence; de Bono, Johann S.; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">393-412</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The strategy of drugging the cancer kinome' has led to the successful development and regulatory approval of several novel mol. targeted agents.  The spotlight is now shifting to the phosphatidylinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway as a key potential target.  This review details the role of the pathway in oncogenesis and the rationale for inhibiting its vital components.  The focus will be on the progress made in the development of novel therapies for cancer treatment, with emphasis placed on agents that have entered clin. development.  Strategies involving horizontal and vertical blockade of the pathway, as well as the use of biomarkers to select appropriate patients and to provide proof of target modulation will also be highlighted.  Finally, we discuss the issues and limitations involved with targeting the PI3K-AKT-mTOR pathway, and predict what the future may hold for these novel anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnmwezNSKUfbVg90H21EOLACvtfcHk0ljht3WzMv3j9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCktL7E&md5=b6a4f3c01a6776977d61cde8222d7201</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DYap%26aufirst%3DT.%2BA.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DWalton%26aufirst%3DM.%2BI.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DDe%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520PI3K-AKT-mTOR%2520Pathway%253A%2520Progress%252C%2520Pitfalls%252C%2520and%2520Promises%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D393%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Kong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">Advances in Development of Phosphatidylinositol 3-Kinase Inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2839</span><span class="NLM_x">–</span> <span class="NLM_lpage">2854</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.2174%2F092986709788803222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=19689267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvVynt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=2839-2854&author=D.+Kongauthor=T.+Yamori&title=Advances+in+Development+of+Phosphatidylinositol+3-Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in development of phosphatidylinositol 3-kinase inhibitors</span></div><div class="casAuthors">Kong, Dexin; Yamori, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2839-2854</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Phosphatidylinositol 3-kinases (P13Ks) are a class of lipid kinases that phosphorylate phosphatidylinositol 4,5-bisphosphate (PIP2) at the 3-OH of the inositol ring to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3), which in turn activates Akt and the downstream effectors like mTOR, and therefore play important roles in cell growth, survival, etc.  The phosphatase and tensin homolog deleted in chromosome ten (PTEN), acts as the catalytic antagonist of PI3K by dephosphorylating PIP3 to PIP2.  PI3K has become an important drug target for cancer therapy, since gain-of-function mutations of PIK3CA encoding PI3Kα, as well as loss-of-function mutations of PTEN, have been frequently found in human cancers.  The pharmaceutical development of PI3K inhibitors has made a great leap forward during the last 3 years.  While PI3Kβ, δ and γ isoform-specific PI3K inhibitors (TGX-221, IC87114 and AS-605240) have been developed for therapy of coronary heart disease, asthma, and glomerulonephritis, resp., a promising PI3Kα specific inhibitor is not yet available.  Correspondingly, almost all of the promising PI3K inhibitors under development for cancer therapy, such as NVP-BEZ235, GDC-0941 and ZSTK474, are pan-PI3K isoform inhibitors.  Each of these pan-PI3K inhibitors seems to induce a common G1 phase arrest.  All have shown favorable in vivo anticancer efficacies and low toxicities, and therefore most have entered evaluation in clin. trials.  P-Akt and p-S6 have been reported to be feasible pharmacodynamic biomarkers for monitoring the efficacy of these agents.  In the process of discovery of these and other PI3K inhibitors, detailed structure-activity relation studies were carried out.  This review summarizes key advances in the development of PI3K inhibitors, which is preceded by an introduction of PI3K family and their functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo34auL80q6urVg90H21EOLACvtfcHk0lgimMfpVdAyIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvVynt7c%253D&md5=7bcedc62a6b1a0b570143d49ba861fee</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F092986709788803222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709788803222%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DD.%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DAdvances%2520in%2520Development%2520of%2520Phosphatidylinositol%25203-Kinase%2520Inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26spage%3D2839%26epage%3D2854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Fan, Q. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mostov, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span> </span><span class="NLM_article-title">A Dual PI3 Kinase/mTOR Inhibitor Reveals Emergent Efficacy in Glioma</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=341-349&author=Q.+W.+Fanauthor=Z.+A.+Knightauthor=D.+D.+Goldenbergauthor=W.+Yuauthor=K.+E.+Mostovauthor=D.+Stokoeauthor=K.+M.+Shokatauthor=W.+A.+Weiss&title=A+Dual+PI3+Kinase%2FmTOR+Inhibitor+Reveals+Emergent+Efficacy+in+Glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DQ.%2BW.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DMostov%26aufirst%3DK.%2BE.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26atitle%3DA%2520Dual%2520PI3%2520Kinase%252FmTOR%2520Inhibitor%2520Reveals%2520Emergent%2520Efficacy%2520in%2520Glioma%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26spage%3D341%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Ihle, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powis, G.</span><span> </span><span class="NLM_article-title">Inhibitors of Phosphatidylinositol-3-kinase in Cancer Therapy</span> <span class="citation_source-journal">Mol. Aspects. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1016%2Fj.mam.2010.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=20176047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFGqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=135-144&author=N.+T.+Ihleauthor=G.+Powis&title=Inhibitors+of+Phosphatidylinositol-3-kinase+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of phosphatidylinositol-3-kinase in cancer therapy</span></div><div class="casAuthors">Ihle, Nathan T.; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-144</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The phosphatidylinositol-3-kinase (PI3K) signaling pathway is implicated in multiple aspects of tumorigenesis and tumor maintenance, and recent years have seen significant efforts towards developing agents to inhibit the pathway.  However, the development of such agents raises issues such as what specific member or members in the PI3K family should be inhibited to achieve maximal therapeutic benefit, and can specific inhibitors be developed with the necessary pharmacol. properties to allow them to proceed to clin. trials.  The no. of PI3K inhibitors has gone from a handful of archetypal inhibitors which largely detd. how the pathway was initially defined through their inhibition of PI3K, but also due to their off target properties, to a much larger no. of inhibitors of not only PI3K but also other members of the PI3K family.  The question remains to be answered whether greater therapeutic efficacy will be obtained through the use of inhibitors with increased specificity, or through inhibitors that target a spectrum of targets within the pathway.  This review will cover the development of agents targeting the pathway, and will discuss current issues surrounding the development of such agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Qmn3244-87Vg90H21EOLACvtfcHk0lgimMfpVdAyIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFGqurg%253D&md5=f32d46e1b410ba190d393553a088468b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2010.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2010.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DIhle%26aufirst%3DN.%2BT.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DInhibitors%2520of%2520Phosphatidylinositol-3-kinase%2520in%2520Cancer%2520Therapy%26jtitle%3DMol.%2520Aspects.%2520Med.%26date%3D2010%26volume%3D31%26spage%3D135%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhari, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donatelli, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luengo, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newlander, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgers, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarpong, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Aller, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkins, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garver, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gontarek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kershner, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raha, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherk, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegrzyn, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span> </span><span class="NLM_article-title">Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml900028r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=39-43&author=S.+D.+Knightauthor=N.+D.+Adamsauthor=J.+L.+Burgessauthor=A.+M.+Chaudhariauthor=M.+G.+Darcyauthor=C.+A.+Donatelliauthor=J.+I.+Luengoauthor=K.+A.+Newlanderauthor=C.+A.+Parrishauthor=L.+H.+Ridgersauthor=M.+A.+Sarpongauthor=S.+J.+Schmidtauthor=G.+S.+Van+Allerauthor=J.+D.+Carsonauthor=M.+A.+Diamondauthor=P.+A.+Elkinsauthor=C.+M.+Gardinerauthor=E.+Garverauthor=S.+A.+Gilbertauthor=R.+R.+Gontarekauthor=J.+R.+Jacksonauthor=K.+L.+Kershnerauthor=L.+Luoauthor=K.+Rahaauthor=C.+S.+Sherkauthor=C.+M.+Sungauthor=D.+Suttonauthor=P.+J.+Tumminoauthor=R.+J.+Wegrzynauthor=K.+R.+Augerauthor=D.+Dhanak&title=Discovery+of+GSK2126458%2C+a+Highly+Potent+Inhibitor+of+PI3K+and+the+Mammalian+Target+of+Rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin</span></div><div class="casAuthors">Knight, Steven D.; Adams, Nicholas D.; Burgess, Joelle L.; Chaudhari, Amita M.; Darcy, Michael G.; Donatelli, Carla A.; Luengo, Juan I.; Newlander, Ken A.; Parrish, Cynthia A.; Ridgers, Lance H.; Sarpong, Martha A.; Schmidt, Stanley J.; Van Aller, Glenn S.; Carson, Jeffrey D.; Diamond, Melody A.; Elkins, Patricia A.; Gardiner, Christine M.; Garver, Eric; Gilbert, Seth A.; Gontarek, Richard R.; Jackson, Jeffrey R.; Kershner, Kevin L.; Luo, Lusong; Raha, Kaushik; Sherk, Christian S.; Sung, Chiu-Mei; Sutton, David; Tummino, Peter J.; Wegrzyn, Ronald J.; Auger, Kurt R.; Dhanak, Dashyant</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-43</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinase α (PI3Kα) is a crit. regulator of cell growth and transformation, and its signaling pathway is the most commonly mutated pathway in human cancers.  The mammalian target of rapamycin (mTOR), a class IV PI3K protein kinase, is also a central regulator of cell growth, and mTOR inhibitors are believed to augment the antiproliferative efficacy of PI3K/AKT pathway inhibition. 2,4-Difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide (GSK2126458, 1 (I)) has been identified as a highly potent, orally bioavailable inhibitor of PI3Kα and mTOR with in vivo activity in both pharmacodynamic and tumor growth efficacy models.  Compd. 1 is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBH6_ywCnjCrVg90H21EOLACvtfcHk0lgimMfpVdAyIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvF2qtw%253D%253D&md5=72fcca85702dba95529ac03281e0bdbc</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fml900028r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml900028r%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DAdams%26aufirst%3DN.%2BD.%26aulast%3DBurgess%26aufirst%3DJ.%2BL.%26aulast%3DChaudhari%26aufirst%3DA.%2BM.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DDonatelli%26aufirst%3DC.%2BA.%26aulast%3DLuengo%26aufirst%3DJ.%2BI.%26aulast%3DNewlander%26aufirst%3DK.%2BA.%26aulast%3DParrish%26aufirst%3DC.%2BA.%26aulast%3DRidgers%26aufirst%3DL.%2BH.%26aulast%3DSarpong%26aufirst%3DM.%2BA.%26aulast%3DSchmidt%26aufirst%3DS.%2BJ.%26aulast%3DVan%2BAller%26aufirst%3DG.%2BS.%26aulast%3DCarson%26aufirst%3DJ.%2BD.%26aulast%3DDiamond%26aufirst%3DM.%2BA.%26aulast%3DElkins%26aufirst%3DP.%2BA.%26aulast%3DGardiner%26aufirst%3DC.%2BM.%26aulast%3DGarver%26aufirst%3DE.%26aulast%3DGilbert%26aufirst%3DS.%2BA.%26aulast%3DGontarek%26aufirst%3DR.%2BR.%26aulast%3DJackson%26aufirst%3DJ.%2BR.%26aulast%3DKershner%26aufirst%3DK.%2BL.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DRaha%26aufirst%3DK.%26aulast%3DSherk%26aufirst%3DC.%2BS.%26aulast%3DSung%26aufirst%3DC.%2BM.%26aulast%3DSutton%26aufirst%3DD.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DWegrzyn%26aufirst%3DR.%2BJ.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DDhanak%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520GSK2126458%252C%2520a%2520Highly%2520Potent%2520Inhibitor%2520of%2520PI3K%2520and%2520the%2520Mammalian%2520Target%2520of%2520Rapamycin%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D39%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunder, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stokoe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">A Pharmacological Map of the PI3-K Family Defines a Role of p110α in Insulin Signaling</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">747</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2006&pages=733-747&author=Z.+A.+Knightauthor=B.+Gonzalezauthor=M.+E.+Feldmanauthor=E.+R.+Zunderauthor=D.+D.+Goldenbergauthor=O.+Williamsauthor=R.+Loewithauthor=D.+Stokoeauthor=A.+Ballaauthor=B.+Tothauthor=T.+Ballaauthor=W.+A.+Weissauthor=R.+L.+Williamsauthor=K.+M.+Shokat&title=A+Pharmacological+Map+of+the+PI3-K+Family+Defines+a+Role+of+p110%CE%B1+in+Insulin+Signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DGonzalez%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DZunder%26aufirst%3DE.%2BR.%26aulast%3DGoldenberg%26aufirst%3DD.%2BD.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBalla%26aufirst%3DA.%26aulast%3DToth%26aufirst%3DB.%26aulast%3DBalla%26aufirst%3DT.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DA%2520Pharmacological%2520Map%2520of%2520the%2520PI3-K%2520Family%2520Defines%2520a%2520Role%2520of%2520p110%25CE%25B1%2520in%2520Insulin%2520Signaling%26jtitle%3DCell%26date%3D2006%26volume%3D125%26spage%3D733%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><div class="note"><p class="first last">At the time of these studies, the X-ray crystal structure of PI3Kα had yet to be realized, though it has since been reported: </p></div><span class="NLM_contrib-group">Huang, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt-Kittler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabelli, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amzel, M.</span><span> </span><span class="NLM_article-title">The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">1744</span><span class="NLM_x">–</span> <span class="NLM_lpage">1748</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2007&pages=1744-1748&author=C.+H.+Huangauthor=D.+Mandelkerauthor=O.+Schmidt-Kittlerauthor=Y.+Samuelsauthor=V.+E.+Velculescuauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=S.+B.+Gabelliauthor=M.+Amzel&title=The+Structure+of+a+Human+p110%CE%B1%2Fp85%CE%B1+Complex+Elucidates+the+Effects+of+Oncogenic+PI3K%CE%B1+Mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%2BH.%26aulast%3DMandelker%26aufirst%3DD.%26aulast%3DSchmidt-Kittler%26aufirst%3DO.%26aulast%3DSamuels%26aufirst%3DY.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DGabelli%26aufirst%3DS.%2BB.%26aulast%3DAmzel%26aufirst%3DM.%26atitle%3DThe%2520Structure%2520of%2520a%2520Human%2520p110%25CE%25B1%252Fp85%25CE%25B1%2520Complex%2520Elucidates%2520the%2520Effects%2520of%2520Oncogenic%2520PI3K%25CE%25B1%2520Mutations%26jtitle%3DScience%26date%3D2007%26volume%3D318%26spage%3D1744%26epage%3D1748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Recent Advances in the Cross-Coupling Reactions of Organoboron Derivatives with Organic Electrophiles, 1995−1998</span> <span class="citation_source-journal">J. Organomet. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">576</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><div class="note"><p class="first last"> and references therein</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1016%2FS0022-328X%2898%2901055-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADyaK1MXivFOlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=576&publication_year=1999&pages=147-168&author=A.+Suzuki&title=Recent+Advances+in+the+Cross-Coupling+Reactions+of+Organoboron+Derivatives+with+Organic+Electrophiles%2C+1995%E2%88%921998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the cross-coupling reactions of organoboron derivatives with organic electrophiles, 1995-1998</span></div><div class="casAuthors">Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">576</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">147-168</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">The Pd-catalyzed cross-coupling reaction between organoboron compds. and org. halides or triflates provides a powerful and general methodol. for the formation of C-C bonds.  Recently, this reaction was called the Suzuki coupling, Suzuki reaction, or Suzuki-Miyaura coupling, although the authors never referred to it as such previously.  In this review, this name will be used with hesitation, simply to express the coupling reaction.  The availability of the reagents and the mild reaction conditions all contribute to the versatility of this reaction.  The coupling reaction offers several addnl. advantages, such as being largely unaffected by the presence of H2O, tolerating a broad range of functional groups, and proceeding generally regio- and stereoselectively.  Also, the inorg. byproduct of the reaction is nontoxic and easily removed from the reaction mixt. thereby making the Suzuki coupling suitable not only for labs. but also for industrial processes.  The authors published previously a comprehensive review of the reaction which covered mainly the refs. until the end of 1994.  Thereafter, a large no. of papers related to the coupling reaction are reported.  Consequently, such new results presented from 1995 to May 1998 are summarized in this review, with 139 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooCbrdm1cvkLVg90H21EOLACvtfcHk0liJAOt7ivurJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFOlsr0%253D&md5=be2fdd114211afa4abdf106008dd9845</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0022-328X%2898%2901055-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-328X%252898%252901055-9%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DRecent%2520Advances%2520in%2520the%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Derivatives%2520with%2520Organic%2520Electrophiles%252C%25201995%25E2%2588%25921998%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D1999%26volume%3D576%26spage%3D147%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Molander, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biolatto, B.</span><span> </span><span class="NLM_article-title">Efficient Ligandless Palladium-Catalyzed Suzuki Reactions of Potassium Aryltrifluoroborates</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1867</span><span class="NLM_x">–</span> <span class="NLM_lpage">1870</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol025845p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=1867-1870&issue=11&author=G.+A.+Molanderauthor=B.+Biolatto&title=Efficient+Ligandless+Palladium-Catalyzed+Suzuki+Reactions+of+Potassium+Aryltrifluoroborates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fol025845p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol025845p%26sid%3Dliteratum%253Aachs%26aulast%3DMolander%26aufirst%3DG.%2BA.%26aulast%3DBiolatto%26aufirst%3DB.%26atitle%3DEfficient%2520Ligandless%2520Palladium-Catalyzed%2520Suzuki%2520Reactions%2520of%2520Potassium%2520Aryltrifluoroborates%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26issue%3D11%26spage%3D1867%26epage%3D1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Molander, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biolatto, B.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Suzuki−Miyaura Cross-Coupling Reactions of Potassium Aryl- and Heteroaryltrifluoroborates</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">4302</span><span class="NLM_x">–</span> <span class="NLM_lpage">4314</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0342368" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=4302-4314&issue=11&author=G.+A.+Molanderauthor=B.+Biolatto&title=Palladium-Catalyzed+Suzuki%E2%88%92Miyaura+Cross-Coupling+Reactions+of+Potassium+Aryl-+and+Heteroaryltrifluoroborates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo0342368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0342368%26sid%3Dliteratum%253Aachs%26aulast%3DMolander%26aufirst%3DG.%2BA.%26aulast%3DBiolatto%26aufirst%3DB.%26atitle%3DPalladium-Catalyzed%2520Suzuki%25E2%2588%2592Miyaura%2520Cross-Coupling%2520Reactions%2520of%2520Potassium%2520Aryl-%2520and%2520Heteroaryltrifluoroborates%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26issue%3D11%26spage%3D4302%26epage%3D4314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Darses, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genet, J. P.</span><span> </span><span class="NLM_article-title">Potassium Organotrifluoroborates: New Perspectives in Organic Synthesis</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">288</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr0509758" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCrsLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=288-325&author=S.+Darsesauthor=J.+P.+Genet&title=Potassium+Organotrifluoroborates%3A+New+Perspectives+in+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Potassium Organotrifluoroborates: New Perspectives in Organic Synthesis</span></div><div class="casAuthors">Darses, Sylvain; Genet, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">288-325</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The purpose of this article is to present an exhaustive review on potassium organotrifluoroborates in org. synthesis.  Prepn. of these boron ate complexes are included.  Interest in the compds. is certainly due to the exceptional stability of these boron ate complexes toward oxygen and moisture as compared to all other described organoboron derivs.  Another interesting aspect of organotrifluoroborate is their ease of prepn. and purifn. compared to boronic acids, and higher yields are generally achieved in their prepn.  It has also been demonstrated that contrary to trivalent organoboranes, these reagents can easily be functionalized using a great variety of reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrZcSx_cnQIrVg90H21EOLACvtfcHk0liJAOt7ivurJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCrsLnJ&md5=06b1f8556b14f8c636292c510f95805a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fcr0509758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0509758%26sid%3Dliteratum%253Aachs%26aulast%3DDarses%26aufirst%3DS.%26aulast%3DGenet%26aufirst%3DJ.%2BP.%26atitle%3DPotassium%2520Organotrifluoroborates%253A%2520New%2520Perspectives%2520in%2520Organic%2520Synthesis%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D288%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Negishi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okukado, N. J.</span><span> </span><span class="NLM_article-title">Selective Carbon−Carbon Bond Formation via Transition Metal Catalysis. 3. A Highly Selective Synthesis of Unsymmetrical Biaryls and Diarylmethanes by the Nickel- or Palladium-Catalyzed Reaction of Aryl- and Benzylzinc Derivatives with Aryl Halides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1821</span><span class="NLM_x">–</span> <span class="NLM_lpage">1823</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00430a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1977&pages=1821-1823&author=E.+Negishiauthor=A.+O.+Kingauthor=N.+J.+Okukado&title=Selective+Carbon%E2%88%92Carbon+Bond+Formation+via+Transition+Metal+Catalysis.+3.+A+Highly+Selective+Synthesis+of+Unsymmetrical+Biaryls+and+Diarylmethanes+by+the+Nickel-+or+Palladium-Catalyzed+Reaction+of+Aryl-+and+Benzylzinc+Derivatives+with+Aryl+Halides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjo00430a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00430a041%26sid%3Dliteratum%253Aachs%26aulast%3DNegishi%26aufirst%3DE.%26aulast%3DKing%26aufirst%3DA.%2BO.%26aulast%3DOkukado%26aufirst%3DN.%2BJ.%26atitle%3DSelective%2520Carbon%25E2%2588%2592Carbon%2520Bond%2520Formation%2520via%2520Transition%2520Metal%2520Catalysis.%25203.%2520A%2520Highly%2520Selective%2520Synthesis%2520of%2520Unsymmetrical%2520Biaryls%2520and%2520Diarylmethanes%2520by%2520the%2520Nickel-%2520or%2520Palladium-Catalyzed%2520Reaction%2520of%2520Aryl-%2520and%2520Benzylzinc%2520Derivatives%2520with%2520Aryl%2520Halides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1977%26volume%3D42%26spage%3D1821%26epage%3D1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><div class="note"><p class="first last">For preparation of <i>N</i>-ethyl-4-methoxybenzenesulfonamide (used to prepare <b>39</b>) and 2-fluoro-<i>N</i>-methylbenzenesulfonamide (used to prepare <b>41</b>), the following reference should be consulted:</p></div><span class="NLM_contrib-group">Booker, S. K.; D’Angelo, N. D.; D’Amico, D. C.; Kim, T. S.; Liu, L.; Meagher, K.; Norman, M. H.; Panter, K.; Schenkel, L. B.; Smith, A. L.; Tamayo, N. A.; Whittington, D. A.; Xi, N.; Yang, K.</span><span> </span><span class="NLM_article-title">Preparation of 2-Aminobenzothiazole Derivatives as Phosphoinositide 3-Kinase (PI3 Kinase) Modulators</span>. PCT Int. Appl. WO2009017822A2,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+K.+Booker&author=N.+D.+D%E2%80%99Angelo&author=D.+C.+D%E2%80%99Amico&author=T.+S.+Kim&author=L.+Liu&author=K.+Meagher&author=M.+H.+Norman&author=K.+Panter&author=L.+B.+Schenkel&author=A.+L.+Smith&author=N.+A.+Tamayo&author=D.+A.+Whittington&author=N.+Xi&author=K.+Yang&title=Preparation+of+2-Aminobenzothiazole+Derivatives+as+Phosphoinositide+3-Kinase+%28PI3+Kinase%29+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBooker%26aufirst%3DS.%2BK.%26atitle%3DPreparation%2520of%25202-Aminobenzothiazole%2520Derivatives%2520as%2520Phosphoinositide%25203-Kinase%2520%2528PI3%2520Kinase%2529%2520Modulators%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Jones, C. D.; Luke, R. W. A.; Mccoull, W.</span><span> </span><span class="NLM_article-title">Preparation of Ethynylpyrimidine Derivatives as Tie2 Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer</span>. PCT Int. Appl. WO2006103449A2,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=C.+D.+Jones&author=R.+W.+A.+Luke&author=W.+Mccoull&title=Preparation+of+Ethynylpyrimidine+Derivatives+as+Tie2+Receptor+Tyrosine+Kinase+Inhibitors+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BD.%26atitle%3DPreparation%2520of%2520Ethynylpyrimidine%2520Derivatives%2520as%2520Tie2%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Cancer%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="note"><p class="first last">An X-ray structure of 2-phenoxypyrimidine (analogous to <b>8</b>) revealed a dihedral angle of 76−79° between the two ring planes (</p></div><div class="NLM_citation" id="rightTab-cit43a"><span><span class="NLM_contrib-group">Bakhtiar, N. S.; Abdullah, Z.; Ng, S. W.</span><span> </span><span class="NLM_article-title">2-Phenoxypyrimidine</span>.  <span class="citation_source-journal">Acta Crystallogr., Sect. E</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">o114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=o114&author=N.+S.+Bakhtiar&author=Z.+Abdullah&author=S.+W.+Ng&title=2-Phenoxypyrimidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBakhtiar%26aufirst%3DN.%2BS.%26atitle%3D2-Phenoxypyrimidine%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520E%26date%3D2009%26volume%3D65%26spage%3Do114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">), while an X-ray structure of <i>N</i>-(pyrimidine-2-yl)aniline (analogous to <b>10</b>) showed a dihedral angle of 31−35° (</p></div><div class="NLM_citation" id="rightTab-cit43b"><span><span class="NLM_contrib-group">Badaruddin, E.; Bakhtiar, N. S.; Aiyub, Z.; Abdullah, Z.; Ng, S. W.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Pyrimidin-2-yl)aniline</span>.  <span class="citation_source-journal">Acta Crystallogr. Sect. E</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">o703</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=o703&author=E.+Badaruddin&author=N.+S.+Bakhtiar&author=Z.+Aiyub&author=Z.+Abdullah&author=S.+W.+Ng&title=N-%28Pyrimidin-2-yl%29aniline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBadaruddin%26aufirst%3DE.%26atitle%3DN-%2528Pyrimidin-2-yl%2529aniline%26jtitle%3DActa%2520Crystallogr.%2520Sect.%2520E%26date%3D2009%26volume%3D65%26spage%3Do703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Bengtsson, M.; Larsson, J.; Nikitidis, G.; Storm, P.; Bailey, J. P.; Griffen, E. J.; Arnould, J. C.; Bird, T. G. C.</span><span> </span><span class="NLM_article-title">5-Heteroaryl Thiazoles and Their Use as PI3K Inhibitors</span>. PCT Int. Appl. WO2006051270A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Bengtsson&author=J.+Larsson&author=G.+Nikitidis&author=P.+Storm&author=J.+P.+Bailey&author=E.+J.+Griffen&author=J.+C.+Arnould&author=T.+G.+C.+Bird&title=5-Heteroaryl+Thiazoles+and+Their+Use+as+PI3K+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBengtsson%26aufirst%3DM.%26atitle%3D5-Heteroaryl%2520Thiazoles%2520and%2520Their%2520Use%2520as%2520PI3K%2520Inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Arnould, J. C.; Foote, K. M.; Griffen, E. J.</span><span> </span><span class="NLM_article-title">Thiazole Derivates and Their Use as Anti-Tumour Agents</span>. PCT Int. Appl. WO2007129044A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+C.+Arnould&author=K.+M.+Foote&author=E.+J.+Griffen&title=Thiazole+Derivates+and+Their+Use+as+Anti-Tumour+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArnould%26aufirst%3DJ.%2BC.%26atitle%3DThiazole%2520Derivates%2520and%2520Their%2520Use%2520as%2520Anti-Tumour%2520Agents%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Cosulich, S.; Griffen, E.</span><span> </span><span class="NLM_article-title">New Thiazole Pyridine Sulfonamides as Orally Bioavailable Highly Potent PI3 Kinase Inhibitors</span>. Presented at the 2007 Keystone Symposia, Santa Fe, NM, February 15−20,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=S.+Cosulich&author=E.+Griffen&title=New+Thiazole+Pyridine+Sulfonamides+as+Orally+Bioavailable+Highly+Potent+PI3+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DCosulich%26aufirst%3DS.%26atitle%3DNew%2520Thiazole%2520Pyridine%2520Sulfonamides%2520as%2520Orally%2520Bioavailable%2520Highly%2520Potent%2520PI3%2520Kinase%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Adams, N. D.; Darcy, M. G.; Johnson, N. W.; Kasparec, J.; Knight, S. D.; Newlander, K. A.; Peng, X.; Ridgers, L. H.</span><span> </span><span class="NLM_article-title">Preparation of <i>N</i>-Pyridinyl Benzenesulfonamide Derivatives as PI3 Kinase Inhibitors</span>. PCT Int. Appl. WO2009055418A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=N.+D.+Adams&author=M.+G.+Darcy&author=N.+W.+Johnson&author=J.+Kasparec&author=S.+D.+Knight&author=K.+A.+Newlander&author=X.+Peng&author=L.+H.+Ridgers&title=Preparation+of+N-Pyridinyl+Benzenesulfonamide+Derivatives+as+PI3+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DN.%2BD.%26atitle%3DPreparation%2520of%2520N-Pyridinyl%2520Benzenesulfonamide%2520Derivatives%2520as%2520PI3%2520Kinase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="note"><p class="first last">The suboptimal hydrogen bond angles between the Lys833 amino group and the sulfonamide oxygen (129°) and nitrogen (146°) atoms are the most likely explanation for this hydrogen bond not being observed.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelias, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A Small Molecule−Kinase Interaction Map for Clinical Kinase Inhibitors</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&issue=3&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+Small+Molecule%E2%88%92Kinase+Interaction+Map+for+Clinical+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520Small%2520Molecule%25E2%2588%2592Kinase%2520Interaction%2520Map%2520for%2520Clinical%2520Kinase%2520Inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26issue%3D3%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="note"><p class="first last">A table of the studied kinases is presented in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="note"><p class="first last">Compound <b>82</b> exhibited a bioavailability of 103% when administered as a 1 mg/kg dose in 20% Captisol, 2% HPMC, and 1% Tween 80, with the compound being dissolved at a pH of 9.0, and then the pH was readjusted to 7.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="note"><p class="first last">Compound <b>73</b> was also evaluated in a a mouse liver (PD) assay, using dosages ranging from 0.01 to 0.3 mg/kg. Human HGF was injected iv 4 h postdose. The dose-response graph is included in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Ali, I. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schriml, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, M.</span><span> </span><span class="NLM_article-title">Mutational Spectra of PTEN/MMAC1 Gene: A Tumor Suppressor with Lipid Phosphatase Activity</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1922</span><span class="NLM_x">–</span> <span class="NLM_lpage">1932</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1093%2Fjnci%2F91.22.1922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=10564676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADyaK1MXotVaitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1999&pages=1922-1932&author=I.+U.+Aliauthor=L.+M.+Schrimlauthor=M.+Dean&title=Mutational+Spectra+of+PTEN%2FMMAC1+Gene%3A+A+Tumor+Suppressor+with+Lipid+Phosphatase+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity</span></div><div class="casAuthors">Ali, Iqbal Unnisa; Schriml, Lynn M.; Dean, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1922-1932</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review with 120 refs.  PTEN/MMAC1 (phosphatase, tensin homolog/mutated in multiple advanced cancers) is a tumor suppressor protein that has sequence homol. with dual-specificity phosphatases, which are capable of dephosphorylating both tyrosine phosphate and serine/threonine phosphate residues on proteins.  The in vivo function of PTEN/MMAC1 appears to be dephosphorylation of phosphotidylinositol 3,4,5-triphosphate.  The PTEN/MMAC1 gene is mutated in the germline of patients with rare autosomal dominant cancer syndromes and in subsets of specific cancers.  Here we review the mutational spectra of the PTEN/MMAC1 gene in tumors from various tissues, esp. endometrium, brain, prostate, and ovary, in which the gene is inactivated very frequently.  Germline and somatic mutations in the PTEN/MMAC1 gene occur mostly in the protein coding region and involve the phosphatase domain and poly(A)6 stretches.  Compared with germline alterations found in the PTEN/MMAC1 gene, there is a substantially increased frequency of frameshift mutations in tumors.  Glioblastomas and endometrial carcinomas appear to have distinct mutational spectra, probably reflecting differences in the underlying mechanisms of inactivation of the PTEN/MMAC1 gene in the two tissue types.  Also, depending on the tissue type, the gene appears to be involved in the initiation or the progression of cancers.  Further understanding of PTEN/MMAC1 gene mutations in different tumors and the physiol. consequences of these mutations is likely to open up new therapeutic opportunities for targeting this crit. gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox1hhrBuiMKrVg90H21EOLACvtfcHk0ljYrDB8SY774g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXotVaitr4%253D&md5=2b00e89439f512e96d9089d0f7312c28</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F91.22.1922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F91.22.1922%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DI.%2BU.%26aulast%3DSchriml%26aufirst%3DL.%2BM.%26aulast%3DDean%26aufirst%3DM.%26atitle%3DMutational%2520Spectra%2520of%2520PTEN%252FMMAC1%2520Gene%253A%2520A%2520Tumor%2520Suppressor%2520with%2520Lipid%2520Phosphatase%2520Activity%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1999%26volume%3D91%26spage%3D1922%26epage%3D1932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Eng, C.</span><span> </span><span class="NLM_article-title">PTEN: One Gene, Many Syndromes</span> <span class="citation_source-journal">Hum. Mutat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1002%2Fhumu.10257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=12938083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos12msLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=183-198&author=C.+Eng&title=PTEN%3A+One+Gene%2C+Many+Syndromes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">PTEN: one gene, many syndromes</span></div><div class="casAuthors">Eng, Charis</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">183-198</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  PTEN, on 10q23.3, encodes a major lipid phosphatase which signals down the phosphoinositol-3-kinase/Akt pathway and effects G1 cell cycle arrest and apoptosis.  Germline PTEN mutations have been found to occur in 80% of classic Cowden syndrome (CS), 60% of Bannayan-Riley-Ruvalcaba syndrome (BRRS), up to 20% of Proteus syndrome (PS), and approx. 50% of a Proteus-like syndrome (PSL).  CS is a heritable multiple hamartoma syndrome with a high risk of breast, thyroid, and endometrial carcinomas.  BRRS is a congenital autosomal dominant disorder characterized by megencephaly, developmental delay, lipomatosis, and speckled penis.  PS and PSL had never been assocd. with risk of malignancy.  Finding germline PTEN mutations in patients with BRRS, PS, and PSL suggests equiv. risks of developing malignancy as in CS with implications for medical management.  The mutational spectra of CS and BRRS overlap, with many of the mutations occurring in exons 5, 7, and 8.  Genotype-phenotype assocn. analyses have revealed that the presence of germline PTEN mutations is assocd. with breast tumor development, and that mutations occurring within and 5' of the phosphatase motif were assocd. with multi-organ involvement.  Pooled anal. of PTEN mutation series of CS and BRRS occurring in the last five years reveals that 65% of CS-assocd. mutations occur in the first five exons encoding the phosphatase domain and the promoter region, while 60% of BRRS-assocd. mutations occur in the 3' four exons encoding mainly the C2 domain.  Somatic PTEN mutations occur with a wide distribution of frequencies in sporadic primary tumors, with the highest frequencies in endometrial carcinomas and glioblastoma multiform.  Several mechanisms of PTEN inactivation occur in primary malignancies derived from different tissues, but a favored mechanism appears to occur in a tissue-specific manner.  Inappropriate subcellular compartmentalization and increased/decreased proteasome degrdn. may be two novel mechanisms of PTEN inactivation.  Further functional work could reveal more effective means of mol.-directed therapy and prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVqzT_tptFgbVg90H21EOLACvtfcHk0ljYrDB8SY774g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos12msLo%253D&md5=dbc551912f25f440d46da96431ca940d</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fhumu.10257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.10257%26sid%3Dliteratum%253Aachs%26aulast%3DEng%26aufirst%3DC.%26atitle%3DPTEN%253A%2520One%2520Gene%252C%2520Many%2520Syndromes%26jtitle%3DHum.%2520Mutat.%26date%3D2003%26volume%3D22%26spage%3D183%26epage%3D198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Rodenhuis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Wetering, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mooi, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Zandwijk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, J. L.</span><span> </span><span class="NLM_article-title">Mutational Activation of the K-ras Oncogene: A Possible Pathogenetic Factor in Adenocarcinoma of the Lung</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">929</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1056%2FNEJM198710083171504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=3041218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A280%3ADyaL2szhsFarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=1987&pages=929-935&author=S.+Rodenhuisauthor=M.+L.+van+de+Weteringauthor=W.+J.+Mooiauthor=S.+G.+Eversauthor=N.+Van+Zandwijkauthor=J.+L.+Bos&title=Mutational+Activation+of+the+K-ras+Oncogene%3A+A+Possible+Pathogenetic+Factor+in+Adenocarcinoma+of+the+Lung"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung</span></div><div class="casAuthors">Rodenhuis S; van de Wetering M L; Mooi W J; Evers S G; van Zandwijk N; Bos J L</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">929-35</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">To define the role of cellular oncogenes in human cancers, we studied the prevalence of mutational activation of ras oncogenes in untreated non-small-cell lung cancer.  Genomic DNA was extracted from 39 tumor specimens obtained by thoracotomy and was examined for activating point mutations in codons 12, 13, and 61 of the H-ras, K-ras, and N-ras genes.  A novel, highly sensitive assay based on oligonucleotide hybridization following an in vitro amplification step was employed.  The K-ras gene was found to be activated by point mutations in codon 12 in 5 of 10 adenocarcinomas.  Two of these tumors were less than 2 cm in size and had not metastasized.  No ras gene mutations were observed in 15 squamous-cell carcinomas, 10 large-cell carcinomas, 1 carcinoid, 2 metastatic adenocarcinomas from primary tumors outside the lung, and 1 small-cell carcinoma.  An approximately 20-fold amplification of the unmutated K-ras gene was observed in a tumor that proved to be a solitary lung metastasis of a rectal carcinoma.  We conclude that mutational K-ras activation may be an important early event in the pathogenesis of adenocarcinoma of the lung but that amplification of ras genes or mutational activation of H-ras or N-ras does not play a major part in non-small-cell lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3KA7iei6rnOvW160gIxP_fW6udTcc2eZIS3DdiMjqerntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2szhsFarsw%253D%253D&md5=5e2688b0cb069f49f8f59ab32c8fce70</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1056%2FNEJM198710083171504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198710083171504%26sid%3Dliteratum%253Aachs%26aulast%3DRodenhuis%26aufirst%3DS.%26aulast%3Dvan%2Bde%2BWetering%26aufirst%3DM.%2BL.%26aulast%3DMooi%26aufirst%3DW.%2BJ.%26aulast%3DEvers%26aufirst%3DS.%2BG.%26aulast%3DVan%2BZandwijk%26aufirst%3DN.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26atitle%3DMutational%2520Activation%2520of%2520the%2520K-ras%2520Oncogene%253A%2520A%2520Possible%2520Pathogenetic%2520Factor%2520in%2520Adenocarcinoma%2520of%2520the%2520Lung%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1987%26volume%3D317%26spage%3D929%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Okudela, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakane, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">KeQin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, H.</span><span> </span><span class="NLM_article-title"><i>K-ras</i> Gene Mutation Enhances Motility of Immortalized Airway Cells and Lung Adenocarcinoma Cells via Akt Activation</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1016%2FS0002-9440%2810%2963100-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=14695323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVCgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2004&pages=91-100&issue=1&author=K.+Okudelaauthor=H.+Hayashiauthor=T.+Itoauthor=T.+Yazawaauthor=T.+Suzukiauthor=Y.+Nakaneauthor=H.+Satoauthor=H.+Ishiauthor=X.+KeQinauthor=A.+Masudaauthor=T.+Takahashiauthor=H.+Kitamura&title=K-ras+Gene+Mutation+Enhances+Motility+of+Immortalized+Airway+Cells+and+Lung+Adenocarcinoma+Cells+via+Akt+Activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma</span></div><div class="casAuthors">Okudela, Koji; Hayashi, Hiroyuki; Ito, Takaaki; Yazawa, Takuya; Suzuki, Takehisa; Nakane, Yuko; Sato, Hanako; Ishi, Haruhiko; KeQin, Xin; Masuda, Akira; Takahashi, Takashi; Kitamura, Hitoshi</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-100</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Point mutations of the K-ras gene, which are found in 10 to 30% of lung adenocarcinomas, are regarded as being an early event during the carcinogenesis.  Autonomous vigorous motility of neoplastic cells, as well as growth and survival advantages, are considered to be necessary for cancer development and progression.  The present study describes the contributions of the K-ras gene mutation and its downstream pathway via phosphatidylinositol 3-OH kinase (PI3K)-Akt to the cell motility in an immortalized human peripheral airway epithelial cell (HPL1D) and lung adenocarcinoma cells (A549, H820, TKB6, and TKB14).  We have also evaluated the relationship between pathol. events and the K-ras-Akt pathway using surgically resected lung tumors.  The HPL1D cells transfected with the mutated K-ras gene (HPL-V12) showed a significant increase in cell motility compared to those transfected with empty vector (HPL-E) or wild-type K-ras gene (HPL-K).  The enhanced motility in the HPL-V12 cells was markedly reduced by either treatment with inhibitors of ras, PI3K, and/or MEK, or by transfection with the dominant-neg. mutant Akt (dnAkt).  The lung adenocarcinoma cells bearing the K-ras gene mutation (A549 and H820) showed consistently higher levels of cell motilities than those without the mutation (TKB6 and TKB14), and the motility of A549 and H820 cells were significantly inhibited by dnAkt transfection.  These results suggest that the K-ras gene mutation could enhance the motility of neoplastic cells through a pathway involving PI3K-Akt.  Actually, among the surgically resected lung tumors, the adenocarcinomas with the K-ras gene mutation tended to show a higher frequency and intensity of immunoreactivity for phosphorylated Akt (p-ser473Akt) than those without the mutation, supporting the in vitro observation that the mutated K-ras can activate the PI3K-Akt pathway.  Immunoreactivity for p-ser473Akt was also seen in the pre-malignant and early lesions at a frequency similar to that in the advanced lung adenocarcinomas,.  No correlation was seen between p-ser473Akt immunoreactivity and lymphatic/organ metastasis or prognosis.  These results taken together suggest that the K-ras-Akt pathway might facilitate the motility of neoplastic cells during the early period of carcinogenesis in lung adenocarcinomas, and may contribute to their non-invasive expansion along the alveolar septa, rather than invasion or metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppxaDuQ3Y8IrVg90H21EOLACvtfcHk0liIFY6W9PHwTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVCgsg%253D%253D&md5=f439b85b4835771a0a34cce7e72b37a5</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2963100-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252963100-8%26sid%3Dliteratum%253Aachs%26aulast%3DOkudela%26aufirst%3DK.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DYazawa%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DNakane%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DIshi%26aufirst%3DH.%26aulast%3DKeQin%26aufirst%3DX.%26aulast%3DMasuda%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DKitamura%26aufirst%3DH.%26atitle%3DK-ras%2520Gene%2520Mutation%2520Enhances%2520Motility%2520of%2520Immortalized%2520Airway%2520Cells%2520and%2520Lung%2520Adenocarcinoma%2520Cells%2520via%2520Akt%2520Activation%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2004%26volume%3D164%26issue%3D1%26spage%3D91%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Velho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suriano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duval, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carneiro, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machado, J. C.</span><span> </span><span class="NLM_article-title">The Prevalence of PIK3CA Mutations in Gastric and Colon Cancer</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1649</span><span class="NLM_x">–</span> <span class="NLM_lpage">1654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=1649-1654&author=S.+Velhoauthor=C.+Oliveiraauthor=A.+Ferreiraauthor=A.+C.+Ferreiraauthor=G.+Surianoauthor=J.+Schwartzauthor=A.+Duvalauthor=F.+Carneiroauthor=J.+C.+Machado&title=The+Prevalence+of+PIK3CA+Mutations+in+Gastric+and+Colon+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVelho%26aufirst%3DS.%26aulast%3DOliveira%26aufirst%3DC.%26aulast%3DFerreira%26aufirst%3DA.%26aulast%3DFerreira%26aufirst%3DA.%2BC.%26aulast%3DSuriano%26aufirst%3DG.%26aulast%3DSchwartz%26aufirst%3DJ.%26aulast%3DDuval%26aufirst%3DA.%26aulast%3DCarneiro%26aufirst%3DF.%26aulast%3DMachado%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520Prevalence%2520of%2520PIK3CA%2520Mutations%2520in%2520Gastric%2520and%2520Colon%2520Cancer%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2005%26volume%3D41%26spage%3D1649%26epage%3D1654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Still, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, A.</span><span> </span><span class="NLM_article-title">Rapid Chromatographic Technique for Preparative Separations with Moderate Resolution</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">2923</span><span class="NLM_x">–</span> <span class="NLM_lpage">2925</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00408a041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADyaE1cXksF2hu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1978&pages=2923-2925&issue=14&author=W.+C.+Stillauthor=M.+Kahnauthor=A.+Mitra&title=Rapid+Chromatographic+Technique+for+Preparative+Separations+with+Moderate+Resolution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid chromatographic technique for preparative separations with moderate resolution</span></div><div class="casAuthors">Still, W. Clark; Kahn, Michael; Mitra, Abhijit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2923-5</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A simple adsorption chromatog. technique has been developed for rapid (<15 min) sepns.  The technique uses a short (e.g., 5 in.) column of 40-63-μm silica gel and operates at high flow rates (2.0 vertical in./min) to allow the sepn. of multigram quantities of compds. which are resolved on anal. TLC by as little as ΔRf 0.15.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCsgCIAoC4VbVg90H21EOLACvtfcHk0liIFY6W9PHwTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXksF2hu7s%253D&md5=34e721c237babee0665e2f9c6f6a3999</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjo00408a041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00408a041%26sid%3Dliteratum%253Aachs%26aulast%3DStill%26aufirst%3DW.%2BC.%26aulast%3DKahn%26aufirst%3DM.%26aulast%3DMitra%26aufirst%3DA.%26atitle%3DRapid%2520Chromatographic%2520Technique%2520for%2520Preparative%2520Separations%2520with%2520Moderate%2520Resolution%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1978%26volume%3D43%26issue%3D14%26spage%3D2923%26epage%3D2925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batty, I. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Priganica, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downes, P.</span><span> </span><span class="NLM_article-title">Nonradioactive Methods for the Assay of Phosphoinositide 3-Kinases and Phosphoinositide Phosphatases and Selective Detection of Signaling Lipids in Cell and Tissue Extracts</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2003&pages=234-245&issue=2&author=A.+Grayauthor=H.+Olssonauthor=I.+H.+Battyauthor=C.+Priganicaauthor=P.+Downes&title=Nonradioactive+Methods+for+the+Assay+of+Phosphoinositide+3-Kinases+and+Phosphoinositide+Phosphatases+and+Selective+Detection+of+Signaling+Lipids+in+Cell+and+Tissue+Extracts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGray%26aufirst%3DA.%26aulast%3DOlsson%26aufirst%3DH.%26aulast%3DBatty%26aufirst%3DI.%2BH.%26aulast%3DPriganica%26aufirst%3DC.%26aulast%3DDownes%26aufirst%3DP.%26atitle%3DNonradioactive%2520Methods%2520for%2520the%2520Assay%2520of%2520Phosphoinositide%25203-Kinases%2520and%2520Phosphoinositide%2520Phosphatases%2520and%2520Selective%2520Detection%2520of%2520Signaling%2520Lipids%2520in%2520Cell%2520and%2520Tissue%2520Extracts%26jtitle%3DAnal.%2520Biochem.%26date%3D2003%26volume%3D313%26issue%3D2%26spage%3D234%26epage%3D245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Walker, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacold, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perisic, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wymann, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. L.</span><span> </span><span class="NLM_article-title">Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">919</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1016%2FS1097-2765%2805%2900089-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=11090628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvVegurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=909-919&author=E.+H.+Walkerauthor=M.+E.+Pacoldauthor=O.+Perisicauthor=L.+Stephensauthor=P.+T.+Hawkinsauthor=M.+P.+Wymannauthor=R.+L.+Williams&title=Structural+Determinants+of+Phosphoinositide+3-Kinase+Inhibition+by+Wortmannin%2C+LY294002%2C+Quercetin%2C+Myricetin%2C+and+Staurosporine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine</span></div><div class="casAuthors">Walker, Edward H.; Pacold, Michael E.; Perisic, Olga; Stephens, Len; Hawkins, Philip T.; Wymann, Matthias P.; Williams, Roger L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">909-919</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The specific phosphoinositide 3-kinase (P13K) inhibitors wortmannin and LY294002 have been invaluable tools for elucidating the roles of these enzymes in signal transduction pathways.  The X-ray crystallog. structures of P13K bound to these lipid kinase inhibitors and to the broad-spectrum protein kinase inhibitors quercetin, myricetin, and staurosporine reveal how these compds. fit into the ATP binding pocket.  With a nanomolar IC50, wortmannin most closely fits and fills the active site and induces a conformational change in the catalytic domain.  Surprisingly, LY294002 and the lead compd. on which it was designed, quercetin, as well as the closely related flavonoid myricetin bind P13K in remarkably different orientations that are related to each other by 1800 rotations.  Staurosporine/P13K interactions are reminiscent of low-affinity protein kinase/staurosporine complexes.  These results provide a rich basis for development of isoform-specific P13K inhibitors with therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgIbTky2xQmbVg90H21EOLACvtfcHk0liIFY6W9PHwTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvVegurY%253D&md5=5dd92f9b48c437e43c0023fdff10c1ac</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2805%2900089-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252805%252900089-4%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DE.%2BH.%26aulast%3DPacold%26aufirst%3DM.%2BE.%26aulast%3DPerisic%26aufirst%3DO.%26aulast%3DStephens%26aufirst%3DL.%26aulast%3DHawkins%26aufirst%3DP.%2BT.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26atitle%3DStructural%2520Determinants%2520of%2520Phosphoinositide%25203-Kinase%2520Inhibition%2520by%2520Wortmannin%252C%2520LY294002%252C%2520Quercetin%252C%2520Myricetin%252C%2520and%2520Staurosporine%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D6%26spage%3D909%26epage%3D919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray Diffraction Data Collected in Oscillation Mode</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm1014605&amp;key=27754618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm1014605&amp;key=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=307-326&author=Z.+Otwinowskiauthor=W.+Minor&title=Processing+of+X-ray+Diffraction+Data+Collected+in+Oscillation+Mode"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Processing of x-ray diffraction data collected in oscillation mode</span></div><div class="casAuthors">Otwinowski, Zbyszek; Minor, Wladek</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part A</span>),
    <span class="NLM_cas:pages">307-326</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Macromol. crystallog. is an iterative process.  Rarely do the first crystals provide all the necessary data to solve the biol. problem being studied.  Each step benefits from experience learned in previous steps.  To monitor the progress, the HKL package provides 2 tools: (1) statistics, both weighted (χ2) and unweighted (R-merge), are provided, and the Bayesian reasoning and multicomponent error model facilitates obtaining the proper error ests. and (2) visualization of the process plays a double role by helping the operator to confirm that the process of data redn., including the resulting statistics, is correct, and allowing one to evaluate problems for which there are no good statistical criteria.  Visualization also provides confidence that the point of diminishing returns in data collection and redn. has been reached.  At that point, the effort should be directed to solving the structure.  The methods presented here have been applied to solve a large variety of problems, from inorg. mols. with 5 Å unit cell to rotavirus of 700 Å diam. crystd. in 700 × 1000 × 1400 Å cell.  Overall quality of the method was tested by many researchers by successful application of the programs to MAD structure detns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3fvBOHqhhrVg90H21EOLACvtfcHk0lj1gepFWcWH4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivFehsbw%253D&md5=c9536971d4e32cc35352c40fb9368131</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DMinor%26aufirst%3DW.%26atitle%3DProcessing%2520of%2520X-ray%2520Diffraction%2520Data%2520Collected%2520in%2520Oscillation%2520Mode%26jtitle%3DMethods%2520Enzymol.%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Navaza, J.</span><span> </span><span class="NLM_article-title">AMoRe: An Automated Package for Molecular Replacement</span> <span class="citation_source-journal">Acta Crystallogr., Sect. A: Found. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm1014605&amp;key=10.1107%2FS0108767393007597" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=157-163&author=J.+Navaza&title=AMoRe%3A+An+Automated+Package+for+Molecular+Replacement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1107%2FS0108767393007597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0108767393007597%26sid%3Dliteratum%253Aachs%26aulast%3DNavaza%26aufirst%3DJ.%26atitle%3DAMoRe%253A%2520An%2520Automated%2520Package%2520for%2520Molecular%2520Replacement%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520A%253A%2520Found.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D157%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of Macromolecular Structures by the Maximum-Likelihood Method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">Part 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&issue=Part+3&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+Macromolecular+Structures+by+the+Maximum-Likelihood+Method"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520Macromolecular%2520Structures%2520by%2520the%2520Maximum-Likelihood%2520Method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26issue%3DPart%25203%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: Model-Building Tools for Molecular Graphics</span> <span class="citation_source-journal">Acta Crystallogr. Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">Part 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2126-2132&issue=Part+1&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+Model-Building+Tools+for+Molecular+Graphics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520Model-Building%2520Tools%2520for%2520Molecular%2520Graphics%26jtitle%3DActa%2520Crystallogr.%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D12%26issue%3DPart%25201%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E8Y" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E8Y','PDB','1E8Y'); return false;">PDB: 1E8Y</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i100"><a href="/doi/suppl/10.1021/jm1014605">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_23888"></div></div></div></div></div><hr /></hr><p class="last">Synthetic methods used for analogues <b>14</b>−<b>45</b>, X-ray data for <b>1</b> and <b>82</b>, enzyme selectivity data for <b>82</b>, analytical HPLC methods, and PD data for compound <b>73</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm1014605/suppl_file/jm1014605_si_001.pdf">jm1014605_si_001.pdf (182.05 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm1014605&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-6%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm1014605%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm1014605" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a9bae0eb83d42","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
